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ABSTRACT 
Bacteriological survey of the fish pathogens in Greek mariculture between 1994- 
1997 was followed by analysis of prevalence in sea bass, sea bream, sharpsnout 
bream and common Dentex and discussion of the impact of various fish pathogens. 
In addition antibiotic resistance profiles and frequencies were studied using 
quantitative antibiogram and MIC analysis for the two most commonly used 
antibiotics Oxolinic acid and Oxytetracycline and clinically relevant MIC breakpoints 
were extrapolated for different fish species and main fish pathogens. 
The kinetics of the above antimicrobials were analysed in eight experiments where 
two fish species namely sea bass and sea bream as well as two water temperatures 
were employed. Muscle, liver, serum, skin samples were analysed by two HPLC 
methods and two bioassay methods were developed. The relative importance and 
significance of these findings was evaluated in the general context of 
pharmacokinetic studies in fish. Kinetic data were compared to clinical data and 
practical implications were evaluated. Issues like antibiotic resistance and its 
implications, the implications of residues and resistance in human health and the 
environment were analysed in order to put this study in context. Conclusions tackled 
important aspects of antimicrobial chemotherapy and future work was suggested. 
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I GENERAL INTRODUCTION 
1.1 Mediterranean mariculture industry 
Supply of Mediterranean fish species depended a few decades ago on coastal fisheries 
and traditional extensive culture in coastal lagoons. In the 70's market demand 
increased leading to extreme intensification of coastal fisheries and lagoon 
management. In the 80's the EU supported extensive research projects as well as a 
development program in order to organise Mediterranean mariculture in the prototype 
of the Japanese and European models of salmon culture. The first phase of 
development of the sector (((research phase))) started in France and Italy in 1969-1970 
and expanded to the rest of the Mediterranean in the 80's. The second phase (((pro- 
developmenb)) started in the mid '70s and finished in the first half of the 80's. During 
this period the first companies were created in France, Spain, Greece and Italy. Many 
of the sector's major problems were started at that period with strong R&D motivation 
and development of common EU fisheries policy. In the following years (1987-1993) 
large scale production (((development phase))) was initiated in Spain, France, Italy, 
Greece, Turkey, Cyprus, Malta, Tunisia, Morocco and Croatia. The last period (1993- 
1998) was a period of a new expansion of the industry (((pro-maturity phase))) with 
groups of major companies with multidisciplinary vertical structure dominating the 
market. These companies are selling know-how and investing into new areas like the 
Arabian Gulf countries (Kuwait, Saudi Arabia) or in South East Asia (Singapore and 
Indonesia). Since 1998 the industry has been facing a maturity phase with supply 
segmentation, structural inefficiencies, lack of defined image and ever drifting prices of 
the final product. 
Mediterranean mariculture in 1994 comprised of 408 production units with 60 of them 
being vertically developed with their own fry supply. In 2000, among 642 fish farms in 
the Mediterranean 41,9% were located in Greece, 27,3% in Turkey and the rest in 
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South Europe and North Africa (Figure 1). In recent years Mediterranean sea bass and 
sea bream production has increased 9 times with estimated production in 1992 at 
around 14.700 tons and 112.000 tons in 2000 (Tables 1,2). Greece is the leading 
producer in the sector with 59.000 tons in 2000 produced from 269 units and 200 
million fry. (Figure 2, Table 3) Greek production exceeds 50% of the European market 
and almost 60% of it is being exported. In the last half of the 90's the mariculture 
industry was facing many problems. Problems included marketing in new markets with 
supply segmentation and market congestion resulting in drifting prices (Figures 3& 4). 
Optimisation of production process, cost cutting management policies coupled with 
increased consumed awareness and strict monitoring on quality and safety are some of 
the sector characteristics. Great interest and effort is devoted in the Quality assurance 
protocols in order to develop products of high quality, low lipid content, and nutritional 
value lacking bacterial human pathogens, antimicrobial agents and dioxin residues in 
order to preserve the natural identity of the product that is not only required but is being 
demanded by the customer. At the same time extensive research on new species 
development is coupled with advances in diagnostic techniques and more effective 
protocols for the prevention and treatment of new pathological conditions in order to 
minimize cost of production, decrease the incidence of diseases and reduce the use of 
antibioticswhilst also ensuring fish welfare. 
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Figure 1: Distribution of Sea bass and Sea bream production units 
in Mediterranean Sea. (2000) - Total number of farms: 642. 
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Figure 2: Total production of Sea bass and Sea bream in Greece (tons) 
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Table 1: Production of Sea bass and Sea bream (tons) 
Year Greece E. U Mediterranean 
1992 6.000 12.480 14.650 
1993 9.000 17.900 21.390 
--.. -......... . 
1994 13.000 24.100 35.710 
1995 17.000 31.475 47.298 
1996 21.000 37.706 55.404 
1997 28.000 47.411 66.937 
1998 36.000 60.188 79.052 
1999 48.000 75.264 96.863 
2000 59.000 92.414 112.114 
Table 2: Production of Sea bass and Sea bream fry (millions) 
Year Greece E. U Mediterranean 
1995 95 171 184 
1996 57 201 222 
1997 100 237 318 
1998 150 331 398 
1999 165 368 451 
2000 200 404 445 
*Source: Federation of Greek Maricultures 
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Table 3: Geographical distribution of fish farms in Greece 
Evia 1 38 11 Kyklades 16 
Fthiotida 1 27 Arkadia 14 
Etoloakarnania 26 Xalkidiki 4 
Attiki 25 Lesvos 4 
Dodekanisa 22 Messinia 3 
Chios 16 Lasithi 3 
Korinthos 15 Samos 2 
Argolida 15 Magnisia 2 
Thesprotia 15 
-'; 
Kavala 2 
Cefalonia 11 Lefkada 1 
Fokida 10 Corfu I 
Prevesa 9 1 Pieria 1 
Viotia j6 Rodopi 1 
Total no. of Farms 269 
*Source: Federation of Greek Maricultures 
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Figure 3: Production and value of Sea bass 
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Figure 4: Production and value of Sea bream 
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The Federation of Greek Maricultures, the leading producer association in Greece, 
founded in 1991 and since then coordinating the development of the sector, 
sponsored this research in order to provide practical views on antibiotic application in 
Greek Mariculture. Four years of research were devoted to detailed recording of 
bacterial fish pathogen frequency and resistance to the most commonly used 
antimicrobial agents in Greek mariculture. In addition this study included research on 
the kinetics of the two most widely used antimicrobial agents in Greek mariculture 
namely Oxytetracycline and Oxolinic acid. The aim was to investigate the clinical 
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efficacy of antimicrobial chemotherapy under "commercial" conditions and to try to 
define in "realistic" terms the period of withdrawal required for fish to be able to be 
marketed safely. Environmental aspects of antimicrobial chemotherapy were also 
described as well as issues of relevance to Consumer safety in order to give a global 
insight of the application of antibiotics in Greek Mariculture. 
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1.2 Antibacterial chemotherapy 
Antimicrobial chemotherapy in aquaculture has raised considerable 
discussion and stimulated intense scientific interest. 
Figure 5.: Antibacterial Chemotherapy Considerations 
Antibacterial 
Chemotherapy 
Considerations 
Pe 
General Aspects: 
  Strategies 
  Code of Practice 
  Methods of Application 
  Agent Characteristics 
  Reasons for treatment 
Specific Aspects: 
  Palatability 
" Leaching 
  Digestibility 
" Bio-availability 
  Tissue Distribution 
" Excretion 
Fish Diseases 
Legislation   
Notifiable 
Diseases 
" MRL 
  ADI 
  Withdrawal 
period 
  Degree Day 
" Annexes 
  NOEL 
  CVMP 
Regulatory 
Framework 
Research 
Considerations 
see Figure 8 
Veterinary Medicine 
Legislation 
A great deal of basic & applied research was devoted to this field and many 
are the considerations that should be taken into account when an 
antimicrobial agent is applied in aquaculture. These considerations include 
Practical aspects, Regulatory issues and Research considerations (Figure 5). 
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1.2.1 Practical aspects 
1.2.1.1 General practical aspects 
Questions that are raised for the Practical aspects of the use of antimicrobial agents 
include, strategies for the control of bacterial infections in fish, codes of practice for the 
appropriate use of antimicrobial compounds in fish farms and methods of application of 
these agents. In order to control bacterial infections several strategies are employed. 
Eradication of the infection is not always possible or necessary. Decrease of bacterial 
numbers along with improvement of fish health status is necessary employing 
husbandry measures in order to "tip the balance" in favour of the fish when 
opportunistic bacterial pathogens cause mortalities. Reduction of stocking densities, 
handling and overfeeding reduces stress levels while avoidance of multiple hatchery 
origin of fry, testing of hatchery sources, broodstock screening, and separation of year 
classes are some of the prophylactic measures used to prevent the introduction of the 
pathogen. Adequate farm distances, fallowing of sites and reduction of cross 
contamination by equipment and personnel movements are on the other hand 
prophylactic measures to reduce the spread of bacterial pathogens. Simple 
suggestions for the appropriate use of drugs in aquaculture are presented in the 
following short and simple code of practice (Table 4): 
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Table 4.: Code of practice for the use of antimicrobial compounds in fish farms 
Restriction of the compounds to authorised Restrict the use of some compounds to 
personnel, use under professional quittance specific diseases 
Use according to the instructions Avoid the use of certain medically important 
drugs in fish 
Proper storage and use before the expiry date Rotate use of different antimicrobial 
compounds 
Storage out of the way of children, inexperienced Dispose of the unused compounds safely 
personnel, and laymen 
Allow the recommended withdrawal periods Ensure the quality of the medicated feed 
preparation 
Organise a logbook for the drugs in stock with Ensure that the farm manager keeps a data 
details for the treatments applied (cage no, logbook with mortalities, disease outbreaks, 
quantity, consumption, problems. ) diagnosis and vet prescriptions and 
comments. 
Avoid free release into the aquatic environment Organise monitoring to ensure that the 
in order to avoid development of resistant code of practice is maintained 
microflora 
The main methods of antimicrobial agent application in aquaculture along with 
basic comments on each method are presented below in Table 5. The selection of 
the antimicrobial agent is based on several necessary characteristics. The 
selected agent must be selective against the microorganism concerned, palatable 
and bio available to the fish. It should not cause toxic effects on the fish or 
exacerbate the disease but should be able to penetrate host's tissues and thereby 
reach the pathogen. It should break down easily and then be eliminated from the 
fish tissues and it should be metabolised into harmless compounds to fish and 
other marine organisms. Each antimicrobial agent should be safe for the 
consumers and even its residues should not form toxic or carcinogenic products 
during heating (cooking of contaminated flesh). In practical terms it should be 
stable under normal conditions of storage and use and should not contain harmful 
additives or impurities in the proprietary product, should be closely supervised 
during all stages of production and should be cost effective. 
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Table 5: Main methods of antimicrobial agent application in aquaculture 
Methods of Application Comments 
Oral treatment Palatable drug 
(Medicated feed) Minimal environmental risk 
Bath Soluble or adequately dispersed compound 
Lengthy exposure needed 
Disposal of dilute compound problematic 
Dip Soluble or adequately dispersed compound 
Brief immersion 
Environmental pollution considerations 
Flush Soluble or adequately dispersed compound 
Brief exposure 
Environmental pollution considerations 
Injection Feasibility only for large or valuable fish 
Anaesthesia may be required 
Slow process 
Negligible environmental risk 
Local application Feasible for treatment of ulcers on valuable pet fish 
In epidemiological terms important drugs used in human medicine should be 
avoided in fish farming to protect the strategic advantage of their application. 
These compounds should not be used if plasmid mediated resistance is known to 
occur or if they have adverse effect on the user, the natural aquatic flora and 
fauna, or land animals which may come into contact with contaminated water. 
The main reasons for treatment failures in clinical practice include possible 
selection of inappropriate antimicrobial agent (resistance), critical delay in 
diagnosis and treatment, inappropriate or variable dose rate (application, mixing) 
and uneven feeding response due to low temperature or hierarchy formation in the 
fish population. In addition palatability, stress factors, inappropriate management 
and inappropriate treatment strategy play significant roles in treatment failures. 
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Pathogen mechanisms to avoid the effect of the antimicrobial agents, reinfection 
due to mixing of year classes or populations with different epidemiological 
background, re-circulation of the effluents in hatcheries as well as cases where 
wild fish act as carriers or bacteria concealed in unusual sites like brain, necrotic 
tissues, macrophages or external surfaces make treatment very challenging and 
failure probable. 
1.2.1.2 Specific practical aspects 
The terminology of drug metabolism includes terms like palatability of the drug 
(pleasant in taste), leaching, digestibility (ability to be assimilated), absorption 
(ability to be absorbed in the gut epithelium), bioavailability (potential of achieving 
high concentration of "active" drug in the target tissues), excretion (expulsion of 
waste material as a result of metabolism) and depletion (reduction of drug 
residues in fish tissues). Palatability is affected by the antibiotic (low in OTC), by 
the method of drug administration (low at oil top coated feed) and by the species 
(sea bass: affected more than sea bream). Leaching is linked to the drug 
incorporation in the feed (high in oil top coated feed), the type of the drug (higher 
in OTC compared to OA) and it is proportionally increased with temperature. 
Digestibility is affected by the drug (lower in OTC compared to OA), it is increased 
proportionally for both antibiotics with increasing water temperature. Tissue 
distribution of the antibiotic in relation to the site of the infection is important. 
Localised infections like skin lesions as well as organised granulomas are 
regarded as difficult to treat because of the mechanical difficulties in accessing 
these tissues. Physicochemical microenvironment in the fish with factors like the 
concentration of Mg++ and Ca++, protein binding as well as water temperature exert 
an important role on the in vivo efficiency of antimicrobial agents. The 
concentration of Mg' and Ca++ in seawater reduce dramatically (>90%) the 
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biological activity of Oxytetracycline (Lunestad and Goksoyr, 1990) as well as in 
oxolinic acid and flumequine (Palmer et al., 1992; Smith et al., 1996). The 
concentration of these ions is higher in the hindgut of the marine fish by a factor 10 
to 100 (Conte, 1969). Since tetracyclines are powerful chelating agents, their 
effectiveness can be reduced or eliminated by high concentrations of divalent and 
trivalent metal ions. Protein binding in the serum reduces the "biologically 
available" drug concentration against bacterial fish pathogens. Fish are 
poikilothermic and treatments are usually applied over a wide range of water and 
host temperatures. The metabolic rate of the fish and the kinetics of the 
antimicrobial agents are highly dependent on the temperature. Bjorklund et al., 
(1992) described the effect of temperature on the metabolism of oxolinic acid in 
rainbow trout. Drug Bioavailability depends on physiological species factors and 
physiochemical drug characteristics. Physiological factors that affect bioavailability 
include body weight / age / sex, physical state, sexual maturity, blood flow, liver 
and Kidney function, stomach emptying rate, motility, pH and enzyme variations in 
gastrointestinal tract as well as circadian / diurnal rhythm and stress levels. In 
addition factors like water temperature, nutrition, drug physiochemical 
characteristics / particle size, dose, type and amount of vehicle substances, 
manufacturing method, presence of a solvate or a hydrate and solubility 
characteristics vastly affect bioavailability. Oxolinic acid bioavailability was found to 
decrease with increasing dose rates, was enhanced by particle size reduction, 
while both OA and OTC bioavailability was markedly negatively affected by the 
health status of fish. Oxolinic acid was retained at a lower concentration and for 
shorter period in the fishes acclimated to seawater. Excretion was influenced by a 
series of factors like temperature, tissue, health status, maturity and environmental 
conditions. 
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1.2.2 Fish Defence mechanisms 
Although Sea bass is known to be susceptible to stress and subsequent invasion 
from opportunistic as well as pathogenic bacteria, in recent years a series of 
studies demonstrated an array of immuno-competence mechanisms that include 
non-specific primary mechanisms like skin mucus (Soltani, 1998), antibacterial 
activity, phagocytosis (Esteban and Meseguer, 1997), macrophage activity 
(Angelidis et al., 1998), gut-associated lympoid organ activity (Abelli et al., 1997) 
and interferon-like activity (Pinto et al., 1993) as well as more specific mechanisms 
like IgM and B cells activity. (Bourmaud et al., 1992; Bakopoulos et al., 1997b; 
Coeurdacher et al., 1997; Dos Santos et al, 1997). 
1.2.3 Overview of the legislative framework 
1.2.3.1 Fish Diseases 
The European Commission has decided that after more than 10 years the 
Community's fish health legislation should be reviewed. DG SANCO, which now 
considers all veterinary issues, has invited representatives of the EU Aquaculture 
Advisory Committee to sit with representative state veterinary administrators to 
consider this. The first Community legislation concerning animal health in 
aquaculture production was adopted in 1991 (Council Directives 91/67/EEC & 
98/45/EC). Today, detailed and harmonised legislation is in place covering animal 
health aspects of aquaculture production. The legislation includes conditions 
governing the placing on the market of aquaculture animals and products, 
measures for the control of certain fish diseases (Council Directive 93/53/EC & 
Commission Decision 2001/288/EC) and of certain diseases affecting bivalve 
molluscs (Council Directive 95170/EEC & Commission Decision 2001/293/EC), 
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sampling plans and diagnostic methods for the detection and confirmation of 
certain fish diseases (Commission Decisions 2001/183/EC) and of certain mollusc 
diseases (Commission Decision 94/306/EC) (Bjomerot, 2001). 
For certain diseases listed in the legislation, several decisions for approval of 
farms and zones have been taken which protect and enhance the trade between 
disease free areas. In addition, decisions have been adopted concerning 
movements of different aquatic animal species and products within and into the 
Community (Commission Decisions 96/490/EC, 98/24/EC, 93/22/EEC, 
1999/567/EC, 93/55/EEC, 93/169/EEC, 95/352/EC) and certain protective 
measures have been taken in respect of infectious salmon anaemia (ISA) in 
salmonids in Norway and Faroe Island (Commission Decisions 1999/766/EC, 
2001/313/EC, 2000/574/EC, 2001/312/EC). Since 1998, when ISA first was 
detected within the Community, decisions have been taken to adapt the legislation 
to new situations, increase in knowledge and to give provisions to the Member 
States for combating the disease in a relevant manner (Council Directives 
2000/27/EC, 93/53/EC). Recently, decisions were adopted on 'Withdrawal" 
measures to be applied in Scotland, England and Wales in case of outbreaks of 
ISA (Commission Decisions 2001/494/EC) and a Council Decision agreed to 
include ISA for compensation to the Member States in case of outbreaks within the 
Community (Council Directive 2001/572/EC). In addition to the regular legislation 
review, an animal health and zoosanitary review of the Community legislation 
concerning aquatic animals and products has been initiated by unit E2 (Health & 
Consumer Protection Directorate) of the European Commission. It has been 
concluded that a revision is needed to take into account the developments in 
aýuaculture production, as well as the practical and scientific experiences gained 
during the last ten years. In the review process, the Member States, including well- 
reputed animal health experts within the aquatic field and the industry are 
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consulted. Although up until recently no diseases of Sea bass or Sea bream were 
listed in any of the EU lists of notifiable diseases, there is an interest on the review 
of the current legislation. Acting as FGM Fish Health Committee chairman and 
FEAP Fish Health Group Vice-chairman I participate twice a year in this review 
process as FEAP representative for the Mediterranean within the framework of the 
Advisory Committee of Fisheries and Aquaculture (ACFA) The main interest for 
Mediterranean Mariculture is to tackle issues like Marine zones allocation and 
conditions for the transport of fry in the future case of a notifiable disease adapting 
the current framework which is custornised for salmonids. The Community aquatic 
animal health legislation should be simplified and made clearer and should be as 
consistent as possible with the International Aquatic Animal Health Code and the 
Diagnostic Manual for Aquatic Animal Diseases of the International Office for 
Epizooties (OIE) (13jornerot, 2001) The fish farmer's point of view is that the 
objective of the legislation should be to facilitate free trade without the spread of 
disease. There has to be harmonisation with countries outside the Community with 
which member states trade, and the socio-economic objectives of aquaculture as a 
justifiable and sustainable method of food production must be maintained. These 
are well-established principles. Some restriction of trade is inevitable when 
diseases are controlled but this has to be as limited as possible. Controls must 
encompass the basic prevention of disease transmission, eradication and/or 
control programs, and also the trade and movement restrictions on fish, fish 
products, equipment, and possibly personnel. Where pertinent, e. g. in eradication 
programs, legislation will have to take into account any financial support be it from 
Member States, the Commission, and the insurance industry or from private 
funding. The legislation must also allow opportunities for international trading by 
allowing member states to demonstrate their disease free status. Official 
authentication by competent authorities is essential to ensure equivalence for 
exports and to facilitate trade (Aquamedia, 2002). The diseases to be regulated at 
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Community level need to be reviewed, as well as the susceptible species and 
vectors of concern. Future legislation should also consider the potential exchange 
of disease agents between farmed and wild aquatic animals and the regulations 
for fish should be separated from the ones for molluscs and crustaceans. 
Furthermore, it has been proposed that the legislation should be more flexible, 
giving provisions for urgent amendments in order to adapt the legislation to 
changed production and health conditions - including emerging diseases - and 
gained knowledge within the Member States and in other countries. Further 
proposals for major changes and issues to be carefully reviewed are: the 
requirements for National and Community reference laboratories; sampling and 
diagnostic methods; introduction of a risk based program including preventative 
measures, registration and monitoring of farms and other establishments; 
management routines for transport and waste; requirements and decentralized 
administrative procedures for approval of farms and zones, including criteria for 
zoning and movements of farmed animals and wild broodstock, control measures 
to be applied in different situations; and provisions for financial support and 
vaccination. There is also an urgent need to lay down harmonised animal health 
conditions for imports of aquatic animals and products from third countries 
(Bjornerot, 2001). 
1.2.3.2 Veterinary Medicines 
The importance of veterinary medicines in aquaculture and the increasing 
recognition of the problems of environmental interactions and impacts deriving 
from the use of such medicines led in 1992 to a conference on chemotherapy in 
aquaculture by the Office International des Epizooties (Michel and Alderman, 
1992). Applicants for licenses for veterinary medicinal products are required to 
satisfy the Licensing Authority as to safety, quality and efficacy of their product. 
The term product includes not only active ingredients but also all other 
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components such as bulking agents, solvents etc. In the case of Veterinary 
medicinal products for use in aquaculture, any environmental impact must be 
assessed in order to satisfy the safety requirements of the license. The amount of 
information needed will depend on the proposed use, route of application and the 
expected extent of usage as well as on the nature of the product itself. Several EU 
directives regulate antimicrobial agent application in aquaculture. Five main terms 
have been designed in the light of these regulations, the Maximum Residue Level 
(MRL), the No Effect Level (NOEL), the Acceptable Daily Intake (ADI), the 
Withdrawal Period and the Degree Day concept. 
Maximum residue Level (MRL) is the antimicrobial agent residue level, which if 
consumed, will not provide any risk to the health of the consumer. MRL is based 
on the "no effecV (NEL) of residue that is the highest dose level without visible or 
biochemical changes in pharmaco-toxicological testing. From the NEL, the 
acceptable daily intake (ADI) of the active substances by man is extrapolated. 
Acceptable Daily Intake (ADI) is calculated on an exaggerated daily food intake 
level (muscle 300g, liver 100g, kidney 50g, fat 50g, egg 100g, and milk 1500ml). 
MRL is calculated from the ADI with a large safety factor added (100-1000). The 
withdrawal period is the period which must elapse after the completion of a 
course of treatment of fish with a veterinary medicine before they may be 
slaughtered for human consumption. Withdrawal periods are affected by 
numerous factors that influence drug residence time in fish. The most important 
factors are water temperature, fish species, and fish tissue and drug 
characteristics. Withdrawal periods are formulated as a period of clearance while 
the level of drugs in edible tissues decrease below the MRL value for each 
antimicrobial agent. Four MRL Annexes were established by Regulation 2377/90 
EEC and the fish related products are presented in a consolidated format (Table 
6). 
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Degree Day is the concept established for the measurement of withdrawal 
periods in homoeothermic animals like fish, in which metabolism and drug 
excretion depends on the prevailing water temperature. It refers tothe sum of the 
average daily water temperatures during the withdrawal period. For all new 
products a Maximum Residue Level (MRL) must be defined, that complies with 
EC regulations according to which all products will need an MRL by 1997 
(Regulation 2377/90/EEC). The MRL pertains to a compound while a withdrawal 
period to a formulation or product. Different formulations of the same compound 
may require different withdrawal periods in order to achieve the same MRL. The 
evaluation of applications for a Community authorisation in the centralised 
procedure and in the residue data evaluation, is carried out by the Committee for 
Veterinary Medicinal Products (CVMP) at the European Agency for the Evaluation 
of Medicinal Products (EMEA). Both the Community marketing authorisations for 
veterinary medicinal products and the adoption of the results of residue evaluation 
are adopted in accordance with a standing committee procedure. Veterinary 
medicinal products subject to a national authorisation (Council Directive 
81/851/EEC) must be authorised by the mutual recognition procedure, if they are 
to be placed on the market of more than one Member State. Each authorisation 
specifies the animal species in which it may be used, the therapeutic indications, 
the dosage and the withdrawal period for food-producing animals (time between 
the last dose and the slaughter and/or obtaining food products provided by 
treated animals). Authorisations are valid for 5 years and are renewed upon 
request and submission of all necessary information. A market surveillance of all 
market products is carried out by the marketing authorisation holder and by the 
competent authorities. For well-established antimicrobials, such as 
oxytetracycline and amoxycillin, the cost of adding farmed fish to the range of 
approved veterinary uses was not great particularly as these approvals took place 
before the increased vigour of licensing procedures was imposed, partly by the 
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needs of harmonisation within the European Union. These products are also 
licensed in most member states for use with aquaculture products, leading to a 
wide acceptability of the case for their safety and efficacy. Only the requirement to 
obtain the necessary data to support the establishment of a maximum residue 
limit (MRL) has so far affected their availability. Companies have made various 
attempts to develop several new compounds in the 1990s, one of which, 
sarafloxacin, would have been exclusively for fish use. Sarafloxacin was finally 
approved in 1998 after more than 10 years of effort. Other well-established 
antimicrobial agents have also been considered by various pharmaceutical 
companies for potential extension into the field of aquaculture, but none have so 
far reached the stage of receiving marketing authorisation. The reasons for this 
undoubtedly lie in the markedly increased regulatory costs imposed on the 
process of licensing veterinary medicines in the last 10 years. These are both in 
the terms of administrative costs and, more specifically, in the much greater 
requirements for demonstration of safety, to the environment, the operator and 
the consumer that are now required, particularly for newer molecules. 
Pharmaceutical companies are reluctant the invest in such products, so that, for 
example, oxolinic acid may well be lost for use with food fish species under the 
provisions of European Council Regulation 2377/90 if no MRL is set (Alderman 
and Hastings, 1998). An Unofficial Consolidated Updated up to 2002 version of 
the Annexes I to IV of Council Regulation n" 2377/ 90 is presented below in Table 
6. 
1.2.3.2.1 Oxolinic acid 
4-Quinolones are broad spectrum compounds with bactericidal effect on a range 
of gram-negative and gram-positive bacteria (Stamm et al., 1986). The mode of 
action is by interference with the bacterial DNA gyrase inhibiting the supercoiling 
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of DNA. The 4-quinolones do not induce plasmid mediated drug resistance in 
bacteria, but resistance may be formed by mutation in a gene encoding a DNA 
gyrase subunit (Smith, 1990; Alderman 1998). The 4-quinolones can be 
combined with other classes of antimicrobial agents without deleterious effect on 
the antimicrobial activity and without any increased toxicity. A synergistic 
bactericidal effect has been observed for oxolinic acid-trimethoprim combinations 
due to a complementary blockage of bacterial DNA synthesis. Oxolinic acid (5- 
ethyl-5,8-dihydro-8-oxo-1,3-dioxolo [4,5g] quinolone-7-carboxylic acid) is widely 
successfully used to control furunculosis (Endo et al., 1973a; Austin et al., 1983) 
vibriosis (Endo et al., 1973b; Austin et al., 1981) and enteric redmouth disease 
(Rodgers and Austin, 1983). The LD5o of Oxolinic acid to rainbow trout (Salmo 
gairdnen) was higher than 5000mg /kg body weight /day in relation to the 
recommended dose in freshwater fish of 10mg/kg b. w /day (Austin et al., 1983). 
A dose rate of 1 Omg/kg b. w per day is recommended for routine use in freshwater 
while 30mg/kg b. w per day are required in the marine environment. 
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Table 6: Unofficial Consolidated version of the Annexes Ito IV of 
Council Regulation n° 2377/ 90 - Updated up to 2002 
Annex I 
(List of pharmacologically active substances for which 
maximum residue limits have been fixed) 
Anti- infectious agents 
Chemotheurapeutics 
Sulfonamides 100 pg/ kg All food producing 
Muscle" species 
Diamino Trimethoprim 50 pg/ kg All food producing 
pyrimidine Muscle" species except Equidae 
derivatives 
Antibiotics 
Penicillins Amoxicillin 50 pg/ kg All food producing 
Muscle" species 
Ampicillin 50 pg/ kg All food producing 
Muscle" species 
Quinolones Enrofloxacin Sum of 100 pg/ kg All food producing 
enrofloxacin and Muscle" species except bovine, 
ciprofloxacin ovine, caprine, porcine, 
rabbits and poultry 
Flumequine 600 pg/ kg Fin fish 
Muscle" 
Sarafloxacin 30 pg/ kg Salmonidae 
Muscle" 
Macrolides Erythromycin A 200 pg/ kg All food producing 
Muscle" species 
Florfenicol and Florfenicol 1000 pg/ kg Fin fish 
related Muscle" 
compounds 
Tetracyclines Chlortetracycline Sum of parent 100 pg/ kg All food producing 
drug and its Muscle" species 
4-epimer 
Oxytetracycline Sum of parent 100 pg/ kg All food producing 
drug and its Muscle" species 
4-epimer 
Lincosamides Lincomycin 100 pg/ kg All food producing 
Muscle" species 
Aminoglycosides Neomycin B 500 pg/ kg All food producing 
Muscle" species 
Spectinomycin 300 pg/ kg All food producing 
Muscle" species exce 
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Antiparasitic ac ents ( ANNEX I 
Pyrethroids Deltarnethrin 10 pg/ kg Fin fish 
Muscle" 
Acyl urea Diflubenzuron 1000 pg/ kg Salmonidae 
derivatives Muscle" I 
Teflubenzuron 500 pg/ kg Salmonidae 
Muscle" 
Annex 11 
(List of substances not subject to maximum residue Ii its). 
Inorganic Hydrogen peroxide All food producing 
chemicals species 
Organic Azamethiphos Salmonidae 
compounds 
Substances Formaldehyde 
generally 
recognised 
as-safe 
Substances used in homeopathic veterinary medicinal products 
Substances used as food additives in foodstuffs for human consumption 
Substances of vegetable origin 
Annex III 
(List of pharmacologically active substances used in veterinary medicinal products for which 
provisional maximum residue limits have been fixed 
Anti- infectious 
agents 
Antibiotics 
Macrolides 
Cephalosporins 
Aminoglycosides 
Quinolones Oxolinic acid 300 pg/ kg Fin fish 
Muscle** 
Provisional MRLs expires on 01/ 01/ 2003; 
Not for use in animals from which milk is produced for human onsumption 
Agents acting 
against 
ectoparasites 
Pyrethroids Cypermethrin 50 pg/ kg Salmonidae 
Muscle" I 
Provisional IVIRIL expires on 01/ 07/ 2003 
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Annex IV 
List of pharmacologically active substances for which 
no maximum levels can be fixed 
Chloramphenicol 
Dimetridazole 
Metronidazole 
Nitrofurans (including furazolidone 
(Source: EMEA Web site: www. emea. eu. int - MRL Frequently Asked Questions) 
Oxolinic acid has relatively low solubility so that a micronised ultra-fine preparation 
has been developed to increase its bioavailability from 16 to 31%. In the EMEA 
decision EMEA/MRU753/00-FINAL taken in July 2000, for Oxolinic acid like the 
other quinolones already recommended for inclusion in Annexes I and III of 
Council Regulation (EEC) No 2377/90, the parent compound was considered to be 
an appropriate marker residue for all the target species. A microbiological ADI of 
2.5 pg/kg bw (i. e. 150 pg/person) was established for oxolinic acid, there was no 
information on the ratio of marker to total residue in the relevant tissues of any of 
the target species; taking into account the limited data available on the metabolism 
of oxolinic acid, and also the evidence that for those quinolones already included 
in the Annexes to Council Regulation (EEC) No 2377/90, the unmetabolised 
parent substance generally accounted for the major portion of the residues, a 
conservative marker to total ratio of 0.5 was used when calculating MRLs for 
oxolinic acid. The Committee for veterinary medicinal products (CVMP) 
recommended according to Article 4 of Council Regulation No 2377/90 as 
amended, a 2-year extension of the provisional MRL for oxolinic acid in 
accordance with the following table: 
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Table 7: Provisional MRL for Oxolinic acid 
Pharmacologically Marker Animal MRLs Target tissues Other provisions 
active substances residue specles 
Oxolinic acid Oxolinic acid Bovine 100 pg/kg Muscle 
Not for use in 
animals from which 
50 pg/kg Fat milk 
is produced 
for human 
150 pg/kg Liver consumption 
Provisional 
150 pg/kg Kidney MRLs expire on 
1.1.2003 
Porcine 100 pg/kg Muscle 
Provisional 
MRLs 
50 pg/kg Skin + fat expire on 1.1.2003 
150 pg/kg Liver 
150 pglkg Kidney 
Chicken 100 pg/kg Muscle 
50 pg/kg Skin + fat 
150 pg/kg Liver 
150 pg/kg Kidney 
50 pg/kg Eggs 
Fin fish 300 pg/kg Muscle and 
skin in natural 
proportions 
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1.2.3.2.2 Oxytetracycline 
Tetracyclines in nature are produced by Streptomyces spp. Their mechanism of 
action is twofold. They enter the bacterial cell either by passive diffusion through 
hydrophile pores in the outer cell membrane or by pumping the drug through inner 
cytoplasmic membrane via energy dependent transport mechanisms leading in 
both cases to the inhibition of protein synthesis through binding to 30S ribosomes. 
Tetracyclines are bacteriostatic and function by interfering with bacterial protein 
synthesis by reversibly binding to the bacterial 30S ribosomal subunit, preventing 
the binding of aminoacyl RNA to messenger RNA ribosome (Jawetz, 1987). They 
are broad-spectrum antibiotics effective against both Gram-positive and Gram- 
negative bacteria and some protozoans. They are used to control bacterial 
haemorrhagic septicaemia, columnaris, furunculosis, enteric redmouth, vibriosis, 
pasteurellosis and cold-water vibriosis. They may be incorporated in feed pellets at 
a dosage of 50-100 mg/kg body weight per day over a 10 day treatment period. In 
the EMEA decision (EMEA/MRL/023/95) for Oxytetracycline, Chlortetracycline, 
Tetracycline, the previously allocated MRLs were suggested to be considered as 
final for oxytetracycline, tetracycline and chlortetracycline and the Committee 
recommended the inclusion into Annex I of Council Regulation (EEC) No 2377/90 
of these compounds for all food producing species (Table 8). 
Table 8-. Provisional MRL for Tetracycline, Oxytetracycline and Chlorotetracycline 
Pharmacologically 
active substance(s) 
Marker 
residue Animal Species. MRLs Target Tissues 
Tetracycline 
600pg/Kg Kidney 
Oxytetracycline 300pg/K2 Liver 
Sum of parent All food 100pg/Kg Muscle 
Chlorotetracycline drug and its 4- producing 1 OOpg/Kq Milk 
epimer species 200pg/Kg Eggs 
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In addition the Committee recommended that muscle and skin in natural 
proportions should be the target tissue for fish. The ADI level was set at 0-3pg/kg 
bw for these tetracycline compounds. Suitable and well-validated HPLC methods 
are available which can be used in the surveillance of residues of Oxytetracycline, 
Chlortetracycline and Tetracycline in tissues of cattle, sheep, pig, turkey, trout, 
carp and milk and eggs. The method takes into account the 4-epimers of 
Oxytetracycline, Chlortetracycline and Tetracycline. Residues of Oxytetracycline 
can be routinely monitored by a microbiological agar diffusion assay with detection 
limit of 1OOpg/kg for milk and meat, and 200pg/Kg for eggs. It appeared that the 
monitoring methods for residues in fat were not reliable and no IVIRL was therefore 
established. 
Figure 6: OA Molecular form 
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Recommended dose rates and withdrawal periods are given below for products 
with a current marketing authorisation for use in aquaculture in the UK (Table 9). 
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Table 9: Recommended dose rates and withdrawal periods 
University of Stirling 
Generic 
Name 
Trade name Fish Species Dose 
(mg / Kg / day) 
Withdrawal 
period 
(degree-days) 
OTC Aquatet AS, RT 75 400 
Tetraplex AS 75 400 
Tetraplex Forte AS, RT, AC 75 AS 500, RT & 
AC 350 
OA Aqualinic AS, RT, BT 10-30 500 
Aquinox AS 10-30 500 
(Alderman D. J. & T. S. Hastings 
, 
1998) 
Where no suitable licensed medicinal product is available, veterinarians may 
prescribe a product licensed for use in another animal species (here a guide 
minimum withdrawal period of 500 degree days is imposed) and in very limited cases 
may prescribe an unlicensed product for use on few animals. Such prescription is 
known as the "cascade principle". The limitation of the right to prescribe to only a few 
animals under the veterinarian's direct control effectively means that unlicensed 
medicines should not be used in aquaculture except perhaps on a few valuable 
broodstock animals. A veterinarian in extreme cases may prescribe a product 
licensed for use in man, or may prescribe an ex-temporaneous preparation. If no 
Withdrawal period has been specified for the species concerned the veterinarian must 
ensure that a withdrawal period of at least 500 degree-days is observed. All 
instances of extra label use of veterinary medicines in aquaculture must be recorded 
and the records must be held available for inspection by the competent authorities for 
a period of at least three years. 
Unfortunately in comparison to other areas of veterinary medicine, the licensing of 
potential aquaculture chemotherapeutants has received limited attention, possibly 
due to the comparatively small size of the market and hence the reluctance of drug 
companies to commit the necessary resources for pursuing costly applications. 
Aquaculture medicines must be licensed to similar standards of quality, safety and 
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efficacy as human pharmaceutical products. However it should be underlined that the 
economic scale of the potential Aquaculture marketplace indicates that it may not be 
economically feasible to bring new products to the aquaculture market. Considerable 
effort has been devoted lately on consultation of the Commission in as an attempt to 
amend existing legislation on veterinary medicinal products. It is considered that the 
revision of the legislation is a big opportunity to present the specific nature and needs 
of Aquaculture industry to the legislator in order to ensure the sustainability of the 
sector, fish welfare, the production of high quality products and last but not least the 
public health. The European Aquaculture industry's aim is the gradual reduction of 
pharmaceutical levels applied but there are several key points that should be raised 
in order to ensure that the consumers as well as the industry's interests are better 
served. The new framework should induce flexibility for the licensing of aquaculture 
medicinal products. Although the foremost objective in the legislation is always 
consumer safety, the legislation should recognise the need for veterinary medicinal 
products in ensuring the health and welfare of animals. It should take into account 
animal health and welfare as well as public health, whereas previously the system 
has focussed exclusively on public health with little regard for the health and welfare 
of animals. The legislation should resolve the problems concerning the availability of 
medicinal products for aquaculture use and should in particular introduce a policy for 
'orphan' medicinal products for veterinary use (with provisional MRLs - like oxolinic 
acid) analogous to that established for human medicinal products by Regulation (EC) 
No 141/2000, implemented through Regulation (EQ No 847/2000. This regulation 
should create the necessary mechanisms to ensure that all needs are covered by at 
least two therapeutic alternatives in European Aquaculture, with the objective of 
guaranteeing both competition and the diversity of available protection options and 
thereby preventing the emergence of resistance. The ten-year industrial-property 
protection period for veterinary medicinal products for fish should be extended to 15 
years in order to enable the pharmaceutical industry to derive full benefit from such 
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products thus initiating renewed incentives to invest and achieve marketing 
authorisations for fish products. The time it takes to obtain registration and to develop 
the data required for the extension of a marketing authorisation to different species 
and to different diseases should be considerably shorter. Both centralised and 
decentralised procedure should be maintained providing the necessary flexibility in 
terms of faster launching of new products in the aquaculture market. Evaluation of 
the operation of the procedures for the granting of market authorisation has revealed 
the need to revise, in particular, the mutual recognition procedure in order to increase 
the scope for cooperation between Member States. Different levels of competence in 
different Member States as well as different level of vigilance often leave more 
options for treating or preventing fish diseases in some countries while leaving none 
in others. A simple example is that a few Member states refuse to act as reference 
Member states in the Mutual recognition procedure. A basic degree of harmonisation 
should be included in the enforcement of the new legislation in order to avoid the 
creation of indirect trade barriers. The large number of aquaculture species and 
relevant pathologies complicate the procedure of extension of use or species and 
emphasis should be made into making this process faster at a Member state level as 
well as at EU level. Systematic extrapolation of MRL values between species would 
make new drugs available faster for minor species. The 'cascade' principle needs to 
be modified. In the case of absence of authorised veterinary medicinal product for a 
condition affecting fish -a familiar case for veterinarians - in order to avoid causing 
unacceptable suffering to the fish population concerned, Member States shall, 
particularly, permit the administration of unauthorised medicines by a veterinarian or 
under his/her direct personal responsibility to a fish population on a particular fish 
farm. The reference to a small number of animals in the legislation is not applicable 
for aquaculture because fish are reared in cages or tanks in large numbers and these 
are treated as units in terms of epidemiology, prevention or treatment of fish 
diseases. The licensing and application of Fish vaccines should be encouraged in 
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order to support the European Aquaculture industry trend to limit the use of 
antimicrobials and to ensure high product quality and safety. 
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1.3 Research considerations 
Research considerations on antimicrobial chemotherapy are revolved around three 
main areas of interest, those regarding the clinical efficacy, their environmental 
impact and their effect (if any) on consumer safety. 
1.3.1 Clinical Efficacy 
A range of factors affects the clinical efficacy of an antimicrobial agent in aquaculture. 
The ability to deliver the antimicrobial agent to the affected tissue of the diseased fish 
depends on the effective dose delivery system the application strategies and the 
shortfalls present in drug application in practice. The pharmaceutical industry's major 
research interest is more in the area of new chemical compounds, than in the 
development of new drug delivery systems like micro and nanocapsules, liposomes, 
osmotic pumps and pellet matrices. Factors that complicate the assessment of 
clinical efficacy of an antimicrobial agent in practice include the fish feeding 
response, the timing of the initiation of the treatment, the presence of unrelated 
stress factors, the economic and ethical reasons that proscribe the use of untreated 
control groups and the loss of appetite evident in diseased fish leading to the 
assumption that only the healthy fish eat, so while the clinician considers therapeutic 
any applied treatment this in a sense acts more like a prophylactic treatment. The 
pharmacokinetic properties of the agent for the specific fish species and at the 
prevailing water temperature affect the concentration of the agent in the infected fish. 
The third main parameter that dictates the clinical outcome of any treatment is the 
susceptibility of the bacterial pathogen to the obtained tissue drug concentration. 
Variations in the interpretation of the term of resistance to an antimicrobial agent 
exist among laboratories and in scientific papers regarding the evaluation of 
antimicrobial agent resistance expressed as M. I. C values or zones of inhibition. 
Classification of bacterial pathogens according to their clinical relevance divides a 
bacterial population into three groups, namely: a) Resistant, b) Intermediate and c) 
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Sensitive or susceptible bacterial pathogen to a certain antimicrobial agent. 
Establishment of critical breakpoint values Minimum Inhibitory Concentration (M. I. C) 
or areas of zones of inhibition are possible only when Bimodal or Polymodal 
distributions of bacterial pathogens exist in relation to their sensitivity to a certain 
antimicrobial agent. Minimum Inhibitory concentration (M. I. C) of a bacterial strain to a 
certain antimicrobial agent is the concentration of this agent that is required in order 
to inhibit the growth of this strain. The disadvantage in this type of extrapolation is 
that they have in them no consideration of the pharmacokinetic data. Problems of 
drug resistance revolve around two main axons. The first is the development of 
resistance to the few effective and legally available antibacterial drugs (Aoki and 
Kitao, 1981; Aoki et al., 1981; Austin, 1985; Aoki, 1988; Richards, 1992; Richards et 
al., 1992). The second is the expressed anxiety that the use of antimicrobials in the 
aquatic environment may lead to transmission of plasmid-mediated resistance, 
producing resistant populations of human microbial pathogens. Whilst the possibility 
of such an event can't be ignored, so far it appears to remain something which 
perhaps may be demonstrated under lab conditions but which has not so far been 
found to occur under natural conditions. Bacteria acquire resistance mechanisms to 
antimicrobial agents by mutation, transduction, transformation and conjugation. 
Mutation is important for 4-quinolones. It refers to a stable genetic change, which is 
often presented naturally; it is not a result of exposure to the agent and persists in the 
absence of drug "selection" leaving only resistant microorganisms while virulence 
may change similarly. Transduction is important for antimicrobial agents like 
Erythromycin, Oxytetracycline and Chloramphenicol. It is based on the ability of 
bacteriophages to carry bacterial DNA in their protein core being able sometimes to 
pass bacterial extra chromosomal DNA (plasmids) on to newly infected bacterial 
cells. This mechanism was proven to exist for plasmids encoding penicillinase 
production. Transformation is an uncommon and probably not very important 
mechanism. It refers to incorporation of free DNA present in the aquatic environment 
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in bacterial cells. Conjugation is an extremely important mechanism for the spread of 
resistance (often multiple drug) especially common in Gram-negative bacteria. It was 
first described in Japan in 1959. It involves the passage of genes from cell to cell by 
direct contact through a "sex pilus" or "bridge". Transferable genetic material has two 
different DNA sequences. The uR" factor or uR Determinant Plasmid" that encodes 
the actual resistance while the "Resistance Transfer Factor' or "RTF" or" Transfer 
Factor Plasmid" that encodes for sex factor which is the transfer apparatus (sex 
pilus). Each of the above can be transferred individually but both must be present for 
successful transfer of antibiotic resistance. Under natural conditions the efficiency of 
transfer is low but antibiotics can exert a selective pressure that allows the 
emergence of resistant bacterial strains. Resistance to tetracyclines is usually 
plasmid mediated and transferable. It is often inducible and appears to be associated 
with the ability to prevent accumulation of the antibiotic in the cytoplasm. The 
frequency rises with extended use and has become pronounced in some farms. 
Where the development of resistance to tetracyclines rises from a change of bacterial 
cell membrane permeability, this can result in cross-resistance to other drugs 
including 4-quinolones. Plasmid -encoded drug resistance of fish pathogens was 
described in several studies (Aoki and Kitao, 1981,1985; Austin, 1985). 
Bacterial strains develop special mechanisms to prevent drug antimicrobial effect by 
the production of enzymes to inactivate the drug at bacterial cell surface, 
impermeability of cell membranes in order to prevent influx of the drug, production of 
local pH changes in order to deactivate some of the antibiotics that are organic acids 
and whose action is pH dependent and production of a local anaerobic environment 
that affects the transport mechanisms of some drugs that are energy dependent. The 
in vivo antibiotic resistance is also a relative term. It depends on the method of 
administration of the antibacterial agent, tissue distribution of the agent in relation to 
the site of the infection and physicochernical microenvironment in the fish. 
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Techniques that are usually applied for in vitro sensitivity testing belong either to Disc 
diffusion method or Dilution methods. Disc Diffusion methods are usually 
modifications of the Kirby-Bauer method. The method is based on the measurement 
of zones of inhibition around antibiotic disks on solid culture media. These zones of 
inhibition depend on several factors like the sensitivity of the microorganism, the 
amount of the agent used, the diffusion rate of the agent, the growth rate of the 
organism, the conditions, the medium composition, pH and volume. Incubation 
temperature, inoculum production method and size and method of inoculation also 
affect the sensitivity of the diffusion methods. Standardised methods are based either 
on detailed internal comparative standards or on rigorous specification. For many but 
not all the antimicrobial agents there is linear relationship between diameter of zone 
of inhibition produced using a standard method and the log of the M. I. C of the agent 
against the organism. However no regression lines have been produced for fish 
pathogens. Dilution methods use either solid or liquid media. These methods have 
several disadvantages. They are time consuming and questioning exists on their 
value for the detection of Quinolone M. I. C. However generally they are perceived as 
the correct approach, they easily can be adapted to determine Minimum bactericidal 
concentrations (M. B. Cs), their use reduces the logistical problems, can provide direct 
extrapolation of numerical data and they are preferred for slow growing bacteria. In 
vitro sensitivity test variations are widely accepted to increase the inability of data 
correlation between laboratories involved in fish diseases diagnosis. The main 
obstacle in obtaining realistic and applied laboratory data originates from the in vitro 
test inability to simulate in vivo conditions. The importance of inter- and intra- 
laboratory reproducibility that can be achieved using a particular in vitro method may 
be more important than the relevance of its results to the in vivo situation (Smith et 
al., 1994). Laboratory test variations refer to the laboratory media formulation and to 
technique protocols. Laboratory media formulation depends on factors like pH, 
nutrient conditions, ionic concentrations (phosphate, iron) while technique protocols 
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differ in factors like the centrifugation of the inocula and temperature used. 
Temperature affects the results of in vitro tests like MAL of oxytetracycline and 
oxolinic acid (Giles et al., 1991; Inglis et al., 1991; Martinsen et al., 1992). By 
convention a concentration of an antibiotic three times the MIC value in serum is 
considered sufficient to kill or inhibit the bacteria at the site of infection. Inability to 
simulate real life situations depends on many factors like the host-defence 
mechanisms. Phenomena and mechanisms like the immunomodulating effect of 
antibiotics, the non specific immune response and its effect on the pathogen as well 
as the effect of sub-inhibitory concentrations on the pathogen are some of the factors 
that prohibit the simulation of the in vivo situation at least based on the existing 
experimental designs and available techniques. 
This is the first study in the Mediterranean where quantitative antibiogram and MIC 
data are linked to achieved antibiotic concentrations in sea bass and sea brearn at 
two prevailing temperatures following applied treatment protocols. 
1.3.2 Environmental impact - Residues in Aquatic Environment 
When drugs and chemicals are applied in Mariculture it is inevitable that some of that 
material will enter the environment (Alderman et al., 1994). The proportion will 
depend on several factors, most important of which is the route of application. 
Compounds applied as oral therapeutants will enter the environment by three routes. 
The most direct will be on uneaten medicated feed where it has been estimated that 
an average of 30% of feed is not eaten by the farmed fish but falls through the sea 
cage to the seabed beneath. This waste feed may then be consumed by feral fish, 
invertebrates or pelagic filter organisms, and may or may not be broken down 
microbiologically, depending on the state of the below-cage environment and the 
drug concerned. The second route will be in the form of un-metabolised drug in the 
faeces and excretions from the kidney, liver or gill of the farmed fish. Faeces will fall 
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to the sea bottom and enter the detrital chain as with waste feed. The third and final 
route will be the excretion of a metabolically altered drug by the fish. Wild fish feeding 
on medicated feed fragments may be caught by human consumers or filter feeding 
organisms (mussels) may be predated by birds and possibly enter the human food 
chain indirectly. Drug withdrawal periods set to ensure that this elimination process is 
complete were displaced later by the concept of Maximum Residue Limit (MRQ in 
order to ensure that no unacceptable residues enter the human food chain via 
farmed fish meat. Nearly all studies show high levels of resistance. The prevalence of 
resistance reflects frequency of the use of the agent and R-plasmid encoded 
resistance is common in fish pathogens. The definition of resistant bacteria in the 
aquatic environment depends on three major considerations. The agent 
concentration used as breakpoint, the method employed and the sensitivity, 
specificity of the methodology and the relevance to chemical concentration and 
bioavailability of the antimicrobials. 
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1.3.3 Consumer safety 
The considerations on the potential risks are usually based on the following 
diagrammatically presented pattern: 
Figure 9: Considerations on the potential risks for consumer safety 
Fish & Aquatic Compartment 
use of antimicrobials 
in fish farming 
M. L. L. R 
phenotypes 
V 
fish farm environment 
enrichment of resistant 
human pathogens 
mating events with 
R-plasmid donors 
I 
Antibiotic Residues 
in fish products 
Residues flow No. 
Resistance 
"flow" 
Multiple low level re§istance bacterial phenotyRes and transient 
persistence mechanisms of resistant phenotypes after a treatment 
play important role. 
MLLR phenotypes of A. salmonicida develop by membrane 
protein change. 
Human compartment 
Transmission of resistant pathogens from 
fish to human environment 
Human Infectious diseases that cannot be 
treated 
Increase of antibiotic resistance levels in 
the intestinal flora - Allergic reaction - 
Hypersensitivity 
The survival of a resistant strain in the environment is based on persistence 
mechanisms: This type of mechanism becomes apparent only in the presence of the 
antimicrobial and may lead to the generation of bacterial strains of intermediate 
resistance. The resistance may result from genotypic or phenotypic changes in the cell 
(e. g. through changes in membrane proteins or the permeability of cell membranes). 
These phenotypes are detected during and shortly after therapy and could cause 
P, Christofilogiarinis 39 
Use of Antibiotics in Greek Mariculture University of Stirling 
problems in surveys of the frequency of resistance. Bryan (1989) suggested that in the 
case of Quinolones persistence was probably the dominant mechanism of clinical 
resistance. A. salmonicida strains in this study became resistant to Oxolinic acid and 
have been isolated years after the last use of Quinolones. R-plasmids have been 
reported to lose resistance genes under low nutrient conditions (Godwin and Slater, 
1979; Griffiths et al., 1990) and scepticism exists on the survival of the plasmids and 
stability in the adjacent aquatic environment. Several studies exist in the literature on 
R-plasmid transfer in the lab (Nakajima et al., 1983; Ervik et al., 1994a; Sandaa et al., 
1994), in simulated marine environment (Coughter and Stewart, 1989; Angles et al., 
1993; Goodman et al., 1993), in marine environment (Saye and Miller, 1989), in the 
sediment under sea cages (Santaa et al., 1992), and in freshwater farms (Brazil et al., 
1986). These studies suggested low frequency of transfer in nature although movement 
of R-plasmid bacteria (not human pathogens) to the human environment - transfer of 
R-plasmids to human pathogens was proven possible. 
Questions refer not only to the existence of human therapy risks associated with fish 
farming but also on the magnitude of such risks. In a simplified version the basic 
question is: "Can fish act as vectors of human diseases? " Inglis et al. (1993) reported a 
list of human pathogens that can be associated with fish farming. The bacteria amongst 
these pathogens are associated with the fish and the aquatic environment, are related 
to pollution of the marine environment and most of these are isolated during 
processing, marketing and preparation of fish. The danger of these infections, which 
most of the time develop as self-limited gastroenteritis, depends on climatic condition 
(appropriate conservation) and sometimes-cultural conditions (consumption of raw 
fish). There are 20 groups of "microbes" isolated from fish that have been pathogenic to 
humans. The bacteria amongst these pathogens can cause intestinal infections 
entering the human host via the mouth as well as septicaernias or localised infections 
entering via the skin. In the case of Salmonella spp. and Campylobacterjejuni it is 
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proven that food products and /or infected humans act as vectors. Resistant 
Salmonella spp. have been isolated from fish. V. parahaemolyticus has been isolated 
from raw and undercooked fish but only 1% of fish pathogens are Kanagawa positive 
while this test is positive in 96% of the human pahogenic strains. Aeromonas 
hydrophila affects only immunocompetent patients while controversial information 
exists on the pathogenicity of Plesiomonas shigelloides and circumstantial evidence 
only relating to Edwardsiella tarda. Infections via the skin refer to bacterial pathogens 
like Erysipelothrix rhusiopathiae (swine pathogen), A. hydrophila, Leptospira interrogans 
the causative agent of Weil's disease and Pseudomonas spp. which is pathogenic for 
hospitalised patients, Mycobacterium marinum which is widely distributed in nature 
swimming pools, freshwater & marine aquaria and Mycobacterium fortuitum that has 
been isolated from aquarium fish as well as human patients after open heart surgery, 
venous stripping and renal homograft recipience. The review of the available literature 
indicates that the health risk from the potential risk of transmission of antibiotic 
resistance from fish pathogens to potential human pathogens (Table 10) is minimal and 
extremely difficult to prove in vivo (Alderman and Hastings, 1998; Smith et al., 1994). 
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Table 10: Bacteria of significance as human pathogens isolated from fish and their 
immediate environment and preferred antimicrobial agents for the treatment they cause 
ir 
Pathogens primarily entering the host via the mouth 
Salmonella spp. Food poisoning Ampicillin, amoxicillin, 
trimethoprim- 
sulphamethoxazole 
Vibrio parahaemolyticus Food poisoning 
Campylobacterjejuni Gastroenteritis Erythromycin 
Aeromonas hydrophila Diarrhoea Ciprofloxacin, norfloxacin, 
trimethoprim- 
sulphamethoxazole 
Aeromonas hydrophila Septicaernia Cephalosporins 
Plesiomonas shigelloides Gastroenteritis trimethoprim- 
sulphamethoxazole, 
tetracycline, ciprofloxacin 
Edwardsiella tarda i Diarrhoea Ampicillin 
Pathogens primarily entering the host via the skin 
Pseudomonas aerughosa Wound infection Arninoglycoside + 
antipseudomonad penicillin 
Pseudomonas fluorescens Wound infection 
Mycobacterium fortuitum Mycobacteriosis Arnicacin + cefoxitin 
Mycobacterium marinum Mycobacteriosis Rifampicin + ethrnbutol, 
trimethoprim- 
sulpharnethoxazole 
Erysipelothrix rhusiopathiae Erysipeloid Penicillin 
Leptospira interrogans Leptospirosis Penicillin G, ampicillin 
a. After Austin and Austin (1987) Modified from Smith et al (1994) 
b. After Bartlett (1992) 
The methods used for the detection of antimicrobials include Biological methods 
(Bioassays) that measure the biologically active agent based on standard addition 
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curves and High Performance Liquid Chromatography methods (H. P. L. C) that measure 
the chemical concentration of the agent. However conflicting data arise from single 
dose studies where different protocols, different methods and assumptions are used for 
the description of the short-term kinetics of an agent and the extrapolation of the real 
life situation through mathematical models. Mathematical modelling is used to define 
resemblance and common ground between the studies, without questioning of the 
approach and its relevance to clinical practice. Only a few studies exist that simulate in 
a more realistic and less optimistic way the actual practice of antimicrobial agent 
application in aquaculture far from the "near perfect" study profile of the highly 
controlled studies. This is the first study where Box Plot Analysis gives the ((full)) 
picture of the clinical relevance of antibiotic application presenting pharmacokinetic 
data of the population. 
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Materials & Methods 
2.1 BACTERIOLOGY 
2.1.1 Bacteriological Survey 
During a period of two years (Sept 1994-Dec 1996), samples from five cultured species 
in the Mediterranean region [Sea bass (Dicentrarchus labrax), Sea bream (Sparus 
atirata), Common dentex (Dentex dentex), Grey mullet (Mugil cephalus) and Sharpsnout 
bream (Puntazzo puntazzo)] were taken. Fish originated from 24 farms in 9 geographical 
regions of Greece. 
North Evoikos 
North Aegian 
lonilin sea 
Patraikos 
Ar, olikos 
South Evoikos 
South Aegian 
. 
0, 
1ý 
Korinthiakos 
SaroilikoS' 
Figure 10: Geographical regions of Greece - Origin of Bacterial Strains 
Samples were taken using aseptic technique with a sterile loop from kidney of 
diseased fish that were not undergoing treatment. Sampling of diseased moribund fish 
was performed personally either on site at the farm or in the lab of Fish Diseases of 
N. C. M. R, Athens, when samples of moribund fish were send to the lab by fish farmers 
or fish veterinarians in the field. In a limited number of cases bacterial strains already 
isolated in regional labs were sent and were simply subcultured in the NCMR lab. 
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Following initial growth and in some cases enrichment, distinct colonies were isolated 
and were subcultured separately in order to identify all bacterial strains involved in an 
outbreak. Tryptone Soy Agar (TSA), Tryptone Citrate Bile Salt Agar (TCBS) and 
Tryptone Soy Broth (TSB) (all supplemented with 1.5% NaCl) were used for the initial 
isolation. Resulting bacterial strains were maintained at 40C, at -200C and at -700C. 
Basic tests were performed for preliminary classification of all bacterial isolates, 
namely, Gram strain, motility test ("hanging drop" method), oxidase test, Oxidative 
versus fermentative metabolism in Hugh-Leifson glucose medium supplemented with 
1.5% NaCI (Hugh-Leifson 1953) and sensitivity to vibriostat 0/129 (2,4-diamino-6,7- 
diisopropylpterydine) and Novobiocin using disks impregnated with 10 and 150 Pg 
0/129 (oxoid) and disks of 5 pg Novobiocin (Pasteur Diagnostics). The Gram stain is a 
fundamental differential stain in microbiology. Gram positive are the bacterial that are 
not decolourised by ethanol or acetone and they are stained blue, while Gram negative 
are the bacteria that are decolourised by ethanol or acetone and are stained red. This 
different colour is due to differences on the cell wall and membrane. The Gram stain 
can be applied either on pure bacterial colonies or on direct tissue smears (as in the 
case of Bacterial Kidney Disease). Some bacterial strains are capable of independent 
directional movement by means of polar flagella, which is different from the non- 
directional random Brown movement. The Oxidase test demonstrates the ability of a 
bacterial strain to produce oxidative enzymes that contribute in the process of electron 
transfer as "electron donors". When the Redox dye tetra methyl-p-phe nyle ned iami ne is 
used as electron receptor this is reduced producing deep blue colour. This test is used 
to demonstrate the aerobic (oxidative) and anaerobic (fermentative) metabolism of 
glucose by the bacterial strains examined. 0-F agar (Hugh-Leifson 1953) 
supplemented with 1.5% NaCI includes Bromothymol blue a pH indicator which turns 
from blue to yellow when acid is produced during the metabolism of Glucose. 
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Tahle 11 - O-F annr result qn:; Iv-qi. -. 
Open tube Closed tube Result 
Green Green No reaction 
Blue (top layer) Green Alkaline reaction 
Yellow Green Oxidation 
Yellow Yellow Fermentation 
Reagent 0/129 (2,4-Diamino-6,7-di-iso-propyl pteridine phosphate) is bacteriostatic for 
Vibrio species and it is used for the differentiation of Aeromonads and Vibrios. 
Sensitivity to Vibriostat 0/129 and to Novobiocin is determined by using disks 
impregnated with 10 and 150 pg 0/129 (Oxoid) and disks of 5 pg Novobiocin (Pasteur 
Diagnostics). 
Table 12: 0/129 result analysis 
Disk 150pg Disk 10pg Result 
No zone of inhibition No zone of inhibition Resistance 
Zone of inhibition No zone of inhibition Intermediate sensitivity 
Zone of inhibition Zone of inhibition Sensitivity 
2.1.1.1 Quantitative Antiblograrn 
A Quantitative Antibiogram is used in order to provide comparable results on the zones 
of inhibition of a certain bacterial pathogen to a range of antimicrobial agents. The 
Antibiogram is performed only in pure cultures. Sensitivity to an antimicrobial agent is 
demonstrated by the formation of zones of inhibition of the bacterial growth around the 
disk impregnated with the antimicrobial agent. If the target is to measure resistance to 
Potentiated sulphonamides agar must not contain inhibitors like lysed blood or 
thymidine. The most appropriate agars for antibiogram use are Mueller-Hinton agar 
and Isosensitest agar. Of the two above Mueller-Hinton was selected because it 
supported better the growth of more fastidious organisms like Photobacterium damsela 
subsp. piscicida. The methods used for inoculum standardisation in the Quantitative 
antibiograrn are presented in Figure 11. In this study a number of colonies were picked 
up, a suspension was made and cfus/ml were adjusted by spectophotometer (wave 
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length: 480 - OD: 0.2). A predetermined volume of 500pl of the adjusted suspension 
was placed on the petri dish and was spread evenly on the surface. The problem of the 
above process was that although for Vibrio anguilarum the final volume referred 
approximately to 103 cells, this process was employed for all bacterial isolates with 
different properties and growth potential. However due to the large number of bacteria, 
a guide based on the study for Vibrio anguillarum was considered the standard 
operating procedure in this study. OD values for every isolate are presented in Annex 
1. Antimicrobial agent disks employed in this study had the following concentration of 
antibiotic: 
T. qhlp 1.3- Antimicrobial acent - Quantitative Antibionram 
Antimicrobial agent Abbreviation Concentration (pg) 
Oxytetracycline OTC 30 
Oxo1inic acid OA 2 
Co-trimoxazole SXT 25 
Furazolidone FR 50 
Amoxicillin AML 10 
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Optical dcnsity 
UI An r0 
McFarland 
standard 
Dry swab 
Wet swab 
Figure 11: Inoculation Protocols for disk diffusion method (from Christofilogiannis 2001) 
Figure 11: presents the two quantitative methods (Optical density / McFarland standard) and three more 
scmiquantitative methods of inoculation in MIC determination with disk diff-usion method. 
Qptical densi :a number of colonies are picked up and a suspension is made and cftis/ml are adjusted by 
spectophotometer. A predeterminedvolume of the adjusted suspension is placed on the petri dish and is spread 
cvcnly on the surface. This method was employed for Quantitative Antibiogram. evaluation in this study. 
McFarland standard: a number of colonies are picked up and a suspension is made and cftis/ml are adjusted by 
visual comparison to a known McFarland standard. A predetermined volume of the adjusted suspension is 
placed on the pctri dish and is spread evenly on the surface. 
Dry swab: a number of colonies are picked up and an approximate suspension is made in a known volume. A 
loop full volume of the suspension is sprcad over all the platc using a loop. 
Wct swab. a numbcr of colonies are picked up and an approximate suspension is made in a known volume. 
Dilutions arc performed if necessary. A sterilc cotton swab is submersed in the solution and is then used for 
spreading a quantity on the agar stirfacc. 
Flooding method: a number of colonies are picked up and an approximate suspension is made in a known 
volume. Dilutions arc performed if necessary. A known volume of the suspension is removed using a 
volumetric tube and then is spread on the agar surface. After a tilting circular movement excess liquid is 
removed and plates are left to dry. 
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2.1.1.2 Minimum Inhibitory Concentration 
2.1.1.2.1 Inoculum Preparation 
A small amount of an overnight bacterial culture at 25'C was diluted in Phosphate 
buffered saline (PBS) to achieve an optical density of 0.2 (wave length: 480nm). As 
mentioned above due to the large number of bacterial isolates and the inability to 
perform separate standard curves, this standard operating procedure for inoculum 
preparation was based in a standard curve for Vibrio anguillarum. For this purpose 
several doubling dilutions of Vibrio anguillarum suspension with the above OID/wave 
length characteristics were cultured in TSA (with 3%NACI) and colonies were 
enumerated. The procedure was repeated in three trials and with two different 
operators. This procedure indicated that a Vibrio angufflarum suspension in the above 
conditions equates to 106 cells/ml, so that a further dilution of 1: 100 produced the final 
working MIC inoculation solution equating to 104 cells/ml. 
2.1.1.2.2 Antibiotic Solution 
An aqueous solution of Oxytetracycline (OTC) of 160 pg\ml was produced from dry 
powder, and the solution was filter sterilised through a 0.22 pm filter. Serial two fold 
dilutions of the antibiotic were made giving concentrations that ranged from 80 to 
0.15625 ppm of OTC. Oxolinic acid as other 4-quinolone antimicrobials is not easily 
dissolved in distilled water. Oxolinic acid was therefore first suspended in distilled 
water, fully dissolved by the dropwise addition of 0.1 M NaOH and readjusted to pH: 9.3 
by drop-wise addition of OAM hydrochloric acid to a nominal concentration of 1280 
pg\ml. The solution was filter sterilised using disposable 0.22pm filters and serial two- 
fold dilutions were made to a final dilution of 0.15625 ppm of OA. 
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2.1.1.2.3 Procedure - 96-well plate preparation 
A 96 well microtitre plate with round-bottomed wells (Nunc Denmark) was employed. 
100pi of Double-strength Isosensitest broth, 100 pI of the appropriate antibiotic solution 
and 5pl of bacterial culture were added to each well. Isosensitest agar was selected in 
this test due to lower interference and higher degree of repeatability achieved in MIC 
values. Two rows of two fold antibiotic dilutions were employed for each bacterial strain 
(4 bacterial strains for each 96 well plate). Inoculation of the bacterial suspension was 
performed from the low to the higher antibiotic dilution. The 96-well plates were placed 
in plastic bags (to avoid loss of humidity) and incubated at 22-25" C for 24 hours 
(Figure 12). 
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Figure 12: Inoculation Protocol for Broth Microdilution method (from Christofilogiannis 2001) 
Figure 12 presents the two quantitative methods (Optical density / McFarland standard) of inoculation 
in MIC determination with broth microdilution method. 
Optical density a number of colonies are picked up and a suspension is made and cftis/ml are adjusted by 
spcctrophotomctcr. A predetermined volume of the adjusted suspension is placed in a double series of wclls in 
a 96 well plate where equal volumes of double strength broth as well as known antibiotic concentration exist. 
This method was cinploycd for MIC cvaluation in this study 
McFarland standard: a number of colonies are picked up and a suspension is made and chis/ml are adjusted by 
visual comparison to a known McFarland standard. A predetermined volume of the adjusted suspension is 
placed in a double series of wells in a 96 well plate where equal volumes of double strength broth as well as 
known antibiotic concentration exist. 
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2.1.1.2.4 Interpretation of the results 
Turbidity in the bottom of the each well was considered to represent bacterial growth. 
Minimum Inhibitory Concentration was considered to be the lowest antibiotic 
concentration that inhibited bacterial growth. 
2.1.1.3 API 20E 
Standardised and rapid identification system API 20E system (Bio Merieux. S. A., Marcy 
- I'Etoile, France) is used for the identification of Gram-negative enteric bacteria but 
also is employed increasingly for the identification of marine and fresh water fish 
pathogens. Mac Donell et al. (1982) suggested the application of 2% marine salt 
solution for the inoculation of the API 20E strip and the characterisation of marine and 
estuarine bacteria. In this study however the use of a 3% salt solution gave consistently 
better results and was chosen as the working solution. 
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2.2 KINETICS - RESIDUE WORK 
The aim of the pharmacokinetics; and residue work was to investigate the kinetics of the 
two most widely used antimicrobials in Mediterranean mariculture, namely Oxolinic 
acid and Oxytetracycline, in two species of cultured fish, Sea bass (Dicentrarchus 
labrax) and Sea bream (Sparus aurata) kept at two water temperatures (high/ 
&I summer" and low/"winter" temperatures). In this context four experiments were 
designed for each antimicrobial agent. 
2.2.1 Oxolinic acid kinetics and residue work 
The following experiments were performed for the Oxolinic acid pharmacokinetic 
investigation. 
Table 14: Oxolinic Acid Experiments 
Experimen 
t 
Fish Species Conditions 
I Sea bream (65g) 22 ±1 `C 
11 Sea brearn (200g) 17+ 1 'C 
III Sea bass (250g) 26± 1 'C 
IV Sea bass (200g) 18+ 1 Oc 
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2.2.2 Oxytetracycline kinetics and residue work 
The following experiments were performed for the Oxytetracycline pharmacokinetic 
investigation. 
Table 15: Oxytetracycline Experiments 
Experimen 
t 
Fish Species Conditions 
V Sea bream (230g) 24+ 1 'C 
vi Sea bream (200g) 18+ 1 Oc 
Vil Sea bass (200g) 24+ 1 'C 
Vill Sea bass (220g) 14+ 1 Oc 
Experiments 1, V, V1, Vll and VIII were performed in the Aquarium of the National Centre 
for Marine Research in Athens, Greece while Experiments 11,111 and IV were performed 
in Kalloni Poros LTD fish farm in Taktikoupoli Troizinias near Poros Island in the 
Saronikos Gulf. Temperature was carefully controlled in aquarium experiments and 
specific periods with minimal temperature fluctuations were selected when experiments 
were performed in the fish farm. Temperature was recorded twice every day at a depth 
of 1 meter in the fish farm and in the bottom of all tanks in the aquarium studies. 
2.2.3 HPLC system - Oxolinic Acid 
The system used comprised of a pump [WaterSTm 510 HPLC pump], an autosampler 
[WaterSTm 717 Plus], a column [H&P Deactivated Hypersil BDS C18 100mm/4mm] and 
a fluorescence detector [WATERS 470 Fluorescence Detector]. The system was 
centrally controlled by a Pentium computer and Waters TM SAVIN modules using 
chromatography software [MillenniuMTM Chromatography Manager Waters@ 1994]. 
Flow rate was adjusted to 0.5ml/minute and pressure upper limit to 2500 psi. 
Fluorescence detector emission wavelength was adjusted to 369 nm and excitation 
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wavelength to 327 nm. Oxolinic acid retention time was 5 minutes. Mean recovery of 
the method was estimated at 77%. Detection limit was 30ppb of Oxolinic acid. 
2.2.4 HPLC system - Oxytetracycline 
The system used comprised of a pump [WaterSTm 510 HPLC pump], an autosampler 
[WaterSTm 717 plus], a column [H&P Deactivated Hypersil BDS C18 100mm/4mm] and 
a UV detector [WaterSTm 484 Tunable Absorbance Detector]. The system was centrally 
controlled by a Pentium computer and Waters TM SAVIN modules using 
chromatography software [MillenniUM TMChromatography Manager Waters@ 1994]. 
Flow rate was adjusted to 0.5ml/minute and pressure upper limit to 2500 psi. Tunable 
Absorbance detector wavelength was adjusted to 360nm. Oxytetracycline retention 
time was 8 minutes. Mean recovery of the method was estimated at 70%. Detection 
limit was 20ppb of Oxytetracycline 
2.2.5 Data Analysis & Presentation 
There are two ways for the presentation of H. P. L. C data. The first includes the 
presentation of the minimum, mean and maximum concentration achieved each day of 
the experiment, while the other includes statistical analysis and presentation of the 
distribution of O. A concentration in the population sampled at each sampling time. In 
the first type of presentation the blue line represented the maximum concentration 
achieved at each sampling time, the green line, the mean concentration and the red 
line the minimum concentration achieved in the muscle of Sea bream and Sea bass. 
The detailed statistical analysis of the H. P. L. C data with Box-Plot Analysis (SPSS(D 
Base, SPSS Inc. Chicago, Illinois, USA) gave a more realistic approach on the O. A 
concentrations achieved in the tissues of the fish sampled. Boxplots are summary plots 
based on the median, quartiles, outlier and extreme values. Boxplots were formed from 
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"boxes", which contain the 50% of values falling between the 25th and 75th 
percentiles, and the "whiskers", lines that extend from the box to the highest and lowest 
values, excluding outliers. A horizontal line inside the box indicates the median. 
Boxplots also convey information about spread and skewness. SPSS boxplot output 
also identifies outliers (o) and extreme values (*). Outliers (o) are considered the values 
that are more than 1.5 box lengths from the 25t' or the 75 th percentile, while Extremes 
(*) are considered the values that are more than 3 box lengths from the 25 th or the 75tý 
percentile. 
Figure 11 Annotated Boxplot Diagram 
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75th Percentile 
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2.3 OXOLINIC ACID KINETICS 
2.3.1 Method of HPLC Analysis - Oxolinic Acid 
Two grams of muscle and 0.5 grams of liver samples were placed in glass tubes with 
an equal quantity of Sodium sulphate (Na2SO4) and 12 ml of Ethyl acetate (H. P. L. C. 
Grade). Samples were homogenised using an Ultra turrax homogenator, while the tube 
was kept in ice-cold water (around 20C) in order to avoid temperature increase resulting 
in decay and loss of the antimicrobial agent. Samples were centrifuged at 1500rpm for 
2min and the supernatant was removed and placed into special tubes that fit in a 
Speed Vac system where samples were evaporated under vacuum. This step lasted for 
50min. In the meantime 12ml of Ethyl acetate were placed in the original tubes and all 
the above steps were repeated for a second time. Care was taken for the samples to 
be "near" dry in order to be able to recover the antimicrobial agent at a later stage. In 
the next step, the remaining combined extract was redissolved by adding 5ml of 
Hexane H. P. L. C. and vortexing for 45sec (dissolving the fat content of the extract) and 
the liquid was removed and placed in other tubes. In the speed Vac tubes 5ml of 
aqueous 0.01 M oxalic acid were also added and after vortexing for 30 sec the aqueous 
phase was placed with the previous phase. The aqueous phase (heavier) was the 
lower phase in the tube. Vigorous vortexing lead to good mixing of the two phases. 
Tubes with samples were then centrifuged at 28OOrpm for 10min and the supernatant 
(organic solvent) was decanted. Oxolinic acid remained in the aqueous layer. 100pl of 
this phase were injected and measured by fluorescent detector (327nm excitation and 
369nm emission wave length). The Mobile phase consisted of 60% 0.01 M oxalic acid, 
30% Acetonitrile H. P. L. C grade and 10% Methanol H. P. L-C grade. Flow rate was 
adjusted to Ilml /min. Retention time was 5 minutes. Flumequine 200ppb final solution 
was used as internal standard. The method was standardised with several standard 
dilution curves (R-squared=99.93 percent, slope 95.83, intercept: 405.86) and spiked 
tissue curves (R square: 99.59%). Mean recovery of the method was found to be 
around 77%. 
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Figure 14ý OA residues detection by HPLC 
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2.3.2 Bioassay-Detection of Oxolinic acid residues 
Yersinia ruckeri (FDL 39/81) was used as the indicator organism for the detection of 
oxolinic acid residues. The method used was a modification of that described by Barker 
(1994) and included: 
a. Preparation of test bacterium 
b. Preparation of test agar 
c. Preparation of antimicrobial agent 
d. Preparation of the muscle/serum samples 
2.3.2.1 Preparation of test bacterium 
A 250 pI Ehrlenmeyer flask containing 100ml Tryptone Soy broth (TSB) (Oxoid) was 
inoculated with Y. ruckeri from an overnight plate. The flask was then incubated 
overnight on a rotary shaker at 100rpm at 300 C. Cells were subsequently harvested, 
centrifuged at 40 C for 20 min at 1 OOOg and washed in fresh phosphate-buffered saline 
(PBSA). They were then re-centrifuged, re-suspended in PBSA and adjusted to a final 
concentration of 107 cells/ml by optical density. 
2.3.2.2 Preparation of test agar 
Isosensitest test agar (Oxoid) was prepared according to manufacturer's instruction 
and adjusted to pH: 6.100ml aliquots were dispensed into 500-ml bottles and 
autoclaved at 121 *C for 15 min. When required, agar was placed in a microwave oven 
and heated until fully molten and then maintained at 45" C in a water bath. Immediately 
before pouring, 0.1ml of the bacterial working concentration of 104 cells/ml (Optical 
Density) Agar was poured into pre-levelled bioassay trays (Nunc, Rosklide, Denmark) 
to give a depth of 1.5-2mm. When set and cooled, 36 evenly spaced wells (Latin 
square), 5mm in diameter, were punched into the agar. 
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2.3.2.3 Preparation of the antimicrobial agent 
Oxolinic acid (Sigma) as other 4-quinolone antimicrobials is not easily dissolved in 
distilled water. Oxolinic acid was therefore first suspended in distilled water to a 
nominal concentration of 1024 pg/ml, fully dissolved by the dropwise addition of OAM 
NaOH and readjusted to pH: 9.3 by drop-wise addition of 0.1 M hydrochloric acid. Using 
this stock solution further serial two fold dilutions were made in distilled water to a final, 
theoretical concentration of 0.008pg/ml. 
2.3.2.4 Preparation of muscle samples 
One-gram samples of antibiotic-free Sea bream and Sea bass muscle were 
homogenised in an equal volume of appropriate drug dilution. These homogenates 
were then centrifuged (10OOg for 20 min) and 3x 50pl aliquots of supernatant were 
added to 3 random wells per assay tray using an electronic pipette. Assay trays were 
performed in triplicate and following overnight incubation at 300C, zones of inhibition 
were measured using a digital calliper. 
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2.3.3 Oxolinic Acid Kinetics in Sea Bream (Sparus aurata) 
2.3.3.1 High Water Temperature 
2.3.3.1.1 Experimental Design 
One hundred and twenty Gilthead bream (Sparus aurata) of average weight 65g were 
kept a semi-closed circulation system comprised of 15 fibreglass rectangular tanks 
(1601t volume) in the aquarium of N. C. M. R. The NCMR aquarium pumping system 
provides a degree of recirculation but a 20% of system water volume is exchanged per 
hour. Water temperature was kept at 22 ± 10C and fish were left for a 10-day 
adaptation period before the experiment. 
2.3.3.1.2 Medicated Feed Preparation 
Fish were fed on a2% per body weight ratio and a dose rate of 30mg O. A/Kg b. w/day 
was used for a period of 10 days. Due to pilot trials where obvious palatability problems 
were encountered and leaching was suspected, it was decided that in all the 
experiments the antibiotics would be incorporated in the diet. The NCMR Fish Nutrition 
lab has extensive experience in feed formulation and manufacturing and based on 
initial observations a parallel study was initiated to elaborate on palatability and 
leaching of medicated diets for sea bass and sea bream. However in order to avoid 
deviation problems commercial extruded feed was decided to be transformed into 
powder and the antibiotic was initially incorporated in a "premix" form and then was 
included in the total quantity of the diet. A small quantity of distilled water was added to 
increase humidity and make pellet preparation easier. Feed was then Iyophilised, pellet 
size was adjusted by use of a crumbler and the feed was kept at 40C. 
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2.3.3.1.3 Sampling 
Fish were sampled on the 0,3,10,11,12,14,16,20,23 and 25 1h day of the experiment. In 
this manner 3 samplings took place during the treatment period and sampling was 
intense in the first days after treatment in order to evaluate the maximum levels of O. A 
obtained in the muscle and liver as well as the speed of O. A depletion in the tissues. 
Each time 9 fish were sampled. Fish in all cases were killed, by a single severing cut of 
the spinal cord, weighed and quickly all the skeletal muscle and liver were removed 
and kept at -200C until analysed by H. P. L. C. This method of slaughter was selected in 
order to avoid possible interference of the anaesthetic with the H PLC analysis. 
2.3.3.2 Low Water Temperature 
2.3.3.2.1 Experimental Design 
Experiment 11 investigated the metabolism of Oxolinic acid in sea brearn kept at water 
temperature 17 + VC. In spring 1995, one hundred and forty sea bream (Sparus 
aurata) of average weight 212g ± 23.6g (m. w + s. d) were kept in a specially designed 
net (3x2x6 m dimensions) in Kalloni Ltd. Water temperature was fairly stable 
throughout all the experimental period at 17 ± 1.40C and fish were left for a 3-week 
adaptation period just before the experiment. Sea bream were treated orally with 
Oxolinic acid at a dose rate of 30mg/kg body weight / day for a period of 10 days. 
2.3.3.2.2 Medicated Feed Preparation 
Fish were fed on a 0.3 % per body weight ratio and a dose rate of 30mg O. A/Kg 
b. w/day was used for a period of 10 days. Medicated diet was prepared using the same 
method mentioned above with incorporation of the antibiotic in the diet. 
2.3.3.2.3 Sampling 
Samples of muscle and liver were taken at 0, l't, Td, 7 Ih, loth, 11 th (morning and 
afternoon), 12 
th, 13 lh, 14 th, 16 th, 1 81h , 
20th 25 th , 
30th and 35 th day of the expedment. In 
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this manner 4 samplings took place during the treatment period and sampling was 
intense in the first days after treatment (11 "' to 14 th) in order to evaluate the maAmurn 
levels of O. A obtained in the muscle and liver as well as the speed of O. A depletion in 
the tissues. Each time an average of 9 fish was sampled. Fish were killed, by a single 
severing cut of the spinal cord, weighed and quickly all the skeletal muscle and liver 
were removed and kept at -200C until analysed by H. P. L. C. 
2.3.4 Oxolinic Acid Kinetics in Sea Bass (Dicentrarchus labrax) 
2.3.4.1 High Water Temperature 
2.3.4.1.1 Experimental Design 
Experiment III investigated the metabolism of Oxolinic acid in sea bass kept at water 
temperature 26 + 10C. In summer 1995, one hundred and twenty adult Sea bass 
(Dicentrarchus labrax) of average weight 252g ± 24.8g (m. w + s. d) were kept in a 
specially designed net (3x2x6 m dimensions) in Kalloni Ltd. Water temperature was 
fairly stable throughout all the experimental period at 26 ± 1.80C and fish were left for a 
3-week day adaptation period just before the experiment. Sea bass were treated orally 
with Oxolinic acid at a dose rate of 30mg/kg body weight I day for a period of 10 days. 
2.3.4.1.2 Medicated Feed Preparation 
Fish were fed on a1% per body weight ratio and a dose rate of 30mg O. A/Kg b. w/day 
was used for a period of 10 days. Medicated diet was prepared using the same method 
mentioned above with incorporation of the antibiotic in the diet. 
2.3.4.1.3 Sampling 
Samples of muscle and liver were taken at 0,1"', 3rd, 7 th, loth, 11 th (morning and 
afternoon), 12 th 13 th 14 th 16 th day of the experiment. In this manner 4 samplings took 
place during the treatment period and sampling was intense in the first days after 
treatment (1 lth to 14th) in order to evaluate the maximum levels of O. A obtained in the 
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muscle and liver as well as the speed of O. A depletion in the tissues. Each time an 
average of 9 fish was sampled. Fish were killed, weighed and quickly all the skeletal 
muscle and liver were removed and kept at -200C until analysed by H. P. L. C. 
2.3.4.2 Low Water Temperature 
2.3.4.2.1 Experimental Design 
Experiment IV investigated the metabolism of Oxolinic acid in sea bass kept at water 
temperature 18 + 1'C. In spring 1995, one hundred and eighty adult Sea bass 
(Dicentrarchus labrax) of average weight 215g ± 32g (m. w + s. d) were kept in a 
specially designed net (3x2x6 m dimensions) in Kalloni Ltd. Water temperature was 
fairly stable throughout all the experimental period at 18 ± 1.4*C and fish were left for a 
3-week day adaptation period just before the experiment. Sea bass were treated orally 
with Oxolinic acid at a dose rate of 30mg/kg body weight / day for a period of 10 days. 
2.3.4.2.2 Medicated Feed Preparation 
Fish were fed on a 0.2 % per body weight ratio and a dose rate of 30mg O. A/Kg 
b. w/day was used for a period of 10 days. Medicated diet was prepared using the same 
method mentioned above with incorporation of the antibiotic in the diet. 
2.3.4.2.3 Sampling 
Samples of muscle and liver were taken at 0,1st, 3rd, 7 th, 1 Oth, 11 th (morning and 
afternoon), 12 th, 13 th, 14 th, 16 th, 18 th , 20th 
25 th , 30th and 
35 th day of the experiment. In 
this manner 4 samplings took place during the treatment period and sampling was 
intense in the first days after treatment (1 1th to 14 th) in order to evaluate the maximum 
levels of O. A obtained in the muscle and liver as well as the speed of O. A depletion in 
the tissues. Each time an average of 9 fish was sampled. Fish were killed, weighed and 
quickly all the skeletal muscle and liver were removed and kept at -200C until analysed 
by H. P. L. C. 
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2.4 OXYTETRACYCLINE KINETICS 
2.4.1 Method of HPLC Analysis - Oxytetracycline 
The detection of OTC in tissues was performed according to Tyrpenou (1995). One 
gram of muscle, liver or sWin tissue were homogenised [Ultra Turrax T-25, IKA 
Labortechnik] with 10 ml McIlvain modified buffer (0.06 M citric acid, 0.02 M 
K2HP04.2H20) at low temperature (40C). The sample was then centrifuged for 10 
minutes at 15000 rpm [Sorvall 0 SUPERSPEED RC2-B Automatic Refrigerated 
Centrifuge] and the supernatant was removed. The procedure was repeated twice and 
combined supernatants were passed through the Solid Phase Extraction column (SPE) 
[Bond Elute C1 8 500mg (IST, lsolute'ý] using a Waters' Sep-PaO Vacuum Manifold. 
Each SPE column, prior sample application, was conditioned with 5ml methanol HPLC 
grade [Lab-Scan Analytical Sciences], then with 5ml McIlvain modified buffer. In the 
combined supernatants from liver samples 2ml of Hexane HPLC grade (Lab-Scan) 
were added, vortexed thoroughly and centrifuged for 5 minutes at 15000 rpm. The 
organic layer (upper layer) with all the lipid content of the sample was decanted and the 
aquatic phase was passed through the SIDE column. After sample application, 10ml of 
water HPLC grade were passed through the SPE column in order to rinse it and then 
the column was vacuum dried for 15 minutes. Elution was performed with 10ml of 
Methanol/Acetonitrile (50: 50) HPLC grade [Lab-Scan] and the eluent was evaporated 
to dryness in Rotary Flask Evaporator [Bucchi] connected with a Refrigerated Bath 
[RB-12A Techne] with temperature control [Tempefteo TE-813 Techne]. Oxyletracyline 
residue was then re-suspended to 0.5 ml of mobile phase (0.01M oxalic acid/ 
Acetonitrile 85: 15). Injection volume was 100pl. 
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Figure 15. OTC residues detection by HPLC 
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2.4.2 Bioassay - Detection of oxytetracycline residues 
A commercial spore suspension of Bacillus cereus (Difco) was employed as the 
indicator organism. 
2.4.2.1 Preparation of Bloassay trays 
Isosensitest agar was prepared according to manufacturer's instructions and 
adjusted to pH: 5.6 by the dropwise addition of OAM hydrochloric acid. 100 ml 
aliquots were dispensed into 500ml bottles and autoclaved at 121 "C for 15 minutes. 
When required, agar was placed in a microwave oven, heated until fully molten and 
then maintained at 500C in a water bath. Before pouring, each bottle was allowed to 
stand at room temperature for 5 minutes. Fifty microlitres of the spore suspension 
was added to the agar and the bottle was gently rolled to give a final bacterial 
concentration of 103 cfu's Iml agar. The seeded agar was then slowly poured into 
pre-levelled sterile plastic bioassay trays (Nunc) to give an agar depth of 1.5 -2 mm. 
When set and cooled at 40C for 30 minutes, 36 evenly spaced wells were punched 
into the agar using a cork borer 6.5mm in diameter. 
2.4.2.2 Preparation of the antibiotic standard solutions 
Oxytetracycline was dissolved in distilled water to a nominal concentration of 1024 
pg/ml. Serial two-fold dilutions were made in distilled water to a final theoretical 
concentration of 0.03125 pg/ml. Solutions that ranged from 4pg/ml to 0.03125 pg/ml 
were used while the rest were discarded. Fifty microlitre aliquots were placed into 
each of 3 wells randomly positioned on the bioassay tray. The remaining wells were 
filled with 50 pi of distilled water and used as negative controls. Trays were then 
incubated for 18 hours at 300C. Zones of inhibition were measured to one decimal 
place using a digital calliper. 
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2.4.3 Oxytetracycline Kinetics in Sea Bream (Sparus aurata) 
2.4.3.1 High Water Temperature 
2.4.3.1.1 Experimental Design 
The OTC kinetics experiment in sea bream at high temperature was performed in the 
aquarium of the NCMR in January 1997. Water was heated to achieve constant 
temperature of 24 +1oC. One hundred and twenty sea bream of mean weight 180 
±23g (m. w + s. d) were divided in three groups and placed in rectangular tanks of 2 
m3 each and were left to acclimatised for two weeks. 
2.4.3.1.2 Medicated feed Preparation 
Fish were fed OTC medicated diet at a feeding rate of 1% b. w per day. OTC dose 
rate was 75 mg / kg b. w / day for 10 days and the antibiotic was incorporated in the 
diet as mentioned above because in initial experiments low palatability was evident 
when OTC was superficially coated. 
2.4.3.1.3 Sampling 
Seven fish were sampled per sampling time at 0,1 st, 3rd, 5th, 7th, 1 Oth, 11 th, 12th, 
13th, 14th, 17th, 21 st, 23rd and 25th day from alternate tanks in order to avoid 
stressing the fish and interfere with their feeding response. 
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2.4.3.2 Low water temperature 
2.4.3.2.1 Experimental Design 
The OTC kinetics experiment in sea brearn at low temperature was performed in the 
aquarium of the NCMR in March 1997. Water temperature during the experimental 
period had an average of IS +1.7 0 C. One hundred twenty sea bream of mean 
weight 200 + 28mg (m. w + s. d) were divided into three groups and placed in 
cylindroconical tanks of 2 M3 each and were left to acclimate for two weeks. 
2.4.3.2.2 Medicated feed preparation 
Fish were fed OTC medicated diet at a feeding rate of 0.3% b. w per day for 10 days. 
OTC dose rate was 75 mg / kg b. w / day and the antibiotic was incorporated in the 
diet, as mentioned above because in initial experiments low palatability was evident 
when OTC was superficially coated. 
2.4.3.2.3 Fish Sampling 
An average of eight fish were sampled per sampling time at 0,16% 3rd, 5th 7 th, 1 Oth, 
11th, 13 th, 1 5th, 1 8t , 
20; h 
, 25th, 
30th and 40th day from alternate tanks in order to avoid 
stressing the fish and interfere with their feeding response. 
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2.4.4 Oxytetracycline Kinetics in Sea Bass (Dkentrarchus labrax) 
2.4.4.1 High Water Temperature 
2.4.4.1.1 Experimental Design 
OTC kinetics experiment in sea bream at low temperature was performed in the 
aquarium of the NCMR in January 1997. Water temperature during the experimental 
period had an average of 24 + 1.8 0 C. One hundred twenty sea bass of mean weight 
200 + 15g (m. w + s. d) were divided into three groups and placed in cylindroconical 
tanks of 2 M3 each and were left to acclimatise for two weeks. 
2.4.4.1.2 Medicated feed preparation 
Fish were fed OTC medicated diet at a feeding rate of 1%b. w per day. OTC dose rate 
was 75mg/kg b. wlday and the antibiotic was incorporated into the diet because in initial 
experiments low palatability was evident when OTC was superficially coated. 
2.4.4.1.3 Sampling 
An average of eight fish were sampled per sampling time at 0,18t, 3rd, 5th, 71h, 1 ()th, 1 1th, 
12 th 13 th , 14'h, 17 
th 
, 21 
s, 23rd and 25th day from alternate tanks in order to avoid stressing 
the fish and interfere with their feeding response. 
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2.4.4.2 Low Water Temperature 
2.4.4.2.1 Experimental Design 
In March 1997, in the aquarium of NCMR an oxytetracycline kinetics experiment was 
performed in sea bass at low temperature (14* C). One hundred and twenty fish of 
average weight 180 g were placed in three cylindroconical tanks of 2 M3 and left for a 
two-week adaptation period. 
2.4.4.2.2 Medicated feed preparation 
Fish were fed OTC medicated diet at a feeding rate of 0.3 % per body weight and an 
OTC dose rate of 75mg/kg b. w/day. Medicated diet was prepared using the same 
method mentioned above with incorporation of the antibiotic in the diet. 
2.4.4.2.3 Sampling 
An average of seven fish were sampled on the 0,5 
Ih 7 Ih, 1 Oth, 11 th, 1 3th, 1 5th, 1 8th 
, 
20th, 
23'd, 26M, 31st, 35 th and 39th day of the experiment in order to monitor efficiently the OTC 
concentration increase as well as the relatively slow depletion process. 
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RESULTS 
3.1 Bacteriology 
The presentation of bacteriological data includes 15 different sections of data: 
3.1.1 Biochemical profile - quantitative antibiograrn & MIC data 
All the data for each strain were presented in Appendix I in a card format which includes 
information concerning the fish species which the strain was isolated from, basic data 
such as Gram stain, Oxidase test, Motility test, Colony form and colouration, Growth on 
TCBS agar, Oxidative-Fermentative metabolism as well as AP120E biochemical profile, 
zones of inhibition in a quantitative antibiogram and the M. I. C values for Oxytetracycline 
and Oxolinic acid. 
3.1.2 Summary statistics - bacterial strain origin & geographical distribution 
Five different species of farmed fish were sampled. Bacterial strain % incidence isolated 
from each species was briefly described. 
sea bass contributed 86.13% of the strains 
sea brearn 16.83% 
sharpsnout brearn 4.95% 
common dentex 1.89% 
grey mullet 0.99% 
Fish samples originated from moribund fish examined on site or send to the lab by 
fish veterinarians or farmers from nine different geographical regions in Greece. 
Saronikos gulf with 25% of the farms contributed 44.55% of the strains 
South Evoikos, 16.67% of the farms contributed 16.83% of the strains 
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M Twenty-four different fish farms were sampled in this study. Samples mainly 
originated from 3 farms (namely farm 8,21 and 22) where every disease outbreak 
was monitored. 
Table 16: Summary statistics: Origin of Bacterial Strains 
Origin code No strains Gulf 
1 RIP 4 Patraikos 
2 Argo 3 Argolikos 
3 SF 3 Ionian sea 
4 NE 1 North Evoikos 
5 Deep 1 North Evoikos 
6 Ast 3 Ionian sea 
7 Ovr 7 Saronikos 
8 Kal 12 Saronikos 
9 PI 4 Saronikos 
10 Agr 2 Saronikos 
11 Petr 2 Saronikos 
12 Chios 1 North Aegian 
13 Nous 8 Ionian sea 
14 Fido, 4 South Evoikos 
15 Prap 5 North Evoikos 
16 Eyr I Argolikos 
17 Ocean 3 North Evoikos 
18 Zant 4 Korinthiakos 
19 Ler 1 South Aegian 
20 myt 1 North Aegian 
21 Makr 9 South Evoikos 
22 Kant 18 Saronikos 
23 Vas I South Evoikos 
24 AqH 3 South Evoikos 
101 
and Geographical distribution of fish farms mentioned in the study. 
I Bacteria[ Strain - summary statistics 
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Geographical region strain 
Gulf No Sites No Strains 
1 Patraikos 1 4 
2 North Aegian 2 2 
3 Saronikos 6 45 
4 Argolikos 2 4 
5 Korinthiakos 1 4 
6 South Evoikos 4 17 
7 South Aegian 1 1 
8 North Evoikos 4 10 
9 Ionian sea 3 14 
24 101 
The aim was to include bacterial pathogenic bacteria that caused mortalities in the field 
from fish farms throughout Greece. Bacterial isolation was coupled with parasitological 
analysis and histopathological analysis but these data are not included here because 
they are beyond the scope of this study. 
3.1.3 API 20E biochemical profiles: Number of strains -% incidence 
Table 17, demonstrates the biochemical profile of the bacterial strains isolated from 
diseased sea bass. 93.1 % of these strains are Gram- while 6.9% are Gram + cocci. 
Among the 87 strains isolated, 21.85% exhibited 12 biochemical profiles from which 
species identification was not possible. The rest (78.15%) exhibited 14 biochemical 
profiles and were identified as 
* Vibrio anguillarum 1 phenon 4b 33.3% 
* V. alginolyticus 8.05% 
* V. anguillarum 1 phenon 2 6.9% 
* V. parahaemolyticus 2.3% 
* V. fluvialis 1.15% 
* V. vulnificus 1.15% 
* Pseudomonas fluorescens 1.15% 
4, Flavobactedum meningosepticum 2.30% 
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,, 
Aeromonas salmonicida 1.15% 
. Photobacterium damsela subsp. piscicida 2.30% 
Gram+ cocci (6 strains) constituted 6.9% of the bacterial strains isolated. These were 
isolated from 4 different fish farms in 3 different geographical regions. Vanguillaruml 
phenon 4b (Grizez et al., 1991) was the dominant bacterial strain being isolated from 
diseased sea bass in 12 fish farms (33.33%). 
Table 17: Bacterial Strains isolated from Sea Bass (Dicentrarchus labrax) 
A/A Sea Bass 
Api20E 
Code number No' 
1 0003004 Agrl, Agr2 2 
2 0000004 Kant4 1 
3 1003004 KantI, Kant 17, MakrI 3 
4 1007004 Kant 2, RP1 , Flavobacerium menigosepticum 2 
5 1047524 Petr3, Ovr5, Prapl, Lerl, Ka12, P12, V. anguillarum 1 phenon 2 6 
6 1047724 Ovr2 1 
7 2000104 Ovr3 A. salmonicida 1 
8 2200004 Ast2, Pseudomonasfluorescens81% 1 
9 2004004 Nous7, Nous8, Photobacteriurn damsela subsp. piscicida 2 
10 3047524 Petr2, P13A Ovr6,7, Makr 2,4,5,6,8,10 Kant8,9,12,14,15, Prap 
3,4,5, Sf2,3, NE1, Deepl, Mytl, Chiosl, SF11, KallO, 11,12 
V. anguillarum 1 phenon 4b 
29 
11 3003004 Kant3 1 
12 3042524 Makr3 1 
13 3044125 Astl, probably (V. fluvialis) 1 
14 4046105 Prap2, V. parahaemolyticus 1 
15 4046505 Ovr4 1 
16 4047520 Ovrl, V. alginolyticus 1 
17 4047125 Ocean3, V. alginolyticus 1 
18 4114735 Nous4, V. parahaemolyticus (ALO test: -++& SAC - 1 
19 4146505 Nous 6 1 
20 4146525 Nous2, Nous3, Kant5, Kai 8, V. alginolyticus 4 
21 4144525 Oceanl, Kant7,19, SF11 4 
22 4174525 Kantl 6 1 
23 4366525 Kant6 1 
24 4347525 Nousl, V. alginolyticus 1 
25 5046105 Ocean 2, V. vulnificus 1 
26 6144525 Nous 5 1 
27 Gram+ cocci PI 1, EyrI, Argo2, Kantl 0, Kantl 1, Kantl 3 6 
28 
1 
Gram+ cocci I 
Argol 
u 
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Table 18: Bacterial Strains isolated from Sea Brearn (Sparus aurata), Sharpsnout brearn 
(Puntazzo puntazzo), Common dentex (Dentex dentex) and Grey mullet (Mugif cephalus) 
A/A Sea Bream 
Api 20E 
Code number No 
1 oomoo Zant4 1 
2 0004125 Zant3 V. ordalii 1 
3 0040777 Fido2 1 
4 0002000 Ast3 1 
5 1004124 Zant2, Pasteurella sm). 1 
6 2005024 Vasni I, Photobacterium damsela subsp. piscicida. 1 
7 4146525 AqHl, V. a1gino1yticus 1 
8 4154525 Fidol, V. alginolyticus (ALO test: -++ 
9 5144565 Fido 3 
10 5446025 Aq. H3 
11 5046305 Fido4 
12 6005004 Makr7, Ka14, Listonella damsela 99.5% 2 
13 6544164 Aq. H2 1 
14 7005100 Zantl 1 
15 Gram+cocci Argo3, Kall 2 
17 
A/A Punt. Puntazz 
o Api 20E 
Code number No I 
1 4144525 Ka16 probably V. alginolyticus (ALO test: -++ 1 
2 3047524 Kal3, Kal 9, V. anguillarum 1 2 
3 4154525 Ka17 1 
4 6005004 Ka15 , Listonella damsela 99.5% 
u 
A/A Dentex. 
Dentex Api 
Code number No I 
1 Gram+cocci RP2, RP4 2 
AJA Mugli 
cephalus Api 
Code number No 
1 Gram+cocci RP3 
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Table 18, demonstrates the biochemical profiles reported for bacterial strains isolated 
from sea bream, sharpsnout bream, common dentex and grey mullet. 
In sea bream where 16.83% (17) of the bacterial strains were identified among the 95 
biochemical profiles (API 20E) only 6 allowed reasonable identification. 88.24% of the 
strains were Gram- and 11.97% were Gram + cocci. 
,, V. ordalli 5.88% 
V. alginolyticus 11.76% 
Photobacterium damsela subsp. piscicida. 11.76% 
. Listonella damsela 11.76% 
0 In sharpnout bream 80% of the strains were identified as 
" V. alginolyticus 20% 
" V. anguillaruml phenon4b 40% 
. Listonella damsela 20% 
while in common dentex and grey mullet 100% of the bacterial strains were Gram+ 
cocci. 
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3.1.4 API biochemical profiles: frequency and % incidence statistical analysis 
Table 19: Frequency of different biochemical profiles 
Api 20E Profile Frequency Api 20E Frequenc 
1003004 3 211 ZMR 5 
1004124 1 4154525 2 
1007004 2 4174525 1 
1047524 6 4347525 1 
1047724 1 4366525 1 
2000104 1 5046105 1 
2004004 2 5046305 1 
2005024 1 5144565 1 
2200004 1 5446025 1 
3003004 1 6005004 3 
3040125 1 6114525 1 
3042524 1 6544164 1 
3047524 30 7005100 1 
4046105 1 Gram- cocci 1 
4046505 1 Gram+ cocci 11 
4047125 1 0044777 1 
4047520 1 0002000 1 
4114735 1 0003004 2 
4144525 5 0004125 1 
4146505 1 0004000 1 
0000004 1 
TOTAL 101 
Table 19, demonstrates all the API 20E biochemical profiles reported in this study along 
with their frequency. Vibrio anguillaruml phenon 4b was the dominant isolate while 
Gram+ cocci were very common in all fish species (10.9%). 
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3.1.5 API identifiable biochemical profiles: number of strains and % incidence 
Table 20, presents different bacterial strains identified by API 20E. The identification of 
the strain, their API 20E profiles, their code name along with their origin and % incidence 
are presented. 
Table 20: Biochemical profiles of identified bacterial strains 
A/A Bacterium Api20E Code No 
I L. damsela 6005004 Ka14 Makr7 Kal5 3 
2 V. vulnificus 5046105 Ocean2 1 
3 V. alginolyticus 4047520 Ovrl 1 
V. alginolyticus 4347525 Nousl 1 
V. alginolyticus 4146525 Nous2,3 Kant5 KaI8, AqHl 5 
V. alginolyticus 4047125 Ocean3 1 
V. alginolyticus 4144525 Ka16 1 
V. alginolyticus 4154525 Fidol 1 
4 V. anguillarum 1 3047524 Petr2, P13,4, Ovr6,7, Makr 2,4,5,6,8,10 
Kant8,9,12,14,15, Prap 3,4,5, Sf2,3, NE 
1, Deepl, Mytl, Chiosl, SF11, 
KallO, l 1,12 Ka13, Kal9 
31 
5 V. anguillarum 1* 1047524 Petr3 Ovr5 Prapl Lerl Ka12 P12 6 
6 V. parahaemolyticus 4046105 Prap2 1 
7 V. ordalii 0004125 Zant3 1 
8 Pseud. fluorescens 2200004 Ast2 1 
9 Photobacterium 
damsela subsp. 
piscicida 
1004124 Zant2 1 
Photobacterium 
damsela subsp. 
piscicida 
2005024 Vasnil 1 
Photobacterium 
damsela subsp. 
piscicida 
2004004 Nous7, Nous8 2 
10 Gram+ cocci PI 1, Eyrl, Argol, Kantl 0, Kantl 1, 
Kantl3, Argo3, Kai 1, RP2, RP4, RP3 
11 
11 Gram- cocci Argo2 
12 Flavobacterium spp 1 1002004 Kantl, 17, Makrl 3 
173 1 
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3.1.6 Bacterial strains - farms: % incidence per geographical region 
Figure 16: Graphical Presentation, Bacterial Strains /Geographical distribution 
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This percentage refers to the number of isolates among the identified bacterial strains in 
this study giving an indication of the clinical relevance of these bacterial pathogens. 
3.1.7 Bacterial Strains: Antibiogram data Summary 
The presentation of the Quantitative Antibiograrn data in the Table 21 is based on the 
following condition: The bacterial isolates were considered resistant to certain 
81 
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antimicrobials when the zone of inhibition to the antimicrobial ranged between diameter 
of the 6 and 15 mm, of intermediate resistance exhibited when zones of inhibition varied 
between 15 and 25 mm and susceptible when zones of inhibition shared a diameter 
greater than 25 mm. 
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Table 21: Presentation of the Quantitative Antibiogram data for bacterial isolates 
Farm Strain Fish 
Species 
AP120E 
profile 
OTC OA SXT FIR 0129 P NV AMP 
1 Rpl Bass 1007004 1 S S S I S 
Rp2 Dentex Gram+ cocci S R S I R I 
Rp3 Mugil Gram+ cocci S R S S R S 
Rp4 Dentex Grarn+ cocci S R S S R 1 
2 Argol Bass Gram- cocci S R S R I S 
Argo2 Bass Gram + S R S R S R 
Argo3 Bream Grarn+ cocci S R S I R I 
3 SF1 Bass 4144525 S S S S R 
SF2 Bass 3047524 R S S S S R 
SF3 Bass 3047524 S S S I S R 
4 NE1 Bass 3047524 S S S S S R 
5 Deepl Bass 3047524 S S S I S R 
6 Astl Bass 3040125 S S S S I S 
Ast2 Bass 2200004 S S I S S I 
Ast3 Bream 0002000 S R S I R S 
7 Ovrl Bass 4047520 S I I I S R 
Ovr2 Bass 1047724 S R R R R R 
Ovr3 Bass 2000104 1 R I R R R 
Ovr4 Bass 4046505 1 1 1 1 R R 
Ovr5 Bass 1047524 S I I I R R 
Ovr6 Bass 3047524 S S S S S R 
OW Bass 3047524 S I I R R 
8 Kall Bream Gram+ cocci S R S S R S 
Ka12 Bass 1047524 S S S I 
Ka13 Puntazzo 3047524 S R I R R R 
Ka14 Bream 6005004 S S I S R R R R 
Ka15 Puntazzo 6005004 S I S I I S 
Ka16 Puntazzo 4144525 S I I I I R 
Ka17 Puntazzo 4154525 S R I I 
I 
R R R 
KaI8 Bass 4146525 S S S S R R R R 
Ka19 Puntazzo 3047524 S S S I I I R R R 
- KaII0 Bass 3047524 S S R S S S R S R 
Kaill Bass 3047524 S S S S S S 
KaI12 Bass 3047524 S S S S S R I R 
I Pill Bass Gram + S R I R R R 
P12 Bass 1047524 S S S S 
P13 Bass 3047524 S S S S 
P14 Bass 3047524 S S S S S R 
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Farm Strain Fish 
Species 
AP120E 
profile 
OTC OA SXT FIR 0129 P NV AMP 
10 Agrl Bass 0003004 S R S I R S 
Agr2 Bass 0003004 S R S I R S 
11 Petr2 Bass 3047524 S S S S S R 
Petr3 Bass 1047524 S S S S R 
12 Chiosl Bass 3047524 S S S S S R 
13 Nousl Bass 4347525 S I S I R I 
Nous2 Bass 4146525 S S S S R R 
Nous3 Bass 4146525 S I S I R R 
Nous4 Bass 4114735 S S S I R 
Nous5 Bass 6114525 
Nous6 Bass 4146505 S I I I R R R 
Nous7 Bass 2004004 R 
Nous8 Bass 2004004 R R S S R R S 
14 Fidol Brearn 4154525 S I I I I R 
Fido2 Bream 0044777 S I S I R R 
Fido3 Brearn 5144565 S I S I I R 
Fido4 Brearn 5046305 R I R I R R 
15 Prap'l Bass 1047524 S S S S S R 
Prap2 Bass 4046105 S I I I R R 
Prap3 Bass 3047524 S S S S R R 
Prap4 Bass 3047524 S S S S I I 
Prap5 Bass 3047524 S S S S I I R 
16 Eyrl Bass Gram+ 
cocci 
S R S S R S 
17 Oceani Bass 4144525 1 R I I R R R 
Ocean2 Bass 5046105 S I S I R R R 
Ocean3 Bass 4047125 S R I R R R 
18 Zantl Brearn 7005100 S S I I R 
Zant2 Brearn 1004124 S I S I I R R 
Zant3 Brearn 0004125 S S S S S R I I 
Zant4 Brearn 0004000 R R R R R R R 
19 Led Bass 1047524 S S S S S R 
20 myti Bass 3047524 S S S I R R R R 
24 AqHI Brearn 4146525 1 R I R R R R 
AqH2 Brearn 6544164 R S R I R R I R 
AqH3 Brearn 5446025 1 1 1 1 R R R I 
21 Makrl Bass 1003004 1 S S S I S 
Makr Bass 3047524 S S S S S R 
Makr3 Bass 3042524 S S S S R R 
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Farm Strain Fish 
Species 
AP120E 
profile 
OTC OA SXT FIR 0129 P NV AMP 
Makr4 Bass 3047524 1 S S S I S 
Makr5 Bass 3047524 S S S S S R I 
Makr6 Bass 3047524 S S S S S R I 
Makr7 Bream 6005004 S S S I I R 
Makr8 Bass 3047524 S S S S S R 
Makrl 0 Bass 3047524 S S S S S 1 
22 Kand Bass 1003004 1 1 S S R S 
Kant2 Bass 1007004 1 S S S I 
Kant3 Bass 3003004 1 R S R R S 
Kant4 Bass 0000004 S S S R R 
Kant5 Bass 4146525 S I S I R R 
Kant6 Bass 4366525 S R S S R R 
Kant7 Bass 4144525 S I S I I R 
Kant8 Bass 3047524 S S S S S R 
Kant9 Bass 3047524 S S S S S R 
Kand 0 Bass Gram+ I R R R I 
Kantl 1 Bass Gram+ S R S R R 
Kand 2 Bass 3047524 S S S S S 
Kant13 Bass Gram+ S S S I S R 
Kant14 Bass 3047524 S S S S 
Kantl 5 Bass 3047524 S S S S S R 
Kant16 Bass 4174525 1 R I R R R 
Kantl 7 Bass 1003004 1 1 S S; I I R 
Kant 19 Bass 4144525 
- - 
S S S S S S 
-- 
I 
23 Vasnil Bream 20056 2 4 S. S S S R I ýF 
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3.1.8 Resistant bacterial strains: API 20E profiles 
Table 22: Presentation of resistant biochemical profiles of bacterial isolates 
Oxolinic 
Acid Oxytetracycline 
Potentiated 
Sulphonarnides Furazolidone 
1047724 2004004 1047724 1047724 
2000104 5046305 5046305 200104 
2004004 6544164 6544164 3003004 
3003004 0004000 0004000 4047125 
4047125 
4366525 
Gram- cocci 
Gram+ cocci 
0002000 
0003004 
00040001 
The API 20E profiles that exhibited resistance to each of the four most commonly used 
antimicrobials in aquaculture. V. anguillarum 1 phenon 2 exhibited resistance to OA, Pot. 
Sulphonamides and Furazoliclone while Gram+ and Gram- cocci were resistant only to 
oxolinic acid. 
3.1.9 Bacterial Strains: Statistical analysis-Anti biotic sensitivity %& 
frequency 
Table 23, presented the Antibiotic Sensitivity % incidence distribution of the bacterial 
strains for Oxytetracycline, Oxolinic acid, Potentiated Sulphonamides, Furazolidone, 
Penicillin, Novobiocin and Ampicillin. 
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Table 23: Antibiotic Sensitivity frequencies 
Oxolinic Acid Frequency Arnpicillin Frequency 
Susceptible 51 Susceptible 2 
Intermediate 21 Intermediate 3 
Resistant 26 Resistant 16 
Missing 3 Missing 80 
101 101 
Penicilin Frequency Novobiocin Frequency 
Susceptible 13 Susceptible 5 
Intermediate 7 Intermediate 10 
Resistant 48 Resistant 19 
Missing 33 Missing 67 
101 101 
P. Sulphonamides Frequency Furazolidone Frequency 
Susceptible 73 Susceptible 48 
Intermediate 20 Intermediate 35 
Resistant 7 Resistant 14 
Missing 1 Missing 4 
101 101 
Oxytetracycline Frequency 
Susceptible 80 
Intermediate 14 
Resistant 5 
101 
3.1.10 Vanguillarum I API 20E-3047524: Antibiotic sensitivity %& 
frequency 
Table 24: Statistical Analysis of Antibiotic Sensitivity 
Frequencies and Percentages of Vanguillarum I AP120E: 3047525 
OA OTC SXT FR p 
Fr % Fr % Fr % Fr % Fr % 
Susceptible 28 93.3 28 93.3 27 90.0 23 79.3 13 19.1 
Intermediate 1 3.3 1 3.3 
1 
2 6.7 5 17.2 7 10.3 
Resistant 1 3.3 1 3.3 1 3.3 1 3.4 48 70.6 
(missing) - 33 
Table 24 shows the susceptibility profile of the dominant bacterial isolate (Vibrio 
angufflarum 1 phenon 4b) to five antimicrobial agents. It is clear that this strain exhibited 
susceptibility to Oxytetracycline, Oxolinic acid, Potentiated Sulphonamides and 
Furazolidone while showing resistance to Penicillin. 
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3.1.11 Statistical Analysis (cross tabulation) of antibiograrn data in each 
farm 
In 4 (16.6916) farms (Farms 2,10,16,17) only resistant strains to oxolinic 
acid were isolated while in 9 (37.5%) farms (3,4,5,11,12,, 19,20,22,24) 
only oxolinic acid susceptible strains were isolated. 
Regarding oxytetracycline 14 (58.3%) farms demonstrated only 
susceptible bacterial isolates while in only 1 (4.16%) farm 21 
intermediate and 8 resistant strains were isolated. Potentatiated 
sulfonamides gave similar result. 
In 13 fish farms (54.1%) (2,4,5,6,8,9,10,11,12,15,16,19,20,24) only 
susceptible strains were isolated and in 1 farm (21) (4.16vo) 
intermediate and resistant strains were dominant. Furazolidone 
resistance only analysis indicated that only susceptible strains were 
reported in 5 farms (20.8%) (4,11,12,16,19) while, in 3 farms (12.5916) 
(2,17,21) only resistant strains were isolated. 
Concluding the analysis of these data referring to antibiotic resistance profiles to 4 
antibiotics of bacteria isolated in each farm, least resistance was reported in farms 
4,11,12, and 19 (susceptible strains to 4 antibiotics) while in farms 3,16,20 and 24 strains 
susceptible to 3 antibiotics were reported. On the other hand, farm 21 provided strains 
resistant to 3 antibiotics, farms 2& 17 to 2 antibiotics. Only in farm 21 it is possible to 
comment that the incidence of only one strain that is resistant to 3 antibiotics could 
indicate inappropriate use of antibiotics in the farm. In the majority of the farms bacterial 
strains exhibited all the range from sensitivity to intermediate resistance, as well as 
resistance to antimicrobial agents tested. 
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Table 25: Statistical Analysis (Cross tabulation) of Antibiogram data 
in each fish farm 
Oxolinic 
Acid 
Oxytetracycline Potentiated 
Sulphonamides 
Furazolidone 
Farms with ONLY 3,4,5,11,12, 2,4,5,6,8,9,10, 1,2,3,4,5,10, 4,11,12,16,19 
Susceptible Bacterial 19,20,22,24 11,12,15,16,19, 11,12,16,19,20, (20.83%) 
strains (%) (37.5%) 20,24 (58.3%) 22,24 (54.16%) 
Farms with only 
Resistant or 2,10,16,17 21 21 2,17,19 
Intermediate and (16.6%) (4.1%) (4.1%) (12.5%) 
resistant strains (%) 
3.1.12 Statistical Analysis (% & frequency) of multiresistant bacterial 
strains 
Table 26: Statistical Analysis Frequency of multi-resistant bacterial strains 
Value Frequency Value Frequency 
1111 5 0200 5 
1212 2 0201 5 
1222 3 0202 3 
2121 1 0211 2 
2222 1 0212 2 
0000 1 0222 1 
0001 31 1000 4 
0002 7 1100 2 
0010 1 1202 1 
0011 2 1202 1 
0020 1 1211 1 
0101 9 2000 1 
0 6 2021 1 
0112 1 2200 101 
The parameter Value on the above table refers to a four-digit figure. Number 2 is used to 
demonstrate Resistance to antibiotics, 1 refers to strains of intermediate resistance and 
0 is used to demonstrate susceptibility to antimicrobials. In the four digit numbers the first 
refers to resistance to Oxytetracycline, the second to Oxolinic acid, the third to 
Potentiated Sulphonamides and the last to Furazoliclone. Profile 0000 for example 
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means susceptibility to all four antimicrobials, 1111 intermediate resistance to all and 
2222 resistance to all antimicrobials. Resistance to four antimicrobial agents was 
exhibited by 1% of the strains, intermediate resistance (1111 profile) was present in 2% 
and susceptibility to all four was present in 30.7% of the bacterial strains. Sixty nine point 
three percent (69.3%) of the strains exhibited intermediate resistance and / or resistance 
to at least one antimicrobial agent. Twelve percent (12%) of the strains were resistant to 
two antimicrobial agents. Finally in 74% of the strains same pattern of resistance was 
evident for both Oxolinic acid and Furazolldone. 
3.1.13 Statistical analysis of % incidence of MIC values to OA and OTC 
Table 27: Statistical Analysis of % Incidence of MIC values to 
Oxolinic acid and Oxytetracycline 
Value OA OTC 
MIC (pg/ml) Frequency Frequency 
0.075 2 1 
0.15 23 6 
0.3 20 38 
0.625 18 25 
1.25 6 11 
2.5 2 4 
5 6 2 
10 3 2 
20 0 2 
40 3 2 
80 7 1 
160 0 1 
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Figure 1T Presentation of the frequency MIC value incidence 
of all bacterial isolates to Oxolinic acid and Oxytetracycline 
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Table 27, and Figure 17 demonstrate the statistical analysis and the graphical 
presentation of MIC value (ppm) distribution for all bacterial isolates regarding Oxolinic 
acid and Oxytetracycline. 
Table 28: Statistical Analysis of Oxolinic acid and Oxytetracycline 
MIC values in relation to Quantitative Antibiogram data 
Oxytetracycline Oxolinic Acid 
mic Susceptible Inter nediate Resistant Susceptible Intermediate Resistant 
0 14 0 0 2 4.8 0 
0.075 8.5 0 0 46 0 0 
0.15 7 0 0 22 4.8 0 
0.3 42.3 30.8 0 18 47.6 3.4 
0.625 22.5 30.8 0 6 33.3 20.7 
1.25 14.1 7.7 0 4 4.8 6.9 
2.5 4.2 7.7 0 0 0 10.3 
5 0 7.7 20 2 4.8 17.2 
10 0 15.4 0 0 0 6.9 
40 0 0 40 0 0 10.3 
80 0 0 20 0 0 24.1 
160 0 0 20 0 o 
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Figure 18 & Figure 19: Representation of the correlation between Quantitative Antibiogram data 
and M. I. C value of the bacterial isolates to Oxolinic acid and Oxytetracycline 
Figure 18: % Incidence of Oxolinic acid M. I. C values in 
relation to Quantitative Antibiogram Data 
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3.1.14 Statistical Analysis of OA/OTC MIC vs Quantitative Antibiogram Data 
The statistical analysis of the correlation between Quantitative Antibiogram data and 
M. I. C values for Oxolinic acid and Oxytetracycline was used in order to establish M. I. C 
breakpoints in relation to the categories obtained from the Quantitative AntibiDgram. The 
condition in order to establish M. I. C breakpoints in this study was the following: For each 
of the categories described in the Quantitative Antibiogram, M. I. C breakpoint was 
considered the M. I. C concentration under which at least 75% of the bacterial isolates of 
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this category belonged in. Employment of this condition made possible to consider the 
following M. I. C breakpoints for Oxolinic acid and Oxytetracycline. 
Table 29: M. I. C breakpoints for Oxolinic acid and Oxytetracycline. 
Oxolinic acid Oxytetracycline 
M. I. C 
breakpoints 
% Incidence M. I. C 
breakp ints 
% Incidence 
Susceptible < 0.3 88% < 0.625 81.7% 
Intermediate 0.15-1.25 85.7% 0.15-2.5 77% 
Resistant > 1.25 75.7% > 2.5 100% 
Strains of intermediate resistance considered belonging in a grey area and regarding the 
extrapolation of % incidence the presence of strains of intermediate resistance with 
MAL that ranged from 0 to 1.25 (Oxolinic acid) was taken under consideration. 
3.1.15 OAIOTC MIC vs Quant. Antiobiogram: Statistical Analysis each fish 
species 
Statistical analysis was based on the presentation of the % incidence of M. I. C values for 
strains that had been characterised as susceptible, intermediate and resistant using 
Quantitative Antibiogram techniques, as well as on the presentation of the actual 
numbers of the bacterial isolates. The aim was to deduct correlations between 
Antibiogram data and MAL values for each antibiotic and possibly for each fish species. 
The interpretation of the actual values seemed to be more effective tool in order to 
estimate M. I. C breakpoints. 
As M. I. C breakpoint for each antibiotic and each bacterial strain group (susceptible I of 
intermediate resistance / resistant) was defined the Minimum inhibitory concentration, 
which inhibited the growth of at least 80% of, the bacterial isolates of this group. 
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Sea Bass 
In sea bass as it is described in Table 29, Oxolinic acid M. I. C breakpoints were: 
Susceptible: < 0.3 pprn 
Intermediate: 0.3 - 0.625 ppm 
Resistant: > 0.625 ppm 
while the Oxytetracycline M. I. C breakpoints were considered the following: 
Susceptible: < 0.625 ppm 
Intermediate: 0.625 -5 pprn and 
Resistant: >5 ppm. 
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Table 30: Correlation of Oxolinic acid and Oxytetracycline MIC data 
and Antibiogram data for Sea bass 
Sea bass -Frequency% 
Oxo1inic Acid Oxytetracycline 
MIC Susceptible Intermediate Resistant Susceptible Intermediate Resistant 
0.075 100 0 0 100 0 0 
0.15 91.7 8.3 0 100 0 0 
0.3 
1 
57.1 35.7 7.1 86.2 13.8 0 
0.6251 11.1 44.4 44.4 82.4 17.6 0 
1.25 50 25 25 87.5 12.5 0 
2.5 0 0 100 66.7 33.3 0 
5 0 33.3 66.7 0 100 0 
10 33.3 0 66.7 0 100 0 
40 0 0 100 100 0 0 
80 0 0 100 0 0 100 
160 1 
0 01 100 
Number of Strains 
Oxo1inic Acid Oxytetracycline 
Mic Susceptible Intermediate Resistant Susceptible intermediate Resistant 
0.075 19 0 0 6 0 0 
0.15 11 1 0 3 0 0 
0.3 8 5 1 25 4 0 
0.625 11 4 4 14 3 0 
1.25 2 1 1 7 1 0 
2.5 0 0 1 2 1 0 
5 0 1 3 0 1 0 
10 1 0 2 0 3 0 
40 0 0 3 1 0 0 
80 0 0 3 0 0 1 
160 0 0 1 
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Figures 20,21,22,23: Correlation of Oxolinic acid and Oxytetracyline MIC data 
and Antibiogram data for Sea bass 
Figure 20: Sea bass: % Incidence of Oxolinic and M. I. C values in relation to 
Quantitative Antibiogram Data 
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Figure 21: Sea bass : Correlation of Oxolinic acid M. I. C data and 
Quantitative Antibiogram Data 
2u 
15 
Co 
M 10 
LO 
Groups of bacterial 
Pathogens 
(Antibiogram Data) 
Resistant 
termediate 
ceptible 
96 
(0 0 C) 6 C) 
00 
Oxolinic acid M. I. C values 
Figure 22: Sea bass: % Incidence of Oxytetracycline M. I. C values in relation to 
Quantitative Antibiogram Data 
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Figure 23: Sea bass: Correlation of Oxytetracycline M. I. C data and 
Quantitative Antibiogram Data 
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3.1.15.2 Sea Bream 
In sea brearn O. A M. I. C as well as OTC M. I. C breakpoint values were: 
Susceptible: < 0.625 ppm 
Intermediate: 
Resistant: > 0.625 ppm 
In this species MAL breakpoint was very clearly defined. 
Table 31: Correlation of Oxolinic; acid and Oxytetracycline M. I. C data 
and Antibiogram data for Sea brearn 
Sea Bream - Frequency % 
Oxo1inic Acid Oxytetracycline 
MIC Susceptible intermediate Resistant MIC Susceptible Intermediate Resistant 
0.075 100 0 0 0.15 100 0 0 
0.3 25 75 0 0.3 100 0 0 
0.625 33.3 50 16.7 0.625 60 40 0 
5 0 0 100 1.250 100 0 0 
80 0 0 100 2.5 100 0 0 
1 
5 0 0 100 
40 01 0 100 
1 1 80 q 0 1 100 
Number of Stra ins 
Oxo1inic Acid Oxytetracycline 
MIC Susceptible Intermediate Resistant MIC I Susceptible Intermediate Resistant 
0.075 3 0 0 0.15 1 0 0 
0.3 1 3 0 0.3 6 0 0 
0.625 2 3 1 0.625 3 
12 
0 
5 0 0 2 1.250 
,1 
0 0 
80 0 0 2 2.5 1 0 0 
5 
4 
0 0 1 
40 0 10 1 1 
80 0 1 
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Figures 24,25,26,27: Correlation of Oxolinic acid and Oxytetracyline M. I. C data and 
Antibiogram data for Sea bream 
Figure 24: Sea bream: % Incidence of Oxolinic acid M. I. C values in 
relation to Quantitative Antibiogram data 
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Figure 25: Sea bream: Correlation of Oxolinic acid M. I. C values and 
Quantitative Antibiogram data 
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Figure 26: Sea bream: % Incidence of Oxytetracycline M. I. C 
values in relation to Quantitative Antibiogram data 
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Figure 27: Sea bream: Correlation of Oxytetracycline M. I. C values 
and Quantitative Antibiogram data 
6 
m 
4) 
0 
0,15 
)ups of Bacterial 
strains 
Resistant 
ntermediate 
sceptible 
100 
U. 15 0,625 1.250 25 5 40 80 
Oxytetracycline M. I. C values 
Use of Antibiotics in Greek Mariculture University of Stiffing 
Sharpsnout bream 
In sharpsnout brearn the O. A M. I. C breakpiont values were defined as: 
Susceptible: < 0.075 ppm 
Intermediate: 0.075 - 0.3 pprn 
Resistant: > 0.625 ppm 
while all the bacterial strains were susceptible to OTC with MIC values less than 1.25 
PPM. 
In gray mullet bacterial strains (100% Gram + cocci) all were resistant to Oxolinic acid 
(M. I. C > 80 ppm) and susceptible to Oxytetracycline (M-I. C < 0.15 ppm). Finally in the 
case of Common dentex isolates (100% Gram + cocci) like the previous species all were 
resistant to O. A (M. I. C > 2.5) and susceptible to Oxytetracycline (M. 1-C < 0.625 ppm). 
OA resistance in these cases most likely refers to innate resistance rather that a result of 
antimicrobial chemotherapy. 
Table 32: Correlation of Oxolinic acid and Oxytetracycline MAL data 
and Antibiogram data for Sharpsnout bream 
Sharpsnout bream - Frequency % 
Oxo1inic Acid Oxytetracycline 
MIC Susceptible Intermediate Resistant MIC Susceptible Intermediate Resistant 
0.075 100 0 0 0.15 106 0 0 
0.3 0 100 0 0.3 100 0 0 
0.625 0 0 100 0.625 100 0 0 
1.25 1 01 01 100 1.250 100 
1 
0. 0 
Number of Stra ins 
Oxo1inic Acid Oxytetracycline 
MIC Susceptible Intermediate Resistant MIC Susceptible Intermediate Resistant 
0.075 1 0 0 0.15 1 0 0 
0.3 0 2 0 0.3 2 0 0 
0.625 01 01 1 0.625 11 01 0 
1.25 01 01 1 1.250 11 01 0 
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Figures: 28,29,30,31 -. Correlation of Oxolinic acid and Oxytetracycline M. I. C data and 
Antibiogram data for Sharpsnout bream 
Figure 28: Sharpsnout bream: % Incidence of Oxolinic acid 
M. I. C values in relation to Quantitative Antibiogram data 
Groups of bacterial 
a) 
L) 
r_ 
cu 
'D 
E 
c 
100 
80 
60 
40 
20 
o 
0,075 i 
strains 
Resistant 
71ntermediate 
Susceptible 
1,25 
0,625 
Oxolinic acid MIC data 
Figure 29: Sharpsnout bream: Correlation of Oxolinic acid M. I. C 
data and Quantitative Antibiogram data 
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Figure 30: Sharpsnout bream: % Incidence of Oxytetracycline M. I. C 
values in relation to Quantitative Antibiogram data 
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Figure 31: Sharpsnout bream: Correlation of Oxytetracycline MIC 
data and Quantitative Antibiogram data 
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3.1.15.4 Grey mullet and Common dentex 
Table 33: Correlation of Oxolinic acid and Oxytetracycline M. I. C data and Antibiograrn data for 
Grey mullet and Common dentex 
Grey mullet - Frequency % 
Oxolinic Acid Oxytetracycline 
mic Susceptible Intermediate R sistant mic Susceptible Intermediate Resistant 
80 0 0 100 0.15 
1 
100 0 0 
Number of Strains 
Oxolinic Acid Oxytetracycline 
mic Susceptible Intermediate R sistant Susceptible Intermediate Resistant 
80 0 0 2 0.15 2 0 0 
Common dentex - Frequency % 
Oxo1inic Acid Oxytetracycline 
mic Susceptible Intermediate Resistant mic Susceptible Intermediate Resistant 
2.5 0 0 100 0.625 100 0 0 
5 0 0 100 
Number of Strains 
Oxo1inic Acid Oxytetracycline 
mic Susceptible Intermediate Resistant Susceptible Intermediate Resistant 
2.5 0 0 2 0.625 3 0 0 
5 0 0 
It is important to note that this cross-bacterial species analysis of MIC and the cross 
reference to antibiogram categorization of resistance or susceptibility serves more the 
fish pathologist on the field but little to the future studies but referring to a certain 
population of bacterial pathogens from Greek Mariculture industry and for the period 
1994-1997 gives a broad quantified picture of antibiotic resistance level of the most 
clinically relevant bacterial pathogens. These data are much more relevant for sea bass 
which contributed the majority of the strains and is subject to the majority of pathological 
conditions and therefore the bulk of antibiotic application. 
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However a specific analysis of MIC analysis is given for the major bacterial pathogen 
Vibrio anguillarum in order to have specific data that could be compared with future 
epidemiological studies that will attempt to quantify bacteria[ resistance in Mediterranean 
Mariculture. 
3.1.15.5 Vibrio anguillarum MIC-Quantitative Antibiogram correlation 
Tables 34: Correlation of OA / OTC Quantitative antibiogram data for Vangufflarum 
Vangufflarum Oxytetracycline Oxolinic acid % distribution 
6-15 mm 3% 6% Resistant 
15-25 mm 6% 3% intermediate 
>25 mm 91% 91% Susceptible 
For each of the categories described in the Quantitative Antibiogram, we described the 
frequencies and in order to establish M-I-CoA M-1-CoTc breakpoints for Vibrio 
anguillarum we employed concentration under which at least 80% of the bacterial 
isolates of this category belonged in. Employment of this condition made possible to 
consider a level of 0,3 ppm as M. I. CoA and 0,625 ppm as M-1-COTC for V. anguillarum 
(Table 35). 
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Tables 35: Correlation of MIC and OA / OTC data for V. anguillarum 
OXYTETRACYCLINE MIC - Vibrio a nguillarum (32 s trains) 
MICVAWE FREQUENCY PERCENT 
CUMULATIVE 
PERCENT 
0.075 4 12,5% 12,5% 
0.15 3 9,4% 21,9% 
0.3 11 34,4% 56,3% 
0.6 9 28,1% 84,4% 
1.25 4 12,5% 96,9% 
1160 1 3,1% 100,0% 
1 321 100,0% 
OXOLINIC ACID MIC - Vibrio an uillarum (32 strains) 
MICVAWE FREQUENCY PERCENT 
CUMMULATIVE 
PERCENT 
0.075 18 56,3% 56,3% 
0.15 6 18,8% _ 75,0% 
0.3 3 9,4% 84,4% 
0.6 1 3,1% 87,5% 
1.25 3 9,4% 96,9% 
180 1 3,1% 100,0% 
1 321 100,0%1 
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3.1.16 API 20E profiles: Cluster analysis-Eucleidian distances dendrogram 
Different phenotypes of Vibrio alginolyticus formed a distinct cluster, while Vanguillarum 
phenon 4b and phenon 2 (Crisez et al 1991) formed close related clusters. Statistical 
interpretation of API 20E data according to the NORDIC manual and employing the ALO 
test (ADH / LDC / OX) revealed that Alo test could be used in order to separate 
Vanguillarum 1 phenon 4b and V. anguillarum 1 phenon 2 along with Listonella damsela 
and Valginolyticus different phenotypes. It was not however possible to be employed 
for the discrimination between V-parahaemolyticus, V. vulnificus and Valginolyticus 
which formed in this type of statistical analysis the same cluster (Figure 32). 
P Christortlogiormis 107 
Use of Antibiotics in Greek Mariculture University of StjjjiRq 
Figure 32: Hierarchical Cluster Analysis 
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3.2 OXOLINIC ACID KINETICS 
3.2.1 Development of Bioassay method for OA detection 
Interpretation of Bioassay results consisted of the presentation of the raw data and the 
statistical analysis of Oxolinic acid residue detection method. In the first step Table 37 
presented the zones of inhibition measured in triplicate in three bioassay plates for the 
detection of method accuracy in the detection of standard dilutions of Oxolinic acid. Each 
bioassay plate is presented as trial 1,2 and 3 while details of the method like pH and 
inolulum size are presented. The detection limit of the method detecting standard 
dilutions of O. A was 125 ppb O. A. The statistical analysis of these trials was presented 
in the following table (Table 36). In trial2 the concentration of 32ppm pf O. A was not 
considered because of odd readings. 
Table 36: Oxolinic acid residues detection bioassay method 
Standard dilutions - Statistical analysis 
Trial 1 R-squared: 98.63%, slope: 9.2, Intercept: 23.05 
Trial 2 R-squared: 98-69%, slope: 11.01, Intercept: 20.71 
Trial 3 R-squared: 96.41%, slope: 11.65, lntercept: 20.17 
('Concentration 32ppm O. A was not considered) 
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Table 37: Oxolinic acid residues detection bioassay method Standard dilutions 
Bioassa trial 1- oxolinic acid pH=9,45 sa ple: 50pl 
number O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median 
1 32 1,505 35,69 36,66 35,93 36,09 35,93 
2 16 1,204 36,05 33,74 33,58 1 34,46 33,74 
3 8 0,903 30,83 31,8T 32,53 31,74 31', 87 
4 4 0,602 25,55 27,71 28,72 27,33 27,71 
5 2 0,301 26,27 27,81 26,04 26,71 26,27 
6 1 0,000 23,87 22,99 24,07 23,64 23,87 
7 0,5 -0,301 21,10 21,48 21,03 21,20 21,10 
8 0,25 -0,602 16,53 17,84 18,88 17,75 17,84 
9 0,125 -0,903 13,48 13,91 12,77 13,39 13,48 
10 0,06 -1,221 
11 0,03 -1,522 
12 01 
Bioass y trial 2- oxolinic cid pH= 9,45 sa ple: 50pi 
number O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median 
1 32 1,505 33,31 32,46 34,68 33,48 33,31 
2 16 1,204 32,47 32,9 34,83 33,40 32,90 
3 8 0,903 31,28 29,43 28,47 29,73 29,43 
4 4 0,602 27,49 28,41 28,06 27,99 28,06 
5 2 0,301 26,1 22,33 23,65 24,03 23,65 
6 1 0,000 21,25 23,2T 21,45 21,98 21,45 
7 0,5 -0,301 17,83 18,28 19,15 18,42 18,28 
8 0,25 -0,602 13,42 14,55 13,79 13,92 13,79 
9 0,125 -0,903 8,71 9,47 10,1 9,43 9,47 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
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Bloassay trial 3- oxolinic acid pH=9,7 sample: 50pl 
number O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median 
1 32 1,505 37,91 33,89 41,86 37,89 37,91 
2 16 1,204 31,93 32,54 32,94 1 32,47 32,54 
3 8 0,903 33,86 30,64 29,41 31,30 30,64 
4 4 0,602 28,09 26,91 29,62 28,21 28,09 
5 2 0,301 28,65 19,23 24,45 24,11 24,45 
6 1 0,000 21,08 25,8 20,82 22,57 21,08 
7 0,5 -0,301 17,84 17,32 22,77 19,31 17,84 
8 0,25 -0,602 10,93 12,43 11,97 11,78 11,97 
9 0,125 -0,903 8,34 8,3 8,49 8,38 8,34 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
In the next stage data from bioassay trials employing "spiked" serum samples were 
presented. The detection limit of the bioassay for "spiked " serum samples was 125 ppb. 
The data from these trials (Trial 1,2) were presented in Table 38 along with method 
technical data. The statistical analysis of the "spiked "serum trials was presented in 
Table 39. 
Finally, the data from the detection of O-A in "spiked " muscle samples using this 
bioassay method were presented along with the statistical analysis. The detection limit of 
the method for muscle samples was 250 ppb O. A. For the statistical analysis only the 
zones of inhibition regarding O. A concentrations from 250ppb to 32 ppm were 
considered because the zones of inhibition seemed to reach a plateau at this 
concentration giving odd readings in higher concentrations. Another test that was 
performed involved the Operator testing. Bioassay methods rely on the Subjectivity of 
the Operator and his capacity to read in the same manner small distances down to two 
decimal points using a digital caliper. Three plates (plate 1,2 and 3) were employed in 
this trial using "spiked" muscle samples. In each of these plates readings were taken by 
two operators (tests A and B). The statistical significance of the difference in the 
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readings of the two operators was examined (S. P. S. S o) using Paired T-test. The 2- 
tailed significance value (p value) was higher than 0.05 suggesting that there were no 
statistically significant differences between the readings. The data from the trial using 
"spiked " muscle were presented in the Tables 40,41,42 while the statistical analysis and 
P-values were demonstrated in the Table 43. 
P. Christorilogiannis 112 
Use of Antibiotics in Greek Mariculture University of Stiffing 
Table 38: Oxolinic acid residues detection bioassay method 
"Spiked" serum samples - Statistical analysis 
Trial 1 R-squared: 98.85%, slope: 11.81, Intercept: 18.82 
Trial 2 R-squared: 98.65%, slope: 11.97, Intercept: 20 
Table 39: Oxolinic acid residues detection bioassay method - Spiked serum samples 
Bioassay serum (25pl) - oxolinic acid d lution (25pl) TRI LI pH= . 55 samp e: 50pl 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Average Median 
1 32 1,505 34,94 35,99 34,95 35,29 34,95 
2 16 1,204 32,1 32,38 32,52 32,33 32,38 
3 8 0,903 29,95 29,65 29,54 29,71 29,65 
4 4 0,602 27,07 26,66 26,5 26,74 26,66 
5 2 0,301 24,75 23,73 22,92 23,80 23,73 
6 1 0,000 19,53 20,52 20,07 20,04 20,07 
7 0,5 -0,301 15,82 15,02 16,04 15,63 15,82 
8 0,25 -0,602 10,46 _1 
0,25 11,47 10,73 10,46 
9 0,125 -0,903 7,03 7,03 7,03 
10 0,06 -1,221 
11 0,03 -1,522 
0 
Bioassay serum(25pl) - oxolinic acid di lution (25pl) TRIA L2 pH=7.55 samp e: 50PI 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C_ Average Median 
1 32 1,505 36,96 36,09 36,34 36,46 36,34 
2 16 1,204 34,6 34,1 34,12 34,27 34,12 
3 8 0,903 31,52 31,21 30,51 31,08 31,21 
4 4 0,602 26,96 28,24 27,63 27,61 27,63 
5 2 0,301 24,44 24,28 24,13 24,28 24,28 
6 1 0,000 20,77 21,95 22,2 21,64 21,95 
7 0,5 . 0,301 16,95 18,44 17,38 17,59 17,38 
8 0,25 -0,602 12,3 11,56 11,65 11,84 11,65 
9 0,125 -0,903 7,1 8,16 - 
7,63 63 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
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Table 40: Oxolinic acid residues detection bioassay method 
"Spiked" Muscle samples Trial 1- Plate I 
Bioassay muscle 50pl) TRIAL 1p ate I tes tA1 )H=7.55 sample: 501 il 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Avera e Median 
1 64 1,806 32,20 33,53 32,34 32,69 32,34 
2 1 32 1,505 30,82 
_31,01 
33,94 31,92 31,01 
3 16 1,204 27,05 29,74 30,38 29,06 29,74 
4 8 0,903 26,63 25,37 23,56 25,19 25,37 
5 4 0,602 21,57 24,2 22,84 22,87 22,84 
6 2 0,301 20,12 19,37 21,46 20,32 20,12 
7 1 0,000 16,32 18,44 15,72 16,83 16,32 
8 0,5 -0,301 13,47 13,18 15,22 13,96 13,47 
9 0,25 -0,602 11,75 10,92 11,29 
_ 11,32 11,29 
10 0,125 -0,903 
11 0,06 -1,221 
12 0,03 -1,522 
13 0 
T - 
Bioassay muscle (50pl) TRIAL 1p ate 1 tes tB PH=7.55 sample: 5 pl 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Averaue Median 
1 64 1,806 30,58 33,10 32,01 31,90 32,01 
2 32 1,505 32,01 31,91 32,97 32,30 32,01 
3 16 1,204 26,35 29,81 30,3 28,82 29,81 
4 8 0,903 26 25,19 24,68 25,29 25,19 
5 4 0,602 21,4 24,35 23,34 23,03 23,34 
6 2 0,301 20,21 20,09 21,1 20,47 20,21 
7 1 0,000 15,62 18,9 16,12 16,88 16,12 
8 0,5 -0,301 13,83 13,07 15,63 14,18 13,83 
9 0,25 -0,602 11,96 10,97 11,16 11,36 11,16 
10 0,125 -0,903 
11 0,06 -1,221 
12 0,03 -1,522 r 
13 0 -4 
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Table 41: Oxolinic acid residues detection bioassay method 
"Spiked" Muscle samples Trial 1- Plate 2 
Bioassay muscle (50pl) TRIAL I late 2 test A pH=7.5 sample: 50pl 
Number 
O. A 
concentration 
(ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Average Median 
1 
_ 
64 1,806 31,75 34,42 31,29 32,49 31,75 
2 32 1,505 36,67 30,48 1 31,04 32,73 31,04 
3 16 1,204 26,66 29,06 29,54 28,42 29,06 
4 8 0,903 26,47 27,04 24,14 25,88 26,47 
5 4 0,602 22,89 24,86 23,05 23,60 23,05 
6 2 0,301 20,53 19,28 22,51 20,77 20,53 
7 1 0,000 15,92 18 17,03 16,98 17,03 
8 0,5 -0,301 14,43 12,61 16,65 14,56 14,43 
9 0,25 -0,602 12,71 11,32 11,17 11,73 11,32 
10 0,125 -0,903 
11 0,06 -1,221 
12 0,03 -1,522 
13 0 
Bioassay muscle (501il) TRIAL Ip ate 2 test B pH=7.55 sample: 5 pl 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Average Median 
1 64 1,806 31,71 33,86 32,26 
_ 
32,61 32,26 
2 32 1,505 32,20 31,70 31,01 31,64 31,70 
3 16 1,204 27,03 28,63 30,09 28,58 28,63 
4 8 0,903 27,06 26,82 24,67 26,18 26,82 
5 4 0,602 23,34 24,58 22,72 23,55 23,34 
6 2 0,301 20,21 19,66 21,42 20,43 20,21 
7 1 0,000 16,66 18,08 16,71 17,15 16,71 
8 0,5 -0,301 13,34 12,19 16,3 13,94 13,34 
9 0,25 -0,602 13,18 11,58 12 12,25 12,00 
10 0,125 -0,903 
11 0,06 -1,221 
12 0,03 -1,522 
13 0 
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Table 42: Oxolinic acid residues detection bioassay method 
"Spiked" Muscle samples Trial 1- Plate 3 
Bloassay muscle (50pl) TRIAL 1p ate 3 test A pH=7.55 sample: 5 pl 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Average Median 
1 64 1,806 33,73 32,93 33,54 33,40 33,54 
2 1 32 1,505 35,50 32,64 33,64 33,93 33,64 
3 16 1,204 29,19 29,36 31,81 30,12 29,36 
4 8 0,903 26,62 25,76 26,37 26,25 26,37 
5 4 0,602 23,39 25,13 24,23 24,25 24,23 
6 2 0,301 21,58 20,57 23,56 21,90 21,58 
7 1 0,000 16,57 19,07 16,95 17,53 16,95 
8 0,5 -0,301 13,82 14,09 15,98 14,63 14,09 
9 0,25 -0,602 11,93 11,37 11,69 11,66 11,69 
10 0,125 -0,903 
11 0,06 -1,221 
12 0,03 -1,522 
13 0 
Bioassay muscle (501il) TRIAL Ip ate 3 test B PH=7.55 sample: 5 pl 
Number 
O. A 
concentration 
(Ppm) 
Log O. A 
concentration 
Zone 
A 
Zone 
B 
Zone 
C Average Median 
1 64 1,806 33,16 1 32,83 33,73 33,24 33,16 
2 32 1,505 36,26 33,58 32,82 1 34,22 33,58 
3 16 1,204 28,64 30,07 31,28 30,00 30,07 
4 8 0,903 26 25,49 26,01 25,83 26,00 
5 4 0,602 22,67 24,42 24,1 23,73 24,10 
6 2 0,301 20,72 20,45 23,29 21,49 20,72 
7 1 0,000 16,44 18,26 15,99 16,90 16,44 
8 0,5 -0,301 14,82 14,76 15,66 15,08 14,82 
9 0,25 -0,602 11,6 12 12,17 11,92 12,00 
10 0,125 -0,903 
11 0,06 -1,221 
12 0,03 -1,522 
13 0 
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Table 43: Oxolinic acid residues detection bioassay method 
"Spiked" Muscle samples - Statistical analysis 
Plate 1 (A) Operator 1 R-squared: 99.32%, slope: 9.37, Intercept: 17.06 
Operator 2 R-squared: 99.76%, slope: 9.82, Intercept: 17.12 
Plate 2 (B) Operator 1 R-squared: 99.57%, slope: 9.75, Intercept: 17.44 
Operator 2 R-squared: 99.69%, slope: 9.48, Intercept: 17.44 
Plate 3 (C) Operator I R-squared: 99.46%, slope: 10.39, Intercept: 17.85 
Operator 21 R-sauared: 99.03%. sloDe: 10.3. Intercent: 17.75 J 
A: (p value = 0.925), B: (p value = 0.599), C: (p value = 0.315) 
The statistical analysis indicated that the % recovery of Oxolinic acid residues in "spiked" 
serum samples was 100% while the % recovery of O. A residues in "spiked " muscle 
samples was 92.74%. 
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3.3 Oxolinic Acid Kinetics in Sea Brearn (Sparus aurata) 
3.3.1.1 High Water Temperature 
3.3.1.1.1 Oxolinic Acid depletion in Muscle 
The concentration of Oxolinic acid achieved in the muscle of Sea bream kept at high 
temperature was presented in Figures 33,34 and 35 while Table 44 presented the 
statistical analysis of the concentration achieved in the muscle and liver. Standard 
deviation of the muscle concentration of Oxolinic acid was very high apparent fact in this 
type of population experimentation. The concentration maximum was presented on the 
1 Oth day (1607.67ppb). The maximum concentration decreased slightly on the 11 th day 
(1467.21 ppb) and sharply until the 14th day (25.85 ppb) and remained low thereafter. 
The line representing the mean O. A concentration increased on the 3 rd day (637.7 ppb) 
followed by a moderate decrease on the 1 Oth day (411.72 ppb) and a slight increase on 
the 11 th day (583.05 ppb) decreasing thereafter and reaching consumer safe levels on 
the 14 th day (11.13ppb O. A). The Box-plot presentation indicated that the maximum 
concentration values on the 3rd, 10th, 1 1th and 12 th referred to outlier (o) and extreme (*) 
values and the majority of the population exhibited muscle concentration of much lower 
levels. The 75% percentile value increased on the 3rd day (958.63 ppb) and after a 
decrease on the I Oth day (423.57 ppb) reached a concentration of 719.25 ppb O. A on 
the 11 th day decreasing thereafter. The metabolism of O. A in the muscle suggested to be 
fairly rapid, reaching consumer safe levels in only four days after the end of the 
treatment. 
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3.3.1.1.2 Oxolinic Acid depletion in Liver 
On the other hand the kinetics of Oxolinic acid in the liver of Sea bream at high 
temperatures was presented in the Figures 36,37 and 38. The data were presented in 
two formats the first including minimum, mean and maximum concentration achieved 
and the other the box-plot analysis and the population distribution of the concentration 
achieved. Maximum O. A concentration in the liver of sea bream increased rapidly on the 
3 rd day (6045.98 ppb) decreasing on the 1 oth day to a level of 2252.98 ppb and reached 
the peak concentration on the 11"' day (7648.51 ppb). The Box-plot analysis of these 
data indicated that the peak concentration achieved on the 1 1'h day referred to an 
extreme value while the maximum concentration present on the 1 Oth day was an outlier 
value (Figure 38). This analysis indicated that peak concentration was achieved on the 
3rd day (median: 1716.09ppb, 755 percentile: 5160.03 ppb O. A) and decreased rapidly 
thereafter consumer safe levels on the 12 th day (maximum concentration: 63.28 ppb). 
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Table 44: EXPERIMENT I Oxolinic acid kinetics in Sea bream 
at high temperature after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxofinic acid concentration - Sea Bream Muscle -High Temperature 
Day 0 Day 3 Day 10 Day 11 Day 12 Day 14 Day 16 Day 1a 
Samples 5 9 10 10 9 8 7 51 
Minimum concentrabon(ppb) 6,38 164,56 122,16 62,64 43,19 2,39 0,05 2,96 
Mean concentration(ppb) 23,66 637,7 411,72 583,05 226,03 11,13 10,28 12,28 
Ma)dmum concentrabon(ppb) 41,99 1450,73 1607,67 1467,21 776,62, 22,85 25,01 29,21 
Standard de%Aafion 14,49 440,51 438,32 377,12 234,94 6,49 10,57 10,17 
25% percentile 9,84 306,02 170,69 362,72 75,5 5,32 0,50 4,56. 
Median 23,1 575,52 300,30 534,13 117,94 11,02 7,13 10,461 
175% Percentile 37,77, 958,63 423,57 719,25 321,57 
_ 
14,52, 20, ýO 20,91 
Day 20 Day 25 
Samples 9 8 
Minimum concentrafion(ppb) 9,55 2,06 
Mean concentration(ppb) 22,38 11,9 
Maximum concentrabon(ppb) 56,69 26,45 
Standard deviation 15,42 9,38 
25% Percentile 10,52 2,6 
Median 17,33 10,97 
175% Percentile 31,73, 20,32 
Oxorinic acid concentration - Sea Bream Liver - High Temperature 
Day 0 Day 3 Day 10 Day 11 Day 12 Day 14 Day 16 Day 18 
Samples 5 4 9 7 5 5 5 6 
Minimum concentrabon(ppb) 27,12 503,99 173,37 100,74 36,12 10,40 28,72 14,42 
Mean concentrabon(ppb) 40,65 2495,54 568,17 1536,39 48,79 14,91 32,46 134,501 
Maximum concentrabon(ppb) 53 6045,98 2252,98, 7648,51 63,28 - , 19,24 35,64 338,891 
Standard de%iabon 110,4 2518,12 681,92 2705,90 9,91 1 3,45 2,76 133,42 
25% percentile 30,37 610,48 186,89 331,42 6 0,4 11,72 29,73 20,93 
Median 42,07 1716,09 213,56 6T9,1 0 2 8E42 
t 
14,74 32,90 101,95 
175% Percentile 50,22, 5160,03 794,99 823,16 ,3 57,3 
i 
18.19 3497 
Sea Brearn Liver - High Temperature 
Day 20 Day 25 
. 
Samples 4 5 
Minimum concentrabon(ppb) 11,2 12,01 
Mean concentrabon(ppb) 33,91 92,04 
Ma)dmum concentration(ppb) 88,68 213 
Standard deNAabon 36,85 107,43 
25% Percentile 11,7 13,13 
Median 17,87 14,58 
175% Percentile 72,15, 209,69 
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Figure 33: Experiment I- Kinetics of Oxolinic acid in the muscle of 
Sea bream (Sparus aurata) at 22 +1 "C 
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Figure 34: Experiment I- Kinetics of Oxolinic acid in the muscle of 
Sea bream (Sparus aurata) at 22 + 10C - Mean and Standard deviation 
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Figure 35: Experiment I- Kinetics of Oxolinic acid in the muscle of Sea bream 
(Sparus aurata) at 22 +1 "C - Box plot presentation 
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Figure 36: Experiment I- Kinetics of Oxo1inic acid in the liver of 
Sea bream (Sparus aurata) at 22 +1 OC 
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Figure 37: Experiment I- Kinetics of Oxolinic acid in the liver of Sea bream 
(Sparus aurata) at 22 -4- 10C - 
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Figure 38: Experiment I- Kinetics of Oxolinic acid in the liver of Sea bream 
(Sparusaurata)at22+ 10C -Box plot presentation 
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3.3.1.2 Low Water Temperature 
3.3.1.2.1 Oxolinic Acid depletion in Muscle 
The concentration maximum was presented in the 7 th day (1979.43 ppb). O. A 
concentration in the muscle seemed to decrease reaching a maximum of 1018.33 ppb 
on the 1 Oth day. The maximum concentration seemed to increase on the 1 1th day 
(1379.73 ppb) and was decreased sharply until the 12 th day (110.67 ppb) and remained 
low thereafter. The line representing the mean O. A concentration exhibited a lag phase 
up until the 3d day (42.58 ppb) followed by a sharp increase on the 7 th day (654.6 ppb) 
and a very slight increase up until the 1 1th day (736.17 ppb). It was evident that the 
median of O. A concentration increased up until the 1 oth day (647.46 ppb) decreasing 
sharply thereafter. The O. A concentration after the 12 th day (110.67 ppb) was found to 
be below the consumer safe levels with 3 samples on the 13 1h and the 14th day above 
this concentration being considered as Outliers. 
3.3.1.2.2 Oxolinic Acid depletion in Liver 
The O. A concentration maximum in the liver of Sea bream at low temperature was 
presented in the 7h day (11095 ppb), decreased reaching 810.78 ppb O. A on the 
afternoon of the 11th day and fell to 173-75ppb on the 12 1h day. The maximum 
concentration seemed to increase slightly on the 13th day (804.07 ppb) but remained low 
thereafter. The line representing the mean O. A concentration exhibited a lag phase up 
until the 3rd day followed by a sharp increase on the 7 1h day (2628 .2 ppb) a moderate 
increase reaching a peak on the 1 Oth day (3029.51 ppb) decreasing sharply until the 
afternoon of the 1 1th day (235.64 ppb). In the box-plot analysis it was demonstrated that 
maximum concentration achieved in the liver on the 7 th day referred to an outlier value 
and the rest of the liver samples had concentrations below 3.5 ppm. 
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The median seemed to increase gradually reaching a peak on the 1 Oth day (2730.94 
ppb) and decreased rapidly thereafter. Consumer safe levels were reported from the 13 th 
day of the experiment onward with extreme and outlier values present in a few of the 
samples taken in the rest days of the experiment. 
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Table 45: EXPERIMENT 11 Oxolinic acid kinetics in Sea brearn at 
low temperature after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxcilinic acid concentration - Sea Bream Muscle - Low Temperature 
Day 0 Day 1 Day 3 Day 7 Day 10 Dayll DayllAft. Day 12 
Samples 8 9 8 9 4 5 10 10 
Minimum concentration(ppb) 3,15 3,64 27,17 44.68 274,84 215,72 67,75 16,36 
Mean concentration (ppb) 11,50 42,05 42,58 654,60 647,02 738,17 302,85 48,53 
Maximum concentration(ppb) 22,89 120,61 57,43. 1979,43 1018,33 1379,73. 871,98 110,6 
Standard deviation 8,00 36,59 9,83 624,87 346,15 514,491 268,00 28,71' 
25% percentile 3,98 16.83 33,51 76,26 317,04 322,261 111,59 28,37 
Median 9,64 30,78 43,81 597,77 647,46 472,431 207,66 40,44 
75% Percentile 20,14. 65,23 49,01 1019,93 . 
976,56 -T 1286,96) 415,88 , 66,49 
Day 13 Day 14 Day 16 Day 25 Day 30 Day 35 1 
Samples 9 10 9 9 10 81 
Minimum concentration(ppb) 9,51 4,61 1,41 8,35 10,37 1,381 
Mean concentration (ppb) 48,48 38,19 11,47 19,02 30,84 8,70 1 
Maximum concentration (ppb) 142,06 122,12 50,51, 38,24 67,84 19,95 1 
Standard deviation 47,85 34,71 15,29 9,63 19,13 6,07 
25% Percentile 16,18 14,18 3,85 11,36 16,10 3,08 
Median 22,76 30,17 4,78 14,91 23,69 8,25 
75% Percentile 84,81 , 
53,08 13,52 24,81, 49,62 , 12,62 
Oxofinic acid concentration - Sea Bream Liver - Low Temperature 
Day 0 Day 1 Day 3 Day 7 Day 10 Day 11 Aft Day 12 Day 13 
Samples 8 10 9 8 4 10 10 8 
Minimum concentration(ppb) 5,50 5,43 26,72 58,96 964,27 75,77 27.03 3,18 
Mean concentration(ppb) 29,81 363,09 62,54 2628,02 3029,51 235,64 90,88 135,45 
Maximum concentration (ppb) 53,22 1118,83 641,44 , 
11095,46 5691,89 810,78 
. 
173,75 804,0 
- Standard deviation 17,97 418,26 25,32 3649,87 1981,58 217,45 46,96 270,94 
25% percentile 15,54 21,19 39,14 105,12 1317,86 93,46 50,36 22,45 
Median 26,79 204,84 60,46 1776,40 2730,94 184,34 96,96 51,01 
175% Percentile 50,30 . 
691,89 87,82 3217,72 
. 
5039,73, 257,63 124,87, 61,331 
Day 14 Day 16 Day 25 Day 30 Day 35 
Samples 9 8 9 10 8 
Minimum concentration(ppb) 15,03 4,65 14,49 8,89 2,77 
Mean concentration (ppb) 54,79 28,76 68,33 38,31 100,71 
Maximum concentration(ppb) 147,53 , 61,91 
229,87, 80,01 478,92 
Standard deviation 51,53 1 19,94 78,85 19,54 161, Z 
25% Percentile 17,67 11,18 19,41 26,56 7,38 
Median 27,49 27,25 39,15 37,79 40,58 
75% Percentile 101,01 45,18 112,74 47,94 
. 
138,25 
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Figure 39: Experiment 11 - Kinetics of Oxolinic acid in the muscle of Sea bream 
(Sparusaurata)at17+ 10C 
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Figure 40. - Experiment 11 - Kinetics of Oxolinic acid in the muscle of Sea bream 
(Sparus aurata) at 17 + 1'C - Mean and Standard deviation 
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Figure 41: Experiment 11 - Kinetics of Oxolinic acid in the muscle of Sea bream 
(Sparus aurata) at 17 + 10C - Box - plot presentation 
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Figure 42: Experiment 11 - Kinetics of Oxolinic acid in the Liver of Sea bream 
(Sparus aurata) at 17 -ý 1 
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Figure 43: Experiment 11 - Kinetics of Oxolinic acid in the liver of Sea bream 
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Figure 44. - Experiment 11 - Kinetics of Oxolinic acid in the liver of Sea bream 
(Sparus aurata) at 17 + 1'C - Box-plot presentation 
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3.3.2 Comparisons 
3.3.2.1 Muscle Depletion versus liver Depletion 
Figure 45: Comparison of CA mean concentration in the muscle and liver of 
sea bream at high temperature 
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Figure 46: Comparison of OA mean concentration in the muscle and liver of 
sea bream at low temperature 
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3.3.2.2 Depletion at High versus Low temperature 
Figure 47 Comparison of OA mean concentration in the muscle of sea bream 
at high and low temperature 
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3.4 Oxolinic Acid Kinetics in Sea Bass (Dicentrarchus labrax) 
3.4.1.1 High Water Temperature 
3.4.1.1.1 Oxolinic Acid depletion in Muscle 
Maximum O. A concentration in the muscle of sea bass at high temperature was reached 
on the 7th day of the oral treatment (995 ppb) decreasing gradually thereafter, reaching 
consumer safe levels on the 14 th day (4-05 ppb). Mean and Median concentration of 
O. A. reached a peak on the 11 th day (250.09 and 352.58) decreasing thereafter. In the 
box-plot analysis, peak concentration on the 7 th day considered was as extreme value. 
Concentration of OA was decreased to "consumer safe" levels by the 13 th day of the 
experiment (78DD)(Table 46, Figures 49,50and 51). 
3.4.1.1.2 Oxolinic Acid depletion in Liver 
Study of mean concentration revealed gradual increase to peak concentration of 718 
ppb on the 1 Oth day. O. A Concentration in the liver of sea bass at high temperature 
increased sharply from 718 ppb on the 1" day reaching almost double, in relation to the 
muscle, peak concentration on the 7 th day (1861.8 ppb). Maximum concentration 
decreased gradually reaching consumer safe levels on the 13 th day (8 ppb) of the 
experiment. Box-plot presentation of the kinetics of O. A in the liver of sea bass 
suggested that peak concentration on the 7th day referred to an outlier value (Table 46, 
Figures 52,53 and 54). Oxolinic acid metabolism in sea bass at high temperature was 
relatively fast, leading to consumer safe levels in 3 days after the end of the treatment for 
muscle and 2 days for liver samples. 
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Figure 49: Experiment III- Kinetics of Oxolinic acid in the muscle of Sea bass 
(Dicentrarchus labrax) at 26 + 1'C 
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Figure 50: Experiment III- Kinetics of Oxolinic acid in the muscle of Sea bass 
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Figure 51: Experiment III- Kinetics of Oxolinic acid in the muscle of Sea bass 
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Table 46: EXPERIMENT III Oxolinic acid kinetics in Sea bass at 
high temperature after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxotinic acid concentration - Sea Bass Muscle - High Temperature 
Day 0 Day I Day 3 Day 7 DayIO I Day II Day 11 Aft. Day 12 
Samples 4 5 5 9 71 9 6 61 
Minimum concentration(ppb) 1,35 14,09 15,55 19,36 20,95 1 3,92 3,75 3,24 
Mean concentration(ppb) 2,79 102,43 104,39 178,94 126,62 1 250.096 47,16 66,64 
Maximum concentrabon(ppb) 5,08 325,62 227,65, 994,55 437,89 518,83 238,28 250,9 
Standard deýAation 1,67 131,17 92,97 320,96 152,97 209,37 93,71 96,28 
25% percentile 1,45 15,37 18,94 22,06 27,25 9,72 5,07 96 
Median 2,38 41,55 85,66 41,28 47,17 352,58 10,78 1 23,62 
75% Percentile 4,5, 219,92 199,21 208,381 216,61, 430,13 69 95 1 132,42 
Day 13 Day 14 Day 16 
Samples 7 4 6 
Minimum concentraflon(ppb) 0 0 0 
Mean concentraticn(ppb) 15.82 1,76 1,47 
Maximum concentrabon(ppb) 88,33 4,05 2,76. 
Standard deviation 32,11 1,83 0,99 
25% Percentile 1,19 0,05 0,6 
Median 4,9 1,64 1,5 
75% Percentile 7,2, 3,6 2,3 
Oxofinic acki concentration - Sea Bass Liver - High Temperature 
Day 0 Day 1 Day 3 Day 7 Daylo I Day 11 Day 11 Aft. Day 12 
Samples 7 8 10 9 71 8 9 8 
Minimum concentration(ppb) 2,7 20,93 35.056 14,25 22,141 20,18 13,98 1,86 
Mean concentration(ppb) 8,16 224,79 435,04 444,84 717,541 451 93,76 34, 
Maximum concentrabon(ppb) 16,07 717,57 1336,78, 1861,82 1366,161 1275,64 226,41 91,61 
Standard deviation 5,7 275,52 456,381 606.56 537,27 454,9 82,43 27,34 
25% percentile 2,75 30,52 68,13 23,76 33,02 138,08 19,26 11,78 
Median 6,81 80,74 225,69 152,18 859,66 220,75 60 ,8 33,44 
175% Percentile 14-26, 501,18 832,45 698,61 1174,44 874,95, 173,611 41,45, 
Sea Bass L iver - High Temperature 
Day 13 Day 14 Day 16 
Samples 5 9 7 
Minimum concentration(ppb) 1,62 0,15 0 
Mean concentration(ppb) 3,53 7,28 3,02 
Maximum concentration(ppb) 7.75 26 11,94, 
Standard deviation 2,43 8,46 5,17 
25% Percentile 1,97 0,453 0 
Median 2,61 7.34 0,4 
175% Percentile 5,56. 11,4 8,92 
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Figure 52: Experiment III- Kinetics of Oxo1inic acid in the liver of Sea bass 
(Dicentrarchus labrax) at 26 + VC 
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Figure 53: Experiment III- Kinetics of Oxolinic acid in the liver of Sea bass 
(Dicentrarchus labrax) at 26 + 10C - Mean and Standard deviation 
1 CJ3 - 
CL 
rý 
ý-, I, lDcl: l 
, 7*1 
L - 4-J 
136 
10 1111 12 13 14 16 
day 
Figure 54: Experiment III- Kinetics of Oxolinic acid in the liver of Sea bass 
2, CCC, - 
1, SCID 
C) 
CL 
4,1, Coo - 
4-J 
SCCI 
4 
r-I - 
day 
(Dicentrarchuslabrax)at26+ 1OC- Box-plot presentation 
137 
ILI 1111 12 13 14 16 
Use of Antibiotics in Greek Mariculture University of Stirling 
3.4.1.2 Low Water Temperature 
3.4.1.2.1 Oxolinic Acid depletion in Muscle 
Standard deviation of the O. A muscle concentration was very high. Concentration 
maximum was presented in the 1 Oth day (1321.78 ppb). Then it was decreased sharply 
until the afternoon of the 1 1th day (84.54 ppb) and remained low until the 16 th day (21.74 
ppb) when an "odd" increase, lead to moderate peak concentration on the 18th day 
(814.1 ppb). O. A concentration decreased to consumer safe levels from the 30th day 
(37.17 ppb) onwards. An O. A concentration plateau was exhibited between 1" (1109.86 
ppb) and 3d day (11107.46 ppb) as well as a slight decrease was evident on the 7 th day 
(844.02 ppb) of the feeding with the antimicrobial compound. Figure 51 presented 
boxplot analysis throughout the experimental period. In the first 11 days of the 
experiment, median O. A concentration in the muscle of Sea bass increased gradually 
achieving highest concentration on the 7 th day. Extreme concentration was present in a 
sample of muscle on the 3rd day. Extreme value existed in one sample on the 14 th day. 
All samples had O. A concentrations under 100ppb and while the general trend was a 
gradual decline, median concentration persisted around 30ppb until the 13 th day and 
then decreased to around 10ppb. Although initial graphs indicated a sharp increase in 
O. A muscle concentration on day 18 it was revealed in the following Figure that all 
samples gave concentrations below 100ppb with the exception of only one sample on 
the 18 th day (around 800ppb)(Table 47, Figures 55,56 and 57). 
3.4.1.2.2 Oxolinic Acid depletion in Liver 
The concentration of Oxolinic acid obtained in the liver of sea bass that was treated 
orally for 10 days at water temperature 18 +1oC was presented in the following 
Figures (58,59 and 60). Maximum and mean concentration fluctuated for a period of 
twenty days (Table 47). Maximum concentration was achieved on the 7 th day (2954 
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ppb) fluctuating to 1516 ppb and the 15t and 599 ppb on the Td day. Maximum 
concentration decreased gradually to 577 ppb on the afternoon of the 1 1th day, 
increased on the 12'h day (1694 ppb) and was reduced to 564ppb on the 16 th day before 
presenting an "odd" peak (1285 ppb) on the 18 th day. Finally in the following days 
concentration was decreased sharply until the 20th day and gradually thereafter to reach 
consumer safe levels on the 30th day (91 ppb). Box -plot presentation of the kinetics of 
O. A in the liver of Sea bass indicated that maximum concentration reported on days 12 
and 18 referred to extreme values. It was evident therefore that consumer safe levels of 
O. A concentration in the muscle and liver of sea bass at prevailing water temperature of 
18o C were reached 20 days after the cessation of the oral treatment (after 340 degree 
days). Maximum O. A concentration achieved in the liver was twice the concentration 
achieved in the muscle of sea bass at both high and low temperature (Figures 61 and 
62) Peak mean concentration in the liver was 2.6 times the muscle concentration at low 
temperature and 2.9 times the muscle concentration achieved at high temperature. 
Oxolinic acid metabolism at low temperature was much slower and twenty days after the 
end of the treatment were needed for consumer safe levels to be reached for both 
muscle and liver samples as opposed to fast metabolism present at high temperature, 
when 4 days post treatment were sufficient (Figures 63 and 64). Peak mean 
concentration in the muscle at low temperature was 1.7 times the concentration 
achieved at high temperature, while mean concentration achieved in the liver at low 
temperature was 1.5 times the concentration achieved at high temperature. Sea bream 
assimilated OA better than sea bass achieving higher concentrations in both tissues and 
both temperature areas. Depletion was similar at high temperature but seem to take 
longer in sea bass at low temperature (Figures 65,66,67 and 68). 
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Table 47: EXPERIMENT IV Oxolinic acid kinetics in Sea bass 
at low temperature after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxo1hic acid concentration - Sea Bass Muscle - Low Temperature 
Day 0 Day I Day 3 Day 7 Day 10 Day 11 Day 11 Aft. Day 12 
Samples 10 6 9 9 9 8 9 71 
Minimum concentration(ppb) 0,00 8,02 8,73 
_ 
80,36 32,46 2,78 8,24 11,82 
Mean concentraflon(ppb) 9,73 332,42 245,11 433,21 410,96 174,79 43,27 33,85 
Ma)dmurn concentration(ppb) 17,27, 1109,86 1107,46, 844,02 1321,78 610,39, 84,54 63,38 
Standard deviation 5,62 488,14 342,91 310,49 479,65 226,75 36,03 18,80 
25% percentile 6,00 13,26 44,24 143,38 87,39 14,15 9,77 13,651 
Median 9,40 37,37 141,69 391,32 134,45 74,74 31,69 32,30 
75% Percentile 15,68 867.64 312,48 803,98 875,82. 368,63 82,65 47,971 
Day 13 Day 14 Day 16 Day 18 Day 20 Day 25 Day 30 Day 35 
Samples 6 9 9 5 9 8 10 8 
Minimum concentration(ppb) 11,07 6,17 3,06 10,23 24,61 21,77 9,78 2,74 
Mean concentration(ppb) 29,28 14,89 11,89 192,96 67,96 79,21 20,10 12,39 
Maximum concentration(ppb) 49,07 38.76 21,74, 814,10 . 137,50 173,64 1 37,17 22,63 
Standard deviation 14,18 10,10 7,791 349,79 32,44 50,681 9,56 7,49 
25% Percentile 13,74 7,80 4,301 10,71 46,99 30,60 11,93 6,80 
Median 32,55 13.15 9,34 18,65 65,22 85,10 16,88 10,15 
, 75% Percentile 39,14, 18,031 20,151 462,37 83,20 101,51 29-01 20,80 
OxoAnic acid concentration - Sea Bass Liver - Low Temperature 
Day 0 Day 1 Day 3 Day 7 DaylO Dayll DayllAft. Day 12 
Samples 10 6 8 6 9 8 9 8 
Minimum concentrabon(ppb) 7.99 28,82 34,03 176,90 25,08 9,83 31,01 19,17 
Mean concentrabon(ppb) 17,18 901,97 227,39 1112,10 409,66 213,92 124,64 278,77 
Ma)dmum concentration(ppb) 31,48, 1567,12 598,60, 2954,24 1518,80 711,821 577,23 1694,35 
Standard de\Aation 7,751 546,43 226,461 1011,89 541,82 300,101 174,91 575,00 
25% percentile 10,67 432,80 45,35 433,08 62,44 31,35 37,45 32,27 
Median 16,37 992,50 110,67 730,61 - 126,87 61,35 51,69 72,50 
, 75% Percentile 23,70 1339,33 454,38 1909,88, 775,11 540,12 134,43. 178,25 
Sea Bass Liver - Low Temperature 
Day 13 Day 14 Day 16 Day 18 
, 
Day 20 1 Day 25 Day 30 Day 35 
Samples 8 8 9 9 
- 
8 17 10 9 
Minimum concentration(ppb) 40,20 15,83 22,36 45,78 38,86 ý24,75 -10, -24 15,83 
Mean concentration(ppb) 206,60 237,97 239,41 275,57 84,67 67,31 31,52 37,96 
Ma)dmum concentration(ppb) 1057,53 597,23 564,88, 1285,34 204,63 135,25 91,37 79.90 
Standard deviation 346,87 234,37 236,121 426,54 52,00 49,70 22,40 19,65 
25% Percentile 47,12 27,09 31,05 50,21 52,24 26,62 20,43 19,18 
Median 84,02 197,82 68,27 81,10 69,55 3-9,26 27,66, 37,21 
175% Percentile 163,58 437,51 479,47 409.66 93,67_ 
_132,93. 
33,261 46,75 
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Figure 55: Experiment IV - Kinetics of Oxolinic acid in the muscle of Sea bass 
(Dicenrarchus labrax) at 18 +1 OC 
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Figure 56: Experiment IV - Kinetics of Oxolinic acid in the muscle of Sea bass 
(Dicenrarchus labrax) at 18 + VC - Mean and Standard deviation 
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Figure 57: Experiment IV - Kinetics of Oxolinic acid in the muscle of Sea bass 
(Dicenrarchus labrax) at 18 + VC - Box-plot presentation 
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Figure 58: Experiment IV - Kinetics of Oxolinic acid in the liver of Sea bass 
(Dicenrarchus labrax) at 18 +1 OC 
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Figure 59: Experiment IV - Kinetics of Oxolinic acid in the liver of Sea bass 
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Figure 60: Experiment IV - Kinetics of Oxolinic acid in the liver of Sea bass 
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3.4.2 Comparisons 
3.4.2.1 Muscle Depletion versus liver Depletion 
Figure 61. - Comparison of OA mean concentration in the muscle 
and liver of sea bass at high temperature 
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Figure 62: Comparison of OA mean concentration in the muscle 
and liver of sea bass at low temperature 
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3.4.2.2 Depletion at High versus Low temperature 
Figure 63: Comparison of OA mean concentration in the muscle 
of sea bass at low and high temperature 
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Figure 64: Comparison of OA mean concentration in the liver 
of sea bass at low and high temperature 
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3.5 Oxo1inic Acid species comparisons 
Figure 65: Comparison of OA mean concentration in the muscle 
of sea bream and sea bass at high temperature 
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Figure 66: Comparison of OA mean concentration in the liver 
of sea bream and sea bass at high temperature 
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Figure 67: Comparison of OA mean concentration in the muscle 
of sea bream and sea bass at low temperature 
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Figure 68: Comparison of OA mean concentration in the liver 
of sea bream and sea bass at low temperature 
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3.6 OXYTETRACYCLINE KINETICS 
3.6.1 Development of Bioassay method for OTC detection 
University of 
This bioassay method was developed the same way like O. A bioassay method. 
Standard dilutions of Oxytetracycline were initially tested and zones of inhibition have 
been recorded. Table 48 presented the data from the two trials where OTC standard 
dilutions while, Table 49 presented the statistical analysis of these data. The detection 
limit of the method (standard dilutions) was 250ppb of Oxytetracycline. 
Table 48: Oxytetracycline residues detection bioassay method 
Standard dilutions 
Bioassay standard dilutions Oxytetracycline - trial - sample: 50pi 
Number OTC 
concentration 
(Ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 47,00 47,00 47,00 47,00 47,00 0,00 
2 16 1,204 43,00 44,00 42,00 43,00 1 43,00 1,00 
3 8 0,903 39,00 40,00 37,00 38,67 39,00 1,53 
4 4 0,602 32,50 34,00 34,90 33,80 34,00 1,21 
5 2 0,301 29,50 29,00 28,50 29,00 29,00 0,50 
6 1 0,000 23,00 25,00 27100 25,00 25,00 2,00 
7 0,5 -0,301 17,00 16,50 18,50 17,33 17,00 1,04 
8 0,25 -0,602 12,00 10,90 11,45 11,45 0,78 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
12 01 
1 
Bioassay standard dilutions Oxytetracycline - trial - sample: 50pl 
Number OTC 
concentration 
(Ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 45,00 45,00 1 45,00 45,00 45,00 0,00 
2 16 1,204 43,50 42,50 42,00 42,67 42,50 0,76 
3 8 0,903 40,00 40,00 39,00 39,67 40,00 0,58 
4 4 0,602 34,00 33,00 34,50 33,83 34,00 0,76 
5 2 0,301 31,00 29,00 29,50 29,83 29,50 1,04 
6 1 0,000 22,00 22,40 26,00 23,47 22,40 2,20 
7 0,5 -0,301 18,00 16,00 17,00 17,00 1,41 
8 0,25 -0,602 11,50 11,50 11,50 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 1,522 
12 0 
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Bioassay standard dilutions - Oxytet acycline - trial 3- sample: 50pl 
Number OTC 
concentration 
(DDM) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 51,00 50,00 46,00 49,00 50,00 2,65 
2 16 1,204 47,00 1 47,00 46,00 46,67 47,00 0,58 
3 8 0,903 40,00 43,00 40,00 41,00 40,00 1,73 
4 4 0,602 33,50 33,50 34,50 33,83 33,50 0,58 
5 2 0,301 30,00 26,00 25,00 27,00 26,00 2,65 
6 1 0,000 22,50 26100 24,25 24,25 2,47 
7 1 0,5 -0,301 
14,00 12,50 
1 
16,00 14,17 14,00 1,76 
8 0,25 -0,602 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
Table 49: Statistical Analysis - OTC Bioassay - standard dilutions 
OTC STANDARD DILUTIONS 
Log OTC 
concentration 
Average 
trial I 
Average 
trial 2 
Average 
trial 3 
Average 
Total Stdv 
1,505 47,00 45,000 49,00 47,00 2,00 
1,204 43,00 42,670 46,67 44,11 2,22 
0,903 38,67 39,670 41,00 39.78 1,17 
0,602 33,80 33,830 33,83 33,82 0,02 
0,301 29.00 29,830 27,00 28,61 1,45 
0,000 25,00 23,470 24,25 24,24 0,77 
-0,301 17,33 17,000 14,17 16,17 
1,74 
-0,602 11,45 1 11,500 1 11.48 0,04 
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Table 50: Oxytetracycline residues detection bioassay method 
Standard dilutions - Inter-operator variability 
Bioassay stan ard dilutions -o ytetracycline - perato A- sample: 50pl 
Number OTC 
concentration 
(Ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 43,80 44,50 42,00 43,43 43,80 1,29 
2 16 1,204 41,00 1 42,00 42,00 1 41,67 42,00 0,58 
3 8 0,903 38,00 38,00 35,00 37,00 38,00 1,73 
4 4 0,602 33,00 33,00 35,00 33,67 33,00 1,15 
5 2 0,301 28,00 29,50 28,00 28,50 28,00 0,87 
6 1 0,000 25,00 23,50 22,00 23,50 23,50 1,50 
7 0,5 -0,301 16,00 16,50 15,00 15,83 1 
16,00 0,76 
8 0,25 -0,602 12,50 11,50 12,00 12,00 12,00 0,50 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
Bioassay stan ard dilutions -o ytetrac H- operato B- sample: 50pl 
Number OTC 
concentration 
(Ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 44,00 44,50 43,00 43,83 44,00 0,76 
21 16 1,204 41,00 42,00 40,00 41,00 1 41,00 1,00 
3 8 0,903 37,00 38,50 37,00 37,50 37,00 0,87 
4 4 0,602 33,50 35,00 32,00 33,50 33,50 1,50 
5 2 0,301 29,00 30,00 30,00 29,67 30,00 0,58 
6 1 0,000 24,00 23,00 21,50 22,83 23,00 1,26 
7 0,5 -0,301 19,00 18,00 18,50 18,50 18,50 0,50 
8 0,25 -0,602 10,50 10,50 10,00 10,33 10,50 0,29 
9 0,125 -0,903 
10 0,06 -1,221 
11 
1 
0,03 -1,522 
12 10 
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Bioassay stand ard dilutions -o ytetrac line - operato C- sarn le: 50pl 
Number OTC 
concentration 
(Ppm) 
Log OTC 
concentration 
Zone 
A 
Zon 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 43,50 44,00 43,00 43,50 43,50 0,50 
2 16 1,204 40,00 41,00 40,00 40,33 40,00 1 0,58 
3 8 0,903 37,00 38,00 39,00 38,00 38,00 1,00 
4 4 0,602 33,00 34,00 32,00 33,00 33,00 1,00 
5 2 0,301 29,50 28,00 29,00 28,83 29,00 0,76 
6 1 0,000 26,00 25,00 25,50 25,50 25,50 0,50 
7 0,5 -0,301 16,50 17,50 16,00 16,67 16,50 0,76 
8 0,25 -0,602 12,50 12,50 14,00 13,00 12,50 0,87 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
Table 51: OTC Bioassay - Statistical Analysis - OTC Standard Dilutions 
Inter-Operator variability 
OTC Standard Dilutions - Inter-Operator variability - Statistical analysis 
Operator A Operator B Operator C Average Log 
12 10,33 13,00 11,777 -0,602 
15,83 18,5 16,67 17,000 -0,301 
23,5 22,83 25,50 23,943 0,000 
28,5 29,67 28,83 29,000 0,301 
33,67 33,5 33,00 33,390 0,602 
37 37,5 38,00 37,500 0,903 
41,67 41 40,33 41,000 1,200 
43,43 43,83 43,50 43,587 1,500 
98,15 97,67 97,7 98,250 R-squared 
15,65 15,65 14,8 15,370 slope 
22,39 22,59 23,18 22,720 intercept 
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Table 52: Oxytetracycline residues detection bioassay method 
Spiked serum samples 
Bioassay - xytetracycline "spiked" serum - triall - sample: 50pl 
number OTC 
concentration 
(ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 51,44 52,54 51,98 51,99 51,98 0,55 
2 16 1,204 45,49 1 46,62 44,72 45,61 45,49 0,96 
3 8 0,903 40,34 39,92 40,96 40,41 40,34 0,52 
4 4 0,602 32,06 33,45 35,06 33,52 33,45 1,50 
5 2 0,301 28,82 30,82 28,81 29,48 28,82 1,16 
6 1 0,000 19,37 18,68 18,81 18,95 18,81 0,37 
7 0,5 -0,301 14,90 15,29 14,51 14,90 14,90 0,39 
8 0,25 -0,602 8,02 8,02 8,02 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
Bioassay - xytetracycline "spiked " serum - tria12 - sample: 50pi 
number OTC 
concentration 
(ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 49,08 53,15 52,29 51,51 52,29 2,15 
2 16 1,204 45,47 46,13 46,80 46,13 1 46,13 0,67 
3 8 0,903 41,15 42,33 42,62 42,03 42,33 0,78 
4 4 0,602 32,86 37,21 33,32 34,46 33,32 2,39 
5 2 0,301 25,53 27,82 26,79 26,71 26,79 1,15 
6 1 0,000 20,10 23,16 21,36 21,54 21,36 1,54 
7 0,5 -0,301 15,45 13,95 13,05 14,15 13,95 1,21 
8 0,25 -0,602 40 8,99 8,45 8,40 0,51 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
P Christorilogiannis 152 
Use of Antibiotics in Greek Mariculture University of Stirling 
Bioassay - xytetracycline "spiked" serum - trial3 - sample: 50pi 
number OTC 
concentration 
(ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median StdV 
1 32 1,505 49,76 53,18 52,04 51,66 52,04 1,74 
2 16 1,204 45,90 48,70 46,82 47,14 46,82 1,43 
3 8 0,903 39,13 42,45 42,90 41,49 42,45 2,06 
4 4 0,602 31,92 35,64 34,69 34,08 34,69 1,93 
5 2 0,301 26,29 25,97 25,13 25,80 25,97 0,60 
6 1 0,000 20,17 23,18 20,00 21,12 20,17 1,79 
7 0,5 -0,301 14,98 16,07 15,41 15,49 15,41 0,55 
8 0,25 -0,602 8,50 8,36 8,00 8,29 8,36 0,26 
9 0,125 -0,903 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 
Table 53: OTC Bioassay - Spiked serum samples - Statistical Analysis 
OTC Spiked Serum sample Analysis 
Log OTC 
concentration 
Average 
trial 1 
Average 
trial 2 
Average 
trial 3 
Average 
Total Stdv 
1,505 51,99 51,510 51,66 51,72 0,25 
1,204 45,61 46,130 47,14 46,29 0,78 
- 0,903 40,41 42,030 41,69 41,38 0,85 
- 0,602 33,52 34,460 34,08 34,02 0,47 
- 0,301 29,48 26,710 25,80 27,33 1,92 
0,000 18,95 21,540 21,12 20,54 I_L39 
- 
-0,301 14,90 14,510 15,49 14,97 0,49 - 
-0,602 8,02 8,450 8,29 8,25 0,22 
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Table 54: Oxytetracycline residues detection bioassay method 
Spiked serum samples - Inter-Operator Variability 
Bl oassav - Oxvte acycline "spiked serum" Operat rA- sample: 50P - pH=5.6 
number OTC 
concentration 
(Ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 42,50 40,00 39,00 40,50 40,00 1,80 
2 16 1,204 38,00 38,00 38,00 38,00 1 38,00 0,00 
3 8 0,903 35,00 33,00 31,50 33917 33,00 1,76 
4 4 0,602 30,00 30,00 29,00 29,67 30,00 0,58 
5 2 0,301 25,00 26,00 25,50 25,50 25,50 0,50 
6 1 0,000 20,00 21,00 21,00 20,67 21,00 0,58 
7 0,5 -0,301 14,00 14,00 14,00 14,00 14,00 0,00 
8 0,25 -0,602 11,50 11,00 10,00 10,83 11,00 0,76 
9 0,125 -0,903 7,00 7,50 8,00 7,50 7,50 0,50 
10 0,06 -1,221 
13 
11 0,03 -1,522 
12 0 
Bloassay -0 ytetracycline "spiked serum" 0 erator - sample: 50pi 
number OTC 
concentration 
(ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
zone 
C 
Average Median Stdv 
1 32 1,505 41,00 40,00 40,00 40,33 40,00 0,58 
2 16 1,204 37,00 36,00 36,00 36,33 36,00 0,58 
3 8 0,903 35,00 33,00 32,50 33,50 33,00 1,32 
4 4 0,602 29,50 29,00 28,50 29,00 29,00 0,50 
5 2 0,301 27,50 26,50 27,00 27,00 27,00 0,50 
6 1 0,000 21,50 19,00 18,00 19,50 19,00 1,80 
7 0,5 -0,301 15,50 16,00 15,00 15,50 15,50 0,50 
8 0,25 -0,602 11,50 10,50 10,00 10,67 10,50 0,76 
9 0,125 -0,903 8,00 8,00 8,00 8,00 0,00 
10 0,06 -1,221 
11 0,03 -1,522 
12 0 1 
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Bioassay - xytetracycline "spiked serum" O : )erator C- sample: 50pi 
number OTC 
concentration 
(ppm) 
Log OTC 
concentration 
Zone 
A 
Zone 
B 
Zone 
C 
Average Median Stdv 
1 32 1,505 39,50 40,00 39,50 39,67 39,50 0,29 
2 1 1,204 37,50 36,50 36,00 36,67 36,50 0,76 
3 8 0,903 33,50 35,50 34,00 34,33 34,00 1,04 
4 4 0,602 30,50 29,50 29,50 29,83 29,50 0,58 
5 2 0,301 26,00 26,00 25,00 25,67 26,00 0,58 
6 1 0,000 21,50 21.00 21,00 21,17 21,00 0,29 
7 0,5 -0,301 14,50 14,00 16,00 14,83 14,50 1,04_ 
8 0,25 -0,602 11,00 12,00 12,00 11,67 12,00 0,58 
9 0,125 -0,903 8,00 8,00 8,00 
10 0,06 -1,221 
11 
1 
0,03 -1,522 
12 0 
Table 55: OTC Bioassay- Spiked serum 
Inter operator variability - Statistical Analysis 
OTC Spiked serum - Inter-Operator variability - Statistical analysis 
Spiked 
serum 
Operator A Operator B Operator C Average log 
7,5 8 8,000 7,83 -0,903 
10,83 10,67 11,670 11,06 -0,602 
14 15,5 14,830 14,78 -0,301 
20,67 19,5 21,170 20,45 0 
25.5 27 25,670 26,06 0,301 
29,67 29 29,830 29,5 0,602 
33,17 33,5 34,330 33,67 0,903 
38 36,33 36,670 37 1.204 
40,5 40,33 39,670 40,17 1.505 
r-squared 99,31 98,99 99,070 99,31 
slope 14,44 13,94 13,800 14,06 
intercept 20,07 20,22 20,490 20,26 
The data and the statistical analysis from the examination of "spiked" serum 
samples were presented in Tables 52 to 55. The recovery of the method for 
serum samples was 91,4%. 
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3.7 Oxytetracycline Kinetics in Sea Brearn (Sparus aurata) 
3.7.1.1 High water temperature 
3.7.1.1.1 Oxytetracycline depletion in muscle 
The analysis of the OTC in muscle samples indicated that except on the 3d day, feeding 
response of the medicated diet was almost optimal. The depletion of the drug in muscle 
of gilthead sea bream showed biphasic elimination since the analysis of the mean OTC 
concentration displayed two distinct peaks at days 7 (0.104 ppm) and 11 (0.122 ppm) 
(Figures 69,70,71and Table 56). Muscle tissues retained the lowest OTC levels when 
compared to other examined tissues. The OTC muscle maximum concentration 
achieved an early peak (175 ppm) on the first day and after a sharp drop on the 3 rd day, 
was gradually increased to reach maximum concentration of 0.275 pprn on the 11 th day. 
In subsequent days, OTC concentration fell quickly (<0.069 ppm). The maximum 
average OTC levels were evident at the conclusion of the medication. Detectable levels 
were found until 15 days after treatment ceased. 
3.7.1.1.2 Oxytetracycline depletion in Liver 
In this analysis, extreme and outlier values present on the 1 s' and 5 th day were excluded. 
Biphasic elimination was also evident in OTC depletion from gilthead sea bream liver 
(Figure 72,73,74 and Table 56). The mean OTC liver concentration presented a peak on 
the 5 th day (3.088 ppm) and maximum concentration reached 4.7 ppm on the 1 oth day 
decreasing sharply on the 1 'Ith day (< 500 ppb). Liver tissues presented the highest OTC 
concentrations with detectable levels until 15 d following the completion of the treatment. 
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3.7.1.1.3 Oxytetracycline depletion in serum 
The OTC depletion pattern in gilthead sea bream serum was not similar to the profile of 
the drug in muscle and liver, displaying only one peak (Figure 75,76,77 and Table 56). 
Mean and maximum OTC serum concentration increased rapidly up until the 5th day 
(980 ppb / 1940 ppb) and decreased gradually reaching the method's detection limit on 
the 21 st day. 
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Table 56: EXPERIMENT V Oxytetracycline kinetics in Sea bream at high temperature 
after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxytetracycline concentration - Sea Bream Muscle - High Temperature 
Day 0 Day 1 Day 3 Day 5 Day 7 Day 10 Dayll Day 12 Day 13 Day 14 Day 17 
Samples 6 9 7 6 5 7 7 6 7 7 71 
Minimum concentration(ppb) 1,74 12,01 11,72 42,93 50,69 29,89 21,53 22,50 24,33 21,56 8,87 
Mean concentrabon(ppb) 1,91 58,40 31,19 65,37 103,64 73,72 121,85 62,01 69,36 42,16 16,17 
Maximum concentration(ppb) 1 2,80 170,51 51,74, 120,10 164,07 144,44 , 275,99 106,60, 92,85 88,59 24,99 
Standard deviation 0,43 56,39 15,451 28,65 47,67 38,55 101,35 35,671 23,98 23,72 6,27 
25% percentile 1,74 13,30 13,311 44,28 57,71 48,41 26,56 2,29 9 52,72 24,94 1,0 
Median 1,74 35,70 34,83 58,11 101,63 63,79 ý1-, 33 5 8 56,46 ,4 
t6 
74,61 34,35 
1 
13,96 
75% Percentile 2,00, 106,16 42,451 81,22, 150,57, 99,45 248,60 4 
300,5 
100,54 88,85, 55 9A 71 
Oxytetracycline concentration - Sea Bream Muscle - High Temperature 
Day 21 Day 23 Day 25 
Samples 7 8 7 
Minimum concentration(ppb) 7,03 7,41 9,33 
Mean concentrabon(ppb) 12,40 12,29 12,02 
Maximum concentration(ppb) 31,89 18,85 18,45, 1 
Standard de%dation 8,68 4,22 3,061 1 
25% percentile 8,06 9,10 9,97 
Median 9,89 11,01 11,21 
175% Percentile 1 10,491 16,86 12,90 1 
Oxytetracycline concentration - Sea Bream, LA(er - High Temperature 
Day 0 Day 1 Day 3 Day 5 Day 7 Day 10 Day 11 Day 12 Day 13 Day 14 Day 17 
Samples 7 9 6 6 7 7 6 7 7 7 6 
Minimum concentrabon(ppb) 1,74 319,15 37,04 1327,84 81,28 343,60 276,53 141,48 157,25 183,41 30,77 
Mean concentrabon(ppb) 4,30 1020,62 72,29 3088,47 652,10 1824,58 420,04 64,20 325,24 373,20 52,50, 
Maximum concentration (ppb) 9,37 3065,02 133,68, 6099,96 2365,03 4665,21 547,54 1138,12 531,461 719,83 86,871 
Standard deviation 3,42 796,16 40,24 1696,27 803,76 1770,211 119,17 355,22 130,03 179,57 21,421 
25% percentile 1,74 676,73 38,10 1799,24 96,31 414,871 289,10 230,33 186,10 242,71 34,64 ' 
, Median 1,74 781,80 57,44 2841,02 314.17 649,961 429,52 329,40 369,10 319, -6 
0 48, 8,40 40 
1 
ý59/6 Percentile 8,47 1001,96 114,79 4123,46, 774,23 3533,531 543,85, 745,29 388,32 485,61 70 19 70,19 
oxytetracycline concentrat ion - Sea Bream Liver - High Temperature 
Day 21 Day 23 Day 25 
Samples 7 8 3 
Minimum concentrabon(ppb) 15,24 52,04 39,67 
Mean concentrabon(ppb) 48,64 111,50 74,40 
Maximum concentration(ppb) 83,19 154,70 128,13, 
Standard deviation 26,62 30,19 47,19 
25% Percentile 25,76 94,69 39,67 
Median 52,17 118,42 55,39 
[75% Percentile 1 76,75. 126,60 
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Oxytetracycrine concentration - Sea Bream Serum (BIOASAY) - High Temperature 
DayO Day 1 Day 3 Day 5 Day 7 DaylO I Day 11 Day 12 Day 13 Day 14 Day 17 
Samples 6 5 5 6 5 1 7 5 5 5 
Minimum concentrabon(ppb) 100,00 151,00 653,00 349,00 342,00 287,00 219,00 197,00 100,00 
Mean concentration (ppb) 474,00 843,00 981,80 807,00 787,40 610,71 526,60 421,80 191,00, 
Maximum concentrabon(ppb) 1150.00 1632,00 1940,00. 1402,00 1188,00 957,00 763,00 . 
709,00 304,001 
Standard de%Aabon 360,88 628,42 
1 
540,46 465,32 302,10 272,08 196,35 1 212,30 102,041 
25% percentile 208,75 217,00 671,50 379,00 539,00 358,00 372,00 214,50 100,00 
1 Median 445,50 905,00 813,00 756,00 812,00 567,00 540,00 446,00 155,00 
175% Percentile 631,00, 1438,00 1376,00 1243,00 1023,001 937,00 674,50 617,00 300,00 
Oxytetracycline concentration - Sea Brearn Serum (BIOASAY) - High Temperature 
Day 21 
Samples 5 
Minimum concentration(ppb) 100,00 
Mean concentraflon(ppb) 100,00 
Maximum concentration(ppb) 100,00, 
Standard deviation 0,001 
25% Percentile 
Median 
175% Percentile 
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Figure 69: EXPERIMENT V- Pharmacokinetics of Oxytetracycline in the muscle of 
sea bream (Sparus aurata) at 24 ± 1. C 
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Figure 70: EXPERIMENT V- Pharmacolkinetics of Oxytetracycline in the muscle of 
sea bream (Sparus aurata) at 24 ±1oC Mean and Standard deviation 
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Figure 71: EXPERIMENT V- Pharmacokinetics of Oxytetracycline in the muscle of 
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Figure 72: EXPERIMENT V- Pharmacokinetics of Oxytetracycline in the liver of 
sea brearn (Sparus aurata) at 24 ±1ýC 
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Figure 73: EXPERIMENT V- Pharmacokinetics of Oxytetracycline in the liver of sea bream, 
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Figure 74: EXPERIMENT V- Pharmacokinetics of Oxytetracycline in the liver of sea bream, 
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Figure 75. EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum of 
sea bream, (Sparus aurata) at 24 ±1 iý, C 
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Figure 76: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum of sea bream 
(Sparus aurata) at 24 ±1ý. C- Mean and Standard deviation 
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Figure 77. - EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum of 
sea bream (Sparus aurata) at 24 ±1ýC- Box plot presentation 
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3.7.1.2 Low water temperature 
3.7.1.2.1 Oxytetracycline depletion in muscle 
The presence of extreme and outlier values on the 3rd, 5th and 7th day and the very low 
concentration present on the 10th day indicated again that analysis of the mean OTC 
concentration achieved in the muscle is a better indicator. The biphasic elimination 
pattern of OTC found at the high water temperature was also recorded at the low 
temperature (Figures 78,79,80 and Table 57). As in the high temperature, the maximum 
concentration was measured at the conclusion of the treatment. Detectable drug levels 
were calculated even at 30 d post-dosing. Mean OTC concentration reached an early 
peak 440 ppb on the 3rd day decreasing gradually up until the 10th day, increased 
rapidly on the 11th day (280 ppb) and reduced rapidly on the 13th day (40 ppb). In 
several time points the measured OTC levels were higher than the relevant OTC levels 
at high temperature. 
3.7.1.2.2 Oxytetracycline depletion in liver 
The biphasic elimination pattern of OTC found at the high water temperature was also 
recorded at the low temperature. Mean and maximum OTC concentration in the liver 
increased reaching a peak on the 5th day (1848 / 5820 ppb) reducing rapidly on the 7th 
day and moderately up until the 10th day (Figures 81,82,83 and Table 57). A second 
peak was reached on the 1 1th day (692 / 2604 ppb) reducing sharply until the 15th day 
remaining low thereafter (<80 ppb). 
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3.7.1.2.3 Oxytetracycline depletion in Serum 
Mean OTC serum concentration increased moderately up until the 5th (650 ppb), 
decreased on the 7th day, increased again gradually reaching a peak on the 18th day 
(1434 ppb) and decreased rapidly below the detection limit on the 25th day (Figures 
84,85,86 and Table 57). It is characteristic that minimum concentration remained below 
the detection limit up until the 13th day giving a peak of 1 ppm only of the 18th day and 
fell below detection limit on the 25th day. It was obvious that feeding response of the fish 
on the 7th day of the treatment period was problematic. 
3.7.1.2.4 Oxytetracycline depletion in skin 
Skin samples displayed the highest OTC levels. Mean OTC concentration in the skin 
increased rapidly reaching a peak (1.7 ppm) on the 3rd day reduced rapidly on the 5th 
day and staying low until the 1 Oth day (Figures 87,88 and Table 57). On the 11 th day 
mean concentration reached another peak (2ppm) and reduced rapidly on the 13th day. 
A slight peak was evident on the 18th day and skin OTC concentration remained very 
low after the 20th day of the experiment. 
R Chfistoftlogiannis 166 
Use of Antibiotics in Greek Mariculture University of Stiding 
Table 57: EXPERIMENT A Oxytetracycline kinetics in Sea brearn at low temperature 
after 10 day oral treatment - Statistical interpretation 
StatisticalAnalysis 
oxytetracychne concentration - Sea Bream Muscle - Low Temperature 
Day 0 Day I Day 3 Day 5 Day 7 Day 10 1 Day 11 Day 13 
Samples 8 5 9 7 8 8 8, 
Minimum concentration(ppb) 4,06 58,11 18,37 53,64 12,21 10,53 4,53 
Mean concentration(ppb) 10,68 439,34 126,33 164,78 34,55 279,67 39,22 
Maximum concentration(ppb) 22,97 1391,48, 359,37 569,68 69,83 970,27 79,73 
Standard deviation 7,79 561,481 113,18 182,47 , 18,10 331,73 26,44 
25% percentile 5,05 67,46 
1 40,54 71,09 23,92 77,28 19,8 
Median 7P39 167,86 
1 87,03 93,30 29,19 119,91 30,35 
75% Percentile 19 rR 946,95 
1 199,44 169,48 47,22 503,59 66,48 
Day 15 Day 18 Day 20 Day 25 Day 30 Day 40 
Samples 8 8 8 8 8 8 
Minimum concentration(ppb) 8,15 4,73 4,66 6,47 4,22 6,76 
Mean concentration(ppb) 17,48 9,37 8,48 13,43 7,77 15,40 
Maximum concentration(ppb) 34,12 16,99 15,44 , 28,73 16,22 25,04 , 
Standard de%viation 11,24 3,92 3,45 7,69 4,69 6,46 
25% Percentile 8,52 6,02 6,23 7,12 4,42 10,40 
Median 10,96 9,15 7,29 11,81 5,90 14,60 
75% Percentil 1 29,30 , 11,73 10,55 18,74 , 12,27 22,19 
oxytetracycline concentration - Sea Bream Liver - Low Temperature 
Day 0 Day 1 Day 3 Day 5 Day 7 Day 10 Day 11 Day 13 
Samples 8 7 8 8 8 8 8 
Minimum concentration(ppb) 6,71 31,57 178,67 282,32 154,46 84,01 11,85 
Mean concentration (ppb) 99,06 1467,62 1848,41 624,02 416,68 691,61 275,64 
Maximum concentration(ppb) 466,75 3611,25, 5820,37 1073,03 949,20, 2604,29 737,55] 
Standard de%. 4ation 158,34 1447,79 2116,10 270,93 300,37 810,88 214,72 
25% percentile 7,03 182,53 _ 
309,79 377,05 204,54 225,81 133,85 
Median 39,58 1161,99 645,48 631,00 255,63 450,76 247,79 
175% Percentile 143,19 3327,36 3556,93 , 852,42 711,52 758,84 335,68 
Day 15 Day 18 Day 20 Day 25 Day 30 1 Day 40 
Samples 7 7 8 8 8 8 
Minimum concentration(ppb) 6,56 12,34 7,29 48,12 6,01 83,34 
Mean concentration(ppb) 62,29 79,00 26,43 175,02 12,52 187,06 
Maximum concentration(ppb) 143,77 171,87 72,13 , 
284,40 25,25 271,86 
Standard deviation 53,59 60,56 21,31 82,63 6,09 , 63,58 
25% Percentile 12,23 28,91 13,76 103,39 8,71 152,41 
Median 41,81 57,90 19,16 167,20 10,77 169,97 
75% Percentile 109,15 146,00 38,09 252,55 15,94 252,83 
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Oxytetracycline concentration - Sea Bream Serum (BIOASSAY) - Low Temperatura 
Day 0 Day I Day 3 Day 5 Day 7 1 Day 10 Day 11 Day 13 
Samples 5 7 9 7 1 8 5 
Minimum concentration(ppb) 100,00 100,00 100,00 100,00 100,00 100,00 
Mean concentrabon(ppb) 100,00 519,00 656,78 300,28 688,25 1299,601 
Maximum concentration(ppb) 100,00 1408,00, 2172,00 470,00 1947,00 3746,001 
Standard deviation 0,00 502,10 669,66 121,44 614,96 1426,611 
25% percentile 100,00 100,00 258,00 159,75 312,501 
Median 470,00 422,00, 273,00 561,50 1011,00 
175% Percentile 1 958,00 984,501 422,001 1038125 
Day 15 Day 18 Day 20 Day 25 Day 30 Day 40 
Samples 7 6 
Minimum concentration(ppb) 1011,00 100,00 
Mean concentragon(ppb) 1434,71 100,00 
Maximum concentrabon(ppb) 2172,00 100,00 
Standard deAabon 399,31 0,00 
25% Percentile 1128,00 
Median 1329,00 
175% Percentile 1744,00, 
-I 
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Figure 78: EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the muscle of 
sea bream (Sparus aurata) at 18 ± 1. C 
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Figure 79: EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the muscle of 
sea bream (Sparus aurata) at 18 ± 1. C- Mean and Standard deviation 
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Figure 80: EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the muscle of sea brearn 
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Figure 81: EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the liver of 
sea brearn (Sparus aurata) at 18 ± 1. C 
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Figure 82: EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the liver of 
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Figure 83. - EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the liver of 
sea bream (Sparus aurata) at 18 ±1oC- Box Plot presentation 
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Figure 84: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum of 
sea bream, (Sparus aurata) at 18 ±1oC 
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Figure 85. - EXPERIMENT VI - Pharmacokinetics of Oxytetracycline in the serum of 
sea bream (Sparus aurata) at 18 ± 1. C- Mean and Standard deviatio 
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Figure 86. - EXPERIMENT V1 - Pharmacokinetics of Oxytetracycline in the serum of 
sea bream (Sparus aurata) at 18 ± I. C- Box Plot presentation 
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Figure 87: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the skin of 
sea bream, (Sparus aurata) at 18 ±1ýC 
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Figure 88. - EXPERIMENT VI - Pharmac-okinetics of Oxytetracycline in the skin of 
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3.7.2 Comparisons 
3.7.1.2 Muscle versus liver versus serum Depletion 
Figure 89, Comparison of OTC mean concentration in the muscle, liver and serum 
of sea breann at high temperature 
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Figure 90: Comparison of OTC mean concentration in the muscle, liver, serum and skin of sea 
bream at low temperature 
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3.7.1.2 Depletion at High versus Low temperature 
Figure 91. - Comparison of OTC mean concentration in the muscle 
of sea bream at high and low temperature 
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Figure 92: Comparison of OTC mean concentration in the liver 
of sea bream at high and low temperature 
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Figure 93. - Comparison of OTC mean concentration in the serum 
of sea bream at high and low temperature 
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3.8 Oxytetracycline Kinetics in Sea Bass (Dicentrarchus labrax) 
3.8.1.2 High Water Temperature 
3.8.1.2.1 Oxytetracycline depletion in Muscle 
Oxytetracycline muscle concentration in sea bass at high temperature increased 
moderately on the I st day and then sharply until the 5 th day reaching a peak of about 700 
ppb while it was reduced sharply to reach 300 ppb on the 11 th day. The following days 
another peak was apparent around the 13th day (350 ppb) while the concentration fell 
sharply on the 21't day reaching consumer safe levels (Figures 94,95,96 and Table 58). 
The estimated withdrawal period was 264 Degree-days 
3.8.1.2.2 Oxytetracycline depletion in Liver 
In the liver of sea bass (if extreme and outlier values are excluded), OTC reached a peak 
concentration around 8 pprn on the 3rd day reducing rapidly until the 11 th day (1ppm), 
while it was increased slightly again on the 13th day (1.6 ppm) to fall gradually below 
consumer safe levels on the 25 th day (Table 58). The estimated withdrawal period was 
15 X 24 = 360 Degree-days. In the presentation of OTC mean and median 
concentration in the muscle and liver (Figures 97,98 and 99) of sea bass at 24o C 
indicated a three-step depletion process on the 3rd, 7 th and 13 th day of the experiment. 
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3.8.1.2.3 Oxytetracycline depletion in Serum 
Mean and maximum oxytetracycline concentration in the serum increased moderately up 
until the first day and rapidly thereafter to reach peak concentrations of 6.25 ppm (mean) 
and 12.4 ppm maximum on the 1 oth day of the experiment (final day of the oral 
treatment). OTC concentration decreased rapidly until the 12 th day and gradually 
thereafter but remained high even on the 21 st day (maximum concentration: 1 ppm, mean 
concentration: 758 ppb). Figures 100,101 and 102 as well as Table 58 indicated High 
standard deviation was evident between the 3d and the 1 1th day and Minimum OTC 
serum concentration remained below the method detection limit up until the 10h day 
reaching a peak on the 12th day (5.2 ppm) and was reduced gradually thereafter. The 
estimated withdrawal period in the serum of sea bass at that temperature was over 264 
degree-days. 
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Table 58: EXPERIMENT VII Oxytetracycline kinetics in Sea bass at high temperature 
after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxytetracycrine acid concentration - Sea Bass Muscle - High Temperature 
Day 0 - Day I Day 3 Day 5 Day 7 Day 10 Day II Day 12 
Samples 4 7 8 7 5 8 8 6 
Minimum concentration(ppb) 3,47 7,59 27,88 23,28 24,27 7,26 10,37 77,69 
Mean concentration(ppb) 3,47 23,97 317,18 275,96 420,87 148,24 152,24 204,21 
Ma)dmum concentration(ppb) 3,47 51,69 574,87 686,05 658,60 391,11 310,28 378,92 
Standard deAation 0,00 15,821 189,96 265,62 284,92 159,36 95,721 114,31 
_ 25% percentile 8.49 125,20 96,08 122,10 16,90 79,58 117,89 
IMedian 26,94 
1 
334,24 192,10 546,99 85,59 145,04 170,29 
175% Percentile 31,59 473,68 622,49 656,59 R32 77 230,40 317,32 
Day 13 Day 14 Day 17 Day 21 Day 231 Day 25 
Samples 8 8 8 8 71 6 
Minimum concentration(ppb) 104,39 17,81 8,21 20,18 9,281 16,86 
Mean concentration(ppb) 247,74 203,00 97,66 37,94 24,57 27,87 
Maximum concentration(ppb) 355,44 93,00 309,33 68,41 36,33 42,08 
Standard deviation 83,561 328,481 91,131 16,93 10,34 9,53 
25% Percentile 193,81 140,24 50,37 23 , 21 12,69 20,10 
Median 241,85 229,561 74,20 35,67 29,16 , 26,32 
75% Percentile 333,44 246,661 108,98 52,211 33,241 36,36 
Oxytetracyline concentration - Sea Bass Liver - High Temperature 
Day 0 Day II Day 3 Day 5 Day 7 Day 10 Day 11 Day 12 
Samples 8 61 5 8 8 7 8 8 
Minimum concentration(ppb) 3,47 6,181 333,19 24,70 22,76 26,94 10,36 484,86 
Mean concentration(ppb) 6,51 96,26 6668,32 987,80 1434,37 1210,79 630,20 
. 746,84 
Maximum concentration(ppb) 19,94 224,64 19410,16 2824,06 3572,68 4182,27 1909,09 1012,91 
Standard deAation 6,08 99,49 7666,44 878,17 1210,19 1 1648,52 626,75 179,35 
25% percentile 3,47 15,60 1521,92 231,31 231,35 66,61 131,60 598,78 
Median 3.47 1 55,2 2803,08 886,25 1403,19 384,67 468,33 711,37 
1 
75% Percentile 9,35 1 219,27 13747,36 1276-69 2282,94 2910,91 1008,83 907,6 0 
r- Sea Bass Liver - High Temperature 
Day 13 Day 14 1 Day 17 Day 21 Day 23 1 Day 25 
Samples 8 81 6 8 81 6 
Minimum concentration(ppb) 373,36 43,55 115,17 41,42 31,231 27,41 
Mean concentration(ppb) 1010,62 838,14 250,10 72,32 173,19 269,95 
Maximum concentration(ppb) 1620,16 2683,30 430,84 118,54 307,34 1253,23 
Standard deviation 487,28 821,91 114,36 27,25 99,53 483,36 
25% Percentile 489,641 416,34 159,78 46,34 89,81 42,10 
Median 1031,031 507,37 240,54 67,18 173,15 76,04 
75% Percentile 1498,751 1105,73 1 331,86 94,52 280 
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Oxorinic acid concentration - Sea Bass Serum (BIOA SSA Y) - High Temperature 
Day I Day 3 Day 5 Day 7 Day 10 Day 11 Day 12 
Samples 5 5 4 6 7 6 6 
Minimum concentration(ppb) 100,00 100,00 100,00 100,00 100,00 1480,00 4066,00 
Mean concentrabon(ppb) 435,20 2132,40 3952,50 4578,33 6274,28 5049,17 4674,33, 
Maximum concentration(ppb) 851,00 1 3161,00 6460,00 10470,00 . 
12440,00 9729,00 5190,00 
Standard de%viation 329,01 1240,36 2719,38 4368,35 4445,51 3489,35 448,55 
25% percentile 100,00 971,00 1162,50 100,00 1190,00 2335,00 4234,00 
Median 524,00 2632,00 4625,00 4270,00 7620,00 3750,00 4725,00 
75% Percentile 1 726,00 3044,00 , 6070,00 8812,50 9460,00, 9156,75 , 
5085,00 
Sea Bass Serum ( BIOASSAY) - High Tem perature 
Day 13 Day 14 Day 17 Day 21 Day 23 Day 25 
Samples 5 6 5 5 
Minimum concentraflon(ppb) 1010,00 2224,00 100,00 570,00 1 
Mean concentration(ppb) 3258,00 3484,83 937,40 758,00 
Maximum concentration(ppb) 4530,00 4658,00, 1890,00 1011,00 
Standard deviation 1453,95 918,371 684,05 163,68 
25% Percentile 1855,00 2543,50 298,50 620,50 
Median 3640,00 3598,00 1010,00 769,00 
F75% Percentile 447000 4300,25 1540,00, 89000 
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Figure 94. - EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the muscle of 
sea bass (Dicentrarchus labrax) at 24 t 1. C 
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Figure 95: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the muscle of 
sea bass (Dicentrarchus labrax) at 24 ± 1. C- Mean and Standard deviation 
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Figure 96: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the muscle of 
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Figure 97: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the liver of 
sea bass (Dicentrarchus labrax) at 24 ± 1. C 
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Figure 98: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the liver of 
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sea bass (Dicentrarchus labrax) at 24 ± 1. C- Mean and Standard deviation 
Figure 99. - EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the liver of sea bass 
(Dicentrarchus labrax) at 24 ± 1. C- Box plot presentation 
184 
10 11 12 13 14 17 21 23 29 
OCID 
r) 
CL IS, COD 
C) 
C, 
-10, LOD 
4-1 
C- 
5, CIDO 
C. 
I-) 
U 
t 
-lr---T-- t -1 
lrj 11 12 13 14 
Day, 
17 a 23 29 
185 
Figure 100. - EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum of 
sea bass (Dicentrarchus labrax) at 24 ± 1. C 
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Figure 101. - EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum Of 
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Figure 102: EXPERIMENT VII - Pharmacokinetics of Oxytetracycline in the serum of 
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3.8.1.2 Low water temperature 
3.8.1.2.1 Oxytetracycline depletion in Muscle 
Analysis of muscle OTC concentration (if extreme and outlier values are excluded) 
increased gradually to reach maximum (about 400ppb) on the 1 oth day decreasing 
gradually below consumer safety levels on the 20th and remained very low thereafter 
(Figures 103,104,105 and Table 59). The estimated withdrawal period was 10 X 14 
140 Degree-days. 
3.8.1.2.2 Oxytetracycline depletion in Liver 
OTC liver concentration on the other hand, remained very low up until the 5 th day, 
increased on the 7 th day reaching a maximum of 600ppb, dropped sharply on the 1 oth 
day, increased on the 11th day reaching a maximum concentration of 740ppb and fell 
gradually reaching consumer safe levels on the 31't day (Figures 106,107,108 and 
Table 59). The estimated withdrawal period was 21 X 14 = 294 Degree-days. 
3.8.1.2.3 Oxytetracycline depletion in Serum 
Mean and maximum OTC concentration (Figures 109,110,111 and Table 59) in the 
serum increased moderately until the 5th day (740ppb/2173 ppb). Maximum 
concentration reached a peak on the 7th day (6.13 ppm) and was reduced up until the 
15th day (4.6 ppm), then sharply until the 18th day (1.4 ppm) and moderately until the 
40th day reaching the detection limit of the method. Mean OTC serum concentration 
reached a plato between the 7th and I Oth day (2.7 ppm) reduced sharply on the 11 th 
day (1.37 ppm) and gradually thereafter. It is important to indicate that minimum 
concentration remained below the detection limit of the bioassay method throughout the 
experimental period. The estimated withdrawal period was 30 X 14 = 420 Degree-days. 
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Table 59: EXPERIMENT VIII Oxytetracycline kinetics in Sea bass at low temperature 
after 10 day oral treatment - Statistical interpretation 
Statistical Analysis 
Oxytetracycline concentration - Sea Bass Muscle - Low Temperature 
Day 0 Day 1 Day 3 Day 5 Day 7 Day 10 Day 11 Day 13 
Samples 4 7 7 8 7 9, 
M um Minimum concentration(ppb) i im Co I 7,27 6,20 4,45 14,23 4,52 6,75 
Mm tr ean concentrabon(ppb) 17,7 28,80 161,35 155,60 93,45 76,21 
MM ximum c aximum concentration (ppb) 28,51 f 110,34 431,19 397,73, 342,80 311,60 
S. -A-A A-A fi, tandard deviation 10.2 36,30 139,93 154,19 124,61 102,54 
25% percentile 8,18 13,44 35,03 28,90 5,50 7,97, 
Median 17,52 16,49 153,10 91,15 36,50 20,221 
75% Percentile 1 27,4 , 22,28, 214,36 , 329,29 1 
i3,92 131,841 
Day 15 Day 18 Day 20 Day 23 Day 26 Day 31 Day 35 Day 39 
Samples 8 9 6 2 8 8 6 6 
Minimum concentration(ppb) 4047 4,71 7,20 24,29 3,47 3,89 4,13 3,47 
Mean concentration (ppb) 25,31 42,92 49,96 47,40 33 , 04 7,35 13,64 8,81 
Maximum concentration(ppb) 84,88 153v29 91,91, 70,42 _ 81,74 1,79. 23,81 23,32. 
Standard deviation 35,94 53,12 36,20 32.54 31,29 3,27 9,60 8,24 
25% Percentile 5,35 7,04 9,91 24,39 5,02 4,01 4,13 3,52 
Median 6,53 11,22 56,84 47,40 26,07 7,49 13,28 4,14 
75% Percentile 1 63,39, 86,29 80,09 62,94 9,84 23,34 16,50 
oxytetracycline concentration - Sea Bass Liver - Low Temperature 
Day 0 Day I Day 3 Day 5 Day 7 Day 10 Day 11 Day 13 
Samples 6 8 5 8 8 9 
Minimum concentrabon(ppb) 5,99 4,56 10,54 3,47 6,33 4,87 
Mean concentration(ppb) 7,63 31,60 243,54 53,56 269,29 174,49. 
Maximum concentration (ppb) 10,42 167.35 605,84 351,57 , 92 735 676,83 
Standard deviation 1,59 55,77 244,75 120,66 . 258,41 257,48 
25% percentile 6,6 6,03 15,68 5,23 10,76 7,56 
Median 7,02 9,99 283,2 10,59 276,80 11,20 
175% Percentile 8,99 , 
30,05, 451,57 24,08 431,42. 379,76 
Sea Bream Uver - Low Temperature I 
Day 15 Day 18 Day 20 Day 23 Day 26 Day 31 Day 35 Day 391 
Samples 7 7 8 8 6 6 61 
Minimum concentration(ppb) 7,48 14,35 7,45 3,47 3,47 4,94 4,52 
Mean concentration(ppb) 344,86 137,8 103,89 48,6 16,60 58,58 29,29 
Maximum concentration (ppb) 1267,47 282 210,42, 148,06 54,80. 120,94 100,36 
Standard deýviation 432,78 105,35 77,34 56,29 20,041 37,58 40,24 
25% Percentile 15,18 15,83 30,11 4,61 3,471 33,67 4,56, 
Median 253,88 152,96 92,44 23,22 8,09 58,68 5,43 
175% Percentile 396,07 247,58 190,39 104,6 29,94 1 78,97 66,66 
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Oxytetracycline concentration - Sea Bass Serum (BIOASSAY) - LowTemperature 
Day 0 Day 1 Day 3 Day 5 Day 7 Day 10 Day 11 Day 13 
Samples 5 5 5 5 5 5 5 
Minimum concentration(ppb) 100,00 100,00 100,00 100,00 100,00 100,00 '00 100,00 100,00 
Mean concentration(ppb) 370,28 1084,62 739,91 2786,42 271 1,10 1376,73 1363,44 
Maximum concentration(ppb) 1129,00 2173,00, 2173,00 6128,00 
_ 2540,26, 4184,00 4929,001 
Standard deviation 446,26 893,281 852,74 2335,76 5806,00 1723,63 2033,811 
25% percentile 100,00 
1 
273,01 100,00 833,16 100,00 100,02 100,00 
Median 100,00 858,73 555,48 2173,33 3365,33 654,32 618,881 
175% Percentile 775,70 2009,18 1472,04 5046,23 4995,09 3014,66 
Sea Bass Serum (BIOASSAY) - Low Temperature 
Day 15 Day 18 Day 20 Day 40 
Samples 5 5 5 5 
Minimum concentration(ppb) 100 100 100,00 100,00 
Mean concentration(ppb) 1165,65 976,7 732,94 100,00 
Maximum concentration(ppb) 4670 1.404 1069,00, 100,00 
Standard deviation 11986,11 532,79 413,921 0,00 
25% Percentile 100 479,36 312,70 
, 
Median 100 1191,52 958,31 
175% Percentile 2764,14, 1366,62 1040,49 
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Figure 103: EXPERIMENT VIII - Pharmacokinetics of Oxytetracycline in the muscle of 
sea bass (Dicentrarchus labrax) at 14 ± 1. C 
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Figure 105: EXPERIMENT VIII - Pharmacolkinetics of Oxytetracycline in the muscle of 
......... .. 
4LID r1 r) 
C2- 
4-J 
WO 
u 
0 
In. e . 414. eq da; 0 
1-*--- 1-11- -1 11TI ** I* *1 
7 1011 13 1S lb ao as 31 39 
Day 
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Figure 106. - EXPERIMENT Vill - Pharmacokinetics of Oxytetracycline in the liver of 
sea bass (Dicentrarchus labrax) at 14 ± 1. C 
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Figure 107: EXPERIMENT VIII - Pharmacokinetics of Oxytetracycline in the liver of 
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Figure 108: EXPERIMENT VIII - Pharmacokinetics of Oxytetracycline in the liver of 
sea bass (Dicentrarchus labrax) at 14 ± I. C- Box plot presentation 
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Figure 109. - EXPERIMENT Vill - Pharmacokinetics of Oxytetracycline in the serum of 
sea bass (Dicentrarchus labrax) at 14 ± 1. C 
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Figure 110: EXPER IM ENT VI II- Pharmacokinetics of Oxytetracycline in the serum of 
sea bass (Dicentrarchus labrax) at 14 ± 1. C- Mean and Standard deviation 
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Figure 111: EXPERIMENT VIII - Pharmacokinetics of Oxytetracycline in the serum of 
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3.8.2 Comparisons 
3.8.2.2 Muscle versus Liver versus Serum Depletion 
Figure 112: Comparison of OTC mean concentration in the muscle and liver and serum 
of sea bass at high temperature 
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Figure 113. Comparison of OTC mean concentration in the muscle, liver and serum 
of sea bass at low temperature 
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3.8.2.2 Depletion at High versus Low temperatures 
Figure 114: Comparison of OTC mean concentration in the muscle 
of sea bass at low and high temperature 
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Figure 115. Comparison of OTC mean concentration in the liver 
of sea bass at low and high temperature 
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Figure 116: Comparison of OTC mean concentration in the serum 
of sea bass at low and high temperature 
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Figure 117ý Comparison of OTC mean concentration in the muscle 
of sea bream and sea bass at high temperature 
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Figure 118: Comparison of OTC mean concentration in the muscle 
of sea brearn and sea bass at low temperature 
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Figure 119: Comparison of OTC mean concentration in the liver 
of sea bream and sea bass at high temperature 
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Figure 120. Comparison of OTC mean concentration in the liver 
of sea bream and sea bass at low temperature 
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Figure 121: Comparison of OTC mean concentration in the serum 
of sea bream and sea bass at high temperature 
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Figure 122: Comparison of OTC mean concentration in the serum 
of sea bream and sea bass at low temperature 
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4. Discussion 
4.1 Greek Mariculture Industry 
Greek Mariculture grew dramatically since 1981 based on ideal climatic conditions 
and extended sheltered coastline (Papoutsoglou, 2000). Breakthrough in hatchery 
technology followed by advances in fish nutrition along with private investment and 
EU funding lead to 20-fold production increased between 1990 and 2000 with 
dramatic drop in ex-farm prices from E15.57/Kg in 1989 to E4.97/Kg in 1999. 
(Theodorou, 1999). Cost optimisation strategies in recent years involved gradual 
replacement of live feeds, production diversification to new species, broodstock 
selection and improved health management to prevent diseases through 
vaccination and reduce losses and antibiotic use. Dietary crisis like dioxins, BSE, 
GMOs, antibiotic residues in farmed animals magnified and often misinterpreted by 
the media led to consumer awareness and demand of high quality safe and 
healthy aquaculture products. Mariculture sustainability depends on product quality 
control and safety supported by codes of conduct and practice (Christofilogiannis, 
2000). Despite good prospects presented in a recent EU funded market research 
(McAlister and Partners, 1999) the industry suffers from framework, technology 
and market perception problems. Supply segmentation, communication gaps 
between farmers, insufficient sector "image" promotion, rigid legislative framework, 
competition with coastal zone users, malpractices and lack of presentation of the 
socio-economic importance in rural communities are only some of the industry's 
practical problems. Federation of Greek Maricultures (FGM) was founded in 1991 
and soon after became the dominant sectoral policy making organisation. FGM 
took initiatives referring to licensing, legal framework development for aquaculture, 
technical issues and sector promotion. Funding of this research by FGM in 1994 
was unique for the Greek standards. Since 1995, this study was co-supported by 
the Greek Ministry's of Development YPER Programme. Increased consumer 
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awareness on healthy, safe nutritious final product and need to minimise 
production cost were the main reasons for this study that aimed to produce "real" 
life applied research that had clinical, economic and consumer safety relevance. 
The first goal was to audit the prevalence and the importance of the main bacterial 
diseases in Greek Mariculture industry and to evaluate by a standard methodology 
the antibiotic resistance level and the possible reasons for treatment failures. The 
second goal was to evaluate the effectiveness of antibiotic treatment under "farm" 
conditions and the dynamics of depletion for the two most commonly used 
antibiotics namely Oxolinic acid and Oxytetracycline. Since the initiation of this 
study, considerable effort was devoted in the development of a Quality Assurance 
scheme for Greek Mariculture. Data from this study have been incorporated in the 
Greek Mariculture's Code of Practice and to the internal audits protocols in order to 
ensure compliance and certification of the Greek sea bass and sea bream by 
AGROCERT, the Ministry' s of Agriculture competent authority for agricultural 
product certification. This scheme will be launched officially in September 2003. It 
is important to state that under this close collaboration the industry utilised the 
technical feedback from this study long before this submission through the FGM 
Fish Health and FEAP Fish Health committees. 
4.1.1 Cultured Species 
Sea bass (Dicentrarchus labrax,. Seranidae) is also a highly euryhaline and 
eurythermal species discontinuously distributed around the Atlantic from Moroccan 
coast to Irish, North, Baltic sea. Ubiquitous also in Mediterranean coasts, enters 
costal inlets and river mouths. (Bamabe, 1990). Its external colour is silver-grey with 
silvery sides and stomach, having a cylindrical body. It is not very well known but this 
species can be adapted to fresh water. Adults leave the lagoons around 
Mediterranean from October to December in order to reproduce in the open sea. 
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Sexual maturity develops in males at 2 years of age (23-30cm) and in females at 3 
years (31-40cm). Its feeding range includes small fish, prawns, cancers and 
cuttlefish (Whitehead et al., 1986). Gilthead sea brearn (Sparus aurata,. Sparidae) is 
an euryhaline, eurythermal species that reproduces from October to December in the 
open sea. It is discontinuously distributed in the Mediterranean sea, but rarely in the 
Black sea, and also in Atlantic from the British islands to Verde Is cape and the 
Canary islands (Whitehead et al., 1986). Sexual maturity develops in 1 to 2 years of 
age (20-30cm) in males and in 2 to 3 years of age (33-40cm) in females. Sea bream 
is protandrous hermaphrodite. Interesting characteristics are its sensitivity at low 
temperatures and at low dissolved oxygen levels. This species is the first that leaves 
the lagoons in early autumn, for the open sea. Its feeding range includes molluscs, 
crustacean, small fish and plants. (Whitehead et al., 1986) New species production 
of 10 million fry including Sharpsnout sea brearn (Puntazzo puntazzo), Dentex 
(Dentex dentex), Pagrus (Pagnis pagrus), White sea bream (Diplodus sargus), Red 
Pandora (Pangelus erythfinus), and Flatfish (Solea sp. ) is about 5% of the total 
production (FEAP 2002). 
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4.2 Bacterial Diseases 
4.2.1 Epidemiological Surveys in Mediterranean Mariculture 
industry 
Bacterial Fish diseases remain a limiting factor for the viability of the marine fish 
culture (Paperna et al., 1977; Colorni et al., 1981; Le Breton, 1999; 
Christofilogiannis 2002). Bacteria of the genera Vibdo, Aeromonas, Pseudomonas, 
Myxobactefia, are ubiquitous in water, present on undamaged skin of the fish, and 
form an important part of the intestinal heterotrophic microflora of sea bream and 
sea bass (Colorni et al., 1981; Le Breton, 1989). However high levels of mortalities 
occur under unsuitable environmental conditions such as, high loads of organic 
material, unbalanced nutrition, extreme or rapid salinity or temperature fluctuations, 
low water oxygen levels and stress due to overcrowding or handling. (Fernardes, 
1977; Colorni et al, 1981; Moller and Anders, 1986). Before the current study only a 
few surveys of bacterial fish diseases in Mediterranean were initiated in Israel 
(Paperna et al., 1977; Papema et al., 1980; Colorni et al., 1981; Balebona et al., 
1993) France (Breuil et al., 1989) Spain (Aquigrup, 1980; Balebona et al, 1998) Italy 
(Salati et al., 1997) and Tunisia (Bakhrouf et al., 1995). 
4.2.2 Current Bacteriological survey 
Due to funding by the Federation of Greek Maricultures this study had to address 
"real "issues like the spectrum of fish bacterial pathogens in Greece between 1994 
and 1997, their distribution and relevance in different areas (Christofilogiannis, 
1996), their clinical importance as primary or opportunistic pathogens, their 
associated pathology -parasitological and histopathological data gathered and 
analysed during the same period (Christofilogiannis, 1997a), are not presented here 
- and most important of all in terms of production cost, which antibiotics are 
effective to combat these diseases in order to avoid treatment failures due to 
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antibiotic resistance. Therefore the scope of this research had to be broad and 
practical and we consider this type of approach more relevant for the industry and 
for the knowledge development between fellow fish pathologist on the field, 
compared to highly technical focused in a certain issue niche research. This study 
is the first in Mediterranean to include along with the biochemical screening and 
identification, two tests like Minimum Inhibitory Concentration (MIC) and 
Quantitative Antibiogram in order to quantify resistance to antibiotics and initiate a 
data bank on resistance profiles, the results of which could be compared with new 
data of future studies as long as the methodology will be kept the same. API 20E 
has been widely used to identify bacterial fish pathogens (MacDonell et al., 1982; 
Kent, 1982). Although apart from the reaction profiles of Valginolyficus, 
V. Parahaemol)dicus and V. damsela, none of the other fish pathogenic vibrios are 
incorporated in the API 20E Analytical Profile index, 3rd ed. (1989), this test-strip 
was employed for the identification of the bacterial strains in this study 
(Christofilogiannis et al., 1997). Large biochemical variability exists between strains 
of Vibrio spp and especially Vangufflarum (Egidius and Andersen, 1977). Mac 
Donell et al., (1982) suggested the application of 2% marine salt solution for the 
inoculation of the API 20E strip and the characterisation of marine and estuarine 
bacteria. In this study however the use of a 3% salt solution gave consistently better 
results. In this survey Sea bass contributed the majority of the strains (86,13%) 
followed by sea brearn (almost 17%) while the new species had very low 
contribution (less than 8% between them). We have to consider two things to 
explain this distribution. In the period of the survey (1994-1997) minor species were 
just in the process of being accepted by the fish farmers and only sharpsnout 
brearn (Puntazzo puntazzo) managed to have a fair share (about 5%) while still the 
rest are being evaluated. On the other hand the vaccine application in order to 
combat diseases like Vibriosis or Pasteurellosis in sea bass just started to be really 
implemented after 1997 due to the perception that sea bass was extremely prone to 
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stress due to handling and farmers were extremely sceptical of practices such as ip 
injection vaccination or even immersion vaccination. These perceptions changed 
with the first optimistic results and due to recent application of effective oral 
vaccines for the major diseases. Saronikos, South Evoikos and North Evoikos were 
the areas most widely surveyed due to the large number of farms, due to the 
proximity to the National Centre of Marine Research in Athens and due to the 
presence of two farms namely Kantali Ltd and Makronisos that were followed more 
closely. Both farms had no veterinarian responsible and both suffered from 
antibiotic misuse. Another important finding in principle but not - up until now - in 
clinical practice was that for the first time Aeromonas salmonicida was isolated from 
sea bass (1,15%) as well as the isolation of Gram-positive cocci in the new species 
Mugil cephalus and Dentex dentex, while Gram negative cocci were isolated in sea 
bream. It was not possible to identify all bacterial isolates based on AP120E 
analysis. Commercial miniaturized kits for biochemical tests (Pathotec and Minitek) 
were found to be inadequate for marine fish pathogen identification. (Colorni et al., 
1981). Despite the limitations, in real practice the API 20 E test is a valuable tool for 
biochemical identification. Cluster analysis-Eucleidian distances dendrograrn 
analysis was employed in order to demonstrate different clusters mainly between 
the Vibrio strains. Different phenotypes of Vibrio alginolyficus formed a distinct 
cluster, while Vlanguillarum phenon 4b and phenon 2 formed closely related 
clusters, which agrees with findings reported by Crisez et al. (1991). Statistical 
interpretation of API 20E data according to the NORDIC manual and employing the 
ALO test (ADH / LDC / OX) revealed that the Alo test could be used in order to 
separate Vanguillarum I phenon 4b and Vanguillarum 1 phenon 2 along with 
Listonella damsela and Valginolyticus different phenotypes. It was not however 
possible to be employed for the discrimination between V. parahaemolyticus, 
V. vulniricus and Valginolyficus which formed in this type of statistical analysis the 
same cluster. The bacterial pathogens isolated during this study as well as those 
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listed in the literature with potential to cause mortalities in sea bass and sea bream 
are listed in Figure 123. 
4.2.3 Gram negative bacterial pathogens 
Most bacterial fish pathogens are Gram-negative rods usually facultative pathogens 
that initiate diseases only under certain conditions (Austin, 1985a; Moller and 
Anders, 1986). 
4.2.3.1 Vibrio Spp. 
Vibfionaceae are small Gram negative, straight or curved rods with a single polar 
flagellum. This family includes Vibrio spp ubiquitous in the marine environment and 
Aeromonas spp. that predominantly occurs in freshwater conditions. Viblionaceae 
are predominant in necrotic tissue of the Mediterranean marine fish while 
Pseudomonadaceae in the necrotic tissue of Atlantic marine fish (Gauthier et al., 
1984). Vibriosis is one of the more serious problems in marine fish 
(Christofilogiannis, 1993). 
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Different species of Vibrio have been described as pathogenic for sea bass and sea 
brearn either in larval stages or in juveniles and adults (Toranzo and Bada, 1990). 
To date 7 species of Vibrio have been considered as fish pathogens (V anguillarum, 
Vordaffi, Valginolyticus, V. carchariae, V. cholerae no 01, L. damsela and 
V. vulnificus) (Vera et al., 1991). Colwell and Grimes (1984) gave detailed 
information on causative agents of Vibriosis of marine fish. Vibrio species 
pathogenic for marine fish include Vibrio alginolyticus, V. anguillarum, V. carchariae, 
V. cholerae, L. damsela, V. ordali, V. vulnificus, and V. parahaemolyticus. The 
strains most often isolated belong to the taxon Vlangufflarum of which 16 different 
serotypes have been already identified but not all of them pathogenic to fish. 
Genovese and Micale (1991) confirmed the presence of non-pathogenic strains of 
Vlanguillarum in sea bass. Vibtio spp. can be separated from Aeromonas spp. by 
exhibiting sensitivity to Novobiocin as well as to Vibriostat compound 0/129 (2,4- 
diamino 6,7 diisopropylpteridine phosphate) (Shotts et al., 1989). Disease caused by 
Vibfio spp. manifests as an "ulcerative haemorrhagic septicaemia". Handling injury 
is the primary factor in the aetiology of acute septicaemia by non-specific Vibrio spp. 
in sea bream in warm water conditions (20-28'3C). Grisez et al. (1997) gave a 
comprehensive review on the intestinal microflora of larval sea bream and sea bass 
and on the factors influencing Vibriosis outbreaks in larvae. Fluctuations in the 
composition of the dominant microflora appeared to reflect the bacterial composition 
of the ingested live feed. Selection towards the genus Vibrio was not observed until 
the larvae reached the end of the larval life stage. Obdo anguillarum and Vibfio 
alginolyficus exhibited significant adhesion to and chemotactic abilities towards 
mucus collected from the skin, gills, and intestine of gilt-head sea bream (Bordas et 
al, 1998). It is generally known that adhesion of bacteria to mucosal surfaces is an 
initial step for many microbial infections. Balebona al., (1995) demonstrated the role 
played by the mucous layer of fish, especially that of sea bream, during colonization 
of fish skin by saprophytic and pathogenic bacteria. 
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4.2.3.2 Vibrio anguillarum serotype I 
In this study, the principal bacterial pathogens in sea bass included Vlangufflarum 1 
phenon 4b (33.3%) and Vanguillarum I phenon 2 (6,9%) while Vangufflarum I was 
isolated also form Puntazzo puntazzo (40%). This pathogen is the most important 
for sea bass farming but has very low significance in sea bream farming. This is 
important because combined vaccines used in Greece against Pasteurellosis in sea 
bream include an unnecessary component. It would be important however in the 
future to include other vibrios that are pathogenic to sea bream like Listonella 
damsela and V. alginolyficus. Paperna 1984 reported that this pathogen was the 
most important and common pathogen that affects only juveniles and adult sea bass 
but has not been described in sea bream. Vibrio angufflarum, one of the most 
frequent bacterial pathogens of marine fish also occurs in freshwater fish. V. 
angufflarum was often detected from sea water especially when water was below 
200C. In vitro experiments indicated that the organism persisted in seawater but 
perished within 3 to 5h in fresh water (Muroga et al., 1986). The main biochemical 
profiles isolated in this study were API 20E: 3047524 belonging to the V. 
angufflarum phenon 4b and API 20E: 1047524 which belongs to the Vangufflarum 
phenon 2. 
Clinical demonstration of the disease in the current study agrees completely with the 
descriptive reports present in the literature (Shotts 1989; Vera et al., 1991; ). The 
acute form of the disease is characterised by absence of apparent clinical symptoms 
and sudden high mortalities. The acute form of the disease is frequent and 
mortalities rise up to 40%. The disease is stress related occurring during periods 
with fluctuating water temperatures such as spring and autumn mainly when water 
temperature is between 15 and 20 OC. The chronic infections unlike the acute form 
are often associated with specific clinical symptoms. Infected fish are inactive, 
lethargic, torpid, dark in colour, with loss of scales. Echymoses, petechiae and 
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dermal haemorrhages are visible between the scales on the head, the ventral side 
of the body, the base of the fins and mainly around injuries (Vera et al., 1991). Skin 
lesions tend quickly to form ulcers that lead to distinct degradation of the skin and 
exposure of the underlying skeletal muscle, while tail and fins begin to fray. 
Internally haemorrhagic septicaemia is linked to congestion and haemorrhages of 
the liver, spleen, kidney, peritoneum, swimbladder and intestinal wall capillaries 
which may lead to necrotic lesion formation while the spleen is enlarged and 
haemorrhagic granulornatous lesions are apparent in the muscle. Plasmid-mediated 
toxins are responsible for the swollen viscera and the haemorrhages (Shotts et al., 
1989). The intestine and mainly the rectum, that is often distended or full of clear 
mucoid liquid was considered a significant port of entry (Olsson et al., 1996). The 
gall bladder is also often distended and full of bile. A rapid ELISA method for the 
diagnosis of Vibriosis in sea bass was first described by Romestand et al. (1993). 
4.2.3.3 Vibrio anguillarum other serotypes 
Variguillarum strain V62 caused mortalities in hatcheries and in on-growing units on 
the Mediterranean coast of France (Breuil et al., 1990), while sea bass and turbot 
are very susceptible to Vibriosis caused by V angufflaium strain 408, which is used 
for vaccine production (Dec et al., 1990). A new serotype of Vibfio anguillarum has 
been implicated in sea bream larvae (15ODD and 350DD). Fish become lethargic, 
inappetant and stay with the head down. Histological examination reveals 
intracytoplasmic bacteria in the epithelial cells of the intestine. Vibrid anguillarum 
serotype 03 has been reported to induce septicaemia in sea bass in France 
(Vigneulle et al., 1993). None of these serotypes was isolated during this study. 
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4.2.3.4 Listonelia damsela 
Ustonella damsela was isolated in sea bream (about 12%) and sharpsnout brearn 
(20%) and is an important pathogen for these species but not for sea bass. This 
strain is one of the emerging pathogens in sea bream farming. It has been described 
in different fish species and was associated with human wounds. Vera et al. (1991) 
reported it from juvenile sea bream. The main clinical symptoms are emaciation, 
darkening of the skin, lethargy, distended abdomen with haemorrhages at the base 
of pectoral fins and in the perianal area. The gut and the rectum are distended, full 
of clear smelly fluid. The clinical picture mirrored the description in the literature. 
The bacterium has also been associated with large abscesses in the kidney of 
broodstock. 
4.2.3.5 Other Vibrio strains 
V. alginolyticus is a misinterpreted bacterial pathogen. Conflicting views are 
included in the literature on whether this is an opportunistic or a facultative fish 
pathogen. In this study it comprised 8% of the bacterial isolates from sea bass, 
about 12% for sea bream and 20% for Puntazzo puntazzo. Clinical practice 
suggests that this bacterium is more important for Sparidae, than for sea bass 
where it is usually present as a secondary pathogen. However in sea brearn and 
sharpsnout bream fry V. alginolyticus can cause significant mortalities. Several 
reports of mortalities in sea bream and sea bass caused by Vibrio spp. exist in the 
literature. Early reports of Vibrio infections in cultured sea bream in Israel by 
Paperna et al. (1977) were followed by more detailed reports of Valginolyficus, 
V. parahaemolyticus and Vangufflarum infections in sea bream by Colorni et al., in 
1981. In the latest case, Valginolyticus was isolated also from the fishmeal used to 
make the pelleted feed, which might be significant for the disease's epidemiology. 
In juveniles and adult fish Vibrio harveyi and Vibiio alginolyticus have been 
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isolated from deep ulcerative lesions of sea bass and sea bream. Vibfio 
alginolyficus has been associated with septicaernia inducing severe losses in 
juvenile sea bass in hatcheries at 260C. The in vivo and in vitro pathogenic 
activities of whole cells and extracellular products of Viblio alginolyficus for 
cultured gilt-head sea bream were evaluated by Balebona et al. 1998. The strains 
examined had the ability to adhere to skin, gill, and intestinal mucus of sea brearn 
and to cultured cells of a Chinook salmon embryo cell line. In addition, the in vitro 
ability of V. alginolyticus to adhere to mucus and skin cells of sea bream was 
demonstrated by scanning electron microscopy. The activity of extracellular 
products of V. alginolyficus was hydrolytic and able to degrade sea bream mucous. 
V. alginolyficus was cytotoxic for fish cell lines and lethal for sea bream. Moreover, 
the extracellular products could degrade sea bream tissues. However, experiments 
performed with the bath immersion inoculation technique demonstrated that V. 
alginolyficus should be considered a pathogen for sea bream only when the mucus 
layer is removed and the skin is damaged (Balebona et al, 1998). Vibfio 
carchadae, that is closely related to Vibfio alginolyficus (Colwell and Grimes, 1984) 
has been isolated from dermal lesions in sea bass. Cruz e Silva et al., 1997 
reported for the first time in Portugal a co-infection of the monogenetict 
Trematodes of the genus Microcotyle and Lamellodiscus ignoratus, the protozoan 
Tfichodina and the presence of epitheliocystis, Viblio alginolyficus and V. vulnificus 
in cultured seabream. Deniz et al, 1993 considered V. harveyi as an opportunistic 
pathogen, which causes disease in Sparus aurata and rainbow trout when they are 
affected by stress. 
In the current study Vlordald was isolated only in sea brearn (6%) but is Considered 
an important pathogen for this species. Vorclaffl, formely Vanguillarum biotype // is a 
well known pathogen in North America. In Europe this strain was isolated from sea 
bream with haemorrhagic septicaemia. Vibrio ordald -like bacteria, close to Vibrio sp. 
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INFL described in Japan (blank intestine syndrome) causes similar pathology in sea 
bass larvae (20ODD-40ODD). In another study Vibrio ordalli was isolated from three 
species of Pacific salmon (Ransom et al., 1984). 
In the current study Vibrios like V. fluvialis, V. vulniricus and V. parahaemolyficus are 
often secondary pathogens for sea bass and were isolated at a low percentage with 
Vlparahaemolyficus being the most important and common of the three strains and 
the one with possible but unsubstantiated human health implications. Vibrio 
parahaemolyticus that is pathogenic to humans was not described in the literature as 
a real fish pathogen. It was suggested that fish simply seem to function as passive 
carriers of the bacterium. Other vibrios of minor importance for sea bass and sea 
bream like Vpelagius, Vharveyi or Vibdo sp associated with DGS were not reported 
in this study. An epizootic of Vibrid pelagius in juvenile turbot (Scophthalmus 
maximus) reared in an experimental system located in the Vigo Estualy was 
described by Angulo et al., 1992. Vibiid harveyi is one of the environmental Vibrios 
often linked with mortalities in different production systems. In addition Vibrio harveY 
was linked with mortalities and isolated from marine fish in Kuwait (Saeed, 1995). 
Distended Gut Syndrome (DGS) was initially reported in the late 80s. Unable to digest 
rotifers and brine shrimp naupfii, the larvae develop a swollen abdomen, exhibit a 
disoriented spinning motion and are swept passively with the current. Bacterial or viral 
infections were suspected. Virus-like particles 80 nm in diameter were observed in 
necrotic cytoplasm of midgut wall cells (Colomi, 1990). DGS still remained a problem 
in hatcheries with poor hygiene throughout the 90s. The aetiological agents of the 
abdominal swelling affecting farmed larvae of sea bream, Sparus aurata L., were 
studied. Four Vibdo strains were isolated from larvae of S. aurata affected by this 
disease, and all strains reproduced the disease in healthy larvae under controlled 
infection experiments, producing a significant increase of the mortality rates 
compared to the control (non-inoculated larvae) (Sedano et al., 1996). 
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4.2.3.6 Photobacterium damsela subsp. pisckida 
Photobacteiium damsela subsp. piscicida isolates comprised small a percentage in 
sea bass (2,3%) but much higher for sea bream (almost 12%). The relative 
importance of this pathogen is high in Greek Mariculture and in Marine farming in 
general. It is possible that at least for sea bass the percentage stated above is 
largely undervalued. The technical problem with this pathogen is its slow growing 
nature that caused many cases to go unrecorded because the bacterium was 
overgrown by more common and fast growing Vibrios especially when plate cultures 
were send to NCMR during the summer period when the disease is usually 
manifested. Pasteurellosis caused by Photobacterium damsela subsp. piscidida is 
one of the most common and serious bacterial diseases affecting yellowtail, (Seriola 
quinqueradiata) aquaculture in Japan (Yoshida et al., 1997) as well as in gilthead 
sea bream and sea bass, in Mediterranean countries. Photobactelium damsela 
subsp. piscicida (Pasteurellaceae) is a small Gram-negative non-motile rod shaped 
bacterium that requires at least 0.5% NaCl for growth in BHI, TSA agar at 17-31" C. 
It differs from other Pasteurellaceae by its lack of growth at 370C, its inability to 
reduce nitrates and also its requirements for NaCl and sensitivity to Obtiostat agent. 
Fish Pasteurellosis first appeared in the Mediterranean area in 1990 causing heavy 
losses in fish farms and affecting also wild populations (Quaglio et al., 1991). 
Pasteurellosis in sea bass develops in an acute and a chronic form. The disease 
affects fish of 0 group causing darkening, anorexia, and high mortalities (acute 
form). Focal necrosis of the gills is the only external sign often observed. Internally 
the spleen is dark and enlarged. During the chronic form lower mortalities occur and 
white granuloma visible to the naked eye are found mainly in the spleen. There is 
evidence that carriers under stressful conditions could suffer from reinfection. 
Necropsy shows haemorrhagic petechia on many tissues and organs and 
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congestion in the intestines, which contained mucous faeces. Moreover fish are 
afflicted by splenomegaly, with small whitish nodules also in the liver and kidney 
parenchyma (Giorgetti and Ceschia, 1994). The first documented outbreak of fish 
pasteurellosis in an offshore cage farm for sea bream in Malta, was described by 
Bakopoulos et al. (1 997a). The pathogen entered the farm with juvenile fish and the 
disease occurred within 2 months of their arrival. The first epizootic pasteurellosis in 
sea bream cultured in a fish farm located in South Gran Canada (Spain), was 
described at the beginning in January 1996. (Real et al., 1997). In this study 
haernorrhagic septicaemia was found in small fish as well as chronic granulomata in 
bigger fish. High mortalities ranging between 50 - 100% in affected batches are 
usually observed as soon as larvae reach 40 days. At this stage resistance to 
antibiotics can develop within a week. In sea bass Pasteurellosis outbreaks have 
been reported for juveniles over 30g. Histopathology reveals characteristic 
granulomata in haemopoietic tissue of the spleen and kidney, which in later stages 
release bacteria to produce a generalised haemorrhagic septicaemia. In an 
exceptional study Matsuoka and Kamada, 1995 described a significant part of the 
epidemiology of the disease, the dynamics of bacterial shedding from experimentally 
infected Yellowtail (Seriola quinqueradiata) weighing 40-92g. Fish were infected with 
an OA resistant strain of Photobactedum damsela subsp. piscicida and it was shown 
that infected fish began to shed bacterial cells one or two days before death and the 
shedding was maintained for about 5 days after death. 
In a microcosm study Photobactedum damsela subsp. piscicida cells survived in 
water and sediment for only 6 to 12 days, depending on the strain and demonstrated 
capacity to enter a viable but not cultivable state. These dormant cells were always 
resuscitated by the addition of fresh medium to the microcosms, were smaller (dwarf 
cells) had increased surface hydrophobicity but maintained their infectivity and 
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pathogenicity (Magarinos et al., 1994). It is obvious therefore that bio-available 
antibiotic residues in the seawater /sediment environment accelerates the selection 
of the above persistent strains. Roberts, (ed., 1978) reported that misinterpretation 
often occurred with atypical Aeromonads and the need to differentiate from 
Mycobacteriosis and granulomatous lesions of nutritional origin Diagnostic 
techniques include Immunohistochemistry (IHC) (Maniatis et al, 2000) and Western 
blotting. (Pretti et al, 1999). The onset of disease is temperature dependent 
occurring at above 200C in ongrowing units and 16-17'C in hatcheries. Magarinos et 
al., (2001) studied the effect of water temperature on the development of 
pasteurellosis in 60-day-old gilthead sea bream larvae obtained from asymptomatic 
carrier broodstock. It was suggested that larvae obtained from asymptomatic carder 
broodstock are also carriers and could develop pasteurellosis when the water 
temperature was increased. This is extremely important for disease eradication in 
hatcheries to control the broodstock. carrier status. This is one of the first steps that 
along with adequate water filtration, strict hygiene practices and lately broodstock 
vaccination could help in the eradication of the disease in the hatcheries. However, 
it was possible to control the disease by maintaining larvae at low temperatures 
(Magadnos et al., 2001). This is useful in nurseries that use filtered seawater where 
correct scheduling of small fry stocking in periods when temperature is low avoids 
the disease establishment. Quantitative Antibiograrn studies are necessary for the 
effective treatment of the disease and for the monitoring of the emergence of 
antibiotic resistance during or after treatment. Systematic prophylactic antibiotic 
bath treatments of sea bream larvae are not recommended. Treatments through live 
food can be used in infected hatcheries prior to handling and grading. Antibiotic 
treatment is problematic in Japan due to the presence of R-plasmids conferring 
transferable resistance to commonly used drugs (Roberts, 1978). Experimental 
vaccine development has been studied since the late 80s but in the last decade 
effective commercial vaccines were developed. This is due to the weak antigenic 
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properties of Photobactetium damsela subsp. piscicida. The mechanism of entry of 
Photobacterium damsela subsp. piscidida were studied by Jung et al (2001). 
Immunohistochemistry (IHC) using monoclonal antibodies revealed colonies of 
bacteria in the kidney, spleen and liver of sea bass, infected with pasteurellosis. 
Colonies were observed around the mucosal layers of the intestinal tissue, 
especially within the lamina propria and were associated with red blood cells and 
blood vessels of the organs examined. This was evident under the microscope in all 
Pasteurellosis incidences reported in this study. Turbot (Scophthalmus maximus) 
mucus (most likely a glycoprotein component) inhibited the growth of the 
Photobactefium damsela subsp. piscicida but mucus from sea bream and sea bass 
did not This is consistent with clinical experience where turbot was not susceptible 
to Photobactefium damsela subsp. piscidida (Magarinos et al, 1995) 
Another study of the peritoneal exudates cells (PECs) of sea brearn concludes that 
the resistance of sea bream to Photobactetium damsela subsp. piscicida depends 
on the size of the fish and may be related to the efficiency of its phagocytes (Noya et 
al 1995). This explains the failed attempts to immunise 0.5g fry against 
Pasteurellosis, in nurseries where poor water filtration and quality initiated 
concurrent disease outbreaks. Current practice allows immersion vaccination in the 
nurseries when fish are 1.2-1.5 g mean weight in order to immunise fish against 
Pasteurellosis. Extracellular products, notably phospholipase and haernolysins, 
siderophores and capsular polysaccharides have been identified as putative 
virulence factors (Yoshida et al, 1997). The extracellular products (ECP) are good 
candidates as protective antigens in the vaccine and are still under investigation 
(Mazzolini et al, 1997). Noya et al. 1993 compared the haematological and 
histopathological changes caused in fingerling gilthead sea bream, Spanis aurata by 
the intraperitoneal injection of Pasteurella piscidida or different concentrations of its 
extracellular products (ECP) while a similar study was performed in sea bass 
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(Magni et al., 1998). All ECP products were cytotoxic for fish possessing 
phospholipase and haernolytic activity (Magarinos et al., 1992). 
4.2.3.7 Aeromonas sp. - Pseudomonas sp. 
Paperna et al. (1977) described deep ulcers filled with yellowish exudate in the 
interorbital region of mature sea brearn associated with Aer-Omonas and 
Pseudomonas sp. Aeromonas hydrophila was isolated in juvenile and adult sea 
brearn reared in land-based systems in Italy and from adult sea bass in Greece 
(Bovo et al., 1995; Doukas et al., 1998). This strain was often associated with 
Pseudomonas anguilliseptica during "Winter Disease Complex7 acting more like an 
opportunistic than a primary pathogen (Domenech et al., 1999). In this study 
isolation of Aeromonas salmonicida from sea bass with haemorrhagic septicaemia 
might refer to an "old" finding but at the same time might indicate a largely 
undervalued component that is confused and misdiagnosed in practice due to 
confluent vibrios in the usual media for bacterial isolation. Winter disease is a sea 
brearn disease syndrome where Pseudomonas anguilliseptica, Aeromonas 
hycfrophila, a virus, a Parvolike? virus, and a Reovitus are thought to be the 
aetiological agents along with a nutritional disorder. (Christofilogiannis et al., 1994; 
Berthe et al., 1995). Sea bass has also been reported to be naturally susceptible 
(Berthe et al., 1995). The syndrome develops as haemorrhagic septicaemia With 
keratitis. High mortalities occur at the end of the winter and early spring when the 
temperature is between 100C and 140C. When the temperature reaches 160C 
mortalities (so-called Picoma-fike) start to decrease. Clinical signs include 
abdominal distension rbelly-up syndrome"), redness of the pectoral fins and the 
peri-anal area, haemorrhages in the liver / intestinal tract and congestion in the 
brain. Isolation of the bacterial strain from the brain and the liver is possible. In vivo 
antibiotic treatments have been unsuccessful. Prevention is based on disinfection, 
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drying-out periods and appropriate feeding rates. It has been reported from 
November to April in marine fish farms on the Croatian side as well as the Italian 
side of the Adriatic Sea. (Sarusic, 1999; Contessi et al., 2000; Sarusic and Bavcevic, 
2000). Winter syndrome caused significant losses in fish farms off the Northeast 
coast of Spain linked to histopathological lesions in intestine, pancreas and white 
muscle in immunosuppressed sea bream in winter months without however isolation 
of bacterial pathogens. (Tort, et al., 1998) In another study Pseudomonas 
anguilliseptica was isolated in incidences of average mortality rate of approximately 
10-15%, although in some fish farms mortality reached 30% and the link to stressful 
environmental conditions was discussed (Domenech et al., 1997). Several bacterial 
isolates obtained from diseased sea bream, sea bass Didentrarchus labrax, and 
turbot Scophthalmus Maximus showed phenotypic similarities with the 
Pseudomonas anguilliseptica in French Mediterranean and Atlantic coasts. It was 
indicated that this represents a potential hazard for many farmed fish species and 
could cause serious economic losses. (Berthe et al., 1995) Microbiological 
investigations of winter syndrome cases in Italy detected in different outbreaks and 
times the presence of different agents: Aeromonas hydrophila. Picoma-like virus, 
Parvolike virus, Reovirus and an unidentified gram-negative rod. (Bovo et al., 1994). 
Currently, Winter syndrome has no important significance in sea bream in Greece 
due to adjustments in the feeding regime during the autumn-winter months. 
However in Italy due to the drop in temperature especially in vallicoltura the disease 
has become of increasing importance. 
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4.2.3.8 Pseudomonas fluorescens 
In this study Pseudomonas fluorescens was isolated in sea bass at a low 
percentage (1,15%), is not commonly cited in the literature to affect sea bass and 
sea bream but from clinical experience is associated with mortalities following 
injection vaccination when the equipment is not kept clean. Pseudomonas 
fluorescens is recognised as one of the causal agents of bacterial haemorrhagic 
septicemia of fish and was first described as a pathogen of mirror and leather carp. 
Pseudomonas 17uorescens was usually associated with bacterial haemorrhagic 
septicaemia generally clinically indistinguishable from motile aeromonad 
septicaemias, and as with the aeromonad infections was associated with 
concomitant environmental stress, especially with high temperatures or 
overcrowding. Pond fishes are most commonly affected but aquarium tropical fish, 
marine fish and salmonids may be secondarily infected in chronic viral infections 
and following traumatic injury. Association with traumatic injury agrees with the 
clinical finding of a Pseudomonas fluorescens link with ip injection vaccination. 
Chronic infections by non specific Vibdo spp. and Pseudomonas spp. seemed also 
to cause a distinct syndrome with white coloration of the head ("White head 
disease") in Israel. Haemorrhagic inflammation of the cephalic branches of the 
lateral line and integumental necrosis, were the main clinical signs (Paperna, 1984). 
4.2.3.9 Myxobacteria 
In this study Flavobactetium meningosepticum was the AP120E characterisation of 
some pathogens belonging to (Flavobacterium / Cytophaga Spp. ). This was isolated 
from the kidney of sea bass with no signs of haemorrhagic septicaemia but 
exhibiting low mortality levels. Myxobacteria are an important cause of mortalities in 
sea bass fry but it was difficult to culture them because they require lower nutrient 
culture media for initial isolation and are easily overgrown by Vibrio spp. It is thought 
however that this is the first report of Flavobactetium meningosepticum in sea bass. 
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It remains to be seen if this type of pathogen could arise as an important pathogen 
in the future but is more likely to play a role of a secondary pathogen masked by 
more common bacteria like Vibrios. Myxobacteria (Myxobacteriales) are long, thin, 
flexible bacteria showing oscillating or gliding movement, and are diagnosed only by 
examination of fresh smears. In fish muscle-sea water broth they demonstrate the 
typical movement, while they grow poorly on solid and semi-solid media. 
Myxobacteria have been found to be the etiological agent in focal necroses of the 
gill filaments, coupled with dermal lesions in high mortalities that occurred in 
juveniles and adult sea bream, in Israel, usually following netting operations 
although spontaneous infections occur occasionally. In some cases the "gill rot' due 
to Myxobactedal gill infection was associated with heavy infections with the 
Monogenean parasite Fumestia echeineis. (Paperna et al., 1977) which develops 2- 
3 days after handling (Colorni, 1981). Remaining filaments assume a dark brown 
colour. There is an increased prevalence of Myxobacterial gill infection in sea bass 
with deformed opercula (Paperna, 1984). Infected fish remain near the surface of 
the water, moving to the edge of the holding facility, they swirn aimlessly but slowly 
and the opercula may not close normally. 
Flexibacter maritimus has developed as a common problem in Mediterranean 
mariculture. Cytophaga -like bacteria (CLB) have been isolated from sea bass. 
Affected juveniles and adults develop ulcerative skin lesions. In juveniles 
haemorrhages can be observed on the mouth as well as thick yellowish mucus. 
Gills exhibit focal necrosis and excess mucus in which long bacterial rods show 
typical gliding motion. Following severe outbreaks of a disease with dermal necrosis, 
several bacterial strains were isolated from sea bass (Dicentrarchus labrax) reared 
on French coasts. A phenotypic study revealed that the isolates closely resembled 
Flexibactermaritimus (Bemardet et al., 1994). Antibiotics have been used by bath or 
oral route. Prevention of stress, regular grading to reduce cannibalism and reduction 
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of mechanical injuries through gentle handling will reduce the risk of infection. 
Vaccine testing in Japan has been unsuccessful. An important problem arose in the 
treatment of Myxobacteriosis in sea bass fry when nitrofurans the most effective 
medicines for surface infections were banned leaving no other approved effective 
alternatives. Two reports of Ectwardsiella spp (Blanch et al., 1990) and Yersinia 
ruckerii (Vignuelle, 1988) isolation in sea bass refer to scientific observations rather 
than clinical diseases of practical importance. 
4.2.4 Gram positive bacterial pathogens 
4.2.4.1 Gram positive cocci 
In this study six Gram-positive cocci (6,9%) were isolated in sea bass, two in Dentex 
dentex and one in Mugil cephalus. Although there was no further identification at a 
genus level, this finding was not odd. It was consistent with another study from Italy 
where Staphytoccocus sp. was isolated from the kidney of diseased cultured sea 
bass (Dicentrarchus labrax) under poor environmental conditions (Tassi and Salati, 
1996). 
4.2.4.2 Mycobacterium spp. - Nocardia spp. - Streptococcus iniae 
A group of bacterial pathogens like Mycobactedum marinum, Nocardia spp. and 
Stmptococcus iniae were reported in the literature but not isolated yet in Greek 
Mariculture. However they are mentioned briefly because it is believed that they 
might soon cause a significant problem in the Mediterranean mariculture industry, 
due to their zoonotic. component, to their limited effective means of therapy and 
eradication and due to the fact that they make fish unmarketable. Mycobactefium 
spp. are acid fast, slightly curved to straight, Gram positive, non-motile rods. Only 
three of the 150 species observed in fish are considered to be fish pathogens. 
(M. marinum, M. fortultum, M. chelonei) (Shotts et al., 1989). Mycobacteriosis is a 
chronic progressive zoonotic disease. (Shotts et al., 1989). There is evidence of oral 
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transmission of the disease to humans when raw contaminated fish products are 
used in the diet, while the cutaneous route also plays a significant role. Infected fish 
become lethargic, separate from the others, have skin ulcerations, small 
perforations on the fins, pigment alteration or may develop spinal curvature. In 
addition bi-lateral exophthalmos may occur. The only effective diagnostic technique 
in asymptomatic fish is the Polymerase Chain Reaction (PCR) test (Colomi et al., 
1993). Internal pathology includes grey-whitish nodules or granulomas in most 
organs but mainly in the kidney, liver and spleen (Shotts et al., 1989). Many lesions 
are purulent while others are necrotic with dark yellow or brown material in the 
centre. 
Feed medicated with Rifampicin for 6 months and subsequently with Cycloserine for 
4 months had no curative effects (Colorni, 1992). Diagnosis can be made by 
staining of histological sections with Ziehl-Neilsen and by culture on selective 
medium. A PCR technique made possible screening of new stocks for latent 
infections, the selective removal of infected individuals from brood stocks as well as 
tracing the possible source of infection (water, feed, or diseased parents). (Knibb et 
al, 1993a) Mycobacterium marinum has been isolated from sea bass both in the 
Mediterranean coast of Israel as well as the Red sea (Colorni, 1992; Knibb et al, 
1992,1993b). Sea brearn (Sparus aurata) and red sea brearn (Pagrus majoý as 
well as wild fish in the vicinity of the cages have also been found infected. The 
disease is impossible to eradicate with antibiotic treatment and makes the affected 
fish unmarketable and may represent a hazard to human health. Sanitation, 
disinfection and destruction of the carrier fish especially spawners is essential for 
the control of this disease. Diamant et al., 2000 discussed the implications of 
spreading of M. marinurn infection in wild fish populations in the Gulf of Eilat. 
Eradication of the pathogen was impossible with any of the treatments (Colomi et 
al., 1998). 
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Nocardiosis is one of the most important diseases of cultured yellowtail Sedola 
quinqueradiata in japan but Vigneuelle et al. (1993) have reported the disease for 
the first time in adult sea bass and broodstock fish. Infected fish exhibit 
haemorrhagic cutaneous zones on the sides near the lateral line, the operculum, the 
pectoral and pelvic fins. Yellow white nodules are present on the epidermis. 
Internally abscesses are detected on the head and the branchial arches. Typical 
bacteria can be observed on fresh smears from the nodules. Treatment with 
antibiotics in vivo is not very effective. Long treatment of 21 days with Sulphonamide 
compounds in Japan had limited success. In order to prevent the disease, handling 
that may lead into skin injuries has to be avoided. Streptococcus iniae was isolated 
from diseased wild fish collected near a mariculture facility where sea bream and 
sea bass exhibited a similar infection. Species-specific PCR and dbotyping 
confirmed that a single S. iniae clone infected wild and cultured fish. Wild fish were 
therefore potential amplifiers of pathogenic S. iniae strains (Zlotkin et al., 1998). This 
bacterium along with Lactococcus spp. has been devastating the trout industry in 
Spain and Italy in the last three years and a potential significance to mariculture 
industry is expected within the next few years. 
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4.3 Antibiotic Application 
4.3.1 Available Compounds 
According to legislation the Greek National Drug Organisation must issue and/or 
approve the marketing authorisation for any veterinary medicinal product 
pharmaceutical or biological for fish disease prevention and control (such as 
antibiotics, vaccines, anaesthetics), for either internal or external use. The 
medicines which have been approved for use in fish are oxolinic acid 50 and 24%, 
Oxytetracycline 75.5% and 20% and trimethoprimsulfadiazine 40 and 50%. The 
process for the use of chemicals is under the consultation prescription and control of 
veterinarians - fish pathologists. 
Oxolinic Acid - Other Quinolones: clinical efficacy 
Oxolinic acid is registered as a fish therapeutant in Japan and several European 
countries and is proven efficacious in vitro against select isolates of Vibrio spp. (V. 
angufflarum, V. ordalfi, V. tubiashfi, V. carchariae, V. damsela), Aeromonas spp. (A. 
hydrophilia, A. sobria, A. caviae, A. salmonicida), Pasteurella piscicida, 
Pseudomonas fluorescens, Y. rucketi, and Edwarrisiella tarda with the MlCs ranging 
from less than 0.075 to 0.3 pg/ml. (Austin et al., 1982; Ledo et al., 1987, Bowser, 
1990; Bowser and Babish, 1991). It was proven efficacious in furunculosis treatment 
in rainbow trout (Austin et al., 1983) and was considered successful in lowering 
bacterial numbers (Cytophaga sp and Pseudomonas fluorescens) on the surfaces of 
eggs of rainbow trout, Oncorhynchus mykiss (Barker et al., 1990). Quinolone and 
fluoroquinolone antibacterials examined in-fish have included nalidixic acid, oxolinic 
acid, piroidic acid, flumequine, norfloxacin, ciprofloxacin, sarafloxacin, and 
difloxacin. Fluoroquinolones are 6-fluorinated carboxylic acid compounds, second- 
generation derivatives of first-generation quinolones such as nalidixic acid and 
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oxolinic acid. These drugs are bactericidal and act by selectively inhibiting 
prokaryotic topoisomerase 11 (DNA gyrase), an enzyme necessary for replication, 
recombination, and transcription of a bacterial (circular) chromosomal DNA (Drlica 
and Coughlin, 1989; Zimmer et al., 1990). The net result is that the treated bacteria 
are unable to reproduce. Fluoroquinolones are bioavailable via enteral and 
parenteral routes, are widely distributed throughout tissues including intracellular 
sites, and have a broad antibacterial spectrum of activity, especially active against 
gram-negative bacteria and intracellular bacteria such as mycoplasma, rickettsia, 
chlamydia, and mycobacteria. (Stoffregen et al, 1996). Vetoquinol, an oxolinic acid 
ester was also compared by oral administration against furunculosis in Atlantic 
salmon in seawater (Samuelsen et al., 1999,2000) while another comparative study 
was performed against Vibriosis in Atlantic halibut Hippoglossus hippoglossus 
(Samuelsen, 1997). In two other comparative studies Florfenicol was more effective 
against Aeromonas salmonicida and Vibfio salmonicida infections in Atlantic 
salmon, Salmo salar L., smolts compared to oxolinic acid and 
trimethoprim/sulphadiazine (Nordmo et al., 1994,1998). 
4.3.1.2 Oxytetracycline -Tetracyclines: clinical efficacy 
Tetracycline antibacterials are bacteriostatic, binding to the 30S subunit of the 
microbial 70S ribosomes and inhibiting protein synthesis (mRNA translation) by 
blocking the attachment of aminoacyl-tRN units (Jawetz, 1987). They can be 
administered enterally or parenterally, have good distribution to tissues including 
intracellular sites, and have a broad spectrum of antibacterial activity. (Stoffregen, et 
al, 1996). OTC is the most widely used antibiotic in fish farming and several in vitro 
as well as in vivo studies have been made in order to demonstrate its clinical 
efficacy against a range of pathogens in different species and production systems. 
In certain cases it was also used in unconventional applications. OTC has been 
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applied by injection in pre-spawning female salmon Oncorhynchus kisutch in order 
to control vertical transmission of Renibacteiium salmoninarum, causative agent of 
bacterial kidney disease (Brown et al., 1990). OTC has also been used to control 
secondary bacterial infections even in clinical cases where the aetiology was viral. 
Fish experimentally treated with oxytetracycline or a combination of OTC and 
chloramine-T had a significantly lower mortality rate than untreated larval and 
juvenile halibut Hippoglossus hippoglossus (Cusack et al, 2001). In a similar 
situation in Greece in cases of a new invasive strain of Lymphocystis virus affecting 
sea brearn OTC is often employed to combat the bacterial component of the 
syndrome due to the subsequent development of Pasteurellosis. OTC application for 
the control of bacterial microflora associated with rotifers, used as live food, in a 
marine fish hatchery (Minkoff et al., 1992) is never employed in practice in order to 
reduce the bacterial flora in mass cultures. In addition treatment failures following 
oral OTC application have been recorded in Atlantic salmon fingerlings 
experimentally infected by Vibtio salmonicida by intraperitoneal injection (Cox and 
Rainnie, 1991). 
4.3.2 Potential Oxolinic acid and Oxytetracycline Side Effects 
Several side effects were associated with Oxytetracycline and Oxolinic acid 
application in fish although several laboratory studies were not able to demonstrate 
them. These include immunotoxic immunosuppressive effects and even skeletal 
deformities for Oxytetracycline. (Table 60) The importance of these effects on 
actual clinical practice and their effect on the success of an antibiotic treatment is 
generally unknown. However registration of both drugs was successful a long time 
ago and their importance in clinical veterinary practice vastly dominates the possible 
minimal side effects. No side effects were recorded during the commercial 
application of OA and OTC during this study. 
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Table 60: Oxolinic acid and Oxytetracycline Side effects reports in literature 
Antibiotic Side effect SPecies'ý' Literature', 
Oxytetracycline Humoral response Rainbow trout Kreutzman, 1977; 
Rijkers et al., 1980; 1981; 
Grondel et al., 1985) 
Oxytetracycline Immunosuppresion Carp Rijkers et al., 1980; 
Oxytetracycline Leukocyte Carp Grondel and Boesten 
mitogenic and 1982 
allogenic Grondel et al. 1985 
responses 
Oxytetracycline Deformities of the Rainbow trout Madsen et al., 2001 
spinal column 
Oxytetracycline Photosensitivity African catfish Stacell and Huffman, 
1994 
Oxytetracycline Hepatic necrosis Atlantic Bruno 1989 
salmon Stoffregen et al., 1996 
Oxytetracycline Modulation of the European eel Van der Heijden et al., 
fish resistance 1996 
Oxytetracycline Suppression of Rainbow trout Lunden et al., 1998 
Oxolinic acid antibody 
production 
Oxytetracycline Mitogen-induced Rainbow trout Lunden and Bylund, 
Oxolinic acid lymphoid cell 2000 
proliferation 
Oxolinic acid Cellular Rainbow trout MoutoU et al., 1997 
histopathological 
changes 
Oxytetracycline Immunotoxic Carp Studnicka et al., 2000 
Oxolinic acid effects 
Oxolinic acid hepatic microsomal Rainbow trout moutou, 1998 
cytochrome P450 
monooxygenases 
Oxolinic acid haematological Marine fish Miyazaki et al.,. 1984 
disturbances 
adverse effects of 
liver 
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OTC was indicated initially to be of low toxicity to fish (Herman, 1969a, b). However 
more recent studies indicate that humoral response is susceptible to low OTC levels 
while cellular response is unaffected (Kreutzman, 1977; Rijkers et al., 1980; 1981; 
Grondel et al., 1985). OTC is bacteriostatic and not bactericidal therefore careful 
consideration regarding prolonged administration is essential, especially when the 
fish immune system may already be compromised by environmental conditions, 
husbandry techniques, and infectious diseases (Grondel and Boesten, 1982). OTC 
injection caused delay in the rejection of allogenic scale transplants in Common carp 
(Cyprinus carpid) demonstrating an immunosuppressive effect (Rijkers et al., 1980). 
In similar studies OTC caused a reduction of leukocyte mitogenic and allogenic 
responses in a dose-dependent manner (Grondel et al., 1985) while in another study 
kinetics of the PFC response were not affected but the PFC numbers were 
decreased and the anti-SRBC antibody production of the pronephros was delayed. 
(Grondel et al., 1987) Although OTC caused spinal deformities in Atlantic salmon 
(Salmo salal and Arctic charr (Salvefinus alpinus) with spinal fractures observed 
only in the first species (Toften and Jobling, 1996) it did not have the same effect in 
rainbow trout (Oncorhynchus mykiss) (Madsen et al., 2001). Exposure to ultraviolet 
light following OTC injection caused photosensitivity in channel catfish (Ictalunis 
punctatus) with necrotic ocular and dorsal epidermal lesions (Stacell and Huffman, 
1994). A series of studies at histopathological cellular level indicated extensive 
hepatic necrosis in broodstock Atlantic salmon furunculosis survivors following OTC 
injection (Bruno, 1989). This was initiated by oxytetracycline via enterohepatic 
recycling and compromised excretion, resulting in this novel hepatopathology 
(Stoffregen et al., 1996). Limited affectivity of OTC versus Flumequine treatment in 
European eel (Anguilla anguilla) infection with the parasitic swimbladder nematode 
Anguifficola crassus, points to a modulation of the fish of the cellular rather than the 
humoral response as a result of the drug treatment. (Van der Heijden et al., 1996). 
Both oxytetracycline and oxolinic acid significantly suppress antibody production as 
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well as the level of circulating white cells, especially lymphocytes, in rainbow trout 
when administered in association with immunisation. The phagocytic activity of 
whole blood leukocytes was stimulated by oxolinic acid and slightly suppressed by 
oxytetracycline (Lunden et al., 1998). Both OA and OTC suppressed the mitogenic 
response of the head kidney cells in rainbow trout (Oncorhynchus mykiss). T-cells 
were more vulnerable than B-cells (Lunden and Bylund, 2000). OA application 
caused compensatory, rather than degenerative haematological, (Miyazaki et al., 
1984), enzymatic, (Moutou, 1998) and cellular changes in the liver of rainbow trout 
(Oncorhynchus mykiss) (Miyazaki et al., 1984; Moutou et al, 1997; Moutzouris et al., 
2000). Although non drug-specific these effects of oxolinic acid were delayed and 
longer lasting compared with flumequine (Moutou, 1998). 
4.3.3 Current Practice Auditing 
The framework in Norway where the Norwegian Medicinal Depot a national drug 
monopoly system is used along with authorised feed mills dispensing medicated 
feed is an ideal system to collect valid and reliable sales data on drugs in fish 
farming (Grave et al., 1990). In Greece like most of the other EU countries such a 
monopoly does not exist and sales of antibiotics by wholesalers and pharmaceutical 
companies only recently started to be collected by the National Drug Organisation. 
Although a common EU legislative framework exists, implementation and control is 
usually problematic due to state inefficiencies, lack of resources and personnel. This 
is the reason why no official data of drug use in Greek mariculture are presented in 
this study. Personal communication with fish vets in the FGM Fish Health 
Committee indicated that total cost of antibiotics used in Greek Mariculture per Kg of 
fish is around EO. 05/Kg, while in this empirical figure if biologicals (fish vaccines) are 
included, the cost is more thanEO. 1/Kg of fish produced. A shift from treatment to 
prophylaxis led to a rapid increase of fish vaccine application against vibriosis and 
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pasteurellosis in sea bass and, to a lesser extent in sea bream. The current practice 
includes the following series of events in relation to antibiotic treatment in a fish 
farm. The fish vet (full-time employee) or a regional fish vet visits the farms on the 
notice of increased mortalities, or samples are sent to the laboratory for analysis. 
Usually this is basic bacteriology along with non-quantitative basic antibiogram. Due 
to the limited number of fish veterinarians, laboratories in institutes perform this 
basic diagnostic service. While it is legally compulsory, there is a misuse of 
veterinary prescription and only big organised companies accompany orders of 
antibiotic to pharmacists by vet prescription. The drug quantity ordered arrives in the 
farm to be mixed in a cement mixer to be oil top coated onto the fish feed (this was 
the sole practice in early 90's when this study was initiated). This on farm mixing 
poses many questions about homogeneity, concentration of the medicated feed 
mixed, the possible lack of therapeutic effect and the hazards of exposure for the 
workers (Grave et al., 1990). Recently, a few feed mills are licensed to manufacture 
medicated feeds and more fish farms, usually the big companies, are using this 
method to treat fish diseases or to incorporate successfully oral vaccines. However, 
the logistics of such operations, the remote rural nature of mariculture and the 
added cost of production line clean up / delay of production of these feed mills still 
make this option less attractive. 
Reports of antibiotic utilisation in different countries come mainly from salmon and 
trout farming in different countries like Norway where Growe et al., 1990 described 
in a comprehensive review for the period 1980-1988 the gradual shift to feed mills 
and the decrease in antibiotic utilisation despite the concurrent increase in 
production from below 40,000 to more than 120,000 tons. OTC was the most 
frequently preschbed antibiotic used, mainly against V. anguilarum. This situation 
was improved gradually in Norway with the development of effective vaccines for 
Furunculosis and Vibriosis as well as for some of the viral diseases. Sales estimates 
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of antimicrobial products used as veterinary medicines in UK in 2000 indicate that 
tetracyclines accounted for 49% of the total sales for use in food animals while 
fluoroquinolones for about 1 tonne as in previous years. Approximately 56% of 
antimicrobial products in food animals were administered via feedstuffs mainly in 
pigs and poultry. It was also described that while 10 tonnes of active ingredient was 
used in 1993 (59,000 tonnes salmon & trout production) only 2 tonnes of active 
ingredient were used in 2000 despite the massive increase in production (130,000 
tonnes). Selected salmonid fish farms in England and Wales were sent a 
questionnaire designed to collect data on enteric redmouth disease (ERM) 
vaccination and the usage of antimicrobial agents. In the farms, which employed 
vaccination, the commonest chemotherapeutant used against ERM was oxolinic 
acid. However, oxytetracycline was the most frequently used antibiotic on farms not 
employing a vaccine (Rodgers, 1991). 
4.3.3.1 Clinical Efficacy 
The terminology of drug metabolism includes terms like palatability of the drug 
(pleasant in taste), leaching, digestibility (ability to be assimilated), absorption (ability 
to be absorbed in the gut epithelium), bioavailability (potential of achieving high 
concentration of "active" drug in the target tissues), excretion (expulsion of waste 
material as result of the metabolism) and depletion (reduction of drug residues in the 
fish tissues). Oil coating of Oxolinic acid and Oxytetracycline was initially tried for the 
kinetics studies but poor palatability, leaching and the creation of an oily film on the 
surface of the tanks led to the preparation of fish feeds where the antibiotic was 
incorporated in the pellet. This strategy improved the acceptability of the feed pellets 
(even of OTC pellets to sea bass that are known to refuse OTC treatments due to 
palatability) in both antibiotics and species. Following these observations the 
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research group in NCMR decided to tackle the issue of leaching and palatability 
initiated by study by Rigos et al., 1999. 
4.3.3.1.1 Palatability 
The most convenient method for treating fish with antibiotics is the use of medicated 
feed. However because of the reduced feeding of fish suffering from bacterial 
diseases and the unpalatability of feed containing drugs (Hustvedt et al., 1991), only 
20-30% of the antibiotics administered are absorbed through the intestinal tract. The 
remaining 70-80% passes into the environment (Samuelsen, 1989a, b, 1991). Sea 
bass was proven in the pilot stages of this study to be reluctant to take OTC oil- 
coated medicated diets, therefore incorporation of the anfibiotics in the feed was 
selected as the method of choice. This significant reduction of OTC oil-coated feed 
consumption in sea bass at two temperatures was confirmed in a study initiated in 
NCMR after these findings while no reduction was evident with OA oil-coated 
medicated feed (Rigos et al., 1999). This study simply confirmed findings of a 
previous study in rainbow trout (Oncorf7ynchus mykiss) using radioactively labelled 
diets. (Hustvedt et al., 1991a). However this negative effect is not present in all 
species. OTC for example did not seem to be a feeding deterrent for Arctic charr 
(Salvelinus alpinus), possibly indicating that the char is a rather unselective feeder 
(Toften et al., 1997). 
4.3.3.1.2 Leaching 
In several studies leaching was proven to be reduced when drugs were incorporated 
in the feed compared to top coating (Rigos et al., 1999) or drug sprayed on the feed 
(Xu and Rogers, 1994). OTC and OA alginate-coating on fish pellets has also been 
used to reduce leaching (Duis et al., 1995). Usually OTC is leaching is more 
significant compared to OA leaching as it is readily dissolved in water while OA 
requires a pH shift to alkaline in order to be dissolved. Increased water temperature 
induced a significant effect on the leaching of both drugs when mixed with the feed, 
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but did not affect the loss of oil-coated drugs (Fribourgh et al., 1969; Xu and Rogers 
1994; Rigos et al., 1999). Often if oil-coating cannot be avoided the concentration of 
OTC is increased or a higher feeding rate is used to compensate for the loss of OTC 
due to leaching. The amount of OTC that must be added to feed depends on type of 
feed, water temperature, and time of consumption by fish (Xu and Rogers, 1994). 
4.3.3.1.3 Digestibility 
In several studies digestibility was proven to be higher for OA than for OTC (Cravedi 
et al., 1987) and was increased proportionally for both antibiotics with increasing 
water temperature (Rigos et al., 1999). A significantly higher digestibility of OTC (59- 
85%) and OA (64-94%). in sea bass was reported compared to other species. (Rigos 
et al., 1999) with at least OTC digestibility being similar to that reported in humans 
(60-80%) (Weinstein, 1970). However in many other studies OTC digestibility was 
10 fold lower in other fish species (Cravedi et al., 1987; Rogstad et al., 1991). Low 
digestibility at lower temperature raises the significance of the interactions between 
fish therapy and marine environment. Digestibility is increased with decreasing 
particle size. Effects of ultra-fine size oxolinic acid on absorption by yellowtail were 
studied by a high performance liquid chromatographic method (Endo et al., 1987). 
4.3.3.1.4 Bioavaillabillity 
Hustvedt et al., (1991 a), discussed limitations on the OA bioavailability studies. OA 
serum levels in Atlantic salmon (Salmo sala6 after injection and after oral 
administration indicated that mean relative OA bioavailability by the oral route 
compared to the intraperitoneal route was about 50% (Hustvedt et al., 1991b). This 
can be explained to be due to either malabsorption or first pass metabolism (i. e 
metabolism in the gut epithelium or in the liver) or due to the use of 
carboxymethy1cellulose (CIVIC) as thickening agent in the medicated diet that 
reduces bioavailability by 10-20%. Low bioavailability after intraperitoneal injection 
could probably be explained by absorption into the intestinal lumen and possibly by 
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leakage from the injection site. Bioavailability of Oxolinic acid in Atlantic salmon was 
reported to be 30.1 % (Martinsen and Horsberg, 1995), while Hustvedt et al., (1991 b) 
reported bioavailability 19.9% at 7.5"C and 21.4% at 90C. However, confusion exists 
on the dependency of OA bioavailability on administered dose level. Dose 
independent OA bioavailability in Atlantic salmon (Salmo saI66 was low (20-22%) 
after the low and high oral dose at two low temperatures (Hustvedt et al., 1991). 
Contrary to that a more recent study by Rogstad et al., 1993 suggested an inverse 
correlation between OA dose level and bioavailability. Bioavailability of the oxolinic 
acid was found to decrease with increasing dose rates in Atlantic salmon (Salmo 
sala6 at 50C being 25% at a dose rate of 50mg/kg b. w/day and 40% at 25mg/kg 
b. w/day (Rogstad et al., 1993). OA oral bioavailability was 13.6% in freshwater 
cultured rainbow trout (Oncorhynchus mykss) (13jorklund and Bylund, 1991). 
Comparative OA per os bioavailability studies in channel catfish (Ictalurus 
punctatus) and rainbow trout (Oncorhynchus mykiss) at two temperatures indicated 
early plasma peaks but increased bioavailability and sustained concentrations for a 
longer period at lower temperature (Kleinow et al., 1994). While in one study OA 
bioavailability in turbot (Scophthalmus maximus) following single oral dose was 
27,9% (Poher and. Blanc, 1998) in another more recent study poor OA metabolism 
was described in turbot (Scophthalmus maximus) after a single oral dose indicating 
that it was dissolved in the liquids present in the gut and absorbed in a non- 
dissociated form depending on the gradient of concentration between gut lumen and 
the environment. In this study 81 % of the dose was rejected along with the faeces in 
the environment - of which at least 28% was in a solid form - which can accumulate 
in the sediments (Guichard, 2000). OA Bioavailability was enhanced by particle size 
reduction (Endo et al., 1987). 
OTC bioavailability was studied less but it was found to be very limited after oral 
application although it was positively correlated with water temperature (Hustvedt et 
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al., 1991,1991a). In rainbow trout (Oncorhynchus mykiss) and common carp 
(Cypfinus carpio) studies oral administration was linked to low bioavailability 
(Grondel et al., 1987a; Rogstad et al., 1991), while intramuscular application gave 
high bioavailability (Grondel et al., 1989). Therapeutic efficacy of OTC via the oral 
route in common carp (Cyprinus carpio) was therefore questioned due to extremely 
low bioavailability possibly due to lack of a stomach and absence of pH variations in 
this species (Grondel et al., 1987). High, but not significant different bioavailability 
was observed in rainbow trout (Salmo gairdnefi) and African catfish (Cladas 
gadepinus) following i. m. OTC administration (Grondel et al., 1989). Oral 
bioavailability of Oxytetracycline HCI investigated in Atlantic salmon (Salmo salarL. ) 
in seawater at 7-8'C was found to be only 2% (Elema et al., 1996). A significant 
difference in OTC bioavailability was revealed between healthy and vibriosis- 
infected ayu (Plecoglossus altivefis), whereas elimination was similar in both fish 
(Uno 1996). 
4.3.3.1.5 Tissue distribution 
Oxolinic acid taken into fish was partly biotransformed to 6,7-diOHOA by 
microsomal monooxygenase, this was further metabolised to 7-01-10A or 6-OHOA, 
and these metabolites as well as the unchanged form were conjugated with 
glucuronic, acid. The difference in the retention among the species may be due to 
the difference in activity of microsomal monooxygenase. Oxolinic acid was retained 
at a lower concentration and for a shorter period in fish acclimated to seawater than 
in fish raised in fresh-water due to the faster excretory rate in seawater fish. 
Metabolic rate was affected by the activity of microsomal monooxygenase and the 
physiological function of fish such as osmotic regulation (Ishida, 1992a). Bjorklund et 
al., (1991) reported that maximum OA concentration in the muscle and serum was 
achieved at the same time at three temperatures. Maximum concentration of O. A in 
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rainbow trout occurred in the order bile>liver>kidney>muscle>serum. In a similar 
study by Ueno et al., (1988) organ distribution of OA level was 
kidney>liver>muscJe>blood. Distribution and elimination of OA after oral 
administration in Nile tilapia (Oreochromis niloticus) were delayed at lower 
temperature, but significant difference of the peak concentrations in the tissues of 
the group at 15'C and 250C was not revealed. However, the changes of maximum 
concentration, absorption and elimination rates in the tissues of fish following bath 
treatment depending on different temperatures were more significantly different from 
the results of the studies with oral administration. OA pharmacokinetics in tissues of 
diseased fish, the main target of drug treatment, also appeared to be distinguishable 
from those of healthy fish (Kim et al., 1998). The distribution profile of flumequine in 
the various compartments of fish appeared to be different from that of oxolinic acid 
following a single oral dose with higher concentration in plasma and liver (Rogstad 
et al., 1993). Highest organ OTC concentrations were found in liver, gills, kidney, 
and gonad (Black et al., 1991) and gastrointestinal tract, liver, vertebral body, skin, 
and mucus (Rogstad et al., 1991). OTC affinity and chelation to calcium namely 
bone and scales made OTC tagging application widespread for salmonids 
(Koenings and Lipton, 1986). OTC tissue distribution and elimination in salmonids in 
seawater generally decreases in the order of liver>kidney>skin>muscle at the end of 
the treatment period. These results show that the pharmacokinetics of OTC in 
Atlantic and Chinook salmon are very similar after per os administration (Namdari et 
al., 1998). In a previous study OTC tissue concentrations in chinook salmon 
(Oncorhynchus tshawytscha) was about twice as high as those of the coho salmon. 
(Oncorhynchus kisutch) (Namdad et al., 1996). The tissue disposition and 
bioavailability of JH-tetracycline were examined in the channel catfish (Ictalunis 
punctatus) after intravascular and per os application. The drug was highly 
concentrated in both hepatobiliary and urinary compartments. The concentrations in 
the edible flesh were the lowest of any compartment examined (Plakas et al., 1988). 
P. Chiistofilogiannis 239 
Use of Antibiotics in Greek Mariculture University of Stirfing 
OTC kinetics and tissue distribution was studied in rainbow trout (Oncorhynchus 
mykiss) following bolus ix administration (Black et al., 1991; Uno et al., 1997). The 
highest drug levels were found in the liver and the lowest were in the brain (Black et 
al., 1991). 
4.3.3.1.6 Excretion 
Four points clearly emerge from the literature. Temperature is an important factor in 
elimination of drugs from fish tissues. However, generalisations concerning this 
relationship should be made cautiously as the type of drug and the species of fish 
are also important factors in determining elimination rates. The current conversion of 
referring to withdrawal periods in fish in "degree days" was often questioned (Ellis, 
1991). Drugs are cJeared at different rates from different tissues. Elimination from 
muscle may be relatively rapid but certain drugs may accumulate and persist in 
bone, scales and kidney. Factors such as species maturity and health status affect 
elimination rates. Environmental parameters play a significant role (eg. Sea water 
versus Freshwater). This study revealed marked differences between Oxolinic acid 
and Oxytetracycline excretion rates. Factors like tissue and water temperature were 
proven more important than species differences. The concept of the relevance of 
Degree-days was questioned as it happened in some studies in the literature. 
Factors like fish health status (only healthy fish were used in the experiments) and 
environment were not evaluated in the current study. 
Temperature is an important factor affecting clearance rates. Some data available 
indicate that the residue time in muscle is approximately proportional to temperature 
and concentrations in the muscle. However large individual variation in elimination 
rate occurs in rainbow trout in seawater and to allow for the slowest elimination rate 
it has been recommended that at temperatures above 10'3C there should be a 
withdrawal period of 60 days and from 7-100C a period of 100 days (Salte and 
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Liestol, 1983). These recommendations are in line with other recommendations 
(Jacobsen, 1989) for rainbow trout in fresh water for achieving levels of less than 
0.01pg/g in whole gutted carcasses. The important point here is that OTC was 
retained in bone and scales for long-periods (Jacobsen, 1989). OTC has also been 
reported to persist in high concentration in the pronephros of carp (Grondel et al., 
1987a). For these reasons, it has been recommended that whole gutted carcasses 
should be analysed rather than just muscle on the assumption that skin may be 
eaten (Jacobsen, 1989). To examine the hypothesis that kinetic processes are 
higher at warmer environmental temperatures in fish several studies that were 
conducted, reported that in warmer water absorption peaked faster in the serum and 
muscle. Terminal elimination rates were consistently more rapid at higher water 
temperatures in all tissues, including muscle (13jorklund and Bylund, 1990; Rogstad 
et al., 1991) OTC elimination rate in rainbow trout and ayu was not affected by 
temperature, with a tendency for faster elimination at lower temperatures. 
Recommended withdrawal times are 20 days (Jacobsen, 1989). In contrast, other 
workers (Ueno et al., 1988a, b) reported that elimination rates in rainbow trout were 
temperature dependent (muscle residues cleared in 18 days at 100 C; 12 days at 
15" C). Species differences could be marked. Amago salmon at 150 C took at least 
30 days to eliminate residues from muscle (Ueno et al., 1988b). 
Ellis (1991) argued that the effect of temperature is not always linear and doubt 
must be cast upon a general "degree days" convention for setting withdrawal times. 
Data for many drugs does not include measurements of elimination rates at different 
temperatures and research reports (eg Salte and Liestol, 1983; Jacobsen, 1989) did 
not use the "degree days" convention but instead recommended withdrawal times 
for specific temperature ranges. A further limitation in the "degree days" convention 
plasma of rainbow trout held at 120 C in 29 days (=348 c) days) and from the plasma 
of catfish held at 250 C in 31 days (= 775 c) days) (Grondel et al., 1987a). At 400 
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degree-days the catfish plasma still contained 2 pg OTC/mi. Thus if a "degree days" 
convention is to be used it would have to be set specifically for each fish species. 
Ellis (1991) suggested withdrawal times for freshwater rainbow trout treated with 
these drugs were not linked to degree days and for OTC were 90 days below 6"C, 
70 days between 6 and 12"C and 60 days above 120C; and for OA, 20 days at 
approximately 180C (Jacobsen, 1989). Based on serum concentrations of OA post- 
treatment in Atlantic salmon (Salmo salao, withdrawal periods of 38 days at 4-60C 
and 31 days at 13-150C were necessary to ensure that the drug levels would remain 
below 1 ng/ml serum (Hustvedt et al., 1992). 
It is apparent that elimination times of certain drugs differ for different tissues. Most 
available data apply to muscle residues, as it is the muscle which is directly 
consumed by humans. However the CVMP monograph for the O. A provisional MRL 
indicates that the sample for residue analysis should contain muscle and skin in 
natural proportions. If skin and bone are retained in edible portions of flesh it is 
possible that leaching into the flesh may occur under certain circumstances. Further, 
there is growing interest in silaging diseased carcasses for processing into fishmeal. 
The fate of antibiotics during such processing is not known (Ellis, 1991). Both liver 
and kidney participate in the excretion of oxolinic acid, although OA elimination 
through the gills must also be considered. Dauble and Curtis (1989) showed that in 
rainbow trout branchial elimination was the primary route of excretion of quinoline, a 
nitrogen-heterocyclic compound with structure similar to Oxolinic acid. Quinaldine 
(2-methylquinoline) on the other hand is also eliminated in rainbow trout by diffusion 
through the gills. Neither Bjorklund et al. (1991) or Ueno (1988) studies have shown 
any identified peaks, which could be interpreted as OA metabolites in serum, bile or 
tissues of rainbow trout or amago salmon (Oncorhynchus rhodrus). However, in a 
study on yellowtail (Seddla quinqueradiata) two metabolites, a glucuronid conjugate 
and an unidentified compound were found in liver and bile after a single oral 
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administration of OA (Ueno et al., 1988). Ishida (1992b) reported three metabolites 
of OA in the bile of rainbow trout namely O. A glucuronide (O. A-G) and two other 
glucuronides and decomposition products (7-OHO. A-G and 6-OHO. A-G). Six to nine 
different metabolites, including conjugates of OA have been found in tissues and 
urine of rabbit, dog and man. Thus compared to mammals, fish seem to have limited 
capacity of metabolising oxolinic acid (13jorklund et al., 1991). Approximately 50% of 
the OA at therapeutic levels is unbound and can freely interact with the secretory 
system in the nephrons. 
In fish and mammals, tetracyclines are removed from the blood by the liver, 
concentrated and excreted by the biliary route and then reabsorbed in the stomach 
and the upper small intestine resulting in an enterohepatic circulation (Fanelli and 
Nigrelli, 1963; Cravedi et al., 1987). Therefore, this class of drug may persist for 
some time after the cessation of therapy (Huber, 1986). The persistence of OTC 
may be related to liver function or to the physiological condition of the fish. In case of 
severe infection, due to damage of the bileducts in man the excretion rate of 
oxytetracycline may be significantly reduced resulting in the accumulation of toxic 
concentration (Dowling and Lepper, 1964; Weinstein, 1970). Other factors, such as 
water temperature also influence antibiotic excretion rates (Herman et al., 1969). 
OTC i. m. Injection monitoring revealed that the drug was accumulating in 
pronephros, bone tissue and scales (Grondel et al., 1987). Jacobsen (1989) and 
Kasuga et al. (1984) indicated that OTC is quickly eliminated from muscle and 
gutted carcasses of rainbow trout and ayu. 
Species difference and salinity as high as 24%o do not play an important role 
in the absorption and elimination of OTC by the salmonids. Moreover, 
freshwater trout may be used as a model salmonid to study OTC 
pharmacokinetics in seawater salmon and vice versa (Abedini et al., 1998; 
Namdari et al., 1999). Other factors affecting elimination rates include 
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maturity and health status. For example, the elimination of OTC in fasting 
Atlantic salmon broodstock was far slower than in growers and furthermore, 
elimination was also prolonged in fish suffering hepatic lesions associated 
with a past furunculosis outbreak (Bruno, 1989). 
OA was retained at higher concentrations and for longer periods in 
freshwater than seawater Coho salmon (Ishida et al., 1990) and sea trout 
(Ishida, 1992b) and OA excretion in seawater Coho salmon was similar to 
that in other seawater fish like Japanese mackerel, red sea bream, yellowtail 
and flounder (Ishida et al., 1990). This difference in regulation was 
considered to be the most probable function responsible for the difference in 
the excretory rate despite the similarity in the metabolic pathway of OA 
between freshwater and seawater fish (Ishida, 1992a). Digestibility as well as 
excretion could be influenced not only by the feeding rate but also by the 
drinking of fish in different environments. Drinking in Atlantic salmon 
commenced after abrupt transfer from fresh water to seawater. In unfed fish 
the rate steadily increased 4 days post-transfer, apparently in response to 
increasing plasma ion concentrations. Drinking rate was independent of gut 
food content but was significantly higher in feeding fish than in unfed fish 
(Usher et al., 1988). On the other hand urine flow in salmonids is dramatically 
reduced in seawater compared to freshwater (Hunn, 1992). 
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4.4 Antibiotic Resistance 
Resistance is always a relative term. A strain can be classified as resistant to a 
specific antibacterial agent if it is able to function, survive and persist in a 
concentration of antibacterial higher than the members of its parental population. A 
species on the other hand can more loosely be classified as resistant when its 
members can function, survive and persist in higher concentrations of an 
antibacterial agent than the members of other species (Smith, 1995). Bryan (1989) 
suggested that there are two forms of antimicrobial resistance: positive function 
resistance and bacterial persistence. Positive function resistance is the form where 
a microbe gains the capability to resist one or more antimicrobial agents by the 
acquisition of a gene function. Usually this results from the transfer of plasmid DNA 
into the bacterial strain. The gene functions are for the most part concerned with 
inactivation or modification of the antimicrobial agent, the addition of an efflux 
system or the specification of a new target or the enzymatic modification of the 
target. In each of these circumstances there is relatively little disadvantage to the 
cell in possessing these additional gene functions. Thus there is a tendency for 
these mechanisms to be relatively stable in a strain and for bacterial populations 
derived from these to contain predominantly resistant organisms. Humans for a 
substantial period of time and from individual, institutional and community reservoirs 
may carry the resistant strain. Control can be achieved in two major ways, either by 
infection control or by the development of new agents or inhibitors, which are 
insensitive to or overcome the resistance mechanism. It is also possible that control 
could be achieved in the long term by restriction of a particular agent, as the strains 
are not likely to be perfectly stable. This is the main mechanism by which bacterial 
pathogens acquire resistance to Oxytetracycline. In relation to Courses of 
antimicrobial therapy positive function resistance is unlikely to appear during therapy 
unless acquired by cross-infection during a course of treatment or more rarely by 
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selection of a minority population of the pathogenic strain. It is likely that this form of 
resistance will be readily detected by susceptibility testing because of the relatively 
high levels of resistance normally specified and the high frequency of resistance in 
the particular bacterial population. Therefore, positive function resistance would 
usually be found at the onset of therapy. Tetracycline inhibits bacterial growth by 
interfering with protein synthesis at the level of ribosome. Plasmid-mediated 
resistance to antimicrobials has been identified in a number of bacterial fish 
pathogens, including Aeromonas salmonicida, A. hydrophila, Vibrio anguillarum, 
Pseudomonas fluorescens, Pasteurella piscicida and Edwardsiella tarda (Starliper et 
al., 1993; Klein et al., 1995; Aoki, 1988) and Yersinia rucked (DeGrandis and 
Stevenson, 1985). Transferable Rplasmids have been found in A. salmonicida in 
Japan and in Ireland (Aoki, 1997). Plasmid-mediated resistance to 4-quinolones has 
not been reported in fish pathogens, presumably because they appear to effectively 
inhibit the process of conjugative plasmid transfer (Nakamura et al., 1976), so that 
the spread of quinolone resistance by gene transfer is unlikely. In the case of A. 
salmonicida, laboratory studies have shown that resistance to oxolinic acid can 
readily be selected in the presence of the antibacterial (Tsoumas et al., 1989). The 
study was carried out with Y. ruckeri, selecting for resistance against oxolinic acid, 
oxytetracycline and potentiated sulphonamide. Stamm (1989) reported a similar 
study with the new fluorinated quinolone, sarafloxacin, which was being developed 
specifically for aquaculture applications. There are several studies that reported R- 
plasmid presence in freshwater fish pathogens (Aoki and kitao, 1981; Toranzo et al., 
1984; Hedges et al., 1985; Brazil et al., 1986; Aoki et al., 1988; De Paola et al., 
1988; Inglis et al., 1991,1993a). The majority of the literature refers to antibiotic 
resistance profiles of Aeromonas salmonicida and other important salmonid 
bacterial pathogens. Widespread resistance in A. salmonicida to approved 
antimicrobials and the capacity of this bacterium to become resistant iI n the fish 
culture environment was described by Starliper et al. (1998). Adams et al., 1998 
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using broth conjugation, transferred OTC resistance encoded by R-plasmids from 
Aeromonas salmonicida to Escherichia coli and to both environmental and clinical 
isolates of Aeromonas spp. Transfer of R-plasmids between different genera of fish 
bacteria was demonstrated with Aeromonas salmonicida and Aeromonas soblia 
showed donor capicity to Yersinia rucketi. (Klein and Boehm, 1994). 
The second form of resistance can be termed 'persistence' and the mechanisms 
responsible, mechanisms of persistence. In these circumstances persistence is the 
result of resistance from mutation or from temporary resistance due to gene 
regulatory events or phenotypic changes that would only become evident during 
exposure of a bacterial population to an antimicrobial agent. Thus persistence is 
only seen during courses of therapy. These changes allow a microbe to persist 
during therapy by giving some levels of antimicrobial resistance. However, they are 
frequently deleterious to the organism in some manner causing growth impairment 
to a variable degree and in some cases a temporary reduction in virulence. 
Mechanistically, these changes operate by reducing permeability or target affinity for 
a drug or by turning on chromosomally specified enzymes capable of degrading the 
drug. In contrast to positive function resistance these changes result in loss or 
reduction of gene function or a functional change that provides a metabolic load to 
the organism. Such forms of resistance are most likely to be effective where there is 
a local or general deficiency of host defences, where drug entry is poor or where the 
local environment is antagonistic to the action of the drug. Persistence may impair 
the organism but after removal of the antibiotic there are strong selective forces for 
the parental form to return or for loss of the regulatory or phenotypic changes 
because of better growth and virulence characteristics. The effect of persistence is 
to slow therapeutic response, establish colonization, or produce outright therapeutic 
failure. This is the mechanism by which bacterial pathogens acquire resistance to 
Oxolinic acid. Flavobactedum psychrophilum isolates showed resistance to oxolinic 
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acid in rainbow trout freshwater farms in Denmark (Dalsgaard and Madsen, 2000). 
Resistance to five fluorinated 4-quinolones against the fish pathogen Aeromonas 
salmonicida appeared to be fairly stable, with only a small decrease in activity after 
10 successive passages of the test strains on drug-free tryptone soya agar (Bames 
et al., 1990,1990a). Persistence mechanisms were illustrated after sequential 
subcultures of strains of Yersinia rucketi. The MIC increased by 20-, 16- or 16-fold 
for oxolinic acid, oxytetracycline and the potentiated sulphonamide, respectively. 
Subsequent attempts to decrease this induced resistance to oxolinic acid were 
unsuccessful. However, it was possible to decrease the induced MICs for 
Oxytetracycline (6-fold) and the potentiated sulphonamide (4-fold), also in a 
stepwise fashion (Rodgers, 2001). 
4.4.1 Current Antibiotic resistance survey 
This study exhibited some unique characteristics. It is the first survey of antibiotic 
resistance among fish bacterial isolates in Greece and it included a large number 
(24) of farm /sources from all over Greece (9 distinct marine areas). It is among the 
very few in the literature to compare "Quantitativen antibiogram data with MIC values 
for the two most widely used antibiotics (Oxytetracycline and oxolinic acid) and to 
address these data statistically according to the clinical relevance of the bacterial 
isolates. Most MIC studies are focused in certain fish pathogens (see 4.4.3.4) but in 
this study all bacteria[ isolates from 5 fish species (sea bass, sea bream, Mugil 
cephalus, dentex and Puntazzo puntazzo) were screened for their antibiotic 
resistance profile and level. 
The quantitative antibiogram evaluation of the bacterial isolates during this survey 
(1994-1997) was based on the condition that a zone of inhibition between 6-15mm 
refers to resistant isolates, 15-25mm zone to intermediate resistance and finally 
zone greater than25mm in diameter indicates susceptible strain. The relevance of 
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this condition was evaluated by the success of the antibiotic treatment and was 
proven to address the issue of clinical relevance. The quantitative antibiogram was 
performed in Mueller Hinton agar with 3% salt without the addition of Mg++ and Ca++. 
The Standard practice of cation addition reduces the availability of antibiotic and the 
zones of inhibition. However, it was found in subsequent studies on sea bass and 
sea bream pathogens - not described in this report - that the effect of these cations 
is variable depending on the bacterial strain, therefore the induced variation reduces 
the extrapolation of clinically relevant results. The analysis of the resistance profiles 
(quantitative antibiogram) revealed the resistance of Vanguillarum 1 phenon 2 to 
Oxolinic acid, Potentiated sulphonamides and Furazolidone while all cocci both 
Gram negative and positive were resistant only to Oxolinic acid. Oxolinic acid 
resistance was expected because at the period of the survey treatments have been 
switched from Oxytetracycline to the newer antibiotic available (Oxolinic acid) due to 
repeated resistance problems. It was encouraging however that the most common 
bacterium isolated V. Angufflarum 1 (API 20E-3047525) was susceptible to most 
antibiotics. Statistical analysis revealed malpractices in certain farms (21) where 
only Oxytetracycline and Potentiated sulphonamide intermediate and resistant 
strains were isolated, while the only multiresistant strain in the study with resistance 
to 3 antibiotics was also isolated from this farm. In addition in four other farms 
(2,10,16 and 17) only Oxolinic acid resistant bacterial strains were isolated. Cross 
tabulation analysis revealed that 12 % of the strains were resistant to two antibiotics 
while 69% exhibited intermediate resistance or resistance to at least one antibiotic. 
A link of the resistance pattern between Oxolinic acid and Furazolidone was evident 
in 74% of the strains. it can be argued that in these type of studies even when the 
conditions in the media employed are identical several factors might interfere with 
and affect the validity of the data produced. The medium used for the quantitative 
antibiogram was Mueller Hinton a widely used and accepted medium. However as 
pointed out in the relevant workshop for the production Of common standards on 
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antibiotic resistance monitoring (Alderman and Smith 2001) and following more 
recent studies on the importance of Mg24' and Ca2+ addition in the medium is now 
currently employed as the method of choice in all media used generating higher MIC 
values. Another potential argument is that the same conditions were applied for all 
fish pathogens and the same inoculum (adjusted by O. D) was employed in all 
quantitative antibiograms for both slow and fast growing bacteria giving a time 
benefit to the fast growing bacteria (e. g Vibrios) that could be able to maintain 
smaller zones against any antibiotic due to confluent growth. All these technical 
issues however are faced daily by most researchers and high variability of 
techniques used results in data which are not readily comparable. However these 
results stand as a clinically relevant report of the antibiotic resistance level in Greek 
Mariculture, between 1994-1997. 
The workshop on the new standards for antimicrobial resistance interpretation 
clearly recognised that the formulation and publication of new standard methods 
could not be taken as a criticism, implied or otherwise, of the many methods that 
have been developed by laboratories working in this area. It was accepted that 
many well-specified and useful methods are currently being employed in many 
laboratories. it is further accepted that in some of these laboratories, the use of 
these methods has, over time, allowed the specification of breakpoints relevant to 
the clinical interpretation of the data generated by the methods. Such interpretative 
schema was, however, method dependent and could not have general applicability. 
(Alderman and. Smith, 2001) An initial part of the resistance profiles from this study 
were presented for the first time in 1997 (Christofilogiannis et al., 1997). 
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4.4.2 MIC Studies 
Antimicrobial sensitivity and resistance are relative terms and provide an 
interpretation of the clinical significance of concentrations of an antimicrobial, which 
inhibit the growth of an organism or kill it in laboratory systems (in vitro). The 
commonly used measure of such concentrations is the Minimal Inhibitory 
Concentration (MIC). This has been defined by the British Society of Antimicrobial 
Chemotherapy (Working Party, 1991) as the lowest concentration of antimicrobial 
that will inhibit the visible growth of a microorganism after overnight incubation. 
MICs are determined according to guidelines for antimicrobial sensitivity testing and 
the basic information upon which this study is based. MIC determinations are 
carried out using agar methods or broth dilution methods, and under strictly 
controlled circumstances, using antimicrobial discs. In the disc method, discs 
impregnated with a known concentration of antimicrobial are placed in a lawn of 
bacteria grown on an agar plate, incubated overnight and examined for evidence of 
growth inhibition. This method is widely used in clinical laboratories, especially 
veterinary ones. When the thickness of the agar, its composition, the concentration 
of the inoculum, and the conditions of growth especially the time are all carefully 
controlled and specified, the results are reproducible. The size of the zone of 
inhibition of growth may be measured to provide the MIC of the organism under test 
by interpretation and previously prepared calibration curves obtained using known 
concentrations of antimicrobial and reference strains of organism. This type of MIC 
determination is frequently reported in the literature as the Kirby Bauer Method 
(Bauer et al., 1966) and is accurate when the conditions have been defined. In most 
literature cited here, veterinary diagnostic and other bacteriology laboratories have 
not used calibration curves and careful controls, but have applied a clinical isolate to 
the agar surface, made a visual assessment of the size of any zone of inhibition and 
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recorded the result as 'sensitive' or 'resistant. In agar or broth dilution methods, 
antimicrobial of known potency is diluted in the medium according in a manner, 
which must be defined. It is common to use two-fold dilutions (doubling dilutions), 
but ten-fold dilutions or non-standard series of dilutions may be used. The 
antimicrobial containing media are then inoculated with a suspension of the bacteria 
under test, which should be of known concentration and are then incubated for a 
standard period of time. On solid media growth is detected by examination for 
colonies and in broth media by examination for visible growth. The presence or 
absence of growth may be quantified by the use of optical density readings. The 
potential sources of error in these methods have been discussed by the British 
Society of Antimicrobial Chemotherapy Working party (Working party, 1991). In 
many cases where these methods are used in clinical practice, proprietary kits in 
plate form are used and the presence or absence of growth in an individual well is 
recorded. In research studies, particularly of difficult organisms or new or 
uncommon antimicrobials, the basic technique used is clearly defined. It is clear 
from the above that, an MIC recorded in the literature may have been obtained in a 
number of different ways and that the accuracy of the MIC is important in assessing 
the quality of the data provided. 
The British Society for Antimicrobial Chemotherapy recommendations for the point 
at which a Minimal Inhibitory concentration is sufficiently high to indicate resistance 
("break-point) is critical to the objective evaluation of sensitivity and resistance of 
bacteria to antimicrobials. The use of different methods to establish MIC has been 
outlined. In many studies sensitivity or resistance are used in the text to describe 
results obtained. Where these are based on MICs and the formula specified above 
(or another comparable formula) they can be justified, but in many cases, 
particularly in clinical veterinary medicine, the MIC was never determined and only a 
visual assessment of size of the zone of inhibition around an antimicrobial disc has 
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been made. More recently the use of breakpoint concentration methods become 
more common in medicine and in vet medicine. Here the growth of a suspension of 
the organism under test is assessed on or in medium containing the breakpoint 
concentration of the antimicrobial under test. The media may be prepared in the 
laboratory concerned, but increasingly are supplied in kit form as multi well plates 
containing the appropriate concentration of antimicrobial. 
4.4.2.1 MIC - Temperature effect 
The most pronounced effect on the MIC studies for OTC and OA is the fact that the 
level of MIC increases with Incubation temperature increase for OTC while it 
decreases for OA. This means that at low water temperature OTC is more effective 
while OA becomes less efficacious. Studies confirmed the effect of incubation 
temperature on the in vitro activities of 4-quinolones and Oxytetracycline against 
Aeromonas salmonicida subsp. salmonicida (Bames et al., 1990b), atypical A. 
salmonicida, Vibiio salmonicida, Vibfio anguillarum, and Yersinia ruckefi using a 
drug microdilution method. When tested against A. salmonicida subsp. salmonicida, 
all of the quinolones, examined had MICs higher at 40C than at 15"C. Similarly 
higher MICs were recorded for all of the quinolones except sarafloxacin at 4"C than 
at 15"C when the drugs were tested against V. salmonicida. In contrast to those of 
the quinolones, the MICs of oxytetracycline were lower at 4 "C than at 15 OC against 
all of the bacterial species tested (Martinsen et al., 1992). In contrast MICs for 
oxytetracycline against V. anguillaium and V. orrialY showed a two-fold increase as 
incubation temperature increased but this pattern was not confirmed seen for A. 
salmonicida (Giles et al., 1991). Higher MICs for OA at lower temperature could be 
explained by decreased drug diffusion into bacterial cells diminishing drug 
availability at the site of action and slower bacterial growth rate and lower 
susceptibility to DNA gyrase-inhibitory activity of quinolones at lower temperatures. 
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A hypothetical explanation refers to reduced quinolone affinity for the DNA gyrase 
complex at lower temperatures, inducing inefficient inhibition of DNA synthesis 
(Martinsen et al... 1992). Lower MICs of OTC were obtained at low temperature 
against all of the bacterial species tested which could indicate a response to 
decreased incubation temperatures but it could hardly be explained by membrane 
permeability variations. However, alterations in the energy-dependent active 
transport mechanisms for tetracyclines in bacterial membranes, or a temperature 
dependent mode of action at the bacterial ribosome, could be possible explanations 
(Martinsen et al., 1992). In fish, bioavailability and plasma drug levels of quinolones 
and oxytetracycline are reduced at low temperatures and their specific effects may, 
in turn, also be reduced. Regarding the quinolones, one might assume that the 
elevated MIC at low temperatures could further impair their clinical efficacy. On the 
other hand, the lower MICs of oxytetracycline could partly compensate for the 
reduced bioavailability at low temperatures, so that low water temperatures might 
less influence the outcome of oxytetracycline treatment. Whether these theoretical 
considerations are of clinical relevance remains to be clarified. Potential 
mechanisms of resistance have been investigated and the development of cross- 
resistance between oxytetracycline and oxolinic acid has been studied. In terms of 
MIC, the fluoroquinolones were highly active against oxolinic acid-sensitive strains 
of A. salmonicida and considerably more active than oxolinic acid against oxolinic 
acid-resistant strains. Oxolinic acid showed poor bactericidal activity against A. 
salmonicida but in contrast, the fluoroquinolones were rapidly bactericidal for the 
bacterium. The frequency of occurrence of mutations leading to resistance against 
the fluoroquinolones was lower than with oxolinic acid. Some oxytetracycline- 
resistant mutants of A. salmonicida showed significant levels of resistance to 
oxolinic acid (Bames et al., 1990b). 
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4.4.2.2 Drug Comparative studies 
Comparisons between Oxolinic acid and the new fluoroquinolones along with cross- 
resistance development between them and between OA and OTC are widely 
discussed in the literature. Oxolinic acid showed poor bactericidal activity against A. 
salmonicida while Flumequine and fluoroquinolones were more potent were rapidly 
bactericidal and also had much lower frequency of mutations (Bames et al., 1990b; 
Barnes et al., 1991a, b 1992a; Martinsen, et al., 1992). On the contrary in other 
studies OA performance was better than those of the newest quinolones. OA was 
the agent that caused highest inhibitory effect against Vibfio anguillarum 04, and 
Photobacterium damsela subsp. piscicida while Tetracyclines displayed the 
strongest bacteriostatic and bactericidal effect against Vibrio damsela strains (Lopez 
et al., 1993). The problem of complete cross-resistance between quinolones has 
previously been demonstrated for various bacterial species. This was confirmed in a 
study for the four 4-quinolones examined, as tested against strains of A. salmonicida 
subsp. salmonicida. However, the cross-resisitance between the old 4-quinolones, 
such as oxolinic acid, and the new and more potent fluoroquinolones, such as 
enrofloxacin and sarafloxacin, might not be of clinical significance. Clinical 
resistance depends on the MIC for the bacterial strain together with the 
pharmacokinetic profile of the drug in the fish species treated. Consequently, strains 
showing decreased in vitro quinolone susceptibility might nevertheless be clinically 
susceptible to potent fluoroquinolones (Martinsen, et al., 1992). Some 
oxytetracycline-resistant mutants of A. salmonicida showed significant levels of 
resistance to oxolinic acid (Barnes, et al 1990b). 
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4.4.2.3 Methodology and interpretation 
Methodology and interpretation difficulties constitute the third element strongly 
presented in the MIC related literature. Different laboratories have employed and 
are employing a wide variety of methods and according to evidence presented they 
are generating widely different results. As a direct result of the use of different 
methods to determine laboratory sensitivity, there were severe problems in 
comparing data generated by different laboratories. Possibly of greater significance 
is the difficulty that method variation presented for the development of appropriate 
breakpoints to facilitate the clinical interpretation of laboratory data on sensitivity 
(Alderman and Smith, 2001). Some of the difficulties in methodology and 
interpretation of antimicrobial sensitivity testing of fish pathogens have been 
discussed by Smith et al. (1994). It should be noted that as yet there is no agreed 
standard method for determining the MIC of fish pathogens to be used in different 
laboratories, so that interpreting the practical meaning of reported differences is 
difficult. Proposals to move towards selecting an agreed method have been made 
by the European Association of Fish Pathologists and by the Working Group on 
Diseases and Pathogens of Marine Organisms of the International Council for the 
Exploration of the Sea (ICES WGDPMO) (Alderman and Hastings, 1998). A 
workshop funded by the European Union as a Concerted Action by DG XIV under 
the FAIR programme-FAIR CT 97-3760 attempted to resolve this chaotic situation. 
The intention of the workshop was to bring together representatives of the major 
European Community laboratories (plus a limited number from outside Europe) 
working on aspects of the use of chemotherapeutants, particularly upon antibiotics 
and the problem of drug resistance in aquaculture. The primary theme of the 
Workshop was to enable these experts to re-examine these problems and, in 
particular, to discuss and gain agreement on recommendations for uniform methods 
for determining minimum inhibitory concentrations for the most important 
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antimicrobials against the most important fish pathogens. (Alderman and Smith, 
2001). The Workshop recognised that the determination of sensitivity was 
composed of two separate but interrelated issues. The first was associated with the 
laboratory methods employed and the second was related to the meaning, in terms 
of clinical relevance, of any data generated by such methods (Alderman and Smith, 
2001). The purpose of these methods was to function as'reference methods'. They 
aimed to provide means of communication between laboratories, means of 
comparing the data generated by local methods and means with which, 
microbiological, pharmacokinetic and clinical data, relevant to the setting of 
breakpoints, could be exchanged between laboratories. Further technical issues 
refer to the means for selection of resistant isolates, the media and the method most 
adequate for the estimation of the level of bacterial resistance without interference, 
the media preparation and validation protocols, the inoculum size etc. 
The reports in the relevant studies refer to three different schools of thought in terms 
of antibiotic level for resistant bacterial isolate selection: Initially the concentration 
can be set according the distribution in the levels of resistance in undisturbed 
microflora. Other scientists refer to a standard breakpoint concentration (OTC 2-4 
pg/ml) at which a high percentage of the natural microflora in an undisturbed 
environment could grow. The third approach is to set the concentration at such level 
that it would select all cells containing R-plasmids. Datta et al., (1971) for example 
set OTC concentration for the selection of R-plasmids to a level of 1 Opg/ml. 
The culture media for marine pathogens used in these studies usually incorporate 
seawater. In one study Samuelsen et al. (1992a) introduced TSCA (trypton soya 
citrate agar) - citrate counteracts the inhibitory effect of the 70% seawater also used 
in the medium. The reported level of reduction of OTC activity was about 80%. 
Tetracyclines have a number of potential metal binding sites. The ability of 
tetracyclines to form complexes with di- and trivalent cations has long been known. 
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This ability is strongly pronounced for hydrophilic tetracyclines (mainly tetracycline 
and oxytetracycline). Lypophilic tetracycline derivatives, such as doxycycline, 
complexes the presence of di- or trivalent cations has also been known to mediate 
the binding of tetracyclines to macromolecules (Lunestad and Goksoyr, 1990). 
Several studies exist on research for appropriate media for OTC MIC testing. 
Despite improvements with new media versus Mueller Hinton large strain-to-strain 
variation gave inconclusive results (Pursell et al., 1996). 
Arguments are presented that the media currently being employed in studies of the 
frequency of resistance in the vicinity of marine fish farms are inappropriate. In 
order to maximize the number of colonies that can be enumerated from the marine 
environment any media must contain Mg++ and Ca++ ions in addition to NaCl 
(Baumann and Baumann, 1981). Seawater with a salinity of 35%0 contains 54 Mm 
Mg++ and 10 mM Ca++. The concentration of Ca++, Mg++ and Fe++ in seawater have 
been shown to significantly limit OTC biological activity in marine environment 
(Lunestad and Goksoyr, 1990). In studies of the frequency of resistance to 
oxytetracycline in sediments under marine fish farms Samuelsen et al. (1992a), 
employed a Tryptone Soya Agar (TSA) made up with 70% sea water and attempted 
to counteract the inhibitory effect of the divalent cations by incorporating citrate ions 
at 10g/I (TSC). Kerry et al. (1994; 1995) employed a medium (2216V), which 
incorporated only 6% seawater and made no compensation for the concentrations of 
divalent cations introduced. It was suggested that media specifically formulated for 
work with antimicrobial agents, such as Iso-Sensitest Agar (ISA) and Mueller Hinton 
Agar (MHA) would be more suitable. Seawater is routinely added to media used to 
enumerate bacteria from the marine environment. The ions present in seawater, 
particularly Mg++ and Ca++, inhibit the antimicrobial activity of oxolinic acid. A 
considerable underestimation of the level of OTC resistance may occur when media 
prepared without seawater are used. In sea water 95% of the OTC is bound by the 
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magnesium and calcium ions present in the water. (Lunestad and Goksoyr, 1990) 
Use of seawater in media for susceptibility testing of amoxycillin or potentiated 
sulphonamides is less important (Barnes et al., 1995). The Mg 2+ content of 
seawater of salinity 35%o can be in excess of 50 mM (Potts and Parry, 1964). 
Indeed, the results of recent research have shown that such concentrations of 
magnesium ions can have a marked effect on both the antibacterial activity and 
uptake by fish of various antimicrobials (Lunestad and Goksoyr, 1990). The problem 
of drug interaction with seawater prior to entry into the fish may be avoided to some 
degree by encapsulations of the antibiotic in feed pellets such as Aqualets 
(Apathekernes Laboratorium AS). However for the drug to be taken up from the 
fish's gut, it must be in the liquid phase, thus interaction with seawater ions at this 
stage would seem to be unavoidable. Beside the medium composition debate refers 
to media preparation & validation protocols. Valid breakpoint concentrations for the 
determination of the frequency of oxolinic acid resistant bacteria in marine 
environments should consider clinical, pharmacokinetic and microbiological data. It 
is indicated that the incorporation of 0.5pg/ml oxolinic acid in Tryptone Soya Agar 
(TSA) would provide a suitable breakpoint for selecting resistant strains of A. 
salmonicida. High MIC values should be interpreted carefully because for example 
Oxolinic acid is not active against anaerobes, non-fermenting gram-negative rods 
and gram-positive strains. Thus physicochernical factors oxygen tension and 
environmental quality support the growth of these microorganisms increase in the 
frequency of resistance. Species innately resistant include mesophilic Aeromonads, 
Yersinia, V. parahaemolyticUS, gram-negative species and, yeasts. Yeasts represent 
25% of the sediment micr0fl0ra in freshwater and are usually resistant to OTC. 
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4.4.2.4 Specific Pathogen MIC studies 
4.4.2.4.1 Aeromonas salmonicida MIC studies 
A limited number of studies concerning the sensitivities of truly marine fish 
pathogens and, therefore, quantitative estimates of appropriate breakpoints have 
been made by reference to data on the sensitivity of Aeromonas salmonicida. In a 
study by Martinsen et al. (1992) it was suggested that therapeutic drug 
concentrations in plasma and tissue around 4 to 10 times the MIC are often 
insufficient if selection of resistant mutants is to be minimized. In another study 
resistant mutants of Aeromonas salmonicida developed at lower frequency to the 
fluoroquinolones than to oxolinic acid or oxytetracycline at 5,10 and 20 times the 
MIC. However, mutants selected with one quinolone were cross-resistant to all the 
other quinolones tested (Barnes et al., 1991a, b). Four bacteria commonly 
associated with diseases of fish (Aeromonas hydrophila complex, Aeromonas 
salmonicida, Flexibacter colummaris-like organisms and Pseudomonas fluorescens) 
were evaluated in a serial dilution system for susceptibility to four antibiotics 
commonly used in the treatment of bacterial fish diseases (chloramphenicol, 
erythromycin, furpyrinol and oxytetracycline). Findings were expressed as minimum 
inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC). MIC 
and MBC's for oxytetracycline were complicated by the presence of R-plasmids, but 
were less than 4 pg/ml for those without plasmids. Pseudomonas fluorescens was 
susceptible only to oxytetracycline (Nausbaum and Shotts, 1981). 
4.4.2.4.2 Vibrio spp MIC studies 
Ledo et al (1987) reported that M. I. C values for Oxolinic acid for different bacterial 
pathogens like Vibrid anguillarum, Vordalfi, V. tubiashfi, V. damsela, V. carchariae, 
Pasteurella piscicida, Axaviae, Asalmonicida, Pseudomonas fluorescens, Yersinia 
ruckerfi and Edwardsiella tarda ranged between 0.075 and 0.3 Pg/ml while for OTC 
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it was around 1.56 pg/ml. Twelve times OTC concentration greater than the average 
MIC of 0,26 pg/ml cited in the literature for sensitive strains of Vibrid spp. was used 
in treatment of post larvae of shrimp Penaeus monodon with OTC encapsulated 
Artemia (Rogue et al., 1998). 
4.4.2.4.3 Photobacterium - Pseudomonas spp. MIC studies 
In a series of papers for the evaluation of drug sensetivity (MIC) of Photobacterium 
damsela subsp piscicida strains using the method of the Japan society of 
Chemotherapy isolated from cultured yellowtail between 1984-1985 and 1986-1988. 
MIC OA was shifted from 12.5 to 6.15 pg/ml, while MIC OTC was estimated at a 
level of 100 pg/mI during the first period (Kusuda et al., 1988; Kusuda et al., 1990). 
The MIC90 values of OA, oxytetracycline, against P. Piscicida were 2.66,35.70, 
pg/ml, respectively (Takahashi and Endo, 1987). 
4.5 MIC Analysis 
Drug resistant bacterial fish pathogens reported to cause problems in aquaculture 
(Watanabe et al., 1971; Toranzo et al., 1984; Aoki and Kitao, 1985; Takashima et 
al., 1985; Hjeitnes et al., 1987; Sorum et al., 1988; Torkildsen et al., 2000). Philips 
(1986) suggested that for bacterial pathogens that exhibit a widely separated 
bimodal distribution of MICs and when MICs of the sensitive strains are very low, 
predictions on the clinical outcome can be made with a high degree of reliability. 
Several studies referred to high number of strains of intermediate sensitivity in 
potentiated sulphadiazine (Tzoumas et al., 1989) and oxytetracycline (Schlotfeldt et 
al., 1985). Breakpoint recommendations were presented from several committees 
and societies like the National Committee for Clinical Laboratory Standards in a 
study based on human strain studies (Waltman and Shotts, 1986) as well as the 
Japanese Society of Chemotherapy (Aoki et al., 1981; 1985; Aoki and Kitao 1985, 
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Aoki, 1992). In addition studies like those by Tzoumas et al. (1989) where MIC 
pharmacokinetic and clinical data were considered and Inglis et al. (1993,1993b) 
where breakpoints were based on zone sizes are included in a spectrum of studies, 
which however are extremely difficult to compare. It is important to state that the 
medium, the method (96-well plate) and the inoculation procedure followed a MAFF 
protocol, initially tested during the current author's MSc studies (Christofilogiannis, 
1992). It was proven that the general guidelines of the method were valid, so many 
of its characteristics were included in the proposed "reference method" (Alderman 
and Smith, 2001) 
In this study an "epidemiological" way of analysis of MIC values to Oxolinic acid and 
Oxytetracycline was employed in order to correlate these data with the quantitative 
antibiograrn data obtained from the same bacterial isolates. The statistical analysis 
of all bacterial isolates and the correlation between Quantitative Antibiogram data 
and M. I. C values for Oxolinic acid and Oxytetracycline was used in order to 
establish M. I. C breakpoints; in relation to the categories obtained from the 
Quantitative Antibiogram. The condition in order to establish MAL breakpoints in 
this study was the following: For each of the categories described in the Quantitative 
Antibiogram, M. I. C breakpoint was considered the M. I. C concentration under which 
at least 75% of the bacterial isolates of this category belonged in. Employment of 
this condition made it possible to consider the following M. I. C breakpoints for 
Oxolinic acid and Oxytetracycline. (Table 61) 
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Table 61: MIC values for O. A and OTC vs quantitative antibiogram classification 
Bacterial strain classification 
(Zone of inhibition) 
O. A 
M. I. C breakpoints 
(Pg/ml) 
OTC 
M. I. C breakpoints 
(pg/rnl) 
Susceptible (6-15mm) < 0.3 < 0.625 
Intermediate (15-25mm) 0.15-1.25 0.15 - 2.5 
Resistant (>25mm) > 1.25 > 2.5 
Strains of intermediate resistance are considered to belong to a "grey" area and 
regarding the extrapolation of % incidence the presence of strains of intermediate 
resistance with M. I. C that ranged from 0 to 1.25 (Oxolinic acid) was taken into 
consideration. In a further step similar analysis was performed for each species with 
sea bass and sea bream being the most important due to their economic importance 
and due to the number of bacterial isolates from these species. The aim was to 
deduct correlations between Antibiogram data and M. I. C values for each antibiotic 
and possibly for each fish species. The interpretation of the actual values seemed to 
be a more effective tool in order to estimate M. LC breakpoints of clinical relevance. 
The Minimum inhibitory concentration which inhibited the growth of at least 80% of 
the bacterial isolates of this group (Tables 62,63) was defined as the MIC 
breakpoint for each antibiotic and each bacterial strain group (susceptible / of 
intermediate resistance / resistant). 
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Table 62: MIC values for O. A and OTC vs; quantitative antibiogram 
Classification in sea bass 
Bacterial strain classification 
(Zone of inhibition) 
O. A 
M. I. C breakpoints 
(jig/ml) 
OTC 
M. I. C breakpoints 
(Pg/ml) 
Susceptible (6-15mm) < 0.3 < 0.625 
Intermediate (15-25mm) 0.3-0.625 0.625-5 
Resistant (>25mm) > 0.625 >5 
Table 63: MIC values for O. A and OTC vs quantitative antibiogram 
Classification in sea bream 
Bacterial strain classification 
(Zone of inhibition) 
O. A 
M. I. C breakpoints 
(Pg/ml) 
OTC 
MIC breakpoints 
(Pg/mI) 
Susceptible (6-15rnm) < 0.625 < 0.625 
intermediate (15-25mm) - - 
Resistant (>25mm) > 0.625 > 0.625 
The precision of these MIC breakpoint values for different species depends on the 
number of the bacterial isolates under consideration. The limited number of bacterial 
isolates from the minor species does not give scope for further elaboration on the 
results recorded. The clear definition of susceptible and resistant strains regarding 
sea brearn bacterial isolates could be the result of either limited number of bacterial 
isolates and / or limited use of antimicrobials in sea brearn farming. A hypothesis 
could be that increased use of antimicrobials leads to increase of the % incidence of 
bacterial isolates of intermediate resistance to the antimicrobials used. This type of 
analysis was not performed in other studies because in we have always to refer MIC 
values of a certain bacterial strain to a specific antibiotic. This was not mistaken but 
it was found that a "general" classification of this type for all isolates in a survey or 
even for the main species studied has important clinical relevance and could provide 
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a generic tool for the veterinarians in regional labs that need to interpret, by the 
results of an "in vitro" method the clinical importance of these findings. 
The British Society for Actimicrobial Chemotherapy (1991) reported that the only 
clear property of breakpoint antibiotic concentrations ('breakpoinf: A discriminating 
concentration which may be used in the interpretation of the results of many types of 
sensitivity testing method) was that they are largely arbitrary, based as they are on 
consensus decisions related to pragmatic considerations. They seek to achieve two 
objectives, which may be irreconcilable: therapeutic relevance and laboratory 
reproducibility. They are nonetheless perceived as necessary by most clinical 
microbiologists, regulatory authorities, and manufacturers of media and discs and 
antibiotic producers. In almost all contexts, the clinician expects and the laboratory 
provides information that designates organisms as sensitive, intermediate 
(moderately sensitive) or resistant. Sensitive implies that the infection is likely to 
respond and resistant that it is unlikely to respond, while intermediate implies that an 
intermediate or indeterminate response is likely, except perhaps in special, defined 
circumstances, such as when high doses can be used, or the antibiotic is 
concentrated at the site of infection. 
The Working Group on Antimicrobial Chemotherapy (BSAC, 1991) suggested a 
certain formula for the calculation of MIC breakpoint values. This formula and the 
associated assumptions are presented in Figure 124. 
P. Christofilogiannis 265 
Use of Antibiotics in Greek Mariculture, University of Stiding 
BSAC Working Party 1991: MIC Breakpoint = (C,,,. f* S) /t*e 
C.,, = "PeaV blood concentration of microbiologically active drug 
f= Protein Binding factor 
Protein Binding level f value 
< 70% binding 1 
70-90% binding 0.5 
>90% binding 0.2 
t= Half Life Factor 
Half - Ufe Mt value 
< 111 2 
1-3h 1 
>3h 0.5 
e= Times that Serum concentration 
should be higher than MIC in Vitro 
s= Shift factor for reproducibility 
s=1 No shift 
s<I Downward shift 
s>1 Upward shift 
The results are rounded to the nearest MIC value in the doubling dilution series 
Figure 124: BSAC MIC breakpoint calculation 
A practical example of an application of the above formula in this study is attempted 
taking a worst-case scenario. The achieved OTC in serum of sea bass at low 
temperature (far lower than the achieved serum OTC at high temperature), protein 
binding of 70-90% due to the OTC chelating nature, half life of more than 3h taking 
into account several single injection studies and the assumption that serum 
concentration should be 4 times higher than MIC values (Martinsen et al., 1992). 
The rounded value of MIC breakpoint for Oxytetracycline was 1 pg/ml (Figure 125). 
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MIC OTC Breakpoint - Example of BSAC formula application 
Mean OTC serum concentration in sea bass (max) - 7nth Day - 2,78 Pg/ml 
BSAC MIC OTC Breakpoint (sea bass) = (2,28 - 0,5 * 1) / 0,5 *4=0,695 
that rounds up to Ipg/ml 
Assumptions 
f=0,5 (protein binding =70-90%) 
t=0.5 (Half life >3h) 
e=4 ((Martinsen, et al. 1992) 
s=1 (No shift) 
Figure 125: MIC OTC Breakpoint - BSAC formula application 
Similar studies with references to MIC breakpoints; for OTC and OA include the 
study by Tzoumas et al 1989 for Aeromonas salmonicida (Table 64). 
Tzoumas et al 1989 
MIC Brea kpoints Aeromonas salmonicida 
Antibiotic Susceptible Intermediate Resistant 
Oxolinic acid / Flumequine 0.0625 0.125-0.5 >1 
JOxytetracycline <1 2 to 4 >4 
jPotentiated Sulfonamides <2 2 to 16 >16 
d 
Table 54: Aeromonas salmonicicia MIG breaKpoints 
A similar analysis was performed in this study for Vibrio anguillarum that was proven 
as the most important bacterial isolate due to the high isolation frequency as well as 
due to the high clinical and economic importance. This approach had two steps. 
Initally the MIC values of 32 Vibrio anguillarum strains were plotted for OA and 
OTC (Table 64) and then an analysis of those MIC values was made with reference 
to their zones of inhibition in the quantitative antibiogram (Table 65). 
P. Chfistofilogiannis 267 
Use of Antibiotics in Greek Mariculture University of Stirlinq 
Table 65: V. anguillarum MIC values for Oxytetracycline and Oxolinic acid 
OXYTETRACYCLINE MIC - Vibrio anguillarum (32 s trains) 
' 
MIC VALUE FREQUENCY PERCENT 
CUMMULATIVE 
PERCENT 
0.075 4 12,50/o 12,50/o 
0.15 3 9,40/o 21,90/o 
0.3 11 34,40/o 56,30/o 
0.6 9 28,10/o 84,40/o 
1.25 4 12,50/o 96,90/o 
160 1 3,10/o 100,00/01 
1 321 100,0%1 
OXOLINIC ACID MIC - Vibrio anc uillarurn (32 str ins) 
MIC VAWE FREQUENCY PERCENT 
CUMULATIVE 
PERCENT 
0.075 18 56,3% 56,3% 
0.15 6 18,8% 75,0% 
0.3 3 9,4% 84,4% 
0.6 1 3,1% 87,5% 
1.25 3 9,4% 96,9% 
80 1 11 3,1% 100,0%1 
1 321 100,0%1 
Table 65: V. anguillarum MIC values versus zones of inhibition in 
Quantitative antibiogram studies 
MIC record Vibrio anguillaru (32 strains) 
Classification 
Antibiogram 
zones of inhibition (mm) MIC OA MIC OTC 
RESISTANT 6 to 15 160 80 
JINTERMEDIATE I IS to 25 0,625-1,25 0,625-1,25 
ISUSCEPTIRE 1>25 0,075 - 1125 
LO 
075 -1 25 
The oucome of the above analysis is that an MIC concentration of more than 1,25 
pg/ml for both OA and OTC seems to inhibit growth of all but the resistant strains of 
Vibrio anguillarum while it is effective for more than 95% of the 32 bacterial strains 
(Table 66). 
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Table 66: Vibrio anguillarum MIC breakpoints for OA and OTC 
MIC BRJEAKPOINT OTC OA 
Vibrio anguillarum >1,25 > 1,25 
Effective for mre than 95% of Vibrio anguillarum strains 
This is in accordance vVith the BSAC formula calculations for OTC mentioned above 
and regarding Oxolinic acid it compares to MIC breakpoint for Aeromonas 
salmonicida (Tzoumas et al., 1989). The difference is that in the above study the 
MIC OTC breakpoint for OTC for Aeromonas salmonicida (> 4pg/ml) was far higher 
than the MIC breakpoint calculated in this study for Vibrio anguillarum. The above 
data suggest a moderate level of antibiotic resistance to OA and OTC especially for 
the most important bacterial pathogen, Vibdo anguillarum for sea bass. This type of 
analysis partly explains why despite problems in tissue distribution, large fish 
variation and although low levels of OA and OTC are achieved in sea bass and sea 
brearn culture, treatments with the above antimicrobial agents are clinically relevant 
and succesfull. As it is suggested in the conclusions achieved antibiotic levels mean 
nothing without the clinical interpretation. It is common however in the literature for 
scientists to draw conclusions of clinical relevance only from bibliographic data. 
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4.6 Consumer Safety 
4.6.1 Antibiotic Residues 
Since it is a well-established principle that residues of medicines given to livestock 
animals should not be found in food for human consumption, considerable efforts 
are made to prevent drug transfer in this way. In the case of OA, the drug is also 
rather thermostable and no reduction in antibacterial activity could be observed 
when an aqueous solution of the drug was boiled for 15 min to simulate conditions 
resembling normal treatment of fish (Samuelsen et al., 1992b). 
This study was designed not to give ideal kinetics records of sea bream and sea 
bass that will probably never be realized under commercial conditions. The aim was 
to treat fish in as natural as possible enclosures (experiments in lab and in the fish 
farm) with antibiotic incorporated in the feed rather that oil top coated. The feeding 
was performed early in the morning and was topped up if needed with regular feed 
in the afternoon. The idea was to see the "real" effect in the treated population rather 
than the "ideal" effect in a single fish. Several studies include stomach catheters or 
even anal tube for enteric accumulation studies while other studies focused on iv, 
interartial application include branchial or dorsal aorta canullation for the 
applications of antibiotics. Usually from these studies ideal graphs arise with minimal 
standard deviation and clear mathematical description. The limitation of these 
studies is that they rarely end up presenting the same type of "compartment" model 
between them for the elimination and tissue distribution of each drug. Usually, each 
study suggests a different compartment model that statistically better describes 
their results. Although these studies carry a lot of information on metabolism of 
different drugs, methods of analysis and interpretation should ideally be harmonized 
and critical review should be made in order to understand the "real" effect of these 
studies. 
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The aim of this study was different. It was the first time in both sea bass and sea 
bream for Oxolinic acid and first time in sea bass and for the second time in sea 
bream for Oxytetracycline that the kinetics of these two antibiotics were studied in 
these species after oral 10 day treatment under "commercial" conditions. Three 
other studies exist in the literature for the above species. The first (Malvisi et al., 
1996) referred to study of OTC oral treatment of sea bream (sea bass in this study 
gave no results due to sudden mortality) while the other two (Poher et al., 1997 and 
Rigos et al., 2002) refer to iv single application of OTC and OA respectively in sea 
bass. Only in the latest study Bioassay assessment was employed for OA residue 
analysis. No study had employed OTC Bioassay for residue studies in the two 
mentioned species. Another limitation was that both Malvisi et al., 1996 and Poher 
et al., 1997 referred to experiments at one prevailing temperature and only Rigos et 
al., 2002 employed two temperatures for experimentation. 
The structure of this study included eight experiments for Oxolinic acid and 
Oxytetracycline kinetics in two species sea bass and sea bream at two water 
temperatures. It was performed in a period of almost three years between the 
NCIVIR aquarium and Kalloni fish farm. The tissues usually employed for analysis 
were muscle and liver for Oxolinic acid (initial experiments) and serum (bioassay) 
and skin were added in OTC experiments. Although according to the legislation skin 
should be in natural proportions with muscle for residue analysis, at the time of the 
experiments this was not very clear in the legislation and on the other hand separate 
analysis aimed to describe tissue reservoirs for OTC (another not tested tissue 
candidate: the vertebrae). Skin was also analysed (along with vertebrae) in the 
study by Malvisi et al., 1996. High standard deviation in the OTC concentration 
achieved under "commercial" conditions was confirmed in the study by Malvisi et al., 
1996. This was a prevailing characteristic in all experiments in the present study for 
both OA and OTC. This deviation could be explained due to low palatability for OTC 
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but for OA protocol application inefficiencies or hierarchy formation within these 
populations could only explain this phenomenon. The confirmation however by 
another study and the repetition in all the current eight experiments (at higher or 
lower degree) probably indicates a phenomenon that exists in the farm environment 
with domination of a fraction of the population that develops high residue levels and 
other fish in the cage which concentrate minimal or very low antibiotic tissue levels. 
One has to consider that this phenomenon should be worst in the case of an 
outbreak where sick fish are usually inappetant. Treating a cage of fish has to be 
considered as a population treatment and sometimes from the environmentalist 
point of view is a water, sediment and wild fauna treatment. Most likely healthy or 
healthier fish are treated in a "pro-phylactic or meta-phylactic mode" rather than 
treating the sick fish that are expected to die during the outbreak. The dynamics of 
this analysis should be elaborated more in future studies so the vet who prescribes 
will understand better the implications of any antibiotic application. 
Detection Methods and Limitations 
The methods used for the determination of antibiotics and their metabolites in 
farmed fish are reviewed and the data presented in tabular form. They can be 
divided into two general types namely those that use microbiological assessment 
and those that use physiochemical techniques (McGill and Hardy, 1992). 
Microbiological methods have certain advantages in that they are relatively 
inexpensive, simple and can provide an assessment of total antimicrobial activity. 
Conversely, they lark specificity, are relatively insensitive, do not differentiate 
between natural antimicrobial substances and synthetic antibiotics that are present, 
are time consuming using present methods, often lack reproducibility and are only 
semi-quantitative. Physiochernical methods using chromatographic techniques 
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coupled with various detectors do not suffer from these disadvantages but 
unfortunately the equipment is complex and expensive, requires skilled operators 
and, except where it is known that only a limited range of antibiotics have been 
used, do not provide an assessment of total antimicrobial activity. Currently, HPLC 
is the most established technique for testing 4-quinolone and tetracycline residues in 
fish tissues and is capable of considerable sensitivity. A comprehensive review of 
HPLC methods and Limits of Detection (LDs) is given by McGill and Hardy (1992) 
where reported LDs range from 300ppb to as low as 0.5ppb. In contrast LDs using 
bioassays are generally far higher. Recommended withdrawal times have been 
based on the detection limit of the assay used, ie zero residues. Obviously this 
depends upon the sensitivity of the assay (Ellis 1991). In the beginning of the 90s 
the detection limit of the microbiological test in use in Norway is 0.10 pg/g the 
detection limits of the different HPLC methods available are 0.005 to 0.10 pg/g 
(Rogstad et al., 1989; Andresen and Rasmussen, 1990; Steffenak et al.,. 1991). A 
wide array of methods is used in the analysis of antibiotic residues in fish. Most of 
the techniques are, or in the case of the microbiological ones could be made, 
sufficiently sensitive and accurate for safety and legislative purposes. There is need 
to define standard methods and for this purpose more inter-laboratory calibration 
exercises are required to compare methods and select the best. A number of 
analytical problems remain. Perhaps the most important is the assessment of total 
residues and metabolites. This can only be done in an experimental situation be 
feeding radioactive drugs to the fish (McGill and Hardy, 1992). 
McGill and Hardy, 1992 presented a summary of papers in which reports on the use 
of microbiological assays have been described. The assays rely to a large extent on 
the use of agar plates containing an appropriate growth medium and 
microoorganism. The most commonly used microorganism is B. cereus although not 
surprisingly some microorganisms are more sensitive to specific antibiotics, eg B. 
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sublifis appeared to be most suitable for the determination of sulphonamide drugs 
(Salte and Liestok 1983; Kanzaki et al., 1984). The tissue sample or extract is 
applied to wells cut or formed in the agar and is used to impregnate a small disk of 
filter paper which is then placed on the agar surface. After incubation of the agar 
plated for the appropriate time and temperature, usually 24h at 300C, the diameter 
of the zone in which no growth occurs is measured. The amount of antibiotic present 
is then estimated from appropriate calibration curves (McGill and Hardy, 1992). The 
technique is relatively simple, it can integrate total antimicrobial activity, use the 
whole tissue sample and thus overcome problems associated with sample 
extraction and is inexpensive to perform, but it does suffer from a number of 
disadvantages. First of all, many of the methods used lack sensitivity. The detection 
limits quoted are >0.1 pg/g which may be greater than the maximum residue limit 
(MLR). Related problems are, the poor differentiation between these and naturally 
occurring inhibitors of microorganisms, such as the lysozymes, and the accuracy 
and precision of the methods (McGill and Hardy, 1992). The method is also time 
consuming in that the total analysis time is in excess of 24h. Many of these 
drawbacks could be overcome by the use of modem rapid methods now developed 
for the estimation of bacterial numbers and growth and indeed have been used to 
demonstrate the presence of bacterial inhibitors in milk (Easter and Gibson, 1989). 
Such methods however do not appear to be used for general assays of antibiotic 
residues (McGill and Hardy, 1992). The rapid and sensitive detection of drug 
residues in farmed fish is essential to meet legislated tolerance levels and to ensure 
consumer confidence. Several antibiotic diffusion tests were made available for 
other food markets. For example, a rapid and sensitive Brilliant Black reduction test 
for the detection of drug residues in farmed animals, flesh and products using 
Bacillus steatotheromophilus as the indicator organism was introduced (Lloyd and 
Van der Merwe, 1987). The test satisfied the need for speed, versatility and simple 
handling. 
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A study using B. cereus as the indicator strain in a conventional bioassay format and 
acid/methanol extraction of tissues (Salte, 1982) suggested a high degree of 
sensitivity to oxytetracycline (OTC). Kusser et al., 1990 described a modified 
bioassay for OTC from fish tissue samples, which combined the speed and 
versatility of the dye reduction assay (Lloyd and Van der Merwe, 1987) with the 
sensitivity of a Bacillus cereus MT 987 strain. To increase the economy and 
sensitivity of the test, a 96-well microtitre format was designed for the assay and 
Brilliant Black BN was used as colour indicator. Using this test, a detection limit of 
0.005 pg OTC determined. Bioassay with brain-heart infusion (BHI) agar plates 
inoculated with the indicator organisms A hydrophila, Bacillus cereus Vibrio 
anguillarum, and Vibrio ordald in another study (Xu and Rogers, 1993). There are 
few references in the scientific literature to bioassays developed for the detection of 
4-quinolone residues in fish tissues. Endo et al., (1973b) described a thin layer cup 
assay for OA residue detection in carp tissues using E. coli, Vibrio anguillarum was 
used by O'Grady et al., (1986) for OA residues in salmon serum and Bacillus subtilis 
(ATCC 6333) by Stoffregen et al. (1993) for enrofloxacin monitoring in salmon 
tissues. In another bioassay study, when OA was detected in the intestinal contents. 
Fish containing OA in faeces usually had high concentrations of the drug in liver, 
muscle and plasma. Considering the positive correlation with the HPLC method, the 
microbiological assay was considered valuable in the investigation of drug residues 
(Samuelsen et al., 1992b). 
The Bioassay methods used in this study derived from MAFF (Barker 1994; Barker 
personal communication). The bioassay for OA detection employed Yersinia ruckerd 
(FDL 39/81) as indicator organism. This method did not employ colour growth 
indicator. The limit of detection was 250 ppb for muscle and 125 ppb for serum 
samples. The method was modified from Barker (1994) for application in sea bass 
and sea bream. On the other hand the bioassay method employed for OTC analysis 
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included Bacilus cereus as indicator organism and had detection limit of 250ppb in 
serum. Other Bacillus strains like B. subfilis and B. stearothermophilus were 
employed in the literature. 
Regarding the High Performance Liquid Chromatography methods, a variety of 
extraction, concentration and analytical conditions have been used even for the 
same antibiotic and consequently the reported recoveries have varied quite 
markedly. Furthermore, in many of the reports recoveries for several species or 
tissue samples have been given. (McGill and Hardy, 1992) In nearly all instances 
the extractions of the residues have been carried out on the homogenised sample 
using polar solvents. In so doing most workers have chosen to ignore the possibility 
of bound residues being present whose extraction can not be mimicked by simply 
extracting added antibiotics to the tissue sample (McGill and Hardy, 1992). After 
extraction the samples were usually passed through a concentration and clean up 
procedure and for this purpose a number of different proprietary solid phase 
cartridges that have markedly different retention characteristics (particularly which 
fish extracts) have been used (McGill and Hardy, 1992). A variety of 
chromatographic methods have been used in final analysis of the extracts most 
commonly in association with UV or fluorescence detectors. Gas chromatographic 
analyses are not common in the determination of fish antibiotics even though 
various forms of this technique have been used in the analysis of sulphonamides 
(Siegret 1985, Simpson et al., 1985; Holtmannpotter and Their, 1982) and 
chloraphenicol (Holtmannspotter et al., 1982; Bodes et al., 1983, Ginkel et al., 1990) 
in meat. There are a number of reports on the use of thin layer chromatography 
(TLC) see Table 60, but notwithstanding the simplicity of the technique it does not 
seem to be a favoured method even though very low detection levels have been 
quoted (McGill and Hardy, 1992). The HPLC conditions vary from one group of 
workers to the next and the quoted accuracy and sensitivities differ accordingly. In 
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contrast to the microbiological methods, the physicochemical methods are relatively 
complex and tend to require several analyses if complex mixtures are suspected as 
being present (McGill and Hardy, 1992). Describing the existing literature in time we 
could see a gradual shift from laborious and less sensitive methods to rapid more 
advanced methods. In this study fluorometric detection and ethyl acetate extraction 
were selected. Oxolinic acid detection method included liquid extraction (Sved et al., 
1991), centrifugation, evaporation to dryness, reconstitution in aqueous phase and 
injection to fluorescent detector. It comprised a simple, robust, fast method of good 
relative sensitivity and OA recovery of 77%. 
Andresen and Rasmussen, (1990) described an automated method by on-line 
dialysis and column switching in an HPLC system for residue analysis of oxolinic 
acid and flumequine in liver of Atlantic salmon Salmo salar The limit of detection 
was 4pg/kg for oxolinic acid and 7pg/kg for flumequine with fluorescence detection. 
Steffenak et aL (1991) described a simple and rapid method for the simultaneous 
extraction and determination of residues of oxolinic acid (OA) and flumequine (FQ) 
in fish tissue, muscle and liver using acetonitrile and ammonia for the extraction. 
Recovery of oxolinic acid was 101-104% while the recovery of flumequine was 88- 
94%. The detection limits were 5 ng/g for oxolinic acid and 10 ng/g for flumequine. 
Degroodt et al., 1994 described another method for residue analysis of oxolinic acid 
and flumequine in fish tissues by HPLC and fluorometric detection and ethyl acetate 
extraction. The quantification limit of the method was 2pg oxolinic acid and 5pg 
flumequine/kg fish tissue. Since 1994 when a research group (Hormazabal et al, 
1994a, 1994b) described a similar HPLC detection method considerable time 
elapsed since the recent presentation of a simple and much more sensitive method 
for the simultaneous determination of flumequine and oxo1inic acid in fish muscle 
with attached skin using NI-13 and acetone extraction., The limit of quantification was 
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30pg/kg for flumequine and 20pg/kg for oxolinic acid. The recoveries were 75-76% 
and 79-82% for flumequine and oxolinic acid, respectively (Hormazabal et al., 2001). 
The Oxytetracycline method (Tyrpenou, 1995) was more complicated than oxolinic 
acid. The difficulty starts from the hydrophilic OTC nature. Following liquid-tissue 
homogenation, liquid extraction with evaporation to dryness is not possible because 
OTC on the contrary of OA is concentrated in the aqueous phase. This makes the 
solid phase extraction also described in the literature (Malvisi et al., 1996; ) time 
consuming, delicate and a necessary expensive step. OTC was eluted by methanol 
and after evaporation to dryness was re-constituted and injected in the UV detector. 
Rigos et al., 2002 at a more recent study employed the same method. In general 
serum residue analysis is far easier than tissue analysis due to the lack of a series 
of steps for the extraction procedure. The use of ethylenediaminetetraacetic acid 
(EDTA) as chelating agent was proven critical for the extraction of OTC in several 
studies. 
HPLC method and modified extraction procedure was used to analyze residues of 
oxytetracycline in channel catfish (Ictalunis punctatus). Mean recovery rates in fish 
muscle were 92.5% for OTC over concentrations of 0.05-1.0 pprn (Du and Marshall 
et al., 1995). Bums et al., (1996) described a Liquid chromatography (LC) method 
for the detection of OTC residues in fish and crustacean tissues and fishery 
products using a reversed phase c-18 column with diode array detection and UV 
spectral confirmation. At the same time the Central Laboratory of the Directorate of 
Fisheries in Bergen Norway announced a method to detect the following 
antibacterial agents in samples of farmed fish: oxytetracycline, nitrofurazolidone, 
florfenicol, oxolinic acid, flumequine and sulfadiazine/trimethoprim. Segawa, 1995 
developed a simple, rapid and sensitive method for determination of oxytetracycline 
(OTC) in the serum of three cultured marine fishes by use of HPLC. OTC was 
extracted with sodium oxalate-acetonitrile (4: 1, v/v) and disodium 
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ethylenediaminetetraacetate. After precipitated serum protein, the supernatant was 
injected into ODS column. OTC and TC were separated with 10mM oxalic acid - 
acetonitrile (72: 18). The average recoveries of OTC were more than 92%. Ueno and 
Aoki, 1995 described the development of a rapid HPLC assay for oxytetracycline in 
the serum and muscle of cultured eel with simple pre-treatment. The extraction of 
oxytetracycline with several solvents from fish muscle was examined. It is known 
that it is hard to extract antibiotics from animal tissues, and so the authors also 
examined the effect of ethylenediaminetetraacetic acid (EDTA) on recovery of the 
drug from tissue. As a result, 90% methanol containing 0.5% EDTA was used as an 
extracting solution in these experiments. The detection limit of the method was 0.05 
pg/ml for serum and 0.1 pg /ml for the muscle sample. This HPLC method did not 
require time consuming and complex extraction and moreover, did not cause 
column clogging, peak broadening or variation of retention times throughout the 
analysis. 
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4.6.1.2 Oxolinic acid kinetics 
In order to draw the necessary conclusions for oxolinic acid metabolism and kinetics in 
sea bream, mean concentration achieved in the muscle and liver was compared in the 
two prevailing water temperatures. During the treatment period liver OA concentration 
at both temperatures was 4 to 5 times the concentration achieved in the muscle. 
Liver concentration exhibited Oodd" peaks at both temperatures after the treatment 
period. Almost the same levels (slightly higher at low temperature) of OA 
concentration were achieved in the muscle at both temperatures. An earlier peak (on 
the 3rd day) was achieved as expected at high temperature, while it was delayed at 
low temperature (11th day). Consumer safe levels were achieved two days earlier at 
low temperature. Earlier but lower OA concentration was achieved in the liver on the 
Tdday at high temperature, while higher concentration was achieved at the 1 Oth day at 
low temperature. It is characteristic that at both temperatures liver concentration was 
reduced to consumer safe levels at the same time. 
In sea bass, tissue comparisons of the OA achieved concentration at high (260C) and 
low (1 8"C) temperature indicated that muscle concentration at high temperature was 2 
to 4 times the concentration on the liver during the treatment period. Muscle OA 
concentration was increased gradually while liver concentration was rapid and 
decreased sharply after the cessation of the treatment. OA concentration in both 
tissues fell to consumer safe levels on the 13 th day. OA concentration in sea bass at 
low temperature followed the same pattern for both tissues. Liver concentration was 2- 
3 times the muscle OA concentration until the 20th day of the experiment except on 
the 10th day when muscle and liver concentration were at the same level. Consumer 
safe levels were reached much earlier in muscle (afternoon of the 1 1th day) than in the 
liver (20th day). 
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Comparison of muscle OA concentration at both temperatures (26T and 18T) 
indicated that OA concentration was increased rapidly at low temperature and kept 2 
to 3 times higher than the concentration achieved at high temperature. In the 
afternoon of the 1 Vh day of the experiment muscle concentration was the same at 
both temperatures indicating that OA excretion rate was not related to water 
temperature. Liver concentration seemed to follow different patterns at high and low 
temperature. At high temperature slow to moderate increase lead to late peak of 700 
ppb on the 1 Oth day, while rapid increase lead to early peaks on the 1st and 7 th day. In 
the afternoon of the 1 Ith day liver concentration was at the same level for both 
temperatures but for the following days OA concentration at low temperature was kept 
much higher than at high water temperature. 
Comparisons of OA kinetics in sea bass and sea bream muscle at high temperature 
indicated an earlier and higher peak for sea bream (3d vs. 1 Ith day) almost 3 times the 
concentration achieved in the sea bass. It is important however to note that in both 
species, despite water temperature differences, OA concentration in the muscle 
achieved fell simultaneously below consumer safe levels (on the 10 day). 
Comparison of the OA liver concentration achieved in both species at high 
temperatures indicated similar pattern of OA kinetics in the muscle with OA depletion, 
in both species, below consumer safe levels on the 12 th day, earlier than in the 
muscle. Comparative study of OA kinetics at low temperature indicated an earlier (7 th 
day VS10th day) but lower peak (450ppb vs. 750ppb) in the muscle of sea bass, but 
concentration followed almost the same dynamics after the 12 th day. The study of OA 
liver concentration indicated the same picture with the muscle with earlier (7 th VS. 1 oth 
day) and lower peak (1 100ppb vs. 3000ppb) in sea bream and except for the reversal 
in OA concentration between 12th and 25th day (where sea bream OA concentration 
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was higher than sea bass liver concentration) OA depletion followed the same pattern 
after the 251h day. 
Three points were clear after this type of analysis: a) the similarity of OA depletion 
dynamics in both species. b) The apparent inability to predict depletion dynamics 
using the degree-day concept. c) The ability of sea bream to assimilate and 
metabolise Oxolinic acid more efficiently than sea bass, obtaining much higher 
concentration in both tissues and at any water temperature. Higher concentration in 
the liver compared to muscle was confirmed in a study of Intorre et al (2000). The 
MIC value of 0,15pg/ml (Table 29a, b, c) was described for the susceptible strains 
Vanguillarum (80% of susceptible strains) in this study. The levels of OA in the liver 
and muscle of both species and at both temperatures from the Td day of the treatment 
up until the I st day post treatment (Day 11) were above this level. The only difference 
was in the liver of sea bass at low temperature where OA concentration remained high 
up until the Day 20 (1 oth day post treatment). A limited number of studies have been 
performed on the kinetics of antibiotics in sea brearn and in fact there is no literature 
on Oxolinic acid kinetics in bream. One study described the pharmacokinetics of 
amoxicillin (AMX) in sea brearn of 90-160 g kept in tanks at 220C, after in-feed (80 
mg/kg b. w. ) or intravenous (i. v. ) (40mg/kg b. w. ) administration. Serum levels were 
collected at cAose intervals and AMX detection was carried out using both a 
microbiological (Bacillus stearothennophilus) and radioisotopic (Charm 11 test for 
beta-lactams) method. AMX serum concentration following Lv. administration 
decreased slowly between the first 8-10 h, and the antibiotic was still detectable at 72 
h. After in-feed medication very low concentrations of AMX were found in serum falling 
below detection limit 25 h after treatment (Della Rocca et al., 1998). The kinetics of 
oxolinic acid in sea bass (Dicentrarchus labrax) and gilthead sea bream (Spafus 
aurata) were presented in three previous reports (Christofilogiannis, et al., 
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1995; 1997b; 1997c). At the same time Poher et al., 1997 published the only other 
available OA kinetics study in sea bass. The fish in that study were kept in seawater at 
15.2"C with a 12h / 12 h photoperiod. Oxolinic acid was injected once in the caudal 
vein of anaesthetized sea bass. Plasma concentrations of oxolinic acid were 
determined using two analytical methods, a plate diffusion bioassay using Escherichia 
coli and a high performance liquid chromatography (HPLC) using solid phase 
extraction and U. V. detection. This report emphasized that the distribution process of 
oxolinic acid is faster in trout and that the elimination phase is shorter in seawater than 
in freshwater fish (Poher et al., 1997). Taking into account data previously published 
(Tsoumas et al., 1989; Lewin & Hastings, 1990; Martinsen et al., 1992), concerning 
the minimum inhibitory concentration (MIC) of oxolinic acid in vitro for many 
susceptible strains (Aeromonas salmonicida, Vibrio anguilarurn., Vibrid salmonicida 
and Yersinia rucken), ranged from 0.005-0.5 pg/mL (for most strains, < 0.1 pg/mL) 
Poher et al., 1997 indicated that OA bolus injection of 10 mg/kg in sea-bass kept in 
seawater at 150C should maintain the concentration above this MIC value for 2 days 
or more than 4 days. Moreover, the high partition of oxolinic acid in the octanol phase 
(13jorklund and Bylund, 1991) explains the large distribution in skin and muscle, which 
are only slightly vascularised in fish (Ellis et al., 1989), and where abscesses caused 
by bacteria may occur. Nevertheless, oxolinic acid is usually administered orally. 
Therefore it was indicated that for OA large-scale therapeutic application, further 
studies with oral application were needed in order to determine the species-dependent 
bioavailability of this drug (Poher et al., 1997). This study attempted to elaborate on 
these issues. Oral medication of sea bass larvae through the use of Arternia nauplii 
as a carrier vehicle appeared to be a promising approach to be used as an alternative 
method of treatment (Touraki et al., 1999). 
Oxytetracycline Kinetics 
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The OTC residue depletion from fish tissues of OTC following a multi-day oral 
medication have been studied for a number of farmed species such as in Atlantic 
salmon (Salmo salao (Namdari et al., 1998; Pye-MacSwain, et al., 1994), in chinook 
salmon (Oncorhynchus tshawytscha) (Namdari et al., 1996; 1998), in coho salmon (0. 
kisutch) (Namdah et al., 1996; Meinertz et al., 2001), in rainbow trout (0. mykiss) 
(Herman et al., 1969; Jacobsen, 1989; Mirzargar et al, 2000), in striped bass (Xu and 
Rogers, 1994), and in channel catfish (Ictalurus punctatus) in Arctic charr (Salvelinus 
alpinus L. ) (Haug and Hals, 2000), Hybrid striped bass (Xu and Rodgers, 1993), 
Tench (Unca tinca Q (Reja et al., 1996), eel (Meitong et al., 1997) and in red tilapia 
(Choo, 1997). For Mediterranean mariculture, only a single study exists on the 
depletion of OTC in sea brearn (Sparus aurata) and sea bass (Dicentrarchus labrax) 
following oral administration (Malvisi et al., 1996). However that study managed to 
produce data only for sea bream due to sudden mortality of sea bass. In the study by 
Malvisi et al, 1996 sea bream in cages were fed a commercial medicated diet at a rate 
of 75 mg. /kg b. w/day for 14 days. Muscle, liver, vertebrae, and skin with scales were 
sampled at different intervals during (2 nd, 4ýh, Uh, 1 oth, and 14 th day) and after 
treatment (1 oth 20th, 30th 4Uh 50th and 601h day). OTC analyses were carried out by 
HPLC, after SIDE extraction. As in this study and most of the oral treatment studies 
great variation in drug intake was evident from the inter-subject differences in OTC 
tissue considerations. Individual differences in feed uptake and metabolism of OTC 
among catfish were considered to contribute to variability in residue (Rawles et al, 
1997). The highest recorded considerations were in skin and pooled liver (7.70±6.71 
pg/g and 14.65 pgfg at the 6 th day, respectively). Vertebrae showed concentrations 
even six fold higher than those in muscle, and reached steady state concentrations at 
the 40th day after the end of treatment (1.73±0.92pg/g), lasting until the end of the 
study. OTC concentrations in muscle were lower than in all the other tissues 
throughout the entire experiment and declined under 0.1 pg/g 20 days after treatment 
P Christofi'logiannis 285 
Use of Antibiotics in Greek Mariculture University of StMing 
ceased (Malvisi et al., 1996). Therefore, the aim of the present work was to provide 
additional data in order to optimise future therapies as well as to investigate the effect 
of water temperature on the kinetics of the drug. 
In order to draw the necessary conclusions for oxytetracycline metabolism and 
kinetics in sea bream, mean concentration achieved in the muscle and liver was 
compared in this study at two prevailing water temperatures. The tissue distribution 
and residue depletion of OTC in sea brearn (Sparus aurata) following a 10 day oral 
medication (75 mg / kg fish / day) at 24 and 180C water temperature was investigated. 
Liver and muscle samples were taken at different time points and analysed for OTC 
levels under HPLC while serum OTC levels were determined with a bioassay. Skin 
OTC concentrations were measured only at the low temperature. The depletion of 
OTC was found to be temperature-dependent. Liver, skin and muscle OTC levels 
displayed biphasic elimination while serum OTC levels revealed a single peak. The 
OTC concentration in skin at 180C was calculated to be higher than the other tissues 
while liver OTC levels were higher than corresponding muscle levels at all time points. 
At the end of the treatment period tissue OTC concentration decreased in the order of 
skin > liver > serum > muscle. At 240C, the highest OTC levels were measured at day 
5 for liver (3.089 pprn) and serum (0.98 ppm) and at day 11 for muscle (0.121 ppm), 
while at 180C, maximum OTC levels in liver, skin, muscle and serum were found at 
days 5 (1.849 ppm), 11 (2 ppm), 3 (0-439 ppm) and 18 (1.438 ppm) respectively. 
The results of the present work show that the extraction method detecting OTC levels 
reached 70%, which is within the range reported in previous studies (60-91%) 
(Bjorkund, 1988; Jacobsen, 1989; Luzzana et al., 1994; Malvisi et al., 1996; Namdad 
et al., 1996; 1998). The present study also demonstrates that the depletion of orally 
incorporated OTC from tissues of sea bream is temperature dependent. Several 
factors that the kinetics of a drug depends upon such as gastric emptying time, 
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absorption, biotransformation and excretion are temperature-dependent in ectotherm 
animals (Bjorkund and Bylund, 1990). 
The elimination of the drug in sea bream appeared to be faster in muscle where OTC 
levels reached consumer safe levels on the 12 th day (below 100 ppb). Although the 
drug concentration in muscle at the corresponding time point was also below MRL at 
the low temperature, detectable OTC levels were evident even at day 40. A markedly 
temperature-dependent elimination of OTC was reported by Bjorklund and Bylund 
(1990) in rainbow trout following a single oral dose. This finding is also in accordance 
with the studies of Namdari et al. 1996,1998 and Jacobsen 1989 where multiple day 
treatments were carried out in chinook salmon and rainbow trout respectively. 
The effect of increased water temperature on the drug depletion was not apparent in 
liver tissues where OTC levels remained above IVIRL (300 ppm) until day 14 at the 
high temperature, depleting to consumer safe levels on the 17'h day. On the contrary, 
at the low temperature the liver OTC concentrations reached consumer safe levels 
following the first depletion day. It is likely that an increased appetite and thus a more 
efficient feeding along with a better distribution and absorption during higher water 
temperatures may have contributed to this discrepancy. The evaluation of 
measurements during and post-treatments indicate a biphasic elimination of the drug 
in all tested tissues and at both water temperatures, with the exception of serum OTC 
levels. This does not agree with a study where OTC depletion in fish tissues revealed 
a single peak (Namdari et al., 1996; 1998; ). However, Malvisi et al. (1996, ) and 
Meinertz et al., (2001) reported a biphasic decrease of OTC in tissues of sea brearn 
when treatment ceased. Although feeding was careful, the creation of hierarchies was 
not possible to be excluded. It is assumed that feeding response in sea bream was 
problematic with a few fish being higher in hierarchy and dominating in each tank 
consuming most of the feed. This was also stressed in previous investigations where 
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variation in drug intake was evident due to the inter-subject differences in drug levels 
(Malvisi et aL, 1996; Meinertz et al., 2001). 
Distribution and absorption of OTC in sea bream serum and liver seemed to be faster 
and higher at the high temperature since OTC concentration was higher than the 
corresponding levels at almost all time points during treatment. In comparison, muscle 
OTC levels at the high temperature show the effect of increased excretory rates since 
the drug concentration at all comparable samplings was higher at the low 
temperature. Skin OTC concentration was measured only at 180C revealing the 
highest concentration among all tissues and its depletion profile showed biphasic 
elimination. At this temperature, at the end of the treatment period tissue OTC 
concentration decreased in the order of skin > liver > serum > muscle. The same 
profile was evident at 240C, where no skin samples were measured. Previously in the 
same species, after completion of treatment, OTC levels followed the order of 
vertebrae > skin > muscle (Malvisi et al., 1996). In salmonids, OTC concentrations 
decreased in the order of liver > bone > kidney = skin > muscle (Namdari et al., 1996) 
or liver > kidney > skin > muscle (Namdari et al., 1998) at the end of the treatment. 
The lowest drug levels were measured in the muscle of sea bream. Previous studies 
have also demonstrate that muscle retain the lowest OTC residues among other fish 
tissues (Jacobsen, 1989; Malvisi et al., 1996; Namdari et al., 1996; 1998). Liver levels 
were measured to be many folds higher than muscle, which is in agreement with the 
aforementioned studies. However when skin samples were included in the analysis, 
measurements revealed even higher concentration than liver, which is not in 
accordance with published literature. Due to the fact that a low number of skin 
samples were analysed, results could be considered provisional. No comparable 
studies exist for OTC serum levels. In conclusion, the residue depletion of OTC from 
tissues of sea brearn showed a different profile than other farmed fish. A biphasic 
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elimination dominated the depletion of the drug that in some instances was 
temperature-dependent. At both water temperatures, the OTC concentration in 
important tissues fell quickly to consumer safe levels almost when medication ceased. 
This indicates that common treatments under recommended OTC levels require short 
withdraw times in sea bream and the market product become safe very fast. 
In sea bass OTC experiments were performed at (26"C) and low (180C) temperature. 
Muscle concentration at high temperature was 2 to 4 times the concentration on the 
liver during the treatment period. Muscle OTC concentration was increased gradually 
while liver concentration was rapid and decreased sharply after the cessation of the 
treatment. OTC concentration in both tissues fell to consumer safe levels on the 13, h 
day. OTC concentration in sea bass at low temperature followed the same pattern for 
both tissues. Except the 1 oth day where muscle and liver concentration were at the 
same levels up until the 201h day of the experiment liver concentration was 2-3 times 
the muscle OTC concentration. Consumer safe levels were reached much earlier in 
muscle (afternoon of the 1 1th day) than in the liver (20th day). Comparison of muscle 
OTC concentration at both temperatures (26"C and 180C) indicated the following: 
OTC concentration was increased rapidly at low temperature and kept 2 to 3 times 
higher than the concentration achieved at high temperature. In the afternoon of the 
1 1th day of the experiment muscle concentration was the same at both temperatures 
indicating that OTC excretion rate was not related to water temperature. Liver 
concentration seemed to follow different patterns at high and low temperature. At high 
temperature slow to moderate increase lead to late peak of 700 ppb on the 10'h day, 
while rapid increase lead to early peaks on the 15t and 7 th day. In the afternoon of the 
1 1th day liver concentration was at the same level for both temperatures but for the 
following days OTC concentration at low temperature was kept much higher than at 
high water temperature. The only other study of OTC kinetics in sea bass following an 
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intravascular administration (40 mg/kg) at 13.5 and 22 OC water temperature was 
carried by Rigos et al., 2002. Serum, muscle and liver samples were taken at 1.2.4. 
B. 16.32.64 and 128 h post-injection. Liver levels indicated higher OTC values than 
respective muscle levels at all time points and for both temperatures. The elimination 
of OTC from tissues tested was faster at the high temperature. Whereas the drug was 
eliminated faster from liver compared to muscle when comparisons are made at the 
same temperature (Rigos et al., 2002). Comparisons of OTC kinetics in sea bass and 
sea brearn muscle at high temperature indicated an earlier and higher peak for sea 
brearn (3d vs. 1 1th day) almost 3 times the concentration achieved in the sea bass. It 
is important however to note that in both species, despite water temperature 
differences, OTC concentration in the muscle achieved fell simultaneously below 
consumer safe levels (on the 14 th day). Comparison of the OTC liver concentration 
achieved in both species at high temperatures indicated similar pattern of OTC 
kinetics in the muscle with OTC depletion, in both species, below consumer safe 
levels on the 12 th day, earlier than in the muscle. Comparative study of OTC kinetics 
at low temperature indicated an earlier (7 th day vs. 1 01h day) but lower peak (450 ppb 
vs 750 ppb) in the muscle of sea bass, but concentration followed almost the same 
dynamics after the 12 th day. The study of OTC liver concentration indicated the same 
picture with the muscle with earlier (7 th VS. 1 oth day) and lower peak (11 00ppb vs. 
3000ppb) in sea brearn and except the reversal in OTC concentration between 12 th 
and 25 1h day (where sea brearn OA concentration was higher than sea bass liver 
concentration) OTC depletion followed the same pattern after the 25 th day. 
Two points were clear after this type of analysis: the similarity of OTC depletion 
dynamics in both species and the apparent inability to predict depletion dynamics 
using the degree-day concept (Christofilogiannis, 1999). 
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Considering the OTC MIC breakpoint described in this study for susceptible 
Vangufflarum strains at 0.625 pg/ml (Table 29a, b, c) then analysis of the OTC levels 
achieved during oral treatment of sea brearn and sea bass at high and low 
temperature reveals that OTC muscle concentration in both species and temperatures 
remained below this MIC value and this was also true of sea bass liver at low 
temperature. In general OTC liver concentration remained above the MIC from the 
first to the 1 oth day of treatment (except day 3) in sea bream at high temperature and 
between 3rd and 7th day of treatment of sea bream at low temperature. In sea bass at 
high temperature OTC liver concentration was higher than MIC between the 3'd and 
14nth day of the experiment. An important element is that serum OTC level remained 
higher than MIC in all species and temperatures between the 3 rd and 20th day of the 
experiment (exception sea bream at low temperature: 3rd -1 Oth). Skin OTC level was 
analysed only in sea brearn at low temperature indicating two distinct peaks at the 3rd 
and 11 th day. A hypothesis can be drawn from these data about the OTC pool in skin 
and vertebrae that is mobilised post treatment keeping OTC levels in serum at levels 
above MIC levels of certain pathogens. This is contrary to what is happening in OA 
kinetics where due to lack of such a pool OA levels decline swiftly after cessation of 
the treatment. 
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4.6.2 Kinetics Conclusions 
There are considerable differences in the anatomy and physiology between fish 
species that indicate that the processing of xenobiotics including drugs is not similar in 
these animals. Previous studies have provided evidence for species-dependent 
differences in drug kinetics or concentration (Grondel et al., 1989; Kleinow et al., 
1994; Namdari et al, 1996) Therefore, it is of vital importance to investigate the 
depletion of the drug residues from edible tissues of the species of interest in order to 
re-establish withdrawal times and secure consumer health. Antibiotics are routinely 
used in aquaculture husbandry practices to control disease. In order to assure the 
consumer that farmed fish contain only reasonable quantities of residual antibiotics, 
regulatory agencies, producers and food associations specify or adopt limits for such 
xenobiotics. While many methods have been reported for the analysis of antibiotic 
residues in fish, most procedures lacked specificity and sensitivity and very few 
protocols have been reported for sea bass and sea bream residue analysis. Despite 
obvious limitations and experimental restrictions involving eight experiments 
performed for the study of the kinetics of two antimicrobial agents supplied at different 
dose rates, in two fish species kept at two areas of prevailing water temperatures, 
some basic comparisons were made in order to give a general idea. 
Comparison and analysis of the kinetics of Oxolinic acid and Oxytetracycline in sea 
bass and sea brearn at low temperature indicated some similarities in both species. In 
both species OTC concentration in the muscle and liver was lower than OA 
concentration and the elimination rate was much faster even at much lower 
temperature (sea bass). Both antimicrobial agents achieved much higher 
concentration in the liver. O. A and OTC demonstrated a two-wave elimination from the 
muscle of sea bass at low temperature. In both sea bass and sea brearn OA 
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elimination rate was the same in muscle and liver. OTC elimination rate on the other 
hand was faster in the muscle than the liver in both fish species. 
In sea bass kept at high water temperature OA achieved lower concentration and 
demonstrated faster elimination rate than OTC, probably due to higher temperature 
(26"C versus 24*C). In all cases liver concentration was higher than muscle 
concentration but for OA liver exhibited faster elimination rate than muscle. In sea 
bream probably due to moderate water temperature during OA kinetics experiment 
(24*C) some controversies were evident. OA muscle concentration was slightly higher 
than OTC concentration but the elimination rates from the muscle were similar. OTC 
elimination rate from the liver was much slower than the rate achieved by OA. Liver 
concentration was always higher than muscle concentration. It is however important to 
underline that the interpretation of any kinetics data achieved should be compared to 
MIC levels applicable to certain fish pathogens in the area where kinetics experiment 
were performed. It is almost irrelevant to compare achieved antibiotic levels in 
different tissues with MIC values from the literature due to differences in the 
characteristics of bacterial strains as well as on the methodology employed by 
different labs. It is important to expand the kinetics studies with modules where clinical 
relevance of these data should be tested. Otherwise data will be constantly generated, 
accepted on the context of statistical analysis or even mathematical modelling but 
they will probably have little population and efficacy relevance. 
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4.6.3 Fish - Human Bacterial Pathogen interactions I resistance 
transfer 
There are 3 possible threats to human health from use of drugs in aquaculture: a) 
residues of drugs in fish destined for human consumption, b) development of drug 
resistance in human pathogenic bacteria and c) direct toxic effects on human from 
handling the drugs (Bernoth, 1991) Four ecological compartments may be considered 
as important for the transfer of resistance to antimicrobials; humans, animals, plants 
and soil-water. The common factors between the four ecological compartments are 
the antimicrobials, the bacteria, and the genes that code for resistance. Some 
resistance genes have been shown to move between bacteria in each compartment 
and it is possible for bacteria to move between the compartments. Bacterial gene 
transfer is now thought to occur not only in the human and animal intestine but 
throughout the biosphere, especially in nutrient-rich sites such as aquatic systems, 
sediments, soils, in the vicinity of plant roots, and in the sludge of the biological 
sewage treatment systems. Antimicrobial resistant bacteria have been isolated from 
all of these sites. Resistance may also be spread from plants and vegetables treated 
with antimicrobials or fertilised with wastes containing animal or human faecal 
residues. Thus resistance should be considered as a phenomenon of global genetic 
ecology. The crucial questions are whether resistance genes are transferable between 
environmental microorganisms and mammalian pathogens, and whether there are 
cascades of exchanges between related species or genera. The chain of resistance 
transfer is probably much more complicated and longer from plant pathogens to 
mammals than from animals to man. At present, no definitive antimicrobial resistance 
rates and predictive models are available. The Advisory Committee on the 
Microbiological Safety of Food in UK (2001) suggested that there are three potential 
routes of spread of antibiotic resistance from fish to human pathogens. The drinking 
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water pathways despite the barrier between temperate environment fish pathogens 
and human pathogens, dilution factors and complex formation / reduced antibiotic 
bioavailability/availability, refers only to antibiotics where transferable resistance 
occurs. In kitchen contamination the route involves all viable bacteria that could 
contaminate uncooked food and wound infection is the last route involving handling 
hazards for fish farm and fish processing unit personnel. There is considerable 
evidence to support the view that antimicrobial use in animals, both in the therapy of 
infections and as feed additives, is associated with an increasing prevalence of 
bacteria exhibiting resistance to the agents used. Many drugs used in animals can 
select for bacteria, which are resistant to antimicrobials used in man. An important 
question is to what extent the increasing prevalence of antimicrobial resistance in 
animals contributes to the increasing prevalence of resistance among human 
pathogens. Transmission to man of zoonotic agents such as Salmonella spp. and 
Campylobacterspp. is of particular importance in assessing this relationship. Humans 
will acquire both pathogenic and non-pathogenic antibiotic resistant organisms from 
animals. This can be partly controlled but not entirely prevented by good food hygiene. 
Zoonotic bacteria like salmonella therefore have to be controlled primarily during food 
production, according to the concept of pre-harvest pathogen control (WHO, 1983). 
Austin (1985b) in experiments with 4 fish farming sites found that during treatment 
with oxolinic acid, oxytetracycline, or a potential sulfonamide, the total count of 
bacteria in the effluent was not markedly altered, but the spectrum slightly sifted to 
Gram-positive species and resistances increased, returning to usual levels with 9 days 
after cessation of treatment (Bemoth, 1991). During a second OTC treatment in a 
microcosm study a significant increase in the number of sediment OTC resistant 
bacteria was observed highlighting the need for prudent use of antibiotics in 
aquaculture (Vaughan et al., 1996). Resistance in microflora has been reported in 
several studies (VanHouweling, 1971; Jacobsen and Berlind, 1988; Bjorklund et al., 
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1990; Samuelsen et al., 1992a; Coyne et al.,., 1994; Kerry et al., 1994; 1995; 1996a; 
1996b; 1997). The quantification of resistance to antimicrobial agents in the fish farm 
environment is based on the study of frequency of resistance in simulated 
environments (McPhearson et al., 1991; Nygaard et al., 1992; Samuelsen et al., 
1992a, b; Hansen et al., 1992a; Spaanggaard et al., 1993; Ervik et al., 1994a; Kerry et 
al., 1994). While some researchers generally suggest that antibiotic use in fish farming 
may add to the environmental resistance pool (Spanggaard et al., 1993) one must 
remember that bacterial isolation using a limited range of culture methods and media, 
gives only a small percentage of the actual flora present and of any changes brought 
about by the antibiotic use or ecological changes induced in the fish farm environment 
(Smith et al., 1994). Problems arise in simulated environments because culture 
methods are fundamentally inefficient (Buck, 1979) supporting growth on any medium, 
in a fraction below 1% of the total viable count (Hoppe, 1976) or for other researchers 
around 0.3% (Buck, 1974). McPhearson et al., (1991) identified aquaculture ponds in 
south eastern US as potential reservoirs of antibiotic resistant bacteria. Regardless of 
whether resistance was mediated by exposure to antibiotics or by other mechanisms 
that pool of antibiotic resistance bacteria may have public health significance. Health 
risks and implications associated with plasmids that were detected in a strain of 
Salmonella, other members of the Enterobactedaceae and several Pseudomonas 
species were discussed after the occurrence of these anti biotic-resistant human 
pathogenic bacteria in integrated fish farms in India (Twiddy and Reilly, 1995). 
During OTC treatment periods, bacterial populations in sediment markedly declined 
but recovered once treatment once treatment had ceased. No increase in resistance 
to antibiotics was recorded among isolates screened during the first treatment period 
with OTC. However, during the second treatment period a significant increase in 
numbers of sediment bacteria resistant to OTC was observed, highlighting the need 
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for prudent use of antibiotics/chemotherapeutants in aquaculture (Barker and Alvarez, 
1993). In a study of horizontal distribution of OTC residues and OTC resistant bacteria 
in the sediments under fish cages resistant bacteria were distributed over a wider area 
than the antibiotic. In addition mussels, microflora growing between the cages and the 
sediments have shown much greater frequencies of resistant bacteria than the 
sediments This implies that they are selected elsewhere and most probably in the fish 
intestine and reach the sediment by a different route than the antibiotic (Kerry et al., 
1993). The study of the intestinal flora of marine fish has been limited (Sera and Isida, 
1972; Silva et al., 1992) but in a very comprehensive research Guichard (2000) 
described the effect of medicated feed in the intestinal flora of turbot (Psetta maxima). 
Kerry et al. (1994) in a study of spatial distribution of elevated frequencies of 
oxytetracycline resistance at a farm noted that their distribution showed an 
independence of the dominant current flow. As argued by Smith et al. (1994) and 
Smith (1995) increases in resistance frequency may arise as a result of the increase 
in the frequency of innately resistant bacteria, bacteria with multiple non-specific 
resistances or bacteria with specific, possible plasmid encoded, resistances. Of these, 
only the latter will have any public health significance or any potential to transfer their 
resistance's to fish pathogens. In a previous study (Christofilogiannis, 1992) was 
possible to transfer R-plasmids in the fish farm environment of a trout farm between a 
multi-resistant environmental isolate to a susceptible isolate of Aeromonas hydrophila 
without the selection pressure of a concurrent antibiotic treatment. Another 
mechanism of resistance besides plasmid mediated and Chromosomally induced 
involves alterations in bacterial outer membrane proteins as an avoidance mechanism 
(Bames et al., 1990b, 1992b). Austin and Austin (1987) proved that the intestine of 
wild fish acts as reservoir of Yersinia ruckeN and Aeromonas salmonicida. 
Simultaneous presence of OA and the fish pathogenic bacterium A. salmonicida in the 
gut of both cultured and wild fish was reported illustrating the potential of development 
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and dispersion of resistance (Samuelsen, 1992a). Although transfer of antibiotic 
resistance from a fish pathogen can take place in the environment of fish intestinal 
content it was not proved in vivo so the likelihood of this being a high-risk route for 
acquisition of resistance by bacteria that can affect humans is low (Del Rio-Rodriguez, 
et al, 1997). While some studies indicated that the gastrointestinal tract of the fish 
serves as a niche for the selection of resistant bacterial strains Spanggaard et al. 
(1993) others suggest that the intestinal microflora of goldfish (Carassius auratus) is 
not affected markedly by the oral administration of OA (Sugita et al., 1989). 
Supporting the findings of the last study Bjorklund et al. (1991) indicated that bacteria 
isolated from the fish farm sediment were OTC resistant while bacteria isolated from 
fish did not show the same degree of resistance. Controversial studies have linked 
human diseases with antibiotic resistant bacteria of animal origin. Potential human 
implication was examined because Aeromonas hydrophila and Plesiomonas 
shigelloides isolated from intestine of catfish as well as water and sediment and 
aquaculture ponds were potential human pathogens. Polyculture of fish with birds 
(ducks) and mammals (pigs) is rather common in Asia. Acquisition of plasmid- 
transferred resistance by bacterial pathogens of homeo therms is then of great 
concern (Michel, 1986), especially when, in these geographical regions, Viblio 
cholerae may be widespread. This organism is a ready recipient of R-plasmids from 
aquatic bacteria (Arai et al., 1980) Levy et al., (1988) described in an extensive study, 
high prevalence of resistant bacteria in the gut flora of ambulatory and hospitalised 
individuals whether or not they were taking antibiotics. Under experimental conditions 
transfer of R-plasmids in the human intestine from animal strains to resident strains 
has been demonstrated (Smith, 1969). Epidemiological evidence of Shoemaker et al. 
(1992) also suggests that R-plasmids originating in animal strains can transfer to 
human strains and that such transfer may have occurred in human intestine. Levy 
(1986) demonstrated the transfer of a plasmid from chickens to two workers in a 
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chicken farm. In each case the plasmid was isolated on only one occasion and did not 
persist in the human host. In a more detailed study O'Brien et al. (1993) examined the 
restriction fragments of plasmids originating from strains causing urinary tract 
infections in women working in a poultry processing plant. These were compared with 
the fragments from plasmids isolated from the poultry microflora. They detected no 
evidence for the transfer of plasmids from the microflora of the chickens to the 
pathogens infecting the women. Walton (1992) suggested that with respect to 
intestinal microflora: 'it is highly likely that the physiological barriers present in man, 
animal and birds prevent the successful colonisation by bacteria from an unrelated 
species whether the bacteria are antibiotic-resistant or not". The diversity of R- 
plasmids subsequently present in both animal and human isolates (O'Brien et al., 
1993) present significant logistical problems in detecting such transfers in the natural 
environment. The use of antibiotics in veterinary medicine probably had an extremely 
low influence on the treatment of human disease either by the direct transfer of 
resistant pathogens from animals to humans or indirectly by the transfer of R plasmids 
from animal to human pathogens (Weidemann, 1993). Although the frequency of R- 
plasmids is elevated in the fish farm environment there are reasons to believe that 
such plasmids make only a very small and transient, contribution to the numbers of R- 
plasmids in human pathogens. The ecological differences between the aquatic 
environment and the human intestine decrease the possibility of resistant transfer 
between aquaculture isolates and human pathogens. Although there is evidence that 
antibiotic resistance can be selected for in normal therapeutic use in aquaculture, the 
risks of transfer of such resistance to human consumers by any of the possible routes 
appears to be low (Alderman and Hastings, 1998). Smith et al. (1994) in a 
comprehensive review suggested that there was no evidence of a continuing increase 
in the frequency of resistance in most human pathogens in the developed world. The 
level of resistance in these pathogens is primarily a function of the use of antimicrobial 
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agents by the medical profession. With the exception of the case of the Salmonella 
there is little compelling evidence that the use of antimicrobial agents in veterinary 
medicine has had an adverse effect on the therapy of human pathogens. 
Epidemiological and ecological considerations of pathogenic bacteria associated with 
fish suggest that resistant variants are unlikely to cause any impact on human 
pathology. In developed countries, the possibility that antibiotic resistant bacteria 
deriving from fish farm application of antimicrobial agents might reach the human 
consumer through the drinking water chain appears to be remote. Factors that need to 
be taken is to consideration include very high dilution factors and the fact that most 
fish pathogens present in temperate climates are not capable of affecting humans. In 
addition, antimicrobials such as oxolinic acid and oxytetracycline (although more 
available in fresh water than in salt water) are complexed by calcium and magnesium 
ions readily available in the aquatic environment and therefore are poorly bio- 
available. There is also a multiplicity of other anthropogenic sources of antibiotics in 
ordinary river water, including those derived from land run-off and, more especially, 
the presence of effluents from sewage plants that may be derived from human 
antibiotic usage. Against all of these factors and sources the comparative input from 
such farming antibiotic use must be recognized to be small. The treatment processes 
ending in chlorination routinely practised in treatment of drinking water should ensure 
that there are no viable microorganisms in that water when it leaves the water 
treatment plant. Thus, the likelihood of transfer of any transferable antibiotic 
resistance to the drinking water consumer from fish farming use should not be 
regarded as a significant possibility (Alderman and Hastings 1998). 
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4.7 Environmental Impact 
The environmental problems caused by fish farming are different in the different 
countries due to geographical, topographical, and physical conditions (Braaten, 1991). 
Environmental Impact Assessment is preclusive in order to lease the site and obtain 
permission for the operation of a fish farm, together with production management 
details and a description of the specific area in tems of physical, chemical and 
biological parameters of the water body (Papoutsoglou 1996; Papoutsoglou et al., 
1996; Karakassis et al., 1998). Unfortunately all data needed are usually obtained 
from published sources, rather than from specific monitoring programmes at individual 
sites. Annual predicted production, stocking denSit y /M3 or production per water 
surface unit, require site-specific environmental data (Papoutsoglou, 1991). The 
criteria for land-based farms are covered by existing legislation, which requires an 
approved special water discharge study, which includes recommendations for the 
treatment of effluents before their discharge. 
Superficial sediment layer beneath sea cages fluctuates between 2cm (February) to 5- 
6cm (July), suggesting a recovery procedure during the winter months when feeding 
rate is reduced the potential for inorganic fermation is increased, the wind generated 
currents that shake up the sediment surface. Loose top segment of the sediment 
consists of 95% water, it has increased chlorophyll due to phytobenthic organisms or 
due to the elevated phytoplankton production beneath the cages due to ammonia and 
phosphorus increase. However, most of the phosphorus is organically bound and not 
bioavailable, which is why the risk of phytoplankton blooms is less in the 
Mediterranean where phosphorus is the limiting factor. In comparison to studies of 
sediment recovery following different activities the sediment recovery in aquaculture 
activities is faster because the scale impact in space is confined, the precipitation 
material (fish feed, fish waste) is more bioavailable than all other urban or industrial 
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waste. A series of factors affect these bio-geo-chemical procedures (Karakassis et al., 
1998). Karakassis et al., 1998 suggested the following measures for the reduction: a) 
avoidance of sites with muddy substance, b) avoidance of low degree of water 
exchange or high level of fluctuation of environmental parameters and c) selection of 
at least 500m minimum distances between farms in order to avoid transfer of 
diseases, parasites etc. (Figure 121). HPLC and bioassay methods have been utilised 
for the detection of the impact of the antimicrobials in the aquatic environment 
(Hansen et al., 1992a; Ervik et al., 1994a, b). Large fraction of antibacterial agents, 
typically in the form of in feed treatment is not absorbed and retained, but is released 
to the environment through any of three routes. First, some fraction of the medicated 
feed is not ingested and instead falls directly to the substratum. Estimates of this feed 
loss in salmonid net-cage culture range from 15% to 40% (Rosenthal et al., 1988), 
and are likely to be highest during a disease outbreak when the cultured fish tend to 
feed less. This proportion of uneaten medicated feed is 30% in another study (ICES, 
1987,1987a, b). It is reasonable to assume that 20% of the feed administered to fish is 
not eaten and passes through the cage and will be deposited on the sediment in the 
vicinity of the cages. Sandaa et al. (1993) have suggested that during a disease 
outbreak this percentage may rise. A proportion of the antibacterial agent leach from 
the pellets, and a further proportion is excreted by the fish. OTC and OA are 
practically un-degradable in sediments, and 60-98% of these chemicals are not 
absorbed in the gut of the fish (Braaten, 1991). Fate of uneaten medicated feed 
depends on fish farm site characteristics. The nature of the environment may 
significantly alter the biological activity, and therefore the extent of the environmental 
impact, of a particular concentration of an antibiotic. The significance of a chemical in 
the environment is not a function of its presence but its impact on processes in that 
environment (Smith et al., 1993). In marine cage sites with fast currents and large tidal 
flows there will be greater dispersal of solid and particulate material than in sites with 
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poor flows. In addition the nature of the agent affects its fate in the marine 
environment. The area of sediments containing measurable oxytetracycline residues 
was very localised, under the cages and to a distance of 30 m, but absent 100 m from 
the site (Capone et al., 1996). At the end of OTC treatment elevated frequencies of 
resistance were detected up to 75 m from the edge of the cage block and ceased one- 
month later (Kerry et al., 1994). 
OTC is poorly absorbed especially in marine fish where the intestinal uptake is 
substantially reduced due to complex formation in seawater as compared to fish in 
fresh water (Smith, 1996). A major portion of the OTC administered to farmed 
salmonids inevitably ends up in the environment, especially in the sediments under 
aquaculture facilities. No mechanism is known for biodegradation of OTC and thus it 
can remain in the sediments long enough to affect the indigenous bacterial flora and 
induce resistance (Lunestad and Goksoyr, 1990; Smith and Samuelsen, 1996). Large 
differences exist in the literature on the level of sediment antibiotic residues following 
treatment in a cage farm. While in Norway, Samuelsen et al. (1992b) detected high 
OTC concentrations other workers in Ireland have reported considerably lower 
concentrations (Coyne et al., 1994). In addition OTC half-life differences exist in 
several studies ranging from 2 weeks (Coyne et al., 1994). to more than 1,5 years 
(Bjorklund et al., 1990) depending on the nature of the sediment. The nature of the 
sediments of farm ponds and beneath cage bottoms therefore seems to exert a major 
role in the persistence of antimicrobials in that environment (Hektoen et al., 1995; 
Alderman and Hastings, 1998). 
Aquaculture operations are often linked with increased densities of wild fish and 
invertebrates in the vicinity due to the shelter provided by the culture structure or 
enhanced food resources (Carss, 1990). Fish and invertebrates in the vicinity of the 
farm may also consume uneaten medicated feed pellets (Nausbaum and Shotts 1981; 
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Samuelsen et al., 1992a). Several studies on the impact of medicated diets on wild 
fauna around fish cages include studies in blue mussels Mytilus edulis (Moster, 1986; 
Ervik et al., 1994b; Coyne et al., 1997), sea trout Bjorklumd et al. (1990) coalfish, 
Pollachius virens, cod Gadus morhua, mackerel Scomber scombus, ballan wrasse 
Labius bergy1ta and haddock Melanogrammus aeglefinus (Carss, 1990) oysters 
(Crassostrea gigas) (Capone et al., 1996), Dungeness crab (Cancer magiste0and red 
rock crab (Cancer productus) and scallop (Capone et al 1996; Skjoelstrup et al., 
2000). OA toxicity to the freshwater crustacean Daphnia magna indicates the potential 
to cause adverse effects on the aquatic environment (Wollenberger et al, 2000). A 
fraction of the antibacterial is not absorbed during gut passage and is released to the 
environment via the faeces. The fraction of antibacterial released through this route 
may be higher that 90% for oxytetracycline (Cravedi et al., 1987). Finally, some 
antibacterials such as oxytetracycline are excreted via the urine and bile fluid in an 
unmetabolized, microbially active form (Bjorklund and Bylund, 1990). Compared to 
OTC, OA reached significantly higher tissue levels in the farmed fish in spite of the 
fact that the OA doses administered were eight to eleven-fold lower than the OTC 
doses. This indicates that, compared to OTC, OA is much better absorbed and 
distributed in the fish when administered mixed in the feed (Bjorklund, 1991). Oxolinic 
acid and oxtetracycline, in particular, have been reported at many farms (e. g. 
Jacobsen and Berglind, 1988; Samuelsen, 1989; Bjorklund et al., 1990,1991; Hansen 
et al., 1992b; Samuelsen et al., 1992a; Coyne et al., 1994). These residues may be 
quite persistent under some conditions, with half-lives exceeding 100 days (Bjorklund 
et al., 1990; Samuelsen et al., 1992a). These residues could be of environmental 
significance if they affect the sedimentary microbial community (Samuelsen et al., 
1988; Hansen et al., 1992a; Herwing et al., 1997; Herwing and Gray, 1997) and affect 
the viability of continued culture if they alter the rate of organic matter degradation or 
promote proliferation of antibacterial-resistant strains of bacterial pathogens. (Capone 
P. Christofilogiannis 304 
Use of Antibiotics in Greek Mariculture University of Stirling 
et a[, 1996) The presence of Aeromonas salmonicida and resistant strains in 
sediments beneath Norwegian fish farms illustrate the potential danger from persistent 
antibiotic concentration as selection factor in the sediment (Husevag and Lunestad, 
1995). The area of sediments containing measurable oxytetracycline residues was 
very localized, however, detectable residues existed only under the cages and to a 
distance of 30 m, but were absent from a 100 rn site (Smith et al., 1994). 
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The persistence of OTC in fish farm sediments may depend significantly on the 
type of sediment, chemical characteristics (02, H2S, pH, etc), temperature and 
bacterial activity in the sediment. Compared to OTC, OA showed a faster loss of 
antibacterial effect in the fish farm sediments. Sediment porosity due to 
bioturbation by Capitella 'capitata'may accelerate antibiotic elimination while in 
other cases a white carpet of the blue/green algae Beggiatoa may decrease the 
antibiotic diffusion (Coyne et al., 1994; Smith et al., 1994), but in cases of extreme 
enrichment even this species may be eliminated. Quinolones may not be broken 
down because there are no enzyme systems to target these synthetic molecules. 
In that case any breakdown will depend on physical factors such as photolysis. 
Oxytetracycline is very soluble in seawater and solution and diffusion process is 
most likely a major mechanism of OTC escape from the sediment. OTC 
degradation in water is much faster than in sediment. Tetracyclines in water 
solutions are degraded by photodecomposition and half-lives depend on 
temperature, pH, air saturation and light intensity (Samuelsen, 1989a). Coyne et 
al., (1994). Oxytetracycline, Oxolinic acid and Flumequine photodegrade in the 
upper levels of the water column (Lunestad et al., 1995) while they exhibit no 
degradation in the sediments (Samuelsen et al, 1992a, b). Only OTC and not OA 
showed reduced antimicrobial activity when exposed to underwater light 
intensities. Photo-degradation is the process in which a component is directly 
altered by the action of light or indirectly altered by the action of the product of 
another component, which has absorbed light. A prerequisite for direct photo- 
degradation is that the chemical absorbs light in the UV - visible region (190-800 
nm). Substances that do not absorb in this region cannot be directly photo- 
degraded. Therefore, photo-degradation will only have a limited effect on the 
drugs when administered as medicated feed. However, applying bath-treatment 
(O'Grady et al, 1988) where drugs are dissolved in water and kept in tanks, photo- 
degradation can be an important tool to decompose the drug and thereby 
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decrease the environmental impact (Lunestad, 1995). OTC, whose binding to 
mineral and organic compounds of the bivalve tissues is stronger than OA, was 
eliminated more slowly from the bivalve tissues than OA. The biotransformations 
of the antibacterials agents by the bivalves did not seem to play a prominent part 
in the contamination and decontamination of the bivalve tissues (Pouliquen et al., 
1996). New methods of monitoring overfeeding and collecting surplus feed and 
dead fish have been developed using Lift up feed collector systems or 
hydroacoustic feed detectors. This equipment can reduce the environmental 
impact of antibacterial agents used in fish farming (Coyne et al, 1993; Ervik et al, 
1994a). 
4.8 Immunostimulants and Fish Vaccines 
Immunostimulants in sea bass increase total leukocyte count, blood leukocytes, 
oxidate leukocyte radical production, phagocytosis, lysozyme activity and total 
protein levels. The effect of glucans was greater than levamisole. The glucans 
ability to play an important role in the prevention of diseases in sea bass was 
proven although in high dose rate they exert an immunosuppressive effect (Jeney 
et al, 1994). The in vitro effect of several beta -glucans on the respiratory burst of 
turbot and sea bream phagocytes was examined in another study. Three 
particulated beta -glucans from yeast, Saccharomyces cerevisiae and a particulate 
glucan from the fungus Schizophyllum commune were used. High concentrations 
of glucan directly induced respiratory burst and led to exhaustion. Low 
concentrations of glucan primed the phagocytes to be capable of enhanced 
production of reactive oxygen species on subsequent activation of the respiratory 
burst. The former may increase disease susceptibility, the latter increase 
resistance (Castro et al, 1999). In a challenge study sea brearn juveniles were fed 
a diet containing beta -1,3 Glucans (0.1%) and then were exposed by bath to 
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Photobacterium damsela subsp.. piscicida. The effects of such diet were: low 
mortality, low pathogen recovery and low number of (apparently intact) colonies of 
bacteria in the spleens. These results seem to indicated that beta-1,3 Glucans 
could play an important role in the prevention of diseases in fish culture 
(Albuquerque et al., 1999). 
Fish Vaccines marketed in Greece to protect against serious bacterial systemic 
diseases of farmed sea bass (Dicentrarchus labrax) and sea bream (Sparus 
auratus) comprise of formalin-killed bacterins monovalent and divalent either water 
based or oil-adjuvanted products. The available vaccines may offer protection 
against several pathogenic serotypeS Of Vibrio anguillarum and/or the 
Photobacterium damsela subspecies piscicida causing pasteurellosis. The 
application methods and the vaccination schemes that are suggested by the 
vaccine distributors differ, but all employ either the immersion in the hatchery 
and/or in the cages and intraperitoneal injection as booster vaccination. Oral 
vaccination started to be employed three years ago producing consistent results 
(Locatelli et al., 1999). The practical needs in terms of personnel, cost, and time, 
differ according to fish size, the type of unit (tank, raceway or cage) and the 
application method employed. Injection vaccination on the cages is considerably 
more time-consuming and labour-intensive, as the fish have to be anaesthetised 
and treated individually. On the other hand, immersion vaccination proceeds fast 
as groups of fish are added simultaneously to a vaccine dilution. Oral vaccination 
is the most attractive option for booster vaccination on the cages. Vaccination 
schemes depend not only on the epizoobology of the site and the duration of the 
production cycle compared to the expected period of immunity, but also on the 
structure and availability of time and labour on each particular unit. New trends in 
fish health management of marine species in Mediterranean include full 
vaccination programmes covering the fish during their whole production cycle 
P. Christorilogiannis 309 
Use of Antibiotics in Greek Mariculture University of Stiding 
coupled with other prophylactic methods, including good hygiene practices, 
husbandry and nutrition management (Le Breton, 1999). Early experiments dealt 
with extracellular products (ECP) of Photobactedurn darnsela subsp. piscicida and 
their importance in vaccine formulation (Magarinos et al., 1992). Another early 
study of two immersion vaccines in sea bream, a whole-cell bacterin (WCB) and a 
toxoid-endched whole-cell vaccine (WCEB), against Photobactelium darnsela 
subsp. piscicida was not successful and none of the formulations confer cross- 
protection against serotypes 01 and 02 of Vibrio angufflarurn. (Magarinos et al, 
1994a). A controversial study of the same group suggested immunity development 
against pasteurellosis in very small sea bream larvae (50mg) following immersion 
with a toxoid-enriched whole-cell bacterin (Magarinos et al, 1999). In another study 
in 57- and 69-days old gilthead sea bream Artemia nauplii were used as an 
antigen delivery system for oral vaccination with a Vibrio anguillarurn bacteria 
indicating that oral vaccination with bio encapsulated vaccines is very promising 
when applied at the right age. Application at too young age seems to induce 
immunosuppression, instead of immunisation (Joosten et al., 1995) 
Photobactedurn darnsela subsp. piscicida cells cultured under iron-limited 
conditions demonstrated an immunogenic low molecular weight lipopolysaccharide 
(Bakopoulos et al., 1997b). In another more recent comparative study washed 
cells of the above pathogen enriched with extracellular products (WC+ECP) 
performed better than O-antigen (0-Ag) and heat inactivated extracellular products 
(ECP) based ip vaccines for sea bass (Fabris et al., 1998). Extracelfular products 
of Photobactetium darnsela subsp. piscicida are haemolytic, cause lymphopenia, 
granulocytosis, increase in the number of peritoneal exudate cells, mobilization 
and degranulabon of the eosinophilic granular cells and toxicity in gills and liver but 
they are not linked to typical lesions in the spleen (Noya et al., 1995a, b). Vibriosis 
and E. R. M vaccines have been available in Italy since 1988. Successful 
vaccination in sea bass but not in sea bream against Vibrio anguillanim (Giorgetti 
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et al, 1990) was confirmed in a later study (Brisinello and Fontebasso, 1991). 
Substitution of antimicrobial chemotherapy with preventive vaccination strategies 
is widely applied in aquaculture, but the need for back up solutions and available 
antibiotics will always be there in case of vaccination protection breakdown or new 
pathogen outbreaks. 
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4.9 CONCLUSIONS 
Veterinarians and fish health specialists will continue to need a variety of 
efficacious, cost-effective and safe chemotherapeutants to enable prompt 
therapeutic intervention to battle infectious fish disease outbreaks. Many important 
questions are raised regarding the integration of bacterial resistance monitoring, 
pharmacokinetics, metabolism, clinical efficacy, drug residue depletion, target 
animal safety, consumer safety, and environmental impact linked to antibiotic 
application in Greek Mariculture. It is hoped and anticipates that this study will 
prove useful in providing the foundation for further and more applied antibacterial 
chemotherapy related research. 
4.9.1 Bacterial Diseases - Antibiotic resistance 
The current study indicated a range of bacterial pathogens affecting sea bass and 
sea brearn in Greek Mariculture. It managed to describe resistance profiles and to 
extrapolate resistance frequencies as well as to identify farms with antibiotic 
application malpractice. The levels of resistant bacteria were relatively low but 
resistant bacteria were isolated for both OA and OTC. Multi resistant profiles were 
analysed. It is believed that qualitative antibiograrn and MIC are very important 
tools in order to estimate the resistance status in an industry and further work 
should include this "quantified" component not only in the clinical epidemiological 
trials but also in the environmental impact trials. At the same time this is one of the 
very few studies where MIC data were correlated with achieved concentrations of 
Oxytetracycline and Oxolinic acid in different tissues. The practical aim of the 
study for the farmers was to identify if the applied treatment protocols and related 
achieved tissue concentrations in vivo were sufficient to control the bacterial 
pathogens of sea bass and sea bream and on the other hand which is the period 
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that should be allowed in order to make sure in practical terms that antibiotic 
concentration falls bellow the MRL level. Extensive data were provided in this field 
illustrating the fast metabolism in both species, the vast differences in achieved 
concentrations of antibiotic in a fish population and the inability to draw similarities 
in depletion studies based on the degree-day concept. An important issue for the 
containment of antibiotic resistance in the aquaculture industry is to define the 
problem and apply good practices and codes of conduct. Several issues should be 
addressed: Research has indicated that many factors are involved in the selection 
and spread of antimicrobial-resistant bacteria. Most important amongst these 
appears to be the extent of usage since the relationship between the amounts of 
antibacterials used and the prevalence of resistance is broadly quantitative. Thus, 
the control and containment of resistance is likely to be successful only if the 
measures employed include a reduction in the use of antimicrobials in all spheres 
of current application. The measures, which need to be considered for control and 
containment of antibiotic resistance, include: Improved prescription use, reduction 
of need and provision of new antimicrobials as well as education of prescribers 
and fish farmers. (S. S. C. A. R 1999) In order to preserve the ability to treat 
bacterial infections in fish, action must be taken to reduce the overall use through 
the implementation of preventive measures and by prudent use. In veterinary 
medicine, antimicrobials may be prescribed for prophylactic or therapeutic 
purposes. In addition, complications arise in aquaculture where disease 
epidemiology and treatment always refers to fish populations in different 
production systems. In those situations it is necessary to administer antimicrobials 
to the whole group even though all fish do not yet demonstrate clinical signs of 
infection at the time of administration, but it is likely that most of them will get the 
disease in the next days. In that sense the "cascade principle" for aquaculture, as 
mentioned, before should be reviewed and amended. Such use of antimicrobials 
is often referred to as metaphylactic use. The veterinary surgeon / fish pathologist 
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prescribing antimicrobials should have knowledge of the disease history including 
disease epidemiology, preventive and other measures undertaken. To achieve an 
optimal and prudent use of antimicrobials, guidelines for the use of antimicrobials 
may be established as a help to the veterinarian. Such guidelines would also 
support the veterinarian against demands for antimicrobials by fish farmers. These 
guidelines should be to achieve three goals; optimal therapeutic effect and/or 
protection and welfare of fish at risk, control of antimicrobial resistance and 
provision of practical, affordable treatment that avoids risks of residues in or 
damage to aquaculture products for human consumption. Emergence and spread 
of resistance is a serious effect of antimicrobial use in animals, so facilities to 
monitor and analyse regularly the prevalence and patterns of resistance should be 
developed as a priority. Antimicrobial susceptibility data should be quantitative and 
produced under strict quality assurance. Interpretation and reporting of results 
from different laboratories must be harmonised. More detailed knowledge about 
the usage of antimicrobials and the impact on epidemiology and prevalence of 
antimicrobial resistance in different environments will assist a greater 
understanding about the forces behind the development and dissemination of 
antimicrobial resistance. Registration of the amounts of veterinary medicines sold 
by each company should be available as well as the recording of indications and 
use of veterinary drugs and pre-medicated feeds by means of a logbook on each 
farm and in each veterinary practice. Such a recording system of health status and 
use of medicines will make it not only feasible to monitor the usage of 
antimicrobials on a farm and by prescription, but also the indications for 
antimicrobial usage and efficacy of antimicrobial therapy under practice conditions. 
It is understood that such studies are undertaken by pharmaceutical companies 
but we believe that they should be made public. All antimicrobials administered on 
farms should be used only as part of a comprehensive veterinary health 
programme. In contrast to the situation in human medicine more drastic and 
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effective management and other disease preventive methods can be undertaken 
in animal production. Batch-wise, year class-segregated production using all-in/all- 
out systems with biosecurity routines together with optimal nutrition, environment, 
management routines and vaccination strategies can greatly improve fish health 
and decrease the need for antimicrobials. The introduction of vaccines against 
furunculosis in fish farming in Norway has eliminated an alarmingly large use of 
antimicrobials. Recent research has been devoted mainly in the field of Probiotics, 
as means to prevent colonisation of the intestine by bacterial pathogens mainly 
Vibrios. It is difficult to find or create truly novel agents, which are patentable. On 
the other hand there may be a finite number of appropriate targets in bacteria. 
Finally it is commercially unattractive to invest in research having little chance of 
producing a return. The cost of research, development and testing of a novel 
antimicrobial is now probably in excess of US$350 million and the time required for 
effective marketing is at least 6-7 years (Cohen, 1992). As a result, the number of 
companies investing in antibacterial research declined even before the recent 
trend towards company mergers occurred. Moreover, there is the risk that a costly 
new antimicrobial drug may well become obsolete within a few years, reducing the 
economic returns that can be expected to a level that is insufficient to justify the 
investment. The ten-year industrial-property protection period for veterinary 
medicinal products for fish should be extended to 15 years in order to enable the 
pharmaceutical industry to derive full benefit from such products thus initiating 
renewed incentives to invest and achieve marketing authorisations for fish 
products. The time it takes to obtain registration and to develop the data required 
for the extension of a marketing authorisation to different species and to different 
diseases should be considerably shorter. Both centralised and decentralised 
procedure should be maintained providing the necessary flexibility in terms of 
faster launching of new products in the aquaculture market. Evaluation of the 
operation of the procedures for the granting of market authorisation has revealed 
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the need to revise, in particular, the mutual recognition procedure in order to 
increase the scope for cooperation between Member States. Different levels of 
competence in different Member States as well as different level of vigilance often 
leave more options for treating or preventing fish diseases in some countries while 
leave none in others. A simple example is that a few Member states deny acting 
as reference Member states in the Mutual recognition procedure. A basic degree 
of harmonisation should be included in the enforcement of the new legislation in 
order to avoid the creation of indirect trade barriers. The large number of 
aquaculture species and relevant pathologies complicate the procedure of 
extension of use or species and emphasis should be made into making this 
process faster at a Member state level as well as at EU level. Systematic 
extrapolation of MRL values between species would make new drugs available 
faster for minor species. The 'cascade' principle needs to be modified. In the case 
of absence of authorised veterinary medicinal product for a condition affecting fish, 
a familiar case for fish veterinarians, the veterinarian is allowed to treat that fish 
population under his/her direct personal responsibility on a particular fish farm, in 
order to avoid causing unacceptable suffering to the fish population, with a 
licensed product in another Member state for fish or for other food producing 
animal The reference however to a "small number of animals" in the legislation is 
not applicable for aquaculture because fish are reared in cages or tanks in large 
numbers and these are treated as units in terms of epidemiology, prevention or 
treatment of fish diseases. The licensing and application of Fish vaccines should 
be encouraged in order to support the European Aquaculture industry trend to limit 
the use of antimicrobials and to ensure high product quality and safety. New 
searches for drugs that interfere with virulence factors or mechanisms of 
resistance, or which seek to modify the molecular biology of multiple resistant 
pathogens are being developed. However all these "new " technology drugs 
should be carefully audited in terms of consumer safety especially when applied to 
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food animals and will take a considerable time, if ever, to reach the aquaculture 
industry. Aspects of antimicrobial therapy are poorly addressed in under-graduate 
and post-graduate education. Thus, there is scope for expanding education of 
health professionals both in terms of good prescribing and how to minimise 
antimicrobial use by preventing infection occurring. For veterinary practitioners this 
might include updating on organised health control programmes mentioned above. 
4.9.2 Kinetics 
The kinetics experiments with all their limitations and novel characteristics 
indicated a new practical approach for the evaluation of clinical importance of 
kinetics work. Population versus individual fish studies are required in order to see 
the shortfalls from clinical and environmental perspective. We believe that this is 
the first study of the population effect and the statistical interpretation, like Box Plot 
analysis, of the antibiotic concentration in different fish in a cage. The coupling of 
achieved antibiotic levels with relevant MIC breakpoint values for known 
pathogens associated with that species and culture conditions is a unique 
combination that puts everything into perspective from the veterinarian's point of 
view. Although kinetics that take into account only the HPLC data gave the 
impression of variable and relatively low levels achieved in different tissues, the 
association with Vangufflarum sensitivity data and MIC breakpoints assumed for 
Oxolinic acid and Oxytetracycline gave the necessary clinical explanations. 
The relatively low MIC breakpoint levels were achieved in different tissues in most 
of the experiments performed in different temperatures and this explained the 
reason why those treatment protocols are effective in practice. However high 
subject deviation in achieved concentration should be further elaborated in future 
studies because it might explain occasional failures as well as reoccurring 
outbreaks. Included in the conclusion could be species differences, tissues 
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differences as well temperature differences but it is believed that all researchers 
must step back and really see the vast number of data that none can compare and 
contrast, in order to realise that we need common language, common 
methodology, common approaches in order to tackle this extremely broad subject. 
One also has to remember that this is undertaken for the welfare of animals, for 
the reduction of the environmental impact, for the consumer protection and for the 
sustainability of aquaculture industry. Therefore one must be practical, accurate 
and give real models that will be able to predict what is really happening in 
practice. 
4.10 FutureWork 
There is a definite lack of good quality information on prevalences of antimicrobial 
resistance, amounts of antimicrobials used, the applied modes of use, and the 
outcomes of use. The first priority is therefore to establish what information is 
currently available and to make suggestions on how it can be improved. This will 
ensure comprehensive, reliable and cost-effective surveillance systems. The work 
started for MIC method harmonisation should continue to kinetics as well as on 
environmental impact methodologies. More research into factors which influence 
the selection of resistant microorganisms is needed, particularly at the in vivo and 
epidemiological levels. More research and epidemiological data are needed to 
clarify the issue of inter-species transfer of antimicrobial resistance. 
It is very important to evaluate the environmental impact from the antibiotic use in 
terms of deposition of residues in the sediment, water column and wild fauna as 
well as to describe the mechanisms and the locations for the selection of resistant 
environmental bacteria. The population dynamics of these bacteria their impact to 
the natural bacterial flora and the likelihood to affect the human flora along with all 
the relative implications should be evaluated because there are a lot of 
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misconceptions and aquaculture is being blamed without any data when 
environmental groups extrapolate data from poultry farms and other terrestrial 
farmed animals with no concern on the enormous differences that the aquatic 
environment poses. Research is needed into ways that might improve the 
prescription use of antimicrobials. Clinical trials of efficacy are presently almost 
entirely funded by the pharmaceutical industry and have objectives largely 
confined to satisfying regulatory authorities. Thus trials, which seek to optimise the 
dose, dose interval and duration of treatment are rarely done. Evaluation of the 
service provided to the industry must be evaluated from an empirical to scientific 
level where all aspects of chemotherapy will be taken into account. Veterinary 
prescription although compulsory, should be re-vitalised in many countries 
because this the way by which at all times a scientist has the responsibility of the 
treatment applied. Focus is needed on methods of reducing the need for 
antimicrobials by lowering the prevalence of infection. Widespread implementation 
and enforcement of methods for reducing transmission of pathogens as well as 
detailed epidemiological studies are needed in Mediterranean Mariculture. 
Effective Vaccination strategies, immunostimulation and a range of other means 
should reduce the need to administer drugs in aquaculture. More studies are 
needed on the impact of changes of farming conditions and management practices 
on fish stress and welfare. Rapid diagnostic methods for bacterial infections 
should be encouraged. Thereby antimicrobial treatments will be aimed directly at 
the infectious agent and the need for broad spectrum or combined antimicrobial 
usage will be more limited. Immunological, molecular techniques of increased 
sensitivity should be made available in the field. Determination of the optimum 
mode of oral administration of chemoterapeutants is very important in order to 
avoid shortfalls. Optimisation of administration will be to vary the feed regime, 
antibiotic concentrations, and feed type. Optimised feed regimes will be used 
subsequently to treat outbreaks of disease. For hatcheries vehicle drug delivery 
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studies should continue in order to increase affectivity and decrease environmental 
impact. Investigation of optimum uptake and residue kinetics will require 
incorporation of population distribution studies where current practice is audited 
and then suggestions are made to ensure increased clinical relevance and 
efficacy. The aim is to provide consumers with healthy safe fish of good quality. 
Determination of withdrawal times is important for a fish farmer in practical terms 
for sales scheduling. The regulatory authorities have to decide how to manage in 
this task in practical terms and what the MRL level means in the daily practice of a 
salmon or a sea bass farmer. A Code of Practice of the Greek Mariculture has 
been developed and adopted by Federation of the Greek Maricultures in order to 
transform relevant issues from this study as well as views from the literature into 
practical guidelines for Greek sea bass and sea brearn farmers to ensure the 
production of high quality, nutritious and safe final product This code was the basis 
for an intense effort of Greek Mariculture industry that is expected to lead in 
September 2003 to the certification of the Greek sea bass and sea bream by 
AGROCERT the Greek Ministry's of Agriculture competent authority for 
certification of all agricultural products (Christofilogiannis 2002a). However 
continuous research should be in progress in order to achieve a "global 
perspective" of issues and factors mentioned above, to understand better the 
dynamics of antimicrobial chemotherapy in aquaculture and to transform those into 
practical advice for the fish farmers in the field. 
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BACTERIAL STRAIN INDEX 
I Fish Farm 1 -1 
I Strain: RPI I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
+ 
,,. 
white/ steaky 
AP120E Profile 
1007004 
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OTC OA SXT FIR 0129 P 
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+ 
32 32.1 46 38 22 S 
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lo 0.15 
Strain: RP2 
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+ + I small white oxidative 
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MIC OTC MICO. A I I I T- 
0.625 1 2.5_A I I I 
Strain: RP3 
Species: Mugil cephalus 
Gram Oxi Motility Colony Growth ! nTC--BS-T O/F 
coccl yellow gree Oxidative 
AP120E Profile 
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Minimum Inhibitory Concentration (ppm) 
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---I 
-qtrqin- RPA 
Species: Dentex Dentex 
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MIC OTC 
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Fish Farm 2 
Strain: Arciol 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
Coccl Red Feffnentative 
AP120E Profile 
Antibiog am (Zones of inhibition mm) OD=0.250 
OTC OA SXT FIR 0129 P 
34 6 16 
Minimum Inhibi ry Concentration (porn) 
MIC OTC MIC O. A 
0.3 80 
Strain. -Aroo2l 
Spec es: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
cocci yellow green 
AP120E Profile 
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OTC OA SXT FIR 0129 P 
S R S R S R 
Minimum Inhibi ry Concentration (ppm) 
MIC OTC MIC O. A 
0.3 40 
[Strain: Arcio3l 
Species: Glithead Sea bream 
Gram ýOAdase I Motility I Colony Growth in TCBS OlF 
cocci 1_.. yellow green 
AP120E Profile 
Antibiog am (Zones of inhibition mm) OD=0.267 
OTC OA SXT I FIR 1 0129 P 
31.91 6 36 1 23.4 1 R 21.87 
Minimum Inhibit ry Concentration (ppm) 
MIC OT c O. A m 0.3 4 % 
Fish Farm 3 
I Strain: SFI I 
Spec! s: Sea bass 
Gram Oxidase Motility I 
_Growth 
inTCBS OlF 
Bacilli + +I yellow yello Fermentative 
AP120E Profile 
4144525 
Antibiograrn (Zones of inhibition mm) OD=0.280 
OTC SXT FIR 0129 P 
32 25 32 30 R 6 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MICO. A 
0.625 0.15 
Strain. -SF2-1 
Sped s: Sea bass 
Gram Oxidase Motility ýoloný Growth in TCBS OlF 
Bacilli + + yellow Yellow Fermentative 
AP120E Profile 
3047524 Vibrio anguillarum Ib 
Antibiogram (Zones of inhibition mm) OD=0.245 
OTC OA SXT FIR 0129 p 
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Minimum Inhibitory Concentration (ppm) 
M IC OTC I MICO. A 
160 1 0.075 
Strain: SFYý 
Sped s: Sea bass 
Gram Oxidase Motility I 
_Growth 
lnTCBS O/F 
Long bacilli + + I yellow Yellow Fermentative 
AP120E Profile 
3047524 Vibrio anguillarum 1b 
Antibiogram Zones a inhibition mm) OD=0.265 
OTC OA SXT FIR 0129 p 
35 30 33 22 S 6 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC: ] MIC O. A 
0.625 1 0.075 
I Fish Farm 41 
Strain: NEI 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS OIF 
Long bacilli + yellow green Fermentative 
AP120E Profile 
3047524 Vibrio anguillarum lb 
--- Antiblogram (Zones of inhibition mm) --- TOD=0.249 
OTC OA SXT FIR 01 2ý P 
34.44 32.49 35.72 32.44 29.56 6 
Minimum Inhibi ry Concentration (ppm) 
M IC OTC MIC O. A 
0.3 0.3 
I Fish Farm 5 -1 
Strain: Deep'! I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth In TCBS O/F 
Bacilli + + yellow yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum 1 
Antibiogram (Zones of inhibition m) OD=0.251 
OTC OA SXT FIR 0129 p 
30.55 30.41 33.98 24.63 27.94 6 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MICO. A 
1.25 1.25 
I Fish Farm 6 
Strain: Asti --I 
Species: Sea bass 
Gram Oxi ýase Motility Colony Growth inTCBS OlF 
Bacilli + yellow yellow Fermentative 
AP120E Profile 
3044125 V. fluvialis 
Antiblog am (Zones of inhibition mm) OD=0.240 
OTC OA SXT FR T 0/129 NV 36 27 34 34 1 24 28 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC O. A 
0.3 0.075 
Strain: Ast27 
Species: Sea bass 
Gram Oxi Motility Colony Growth inTCBS O/F 
Bacilli + + yellow whitish/green Fermentative 
AP120E Profile 
2200004 81% Pseudomonas fluorescens 
Antibiog am (Zones of inhibition mm) OD=0.250 
OTC OA SXT FIR 0129 P 
35 32.1 23 26 26 22 
Minimum Inhibitory Concentration (pDm) 
MIC OTC MIC OA I 1 -1 
0.3 0.3 fI I 
- 
I Strain: Ast-3-1 
Species: Gilthead Sea bream 
' Gram Oxidase T motinty Colony J Growth in O/F 
bacilli yellowsticky 
AP120E Profile 
0002000 
Antibiograrn (Zones of inhibition mm) D=0.256 
OTC OA SXT Fý 0129 P 
32.09 6 32.81 16 1 6 34.64 
Minimum Inhibitory Concentration (ppm) 
mic oTLý [ MIC O. A 
0.625 
_I 
_ 80 
I Fish Farm 71 
I Strain: Ov 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS 0/ 
bacilli + + yellow y How Fe ientative 
AP120E Profile 
4047520 V. alginolyticus 
Antiblogr m(Zones finhibition m) OD=0.244 
OTC OA SXT FIR 0129 P 
38 36 32 30 26 6 
AMP NV 
8 25 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC OA 
0.3 0.3 
strain: ovr2-] 
Species: Sea bass 
Gram Oxidase Motility Colony k Growth in TEEBSý OlF 
bacilli + + 
I 
I Fermentative 
AP120E Profile 
1047724 
Antiblog m (Zones of inhibition mm) OD=0.23 
OTC OA SXT FIR 0129 p 
26 12 6 6 R 
Minimum Inhibitory Concentration (t)r)m) 
MIC OTC MIC O. A 
0.075 2.5 
I Strain: Ovr3 
Species: Sea bass 
Gram Oxidase Motility Colony owth in TCBS-- j 0/ 
Bacilli + + yellow yellow Fermentative 
AP120E Profile 
2000104 
Antiblogram (Zones of inhibition mm) OD=0.2. - 
OTC OA SXT FIR 0129 P 
23.97 1 14.83 20.22 6 R 6 
Minimum Inhibitory Concentration (1313m) 
MIC OT-C-1 - MIC OA I 
0.3 1 0.6 1 
- 
Strain: ovr4l 
Species: Sea bass 
Gram 4 Oxidase P Motility Colon owth in TCBS O/F 
baci-Iri 
+ 
- 
+ yeliow yellow Fermentative ___ AP120E Profile 4046505 
Antibio ram (Zones f inhibition mm 10 OD=0.264 
OTC OA 
n 
SXT FIR 0129 
7 
P 
24 8 I 2A 
ER 
6 
Minimum Inhibito Concent ation (ppm) 
MIC OTC IC O. A 
0.3 0.625 
I Strain: Ovr5 I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
bacilli + + yellow green Fennentative 
AP120E Profile 
1047524 V. anguillarum 2 
Antibiogram (Zones of inhibition mm) OD=0.222 
OTC OA SXT FIR 0129 P 
26 15 25 19 S 10 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC O. A 
0.075 0.625 
strain: ovr67 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS OlF 
bacilli + + yellow yellow Fermentative 
AP120E Profile 
3047524 
_V. 
anguillarum I 
Antiblograrn (Zones of inhibition mm) OD=0.265 
OTC OA SXT FIR 0129 P 
32.42 31.76 34.08 27.9 25.45 6 
Minimum Inhibitory Concentration (ppm) 
- MIC OTC MIC O. A 
0.3 0.15 
I Strain: Ovr7 I 
Spec es: Sea bass 
Gram Oxidase Motility Colony Growth in ý ý'O/F 
bacilli + + yellow yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum 1 
Antibiogram (Zones of inhibition mm) 013: 0.247 
OTC OA SXT FIR 0129 P 
26 19 22 R R 
Minimum Inhibitory Concentration (ppm) 
MIC OTC- LMIC O. A 
0.625 1.25 
I Fish Farm 81 
Strain: Kallý 
Species: Gilthead Sea bream 
Gram Oxidase I Motility Colony Growth in TCBS O/F 
Cocci yellow yellow Oxidative 
AP120E Profile 
Antibioc ram (Zones of inhibition m OD=0.250 
OTC OA SXT FIR ý- 0129 P 
34.46 7 33.3 26.26 R 27.59 
Minimum Inhibi 
, 
tory Concentr tion (ppm) 
MIC OTC MIC O. A 
0.625 5 
1 Strain: Ka12 I 
Sp cies: Sea bass 
Gram Oxidase Motility Colony Growth inýTCBSý O/F 
bacilli + + yellow yellow Fermentative 
AP120E Profile 
1047524 V. anguillarum 2b 
Antibiog ram (Zones of inhibition m OD=0.257 
OTC OA SXT FIR 0129 AM P 
35 6 30 15 18 30 
NV 
26 
Minimum Inhibitory Concentr tion (ppm) 
MIC OTC M IC O. A 
I Strain- Kal-T 
Specie Puntazo puntazo 
Gram -T Oxidase7 Motility Colony Growth in TCBS OlF 
bacilli + + yei. cream. egg yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum I 
Antibiog ram (Zones of inhibition m OD=0.248 
OTC OA SXT FIR 0129 AMP 
25 11 23 22 R R 
NV 
R 
Minimum Inhibit 
, 
ory Concentration (ppm) 
MIC OTC MIC O. A 
1.25 1.25 
I Strain: Kal-41-ý 
Species: Gilthead Sea bream juveniles 
Gram = Oxidase Motility I Colony Growth in TCBS O/F 
bacilli + +I smalftund/shny green Fennentative 
AP120E Profile 
6005004 99.5% Listonella damsela 
Antibioc ram (Zones of inhibition m OD=0.250 
OTC OA SXT FIR 0129 AMP 
33 30.5 23 26 14 7 
NV 
11 
Minimum Inhibitory Concentration (ppm) 
- MICOTC MICO. KJ 
0.625 0.625 1 
I Strain: Kal5 1 
Species: Puntazzo puntazzo 
Gram Oxidase =Motility Colony Growth In TCBS O/F 
bacilli + + whitish gree Fermentative 
AP120E Profile 
6005004 99.5% Listonella damsela 
Antibiog ram (Zones of inhibition m 013: 0.252 
OTC OA SXT FIR 0129 NV 
30 24 30 22 S 
Minimum Inhi itory Concentration (ppm) 
MIC OTC MIC O. A 
0.3 0.3 
Strain: Kal6 
Species: Puntazzo puntazzo 
Gram Oxidase =Motility Colony Growth iný ý O/F 
bacilli + + swanning yell w Fermentative 
AP120E Profile 
4144525 (according to the ALO test -++ V. alginolyticus) 
Antibioq rarn (Zones of inhibition m OD: 0.254 
OTC OA SXT FIR 0/129 
34 20 23 24 R 
Minimurn Inhi itory Concentration (ppm) 
MIC OTC _ M IC O. A 
0.3 0.3 
Strain: Kal7l 
Species: Puntazzo puntazzo 20-30g 
Gram Oxidase Motility Colony Growth in TCý OIF 
bacilli + + yellow yellow Fermentative 
AP120E Profile 
4154525 
AntibioC ram (Zones of inhibition m OD=0.253 
OTC OA SXT FIR 0129 P 
26 12 21 19 6 6 
AMP NV 
6 12 
Minimum Inhi itory Concentration (ppm) 
M IC OTC M IC OA 
0.625 0.625 
I Straln: Kal8 I 
Species: Sea bass 350cl 
Gram Oxidase] Motility Colony Growth in -T-CB-S-- T- O/F 
bacilli + + yellow vellow Fermentative 
AP120E Profile 
4146525 V. alginolyticus 
Antibiog ram (Zones of inhibition m OD=0.240 
OTC OA SXT FIR 0129 P 
36 23 38 25 6 
AMP NV 
6 14 
Minimum Inhibitory Concentr tion (ppm) 
MIC OTC MIC O. A 
0.625 0.625_ 
I Strain: Ka19 I 
Species: Puntazo puntazo 
Gram Oxidase Motility ColonV Growth ! nTCBS-- F- O/F 
bacilli + + yellow 
--- 
green Fennentative 
AP120E Profile 
3047524 V. anguillarurn 1b 
Antibiog ram (Zones of inhibition m OD=0.258 
OTC OA SXT FIR 0129 P 
28 26 25 22 20 6 
NV AM P 
14 10 
Minimum Inhi itorV Concentration (Dom) 
M IC OTC-] M IC O. A] 
_ E 0.15 J - 2.075 1 1 
Strain: KallOl 
Species: Sea bass 150g 
Gram Oxidase Motility Colony Growth inýTCBSý O/F 
bacilli + + swarming yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum 1b 
Antiblog rarn (Zones of inhibition m OD=0.250 
OTC OA SXT FIR 0129 P 
30 37,5 5 28 36 6 
AMP NV 
6 28 
Minimum Inhibitory Concentr tion (ppm) 
MIC OTC MIC OA 
0.15 0.075 
Strain: Kalll 
Species: Sea bass 350g 
Gram Oxidasel Moti! qq Colony Growth inTCBS- 7 O/F 
bacilli + + yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum 1b 
AntibioC ram (Zones of inhibition m 013: 0.252 
OTC OA SXT FIR 0129 NV 
34 30 30 32 25 28 
Minimum Inhibitory Concentration (ppm) 
-- MIC OTC LMICO. A 
0.3 0.15 
Straln: KaI12ý 
Species: Sea bass 35 g 
Gram oxid=ase Motility Colony Growth in TCBS O/F 
bacilli + + yellow Fermentative 
AP120E Profile 
3047524 V. anguillarurn 1b 
AntibioC ram (Zones of inhibition m OD: 0.253 
OTC OA SXT FIR 0129 NV 
35 34 32 31 26 22 
P AMP 
6 6 
Minimum Inhibitory Concentration pm) 
MIC OTC MICO. A 
- 0.3 0.15 
Fish Farm 9 
I Strain. --PL-I1 
Species: Sea bass 
Gram Oxi ýase ýMotility Colony Growth in TCBS O/F 
cocci yellow no reaction 
AP120E Profile 
Antibiouram (Zones of inhibition m) OD: 0.254 
OTC OA SXT FIR 0129 P 
30 
_6 
24 6 R 6 
Minimum Inhibi ry Concentration (ppm) 
MIC OTC MIC O. A 
1.25 5 
strain: PL2 
Spec es: Sea bass 
Gram Oxidase Motility Colony Growth in T CBS-T O/F 
bacilli + + yeiiow yellow Fermentative 
AP120E Profile 
1047624 V. anguillarum 2 
Antiblogram (Zones of inhibition m) OD: 0.254 
OTC OA SXT FIR 0129 P 
43.74 43.72 43.78 42.06 
Minimum Inhibi ry Concentration (ppm) 
MIC OTC MIC 
Strain: PUý 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
bacilli + + 
-- yellow yellow 
Fennentative 
AP120E Profile 
3047524 V. anguillarum 
Antibiogram (Zones of inhibition m) OD: 0.256 
OTC OA SXT FIR 0129 P 
38.30 40.7 36.9 34.22 20.12 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC OA 
0.076 0.075 
Straln: PL4 I 
Spec es: Sea bass 
Gram Oxidase Motility I Colony_j Growth in TCBS O/F 
Bacilli I whitish yellow Fermentative 
AP120E Profile 
3047524 Vibrioanquillarumlb 
Antibiograrn (Zon s of inhibition mm) OD= 
OT&-- 0 SXT FR- d 0129 P 
35 36 35 33 28 6 
Minimum Inhibit ry Concentration (o m) 
MIC OTC M IC O. A 
0.3_ 0.15 
I Fish Farm 10 
Strain: AGR11 
Species: Sea bass 
Gram Oxidase Motility Colony FGrowth InTCBS OIF 
Bacilli + + yellow green Fermentative 
AP120E Profile 
0003004 (according to ALO test --- : V. ordalil) 
Antibiog am (Zones of Inhibition mm) OD=0.26 
OTC OA SXT FIR 0129 P 
34 6 38 23 R 38 
Minimum Inhibi ory Concentration (ppm) 
MIC OTC MICO. A 
0.625 40 
Strain: AGR21 
Species: Sea bass 
Gram Oxidase Motility I Colony Growth in O/F 
Bacilli + + yellow green Fennentative 
AP120E Profile 
0003004 (according to ALO test --- : V. ordalii) 
Antibiog am (Zones of inhibition mm) OD=0.258 
OTC OA SXT FIR 0129 P 
38 6 38 21 R 33 
Minimum Inhibi ory Concentration (ppm) 
MIC OTC MIC O. A 
0.075 40 
I Fish Farm 11 1 
I Strain: Petr2 1 
Spec es: Sea bass 
- Gram Oxldýase Motility Colony Growth inT CBS O/F 
Bacilli + + yellow Yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum 1 
Antibiogr m (Zones of inhibition mm) OD=0.265 
OTC OA SXT FIR 0129 P 
33.8 32.22 31.64 26.54 27.52 6 
Minimum Inhibi ry Concentration (ppm) 
MIC OTC MIC O. A 
0.3 0.075 
Strain: PetrTl 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS OlF 
Bacilli + + yellow Yellow Fermentative 
AP120E Profile 
1047524 V. anguillarurn 1b 
Antibiogr rn (Zones of inhibition mm) OD=0.249 
OTC OA SXT FIR 0129 P 
30.27 39.3 35.78 36.42 28.84 13.12 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MIC O. A_ 
0.625 0.3 
I Fish Farm 12 1 
Strain: Chiosl 
Sped s: Sea bass 
Gram Oxidas: e: ] Motility Colony Growth in TCBS O/F 
Bacilli + + yellow Yellow Fennentative 
AP120E Profile 
3047524 V. anguillarum I 
Antibiogram (Zones of inhibition mm) OD=0.21 
OTC OA SXT FIR 0129 p 
37 35 32 34 S 6 
Minimum Inhibit ry Concentration (ppm) 
Mic OTC MICO. A 
1.25 0.075 
I Fish Farm 13 
Strain: Nousl 
Species: Sea bass juvel! iles 
Gram Oxidasej Motility Colony Growth in Tý O/F 
+ + swarming Yellow Fermentative 
AP120E Profile 
4347525 V. alginolyticus 
Antibiogram (Zones of inhibition mm) OD=0.250 
OTC OA SXT FIR 0129 NV 
28 21.5 28 24 7 20 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC I MIC O. A I L 
0.3 1 0.3 1 1 
I Strain: Nous2l 
Spec es: Sea bass 
Gram Oxi ýase Motility Colony Growth in TCBS O/F 
Bacilli + + yellow Yellow Fennentative 
AP120E Profile 
4146525 V. alginolyticus 
Antiblograrn (Zones o inhibition mm) OD=0.253 
OTC OA SXT FIR 0129 NV 
32 28 30 25 7 14 
AMP 
6 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MIC O. AT I I 
0.3 0.3 1 L 
. -. 
I 
I Strain: Nous3l 
Species: Sea bass 
Gram Oxidase Motility I Colony Growth in TCBS 6/F 
Bacilli + +J 
_ 
swarming Yellow Fermentative 
AP120E Profile 
4146525 V. alginolyticus 
Antibiograrn (Zones o inhibition mm) OD=0.241 
OTC OA SXT FIR 01 2T NV 
29 19 25 20 6 13 
AMP 
11 
Minimum Inhibit ry Concentration (ppm) 
MICOTC =MICOA _ 
0.3 L_2.3 
Strain-Mous4l 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS OlF 
+ + swarming Yellow Fermentative 
AP120E Profile 
4114735 (ALO test: -+ +) 
Antibio r rn (Zones of inhibition m) OD=0.250 
OTC OA SXT FIR 0129 NV 
25 27 25 18 R 
Minimum Inhibit ry Concentration (ppm) 
Mic OTC MIC O. A 
0.3 0.3 
I Strain: Nou-s-51 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
Bacilli + + yellow Yellow 
AP120E Profile 
6144525 
Antibio r rn Zones of inhibition M) OD= 
OTC 
- -SXT 
FIR 0129 NV ý 
- Minimum Inhibit ry Concentration (ppm) 
M IC OTC M IC O. A 
0.3 0.625 
I-Stra in -Nous6 I 
Species: Sea bass 
Gram Oxidase Motility Growth in TCBS OlF 
short Bacilli + + Green 
AP120E Profile 
4146505 
Antibiograrn (Zones o f inhibition M) OD=0.250 
OTC OA SXT FIR 0129 NV 
26 18 24 19 R 10 
AMP NV 
6 10 
Minimum Inhibit ry Concentration (pg)m) 
M IC OTýa M IC OA 
1.25 1 5 
_L_ 
(, ýLO test -++& SAC -& TCBS: green = V. parahaemolyticus) 
--I Strain: Nous7 
Spec es: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
short bacilli + swarming 
_ AP120E Profile 
2004004 Pasteurella spp. 
Antiblogr rn (Zones of inhibition mm) OD=0.250 
OTC OA SXT 0129 NV 
6 
Minimum Inhibit ry Concentration (ppm 
MIC OTC MIC O. A 
20 1.25_ 
I Strain: Nous8l 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS OlF 
Bacilli + yellow 
AP120E Profile 
2004004 Pasteurella spp. 
Antibiogram (Zones o Inhibition mm) OD=0.253 
OTC OA SXT FIR 0129 NV 
8 10 40 30 6 10 
AMP 
38 
Minimum Inhibit ry Concentration (ppm) 
MICOTC MICOK E 
40 1.25 1 
I Fish Farm 14 
- --l Straln: Fidoll 
Species: Gilthead Sea beam juveniles 
- - Gram Oxii a se Motility Colony Growth in TCBS O/F 
short bacilli + + yellow Yellow Fermentative 
AP120E Profile 
4154525 
Antibloaram (Zones of inhibition m) OD=0.258 
OTC OA SXTý ýFR 0129 P 
28.83 19.52 24.21 1 19.29 15.16 6 
Minimum Inhibit ry Concentration (ppb) 
MIC OTC MIC OA 
0.3 0.625 
I( ALO test: - ++V. alginolyticus) 
I Strain: Fldo2 I 
Species: Gilthead Sea brea juveniles 
Gram Oxidase Motility =Colony Growth inTCBS O/F 
Long Bacilli + +I yeiiow Yellow Fermentative 
AP120E Profile 
0040777 
Antiblogr rn (Zones of inhibition M) OD=0.246 
OTC OA SXT FIR 0129 P 
29.25 24.03 28.81 23.61 
+ 
12.65 10.12 
Minimum Inhibito Concentration (Ppm) 
MIC OTC MIC ý I 
0.15 0.3 1 1 :d 
- --I Strain: Fiido3l 
Species: Gilthead Sea br2a juveniles 
Gram Oxidase I Motility ColonyJ Growth in TCBS O/F 
Bacilli + yellow Yellow Fermentative 
AP120E Profile 
5144565 
Antibiogram (Zones of inhibition M) OD=0.258 
OTC OA SXT FIR 0129 NV 
27.5E 27.4 1 20.88 15.16 6 
Minimum Inhibitory Concentration (ppm) 
MICOjTc--J MICOA I 
31 
I 
-Rfrqin-Fido4 
I 
S ecies: Gilthead Sea brearn juveniles 
Gram OExidase Motility Colon r. rt%vArfh I OIF 
Bacillai + + Tnenýtafive 
AP120E Profile 
5046305 
Antibiograrn (Zones of inhibition m --- [-OD=0.250 
OTC OA SXT FIR 0129 NV 
7 16 R 17 R R 
Minimum Inhibitory Concentration (ppml 
mIC OTC - j-MIC OA I 
40 1 0.3 1 
I Fish Farm 15 
Strain. -Praoll 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS 
bacilli + + yellow Yellow Fermentative_ 
AP120E Profile 
1047524 V. anguillarum 2 
Antibiog m (Zones of inhibition mm) OD=0.246 
OTC OA SXT FIR 0129 P 
34 33 28 S 7 
Minimum Inhibitory Concentration (ppm) 
MIC OTCý MIC O. A 
0.15 1 0.075 
I Strain: Prai)2 I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS OlF 
Bacilli + yellow green Fennentauve 
_ AP120E Profile 
4046105 V. parahaemolyticus 95.5% 
Antibiog m (Zones of inhibition mm) OD=0.252 
OTC OA SXT FIR 0129 P 
26 18 24 16 R 6 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MIC OA 
1.25 
I 
-qfr: iin-Pran3 
I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
Bacilli + + yellow Yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum Ib 
Antibiog m (Zones of inhibition mm) OD=0.26 
O-TC OA SXT FIR 0129 P 
35 31 31 26 R 6 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC OA 
1.25 1.25 
I QfrminoPrnnA 
Species: Sea bass 
Gram 0 iKa: s, e ý Motility Colony Growt'h in TCBS O/F 
Bacilli + + yellow yellow 
AP120E Profile 
3047524 V. anguillarum I b, 
Antibiogr m (Zones of inhibition mm) OD=0.254 
5-T-C OA SXT FIR 0129 NV 
j-8- 
__ 
L_33.5 29 27 22 20.5 
Minimum Inhibit ry Concentration ppm) 
MIC OTC MIC O. A 
2e5 0.15 
-1 
I Qfrtain-Pr-nn-ril 
Species: sea bass 
Gram Oxidase Motility Colony =Gro=wth inTCBS O/F 
Bacilli + + yellow Yellow Fermentative 
AP120E Profile 
3047524 V. anguillarurn 1b 
Antibioar m (Zones of inhibition m) OD=0.240 
OTC OA SXT FIR 0129 NV 
38 35 32 29 22 19 
AMP 
8 
Minimum Inhibitory Concentration_(ppm) 
MICOT-C l MICO. A 
0.3 1 0.075 
I Fish Farm 16 1 
I Strain: Evrl I 
Species: Sea bass 
Gram Oxidase Motilit Colony Growth In TCBS OIF 
cocci hitish 
AP120E Profile 
Antiblograrn (Zones of inhibition M) OD=0.25 
OTC OA SXT FIR 0129 p 
36 6 35 26 R 28 
Minimum Inhi itory Concentration 
MIC OTC MICO. A 
0.625 5 
I Fish Farm 17 
Strain: Oceani 
Species: Sea bass 
Gram Oxi Motility Colony Growth in ýTCBSý O/F 
bacilli + + brownpigment Yellow Fennentative 
AP120E Profile 
4144525 
Antibiog ram (Zones of inhibition rn OD=0.258 
OTC OA SXT FIR 0129 AMP 
26 18 26 24 R 6 
NV 
R 
Minimum Inhib itory Concentra tion (ppm) 
MIC OTC MIC O. A 
0.3 0.625 
Strain: Ocean2 
Species: sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
Bacilli + + yellow Green Fennentative 
AP120E Profile 
5046105 V. Vulnificus 
Antibioc iram (Zones of inhibition m OD=0.257 
OTC OA SXT FIR 0129 AM P 
28 16 25 24 R R 
NV 
R 
Minimum Inhib itory Concentration (ppm) 
MIC OTC-] MIC O. A 
1.25 0.3 
Strain: Ocean37 
Spe les: sea bass 
Gram Oxidase_ l Motility Colony Growth in TCBS O/F 
coccobacilli + + swarming vellow Fermentative 
AP120E Profile 
4047125 V. alginolyticus 
Antibio. ram (Zones of inhibition m Dlo tl OD=0.250 
OTC 
A 
SXT OA FIR 0129 NV 
22 15 
21 9 R 11 
Minimum Inhibitory Concentration M) 
MIC OTC MIC OA 
0.625 0.625 
I Fish Farm 18 1 
I Strain: Zantl I 
Species: Gilhead Sea brearn 
Gram Oxidase Motiiýýd Colony I Growth in TCBS =01F 
bacilli yellow green Fermentative 
AP120E Profile 
7005100 
Antibiogram (Zones o f inhibition m) OD=0.255 
OTC OA SXT FIR 0129 p 
28 33 18 24 12 
NV 
8.5 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC OA 
0.3 0.075 
I Strain: Zant2j 
Species: Gilhead Sea bream 
Gram OFxIdase Motility I Colony I Growth in TCBS [ O/F 
Bacilli + ---- I whit. yellow Yellow Fermentafive 
AP120E Profile 
1004124 Pasteurella spp. 
Antibiogram (Zones of inhibition m) OD= 
OTC OA SXT FIR 0129 P 
30 18 36 22 23 
AMP NV 
13 12 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MICOA 
1.25 0.625 
I Strain: Zant3 I 
Species: Gilhead Sea bream 
Gr dase I Motility I Colony I Growth in TCBS O/F 
Bacilli I+ I+I yeiiow 
- 
I yellow Fermentauve 
AP120E Profile 
0004125 V. ordalii 
Antibiogram (Zones of inhibition m) OD= 
OTC OA SXT FIR 0129 p 
40 46 S 32 36 8 
AM P NV 
15 20 
Minimum Inhibitory Concentration h3pm) 
MIC OTC MIC OA 
0.3 0.075 
strain: zanti 
Species: Gilhead Sea bream 
Gram Oxidase , Motility Colony Growth in TCBS O/F 
Yellow Fermentative 
AP120E Profile 
0004000 
Antibiogram (Zones o f inhibition m) OD=0.250 
OTC OA SXT FIR 0129 AMP 
R R R R R R 
NV 
R 
Minimum Inhibito Concentration (ppm) 
M IC OTC M IC OA 
5 80 
I Fish Farm 19 
I Strain: Lerl I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth inTCBS O/F 
bacilli + + yellow Yellow Fermentative 
AP120E Profile 
1047524 V. anguillarum 2 
Antibiociram (Zones of inhibition m) OD=0.258 
OTC OA SXT FIR 0129 p 
31.12 30.72 31.92 29.22 26.54 6 
Minimum Inhibi ry Concentration (ppm) 
MIC OTC MIC O. A 
0.3 0.075 
I Fish Farm 20 1 
I Strain: Myti I 
Species: sea bass 
- - Gram ýOx lid ase Motility Colony Growth in TCBS O/F 
+ + yellow Yellow Fermentative 
AP120E Profile 
3047524 V. anguillaruml 
Antibiogram (Zones o f inhibition M) OD=0.253 
OTC OA SXT FIR 0129 p 
30 26 21 6 6 
AMP NV 
6 12 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MICOA 
0.075 0.075 
I Fish Farm 21 -1 
I Strain: Makrl I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
Bacilli + weak yellow Fermentauve 
AP120E Profile 
1003004 
Antibiogr rn (Zones of inhibition m) OD=0.256 
OTC OA SXT FIR 0129 p 
18.05 27.1 42 28 16 S 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC O. A 
5 0.3 
Strain: Makr2l 
Species: Sea bass 
Gram Oxidase, Motility Colony Growth in TCBS O/F 
bacilli + + yellow yellow Fermentafive 
AP120E Profile 
3047524 V. anguillaruml 
Antibiogram (Zones of inhibition m) OD=0.252 
OTC OA ST FIR 0129 p 
30 32 31.5 32_ 28 6 
Minimum Inhibitory Concentration (13g)m) 
MIC OýTc MIC O. A 
0.3 0.075 
I Strain: Makr3 I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TC O/F 
short bacilli + +- yellow Fermentative 
AP120E Profile 
3042524 
Antiblogram (Zon s of inhibition M) 13=0.252 
OTC OA SXT FIR 0129 p 
25.7 37.42 31.87 32.6 R 9.40 
Minimum Inhibitory Concentration (ppm) 
MIC anc I MIC O. A 
0.3 1 0.075 
Strain: Makr74 
Species: Sea bass 
Gram Oxi e Motility Colony I Growth in TCBS OlF 
bacilli + weak yellow yellow 
AP120E Profile 
3047524 V. anguillarum I (Leuven) 
Antibioar m (Zon s of inhibition m) OD=0.250 
OTC OA SXT FIR 0129 P 
17.5 30 42 32 18 S 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC O. A 
0.625 0.075 
IS tra 1 n: M 
Species: Sea bass 
Gram Oxidase Motility Colony I Growth in TCBS O/F 
+ + yellow yellow Fermentafive 
AP120E Profile 
3047524 V. anguillarum 1 
Antibioaram (Zones of inhibition m) 013: 0.247 
OTC OA SXT FIR 0129 NV 
37 38.5 32 33 28 23 
p 
6 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIO. A 
0.625 0.075 
I Strain: Makr6l 
Species: Sea bass juve iles 
Gram= Oxidase Motility Colony Growth in TCBS O/F 
+ + yellow yellow Fermentatve 
AP120E Profile 
3047524 V. anguillarum 1b 
Antibiogram (Zones o f inhibition M) OD: 0.254 
OTC OA SXT FR 0/129 p 
33 34 33.5 33 26 7 
NV 
24 
Minimum InhibitoEy Conce tion (ppm) 
MIC OTC MICO. A 
0.625 0.075 
--l Strain: Makr7 
Species: Gilthead Sea brea juveniles 
Gram Oxidase Motility Colony Growth in TCBS OF 
bacilli + + yellow Green Fermentative 
AP120E Profile 
6005004 99.5% V. damsela 
Antibioararn (Zones of inhibition m) 
- 
OD=0.250 
OTC OA SXT T FR 0129 P 
26 30 25 22.5 24 6 
Minimum Inhibito Concentration (ppm) 
M ic OTC 
_MIC 
O. A 
0.3 0.075 
I Strain-Makr8l 
Species: Sea bass (400g) 
Gram Oxidase I Motility Colony- 1 Growth in TCBS OlF 
short bacilli + + yellow yellow Fermentafive 
AP120E Profile 
3047524 V. anguillarum 1 
Antibioar m (Zones of inhibition m) OD: 0.228 
OTC OA SXT FIR 0129 NV 
34.34 35.26 34.16 36.18 29.12 6 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MICO. A 
0.625 0.075 
I Strain: MakrIO I 
Species: Sea bass 
Grarn Oxidase Motility Colony Growth En =TcBs O/F 
+ + yellow yellow Fermentauve 
AP120E Profile 
3047524 V. anguillarum Ib 
Antiblogram (Zones of inhibition m) OD: 0.247 
OTC- I OA SXT FR_ 0/129 NV 
33 1 36 30 30 26 23 
Minimum Inhibitory Concentration (ppm) 
MIC 6T--C MIC O. A I 
0.075 0.075 1 
I Fish Farm 22 
I Strain: Kantl I 
Species: Sea bass juveniles 
Gram Oxi ýase Motility Colony Growth in TC=BS ý/F 
Bacilli + + WhiUSh Sficky 
AP120E Profile 
1003004 
Antibiogram (Zones of inhibition mm) OD=0.248 
OTC OA SXT FIR 0129 p 
22.9 23.48 41.94 32.32 11.7 45.5 
Minimum Inhibito Concentration (ppm) 
MIC OTC MIC O. A 
1.25 0.3 
I Strain: Kan-t-21 
Species: Sea bass juveniles 
Gram Oxi se Motility Colony Growth in Tý O/F 
bacilli + + yellow 
AP120E Profile 
1007004 
Antibiogram (Zones of inhibition mm) 013=0.2.59. 
OTC OA SXT FIR 0129 p 
19.46 30.94.. 46 30.78 16.7 
Minimum Inhibitory Concentration (ppm) 
M IC OTC MIC O. A 
2.5 0.15 
I Strain: Kan-t-31 
Species: Sea bass juve iles 
Gram Oxidase Motility Colony Growth in TCBS O/F 
bacilli + + yellow 
AP120E Profile 
3003004 
Antibiograrn (Zones of inhibition mm) OD=0.254 
OTC OA SXT FIR 0129 P 
16.93 6 35.54 11.4 R 44 
Minimum Inhibito Concentration (ppm) 
MIC OTC MIC O. A 
0.625 10 
Strain: Kant4lý 
Species: Sea bass 
Gram Oxi motility Growth inTCBS O/F 
thin bacilli + + yellow 
AP120E Profile 
0000004 
Antiblogram (Zones of inhibition mm) OD=0.242 
OTC OA SXT FR 0129 P 
33.28 38.78 27 6 6 
Minimum Inhibito Concentration (ppm) 
MIC OTC MIC O. A 
1.25 80 
--: I Strain: Kant5) 
Species: Sea bass 
- --- Gram Oxi Motility Colo n ] Growth in TCBS O/F 
+ + yellow yeflo Fermentative 
AP120E Profile 
4146525 V. alginolyticus 
Antibiogram (Zones o inhibition mm) OD: 
OTC OA SXT FIR 0129 NV 
28 24 25 20 6 22 
p 
6 
Minimum Inhibito Conc entration (ppm) 
M IC OTC M IC O. A 
0.3 0.625 
I Strain: Kant6l 
Specie Sea bass 
Gram Oxidase I Motility Colony J_Growth InTCBS OF 
+ 
--- 
I+ L Yellow I yellow Fermentauve 
AP120E Profile 
4366525 
Antibiogram (Zones of inhibition mm) OD: 0.240 
OTC OA SXT 1 0/129 P 
34.88 10.84 29.44 27.45 8 6 
Minimum Inhibito Concentration (ppm) 
MIC OTý MIC O. A 
0.15 1 0.3 
I Straln: Kant7 I 
S ecles: 
Gram Oxi ýase Motility Colony Growth in TCBS O/F 
bacilli + + yeilow yell Fermentatve 
AP120E Profile 
4144525 
Antibiogram (Zones ofinhibition mm) OD=O. 56 
OTC OA SXT FIR 0129 p 
31.18 23.78 28.39 23.21 16.66 6 
Minimum Inhibitory Concentration (ppm) 
MIC OTC MIC O. A 
0.3 0.625 
Strain: Kant8', ý 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
bacilli + + yellow yello Fermentative 
AP120E Profile 
3047524 V. anguillarum 1 
Antiblogr m (Zones of inhibition m) 013: 0.255 
OTC OA SXT FIR 0129 p 
36.4 34.22 30.28 32.05 31.59 6 
Minimum Inhibito Concentration (ppm) 
MIC OTC MIC O. A 
0.3 0.3 
I Strain: Kant9 1 
Species: Sea bass 
Gram Oxidase I MotilitjE: [ Colony Growth in TCBS O/F 
+ + t yeiiow yello Fermentauve 
AP120E Profile 
3047524 V. anguillarum 1 
Antibiogram (Zones of inhibition m) 013: 0.243 
OTC 7 OA SXT FR 0/129 p 
35.83 1 32.94 32.11 28.5 26.73 6 
Minimum Inhibito Concentration (ppm) 
MIC OTC -4 MýC 
0.3 _ 0.15 
Strain: KantIO7 
Species: sea bass 
Gram Oxidase: j Motility Colony Growth in TCBS 0/ 1F 
cocci yellow Yellow Fermenta-five 
AP120E Profile 
Antibiograrn (Zones of inhibition M) OD=0.248 
OTC OA SXT FIR 0129 P 
21.73 10.72 6 13.1 16. H7- 
Minimum Inhibito Concentration (ppm) 
MIC OTC MIC O. A 
0.625 5 
Strain: Kantil-I 
Species: sea bass 
Gram Oxi ýase Motility Colony Growth inTCBS O/F 
cocci Yellow Yellow (weak) 
AP120E Profile 
Antibiogr m (Zones of inhibition mm) OD=0.259 
OTC OA SXT FIR 0129 P 
30.12 6 36.46 6 6 
Minimum Inhibito Concentration (ppm) 
MIC OTC M IC O. A L 
20 80 1 
I Strain: Kantl-2-1 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
bacilli + yellow Yellow Fermentafive 
AP120E Profile 
3047524 V. anguillaruml 
_ Antiblogr m (Zones of inhibition mm) OD=0.2r-3 
OTC OA SXT 0129 P 
34.54 35. 27.58 
Minimum Inhibitory Concentration (ppm) 
M IC OTý M IC O. A 
0.625 1 0.15 
Strain: Kantl3 
Species: sea bass 
Gram =0x=idase Motility Colony Growth in TCBS O/F 
cocci + Orange 
AP120E Profile 
Antiblogram (Zones of inhibition mm) OD: 
OTC OA SXT FIR 0129 P 
33.38 28.16 39.82 22.90 28.77 10 
Minimum lnhibitoýy Concentration (ppm) 
MIC OTC MIC OA - ----- 
0.3 0.3 
Strain: Kantl4l 
Species: Sea bass 
Gram Oxidase Motility Colony Growth in TCBS O/F 
+ + yellow yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum I 
Antibiogram (Zones of Inhibition M) 013: 0.28 
OTC OA SXT FIR 0/129 p 
36.58 38.57 31.85 25.19 
Minimum Inhibito Concentration (ppm) 
MIC OTC MICO. A 
2.5 10 
I Strain: Kantl5 I 
Species: Sea bass 
Gram Oxidase Motility Colony Growth In TCBS O/F 
short bacilli + + yellow yellow Fermentative 
AP120E Profile 
3047524 V. anguillarum 1 
Antiblogram (Zones of inhibition mm) OD=0.242 
OTC OA SXT FIR 0129 p 
34.98 34.84 33.12 31.94 27.04 6 
Minimum Inhibito y Concentration (ppm) 
MIC OT&-] MIC O. A 
0.3 1 0.07 
1 Strain: Kant16 I 
Specie : Sea bass 
1 Gram Oxýidase Motility Colony Growth in TCBS 0/ F 
COCCi + + Yel. varm. yell Fermentative 
AP120E Profile 
4174525 
Antibiograrn (Zones of inhibition mm) OD: 0.253 
OTC OA SXT FIR 0129 P 
21 8 13 9 6 6 
AMP 
6 
Minimum Inhibitory Concentr tion (ppm) 
MIC OTC MIC O. A] 
_ 0.3 0.625 1 
Strain- Kantl7l 
Specie Sea bass 
Gram OxI=dase Motility Colony Growth in TCBS OF 
bacilli + + yeiiow yellow 
AN 20E profile 
1003004 
ntibiogram (Zones of inhibition mm) OD: 0.257 
OTC OA SXT FIR 0/129 P 
5 34 46 26 20 
AMP NV 
6 24 
Minimum Inhibito Concentration (ppm) 
M ic OTC 
10 T --P. l 5 
I qtrnin- Knnt-19ý1 
Specie Sea bass 
Gram oxidase I Motility Colony Growth in TCBS 61F 
bacilli + small white yello Fermentative 
AP120E Profile 
4144525 
Antibilo, rm (Zones o 10 Ea inhibition m) OD: 0.254 
OTC OA SXT FIR 0/129 P 
38 26 36 33 31 25 
AMP NV 
26 22 
Minimum Inhibitor Concentration (ppm) 
M IC OT ýA 
+ ýýIý 0 
0.625 1 5 0.625 
-j 
I Fish Farm 23 
Strain: Varniill 
Species: Sea brearn 
Gram Oxidase Motility C lony Growth in TCBS O/F 
+ + yellow Yellow Fermentauve 
AP120E Profile 
2005024 Pasteurella spp. 
Antibiogram (Zones of i nhibition m OD=0.251 
OTC OA SXT FR 0129 p 
28 27 S 27 10 24 
AMP NV 
34 S 
Minimum Inhibito Concentration ppm) 
MICOTC-1 MICO. A 
2.5 1 0.3 
I Fish Farm 24 
LS t r-a in "-*. A q H-1 I 
Species: Gilhead Sea brearn juveniles 
Gram Oxidase Motility Colony Growth in TCBS OIF 
bacilli + + egg like yellow Fermentative 
AP120E Profile 
4146525 V. alginolyticus 
Antibiogram (Zones f inhibition mm) OD=0.260 
OTC OA SXT FIR 0129 P 
24 12 19 8 6 6 
AMP 
6 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MICOA 
0.6 0.6 
Strain: AqH21 
Species: Gilhead Sea brea juveniles 
Gram Oxidase Motility Colony Growth in TCBS O/F 
Bacilli + + creamy Yellow Fermentauve 
AP120E Profile 
6544164 
Antibiogram (Zones f inhibition mm) OD=O. i53 
OTC OA SXT FIR 0129 P 
6 30 6 22 6 8 
AMP NV 
18 8 
Minimum Inhibit ry Concentration (ppm) 
MIC OTC MICOA 
80 0.6 
Strain: AqH31 
. 
Species: Gilhead Sea bream 
Gram Oxidase I Motility Colony Growth in TCBS 0F 
Bacilli + yeiiow yel ow Fermentative 
AP120E Profile 
5446025 
Antibiogram (Zones f inhibition mm) OD= 
OTC OA SXT FIR 0129 P 
24 15 20 20 12 6 
AMP 
6 
Minimum Inhibit ry Concentration m 
MIC OTC I MICOAT 
0.6 L_ý. 6 
_ 
L 
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